variant_id	variant_civic_url	gene	entrez_id	variant	summary	variant_groups	chromosome	start	stop	reference_bases	variant_bases	representative_transcript	ensembl_version	reference_build	chromosome2	start2	stop2	representative_transcript2	variant_types	hgvs_expressions	last_review_date
1	https://civic.genome.wustl.edu/links/variants/1	ABL1	25	BCR-ABL	The BCR-ABL fusion protein, commonly referred to as the Philadelphia chromosome, is one of the most studied fusion genes in cancer. It has widely been considered the initiating event in chronic myelogenous leukemia (CML). However, despite its ability to initiate disease in mice, its status as an initiating mutation is in dispute. In what is commonly used as the poster-child for targeted therapeutics, the development and use of imatinib in the clinic has led to profound improvements in the prognosis of the disease. However, imatinib resistance is still seen in patients with mutations in the ABL kinase domain of the fusion, most notably the T315I variant. In patients resistant to imatinib, either acquired or otherwise, second generation BCR-ABL TKI's (dasatinib and nilotinib) have seen some success in delivering a tumor response. Third generation ABL1 inhibitor ponatinib is the only FDA approved drug with activity against T315I . However due to risk of life-threatening blood clots and severe narrowing of blood vessels ponatinib is ONLY approved for T315I-positive CML or T315I-positive Ph+ ALL or in cases of CML, Ph+ ALL with resistance or intolerance to other approved ABL1 inhibitors.		22	23522397	23632600			ENST00000305877.8	75	GRCh37	9	133729451	133763063	ENST00000318560.5	transcript_fusion		2017-11-28 15:21:25 UTC
2	https://civic.genome.wustl.edu/links/variants/2	ABL1	25	BCR-ABL T334I	While the efficacy of imatinib has revolutionized chronic myelogenous leukemia (CML) treatment, it is still not a cure-all. Both initial resistance and acquired resistance as a result of selection have been seen in a small subset of CML patients. The ABL kinase domain mutation T315I (aka T334I) has been shown to be one such mutation that confers resistance to imatinib. Second generation TKI's (dasatinib and ponatinib) specific to BCR-ABL have shown efficacy in treating resistant cases.	Imatinib Resistance	9	133748283	133748283	C	T	ENST00000372348.2	75	GRCh37					transcript_fusion,missense_variant	NM_007313.2:c.1001C>T,NP_005148.2:p.Thr315Ile,ENST00000372348.2:c.1001C>T,NC_000009.11:g.133748283C>T	2017-11-22 19:45:52 UTC
3	https://civic.genome.wustl.edu/links/variants/3	ABL1	25	BCR-ABL E255K	While the efficacy of imatinib has revolutionized chronic myelogenous leukemia (CML) treatment, it is still not a cure-all. Both initial resistance and acquired resistance as a result of selection have been seen in a small subset of CML patients. The ABL kinase domain mutation E255K has been shown to be one such mutation that confers resistance to imatinib. Second generation TKI's (dasatinib and nilotinib) specific to BCR-ABL have shown efficacy in treating resistant cases.	Imatinib Resistance	9	133738363	133738363	G	A	ENST00000318560.5	75	GRCh37					transcript_fusion,missense_variant	NC_000009.11:g.133738363G>A,NM_005157.5:c.763G>A,NP_005148.2:p.Glu255Lys,ENST00000318560.5:c.763G>A	2017-11-22 19:45:46 UTC
4	https://civic.genome.wustl.edu/links/variants/4	AKT1	207	E17K	AKT1 E17K is a recurrent mutation that has been observed in breast, colorectal, lung, and ovarian cancer. It has been convincingly shown to be an activating mutation resulting in PI3K/AKT/mTOR pathway activity. It has been suggested that this mutation decreases the cell's sensitivity to AKT1 allosteric kinase inhibitors. This, and other AKT1 mutations, are the subject of much research and development for therapeutics.		14	105246551	105246551	C	T	ENST00000407796.2	75	GRCh37					missense_variant	NC_000014.8:g.105246551C>T,NM_001014432.1:c.49G>A,NP_001014432.1:p.Glu17Lys,ENST00000407796.2:c.49G>A	2017-11-22 19:45:49 UTC
5	https://civic.genome.wustl.edu/links/variants/5	ALK	238	EML4-ALK	The EML4-ALK fusion variant 1 consisting of ALK kinase domain (exons 20-29) fused to EML4 exons 1-13 is the most common EML4-ALK variant, and was discovered in non-small cell lung cancer. Multiple EML4 breakpoint shave been described with differential sensitivity to inhibitors with variant 1 showing greater sensitivity than 3a in cell lines. EML4-ALK is crizotinib sensitive; however, several mutations that confer resistance mutations have been described in case studies. In the only clinical trial for crizotinib that included determination of EML4-ALK variant type in a subset of its participants, a very high response rate was observed, although the numbers were insufficient to validate correlation of variant type to outcome. Preclinical studies with this variant have indicated sensitivity to Hsp90 inhibitors.	ALK Fusions	2	42396490	42522656			ENST00000318522.5	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2017-11-22 19:45:53 UTC
6	https://civic.genome.wustl.edu/links/variants/6	ALK	238	EML4-ALK C1156Y	In patients with non-small cell lung cancer exhibiting EML4-ALK fusion, C1156Y has been shown to confer resistance to crizotinib. Case reports indicate that secondary mutations can modulate drug sensitivity. EML4-ALK C1156Y/L1196M maintained crizotinib resistance while the lorlatinib resistant combination EML4-ALK C1156Y/L1198F re-sensitized the tumor to crizotinib treatment.	ALK Fusions,Crizotinib Resistance	2	29445258	29445258	C	T	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	ENST00000389048.3:c.3467G>A,NC_000002.11:g.29445258C>T,NM_004304.4:c.3467G>A,NP_004295.2:p.Cys1156Tyr	2017-11-22 19:45:46 UTC
7	https://civic.genome.wustl.edu/links/variants/7	ALK	238	EML4-ALK L1196M	In patients with non-small cell lung cancer exhibiting EML4-ALK fusion, L1196M has been shown to confer resistance to crizotinib. This was also true in a patient with both EML4-ALK C1156Y & L1196M.	ALK Fusions,Crizotinib Resistance	2	29443631	29443631	G	T	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	ENST00000389048.3:c.3586C>A,NC_000002.11:g.29443631G>T,NM_004304.4:c.3586C>A,NP_004295.2:p.Leu1196Met	2017-11-22 19:45:46 UTC
8	https://civic.genome.wustl.edu/links/variants/8	ALK	238	F1174L	ALK F1174L has been observed as recurrent in neuroblastoma, non-small cell lung cancer (NSCLC), and other cancer types. Neuroblastoma cells containing this mutation have shown resistance to low doses of criztonib. However, increased dosage can overcome this resistance in cell lines studies. TAE684 has also proven effective in both NSCLC and neuroblastoma F1174L containing cells.	Crizotinib Resistance	2	29443695	29443695	G	T	ENST00000389048.3	75	GRCh37					missense_variant	NM_004304.4:c.3522C>A,NP_004295.2:p.Phe1174Leu,NC_000002.11:g.29443695G>T,ENST00000389048.3:c.3522C>A	2017-11-22 19:45:48 UTC
9	https://civic.genome.wustl.edu/links/variants/9	ALK	238	R1275Q	ALK R1275Q has been observed as a recurrent mutation in  neuroblastoma, non-small cell lung cancer (NSCLC), as well as other cancer types. Neuroblastoma cells with this mutation have shown sensitivity to the ALK-inhibitor TAE684. This and the geldanamycin deriviative 17-DMAG have been shown to be effective in NSCLC cell lines.		2	29432664	29432664	C	T	ENST00000389048.3	75	GRCh37					missense_variant	NM_004304.4:c.3824G>A,NP_004295.2:p.Arg1275Gln,NC_000002.11:g.29432664C>T,ENST00000389048.3:c.3824G>A	2017-11-22 19:45:51 UTC
10	https://civic.genome.wustl.edu/links/variants/10	ARAF	369	S214C	ARAF S214C has been found to be a recurrent oncogenic mutation in non-small cell lung cancer. It has been shown to confer sensitivity to sorafenib and trametenib in cell lines. In a case study of advanced stage lung adenocarcinoma harboring this mutation, sorafenib also acheived near-complete clinical remission. This case has brought more interest to the variant from a research and clinical perspective.		X	47426121	47426121	C	G	ENST00000377045.4	75	GRCh37					missense_variant	NC_000023.10:g.47426121C>G,NM_001654.4:c.641C>G,NP_001645.1:p.Ser214Cys,ENST00000377045.4:c.641C>G	2017-11-22 19:45:48 UTC
11	https://civic.genome.wustl.edu/links/variants/11	BRAF	673	V600D	Patients harboring mutations in valine 600 residue of BRAF have been shown to be sensitive to dabrafenib. For more information on the V600 locus, see the V600E entry.	Other V600's	7	140453135	140453136	CA	TA	ENST00000288602.6	75	GRCh37					missense_variant	NC_000007.13:g.140453135_140453136delinsAT,NM_004333.4:c.1799_1800delTGinsAT,NP_004324.2:p.Val600Asp,ENST00000288602.6:c.1799_1800delTGinsAT,NC_000007.13:g.140453135_140453136delinsTA	2017-11-22 19:46:01 UTC
12	https://civic.genome.wustl.edu/links/variants/12	BRAF	673	V600E	BRAF V600E has been shown to be recurrent in many cancer types. It is one of the most widely studied variants in cancer. This variant is correlated with poor prognosis in certain cancer types, including colorectal cancer and papillary thyroid cancer. The targeted therapeutic dabrafenib has been shown to be effective in clinical trials with an array of BRAF mutations and cancer types. Dabrafenib has also shown to be effective when combined with the MEK inhibitor trametinib in colorectal cancer and melanoma. However, in patients with TP53, CDKN2A and KRAS mutations, dabrafenib resistance has been reported. Ipilimumab, regorafenib, vemurafenib, and a number of combination therapies have been successful in treating V600E mutations. However, cetuximab and panitumumab have been largely shown to be ineffective without supplementary treatment.		7	140453136	140453136	A	T	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1799T>A,NP_004324.2:p.Val600Glu,NC_000007.13:g.140453136A>T,ENST00000288602.6:c.1799T>A	2017-11-22 19:45:50 UTC
13	https://civic.genome.wustl.edu/links/variants/13	BRAF	673	V600E+V600M	A case study of a single patient harboring both a V600E and a V600M mutation, dabrafenib was shown to acheive clinical response.	Other V600's	7	140453135	140453137			ENST00000288602.6	75	GRCh37					missense_variant		2017-11-22 19:45:46 UTC
14	https://civic.genome.wustl.edu/links/variants/14	BRAF	673	V600E AMPLIFICATION	Amplification of BRAF V600E has been shown to confer resistance to MEK inhibitors. For more information on the V600 locus, see the V600E entry.		7	140434279	140624564			ENST00000288602.6	75	GRCh37					transcript_amplification,missense_variant		2017-11-22 19:45:46 UTC
17	https://civic.genome.wustl.edu/links/variants/17	BRAF	673	V600	BRAF mutations of the valine 600 residue have been shown to be recurrent in many cancer types. Of the V600 mutations, V600E is the most widely researched. V600 mutations as a whole have been correlated to poorer prognosis in colorectal and papilarry thyroid cancers. V600 mutations have also been shown to confer sensitivity to the BRAF inhibitor dabrafenib. For a more detailed summary, click the individual mutations.	Other V600's	7	140453136	140453137			ENST00000288602.6	75	GRCh37					protein_altering_variant		2017-11-22 19:46:07 UTC
18	https://civic.genome.wustl.edu/links/variants/18	CCND1	595	AMPLIFICATION	CCND1 amplification has been implicated in poorer prognosis in non-small cell lung cancer.		11	69455855	69469242			ENST00000227507.2	75	GRCh37					transcript_amplification		2017-11-22 19:45:46 UTC
19	https://civic.genome.wustl.edu/links/variants/19	CCND1	595	EXPRESSION	CCND1 expression, and its prognositc impact, is still in dispute. Three experiments in non-small cell lung cancer have shown it to have no impact on survival, but three additional studies have shown it results in poorer prognosis. There is also some ambiguity in how the boundaries between expression and overexpression are defined.		11	69455855	69469242			ENST00000227507.2	75	GRCh37					N/A		2017-11-22 19:45:46 UTC
20	https://civic.genome.wustl.edu/links/variants/20	CCND1	595	OVEREXPRESSION	Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are misregulated are widely variable, and range from genomic amplification to promoter methylation changes. While Cyclin D2 has only been found to be significantly misregulated in glioma, Cyclin D1 in particular seems to be a pan-cancer actor. Cyclin D misregulation has been shown to lead to poorer outcomes in a number of studies, and currently there are no FDA-approved targeted therapies.		11	69455855	69469242			ENST00000227507.2	75	GRCh37					N/A		2017-11-22 19:45:46 UTC
21	https://civic.genome.wustl.edu/links/variants/21	CCND2	894	OVEREXPRESSION	Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are misregulated are widely variable, and range from genomic amplification to promoter methylation changes. While Cyclin D2 has only been found to be significantly misregulated in glioma, Cyclin D1 in particular seems to be a pan-cancer actor. Cyclin D misregulation has been shown to lead to poorer outcomes in a number of studies, and currently there are no FDA-approved targeted therapies.		12	4382938	4414516			ENST00000261254.3	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
22	https://civic.genome.wustl.edu/links/variants/22	CCND2	894	PROMOTER DEMETHYLATION	Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are misregulated are widely variable, and range from genomic amplification to promoter methylation changes. While Cyclin D2 has only been found to be significantly misregulated in glioma, Cyclin D1 in particular seems to be a pan-cancer actor. Cyclin D misregulation has been shown to lead to poorer outcomes in a number of studies, and currently there are no FDA-approved targeted therapies.		12	4381437	4382937			ENST00000261254.3	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
23	https://civic.genome.wustl.edu/links/variants/23	CCND3	896	LOSS	Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are deregulated are widely variable, and range from genomic amplification to promoter methylation changes. Cyclin D3 loss has been reported in T-cell acute lymphoblastic leukemia (T-ALL), a seemingly unique trend when compared to the amplifcations and overexpressions of the other cyclin D's. Treating cyclin D3 knockout mice with the targeted therapeutic palbociclib significantly increased the median survival of a Notch-driven model of T-ALL.		6	41902671	41909586			ENST00000372991.4	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:46 UTC
24	https://civic.genome.wustl.edu/links/variants/24	CCNE1	898	OVEREXPRESSION	Cyclin E, while currenly not as widely implicated as its counterpart, cyclin D, has been implicated in various carcinomas, including breast, gastric, stomach and colorectal. High levels of cyclin E, either by gene amplification or overexpression, are correlated with later stage disease and have been shown to lead to poorer prognosis in gastic carcinoma. It has also been shown, in lung cancer specifically, that neoplastic cells with higher levels of the cyclin E/CDK2 complex are more radiosensitive than their lowly expressed counterparts.		19	30302805	30315215			ENST00000262643.3	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
25	https://civic.genome.wustl.edu/links/variants/25	CDK4	1019	EXPRESSION	CDK4, along with its partner CDK6, are key players in cell cycle progression. The complex has been implicated in a number of cancer types, and is the focus of therapeutic research and development. One targeted therapy for CDK inhibition is palbociclib, which may slow the growth of advanced stage breast cancers. It has also been shown, in mouse, that CDK inhibition may sensitize mutant PIK3CA tumors to PI3K inhibitors.		12	58141510	58146304			ENST00000257904.6	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
27	https://civic.genome.wustl.edu/links/variants/27	CDKN2A	1029	PROMOTER HYPERMETHYLATION	CDKN2A loss has been shown to be a significant event in a number of cancer types. One mechanism by which this can occur is by hypermethylation of the CDKN2A promoter region. While no targeted therapeutic has been engaged in clinical trials, the prognostic impact has been studied by a number of meta-analyses. The prognostic impact of promoter hypermethylation has been relatively ambiguous. Many studies have shown significant p-values suggesting poorer prognostic outcomes for patients with hypermethylation in colorectal, liver, and younger lung cancer patients. This being said, there is still research to be done before this becomes a widely-accepted prognostic indicator.		9	21974827	21994591			ENST00000498124.1	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
28	https://civic.genome.wustl.edu/links/variants/28	CEBPA	1050	N-TERMINAL FRAME SHIFT	CEBPA N-terminal frame shift mutations that result in a premature stop codon are associated with cytogenetically normal acute myeloid leukemia (CN-AML). CEBPA mutations are associated with a favorable prognosis; however, NPM1 and FLT3 mutations should also be assessed in CN-AML patients as concurrent mutations may have prognostic implications. N-terminal frame shift mutations within amino acids 1-120 have been shown to disrupt expression of the full-length 42kDa isoform while maintaining expression of a 30kDa isoform (translated from the AUG at full-length protein isoform amino acid M120). This 30kDa isoform exhibits dominant negative activity.		19	33792961	33793470			ENST00000498907.2	75	GRCh37					dominant_negative_variant,frameshift_truncation		2017-11-22 19:45:47 UTC
29	https://civic.genome.wustl.edu/links/variants/29	CEBPA	1050	MUTATION	CEBPA mutations are associated with cytogenetically normal acute myeloid leukemia (CN-AML) and a favorable prognosis. However, NPM1 and FLT3 mutations should also be assessed in CN-AML patients as concurrent mutations may have prognostic implications.		19	33790840	33793470			ENST00000498907.2	75	GRCh37					loss_of_function_variant,transcript_variant		2017-11-22 19:45:47 UTC
30	https://civic.genome.wustl.edu/links/variants/30	CSF1R	1436	MEF2D-CSF1R	MEF2D-CSF1R is a fusion that has been observed in acute lymphocytic leukemia. In cell lines harboring this event, treatment with imatinib has shown notable sensitivity.		1	156446804	156470620			ENST00000348159.4	75	GRCh37	5	149433787	149441412	ENST00000286301.3	transcript_fusion		2017-11-22 19:45:46 UTC
31	https://civic.genome.wustl.edu/links/variants/31	PRKACA	5566	DNAJB1-PRKACA	This fusion has been found to be very recurrent in the rare form of adolescent liver cancer, fibrolamellar hepatocellular carcinoma. In one study, this fusion was observed in 15/15 FL-HCC cases examined and functional studies found that the fusion retained kinase activity. The presence of this fusion may be used as a diagnostic marker for this rare tumor type.		19	14628951	14629232			ENST00000254322.2	75	GRCh37	19	14202500	14218221	ENST00000308677.4	transcript_fusion		2017-11-22 19:46:01 UTC
32	https://civic.genome.wustl.edu/links/variants/32	DNMT3A	1788	R882	DNMT3A R882 mutations are associated with cytogenetically normal acute myeloid leukemia (CN-AML) with R882H as the most common form. Mutations in DNMT3A have largely been associated with poorer prognosis, however this is not consistent across all studies. This may be a result of patient age or combining R882 and non-R882 mutations during analysis as studies have indicated independent mechanisms of action and differential prognostic implications for these mutation types. One study that independently analyzed R882 and non-R882 mutations showed R882 mutations were associated with poorer prognosis than patients with wildtype and non-R882 mutations, but only in older patients with AML.		2	25457241	25457243			ENST00000264709.3	75	GRCh37					missense_variant		2017-11-22 19:45:50 UTC
33	https://civic.genome.wustl.edu/links/variants/33	EGFR	1956	L858R	EGFR L858R has long been recognized as a functionally significant mutation in cancer, and is one of the most prevalent single mutations in lung cancer. Best described in non-small cell lung cancer (NSCLC), the mutation seems to confer sensitivity to first and second generation TKI's like gefitinib and neratinib. NSCLC patients with this mutation treated with TKI's show increased overall and progression-free survival, as compared to chemotherapy alone. Third generation TKI's are currently in clinical trials that specifically focus on mutant forms of EGFR, a few of which have shown efficacy in treating patients that failed to respond to earlier generation TKI therapies.		7	55259515	55259515	T	G	ENST00000275493.2	75	GRCh37					missense_variant	NC_000007.13:g.55259515T>G,NM_005228.4:c.2573T>G,ENST00000275493.2:c.2573T>G,NP_005219.2:p.Leu858Arg	2017-11-22 19:46:00 UTC
34	https://civic.genome.wustl.edu/links/variants/34	EGFR	1956	T790M	EGFR T790M was one of the very first mutations recognized to confer resistance to targeted therapies in non-small cell lung cancer. While successful in amplified EGFR, the efficacy of the first and second generation TKI's (erlotinib, gefitinib, neratinib) in treating patients harboring this mutation before treatment is notably lower. This lack of efficacy can likely be to blame for the poorer prognosis for patients with this mutation as compared to patients with wildtype EGFR or other types of EGFR mutations. Approximately half of EGFR mutant tumors with acquired resistance to TKI inhibition have been shown to harbor this mutation, implicating it as a mechanism of acquired therapy resistence. A third generation TKI (osimertinib) has been approved for the treatment of EGFR T790M mutant NSCLC. Patients positive for T790M in a plasma-based test have similar outcomes like those with tumor biopsy testing.	EGFR TKI Resistance	7	55249071	55249071	C	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2369C>T,NM_005228.4:c.2369C>T,NP_005219.2:p.Thr790Met,NC_000007.13:g.55249071C>T	2017-11-22 19:45:53 UTC
35	https://civic.genome.wustl.edu/links/variants/35	ERBB2	2064	D769H	ERBB2 D769H was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines were shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 activating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37880261	37880261	G	C	ENST00000269571.5	75	GRCh37					missense_variant	NM_001289937.1:c.2305G>C,NP_001276866.1:p.Asp769His,ENST00000269571.5:c.2305G>C,NC_000017.10:g.37880261G>C	2017-11-22 19:46:00 UTC
36	https://civic.genome.wustl.edu/links/variants/36	ERBB2	2064	D769Y	ERBB2 D769Y was one of the first ERBB2 variants to be functionally classified (Bose et al., 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37880261	37880261	G	T	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2305G>T,NC_000017.10:g.37880261G>T,NM_004448.3:c.2305G>T,NP_004439.2:p.Asp769Tyr	2017-11-22 19:46:08 UTC
37	https://civic.genome.wustl.edu/links/variants/37	ERBB2	2064	DEL 755-759	ERBB2 in-frame deletion of 755-759 was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.		17	37880219	37880233	TTGAGGGAAAACACA		ENST00000269571.5	75	GRCh37					inframe_deletion	ENST00000269571.5:c.2263_2277del,NC_000017.10:g.37880219_37880233del,NP_004439.2:p.Leu755_Thr759del,NM_004448.3:c.2263_2277delTTGAGGGAAAACACA	2017-11-22 19:45:47 UTC
38	https://civic.genome.wustl.edu/links/variants/38	ERBB2	2064	G309A	ERBB2 G309A was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37868205	37868205	G	C	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.926G>C,NC_000017.10:g.37868205G>C,NM_004448.3:c.926G>C,NP_004439.2:p.Gly309Ala	2017-11-22 19:45:48 UTC
39	https://civic.genome.wustl.edu/links/variants/39	ERBB2	2064	L755S	ERBB2 L755S was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was not shown to be an activating mutation, unlike many of the other variants queried. This mutation was also shown to confer resistance to the tyrosine kinase inhibitor lapatinib in MCF10A cell lines.		17	37880220	37880220	T	C	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2264T>C,NC_000017.10:g.37880220T>C,NM_004448.3:c.2264T>C,NP_004439.2:p.Leu755Ser	2017-11-22 19:45:55 UTC
40	https://civic.genome.wustl.edu/links/variants/40	ERBB2	2064	L755W	ERBB2 L755W was one of the first ERBB2 variants to be functionally classified (Bose et al., 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.		17	37880220	37880220	T	G	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2264T>G,NC_000017.10:g.37880220T>G,NM_004448.3:c.2264T>G,NP_004439.2:p.Leu755Trp	2017-11-22 19:45:52 UTC
41	https://civic.genome.wustl.edu/links/variants/41	ERBB2	2064	P780INS	ERBB2 P780 insertion was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 activating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37881011	37881012		GGCTCCCCA	ENST00000269571.5	75	GRCh37					inframe_insertion	ENST00000269571.5:c.2340_2341insGGCTCCCCA,NC_000017.10:g.37881011_37881012insGGCTCCCCA	2017-11-22 19:46:01 UTC
42	https://civic.genome.wustl.edu/links/variants/42	ERBB2	2064	R678Q	ERBB2 R678Q was shown to have NO functional effect in tissue culture assay (Bose et al 2013). This conclusion was confirmed by a second, independent lab.		17	37879658	37879658	G	A	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2033G>A,NC_000017.10:g.37879658G>A,NM_004448.3:c.2033G>A,NP_004439.2:p.Arg678Gln	2017-11-22 19:45:54 UTC
43	https://civic.genome.wustl.edu/links/variants/43	ERBB2	2064	R896C	ERBB2 R896C was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37881616	37881616	C	T	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2686C>T,NC_000017.10:g.37881616C>T,NM_004448.3:c.2686C>T,NP_004439.2:p.Arg896Cys	2017-11-22 19:45:48 UTC
44	https://civic.genome.wustl.edu/links/variants/44	ERBB2	2064	V777L	ERBB2 V777L was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37881000	37881000	G	T	ENST00000269571.5	75	GRCh37					missense_variant	NM_004448.3:c.2329G>T,NP_004439.2:p.Val777Leu,ENST00000269571.5:c.2329G>T,NC_000017.10:g.37881000G>T	2017-11-22 19:45:50 UTC
45	https://civic.genome.wustl.edu/links/variants/45	ERBB2	2064	V842I	ERBB2 V842I was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37881332	37881332	G	A	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2524G>A,NM_004448.3:c.2524G>A,NP_004439.2:p.Val842Ile,NC_000017.10:g.37881332G>A	2017-11-22 19:45:51 UTC
46	https://civic.genome.wustl.edu/links/variants/46	ESR1	2099	L536Q	ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y536Q is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.	ESR1 Ligand-Binding Domain	6	152419920	152419921	TC	AG	ENST00000440973.1	75	GRCh37					missense_variant	NC_000006.11:g.152419920_152419921delinsAG	2017-11-22 19:45:49 UTC
47	https://civic.genome.wustl.edu/links/variants/47	ESR1	2099	D538G	ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. D538G is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.	ESR1 Ligand-Binding Domain	6	152419926	152419926	A	G	ENST00000206249.3	75	GRCh37					missense_variant	ENST00000206249.3:c.1613A>G,NC_000006.11:g.152419926A>G	2017-11-22 19:45:47 UTC
48	https://civic.genome.wustl.edu/links/variants/48	ESR1	2099	Y537C	ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y537C is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.	ESR1 Ligand-Binding Domain	6	152419923	152419923	A	G	ENST00000206249.3	75	GRCh37					missense_variant	ENST00000206249.3:c.1610A>G,NC_000006.11:g.152419923A>G	2017-11-22 19:45:48 UTC
49	https://civic.genome.wustl.edu/links/variants/49	ESR1	2099	Y537N	ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y537N is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.	ESR1 Ligand-Binding Domain	6	152419922	152419922	T	A	ENST00000206249.3	75	GRCh37					missense_variant	ENST00000206249.3:c.1609T>A,NC_000006.11:g.152419922T>A	2017-11-22 19:45:48 UTC
50	https://civic.genome.wustl.edu/links/variants/50	ESR1	2099	Y537S	ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y537S is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.	ESR1 Ligand-Binding Domain	6	152419923	152419923	A	C	ENST00000206249.3	75	GRCh37					missense_variant	ENST00000206249.3:c.1610A>C,NC_000006.11:g.152419923A>C	2017-11-22 19:45:48 UTC
52	https://civic.genome.wustl.edu/links/variants/52	FGFR2	2263	FGFR2-MGEA5	In a clinical sequencing program for advanced stage cancers, Wu et al (2013, Cancer Discovery) has idenified a number of FGFR fusions in patients with many different cancer types. These fusions were also found to retain oligomerization capability, and result in enhanced cell proliferation. Cell lines harboring these fusions were shown to respond to pazopanib. Additionally, tumor size reduction was achieved by both ponatinib and pazopanib treatments administered separately in a single patient with intrahepatic cholangiocarcinoma and this fusion. The authors use these cases to highlight the need for enhanced clinical sequencing efforts.	FGFR fusions	10	123243212	123357917			ENST00000457416.2	75	GRCh37	10	103544209	103552700	ENST00000361464.3	transcript_fusion		2017-11-22 19:46:01 UTC
53	https://civic.genome.wustl.edu/links/variants/53	FGFR3	2261	FGFR3-BAIAP2L1	In a clinical sequencing program for advanced stage cancers, Wu et al (2013, Cancer Discovery) has identified a number of FGFR fusions in patients with many different cancer types. These fusions were also found to retain oligomerization capability, and result in enhanced cell proliferation. These fusions were shown to respond to pazopanib. The authors use these cases to highlight the need for enhanced clinical sequencing efforts.	FGFR fusions	4	1795039	1810599			ENST00000340107.4	75	GRCh37	7	97991744	97920963	ENST00000005260.8	transcript_fusion		2017-11-22 19:45:47 UTC
54	https://civic.genome.wustl.edu/links/variants/54	FGFR2	2263	FGFR2-TACC3	In a clinical sequencing program for advanced stage cancers, Wu et al has identified a number of FGFR fusions in patients with many different cancer types. These fusions were also found to retain oligomerization capability, and result in enhanced cell proliferation. These fusions were shown to respond to pazopanib. The authors use these cases to highlight the need for enhanced clinical sequencing efforts.	FGFR fusions	4	123243212	123357598			ENST00000358487.5	75	GRCh37	4	1723266	1741505	ENST00000313288.4	transcript_fusion		2017-11-22 19:46:01 UTC
55	https://civic.genome.wustl.edu/links/variants/55	FLT3	2322	ITD	FLT3-ITD (internal tandem duplications) frequently occur in patients with hematologic malignancies such as chronic myelogenous leukemia, acute myeloid leukemia (AML) and myelodysplastic syndrome, but particularly in cytogenetically normal AML (CN-AML). These duplication events disrupt the juxtamembrane domain of FLT3 and can be the result of a duplication of internal FLT3 sequence or other unrelated sequence resulting in an in-frame duplication event. The length of these duplications can vary widely which may have prognostic consequences, but this has not been conclusively determined. FLT3-ITD mutations overall have generally been associated with poor prognosis. Additional genes associated with CN-AML such as NPM1 may modulate the prognosis associated with this variant.		13	28608219	28608351			ENST00000241453.7	75	GRCh37					inframe_insertion		2017-11-22 19:45:53 UTC
56	https://civic.genome.wustl.edu/links/variants/56	FLT3	2322	TKD MUTATION	FLT3 tyrosine kinase domain mutations (FLT3-TKD) are much less common than FLT3-ITD (internal tandem duplication) mutations and may not confer the same prognostic impact. Although the majority of mutations are point mutations effecting D835 (most frequently D835Y), a small proportion involve an in-frame deletion of I836. These mutations are within the activation loop of the second tyrosine kinase domain of FLT3 and thought to result in constitutive activation of the receptor.		13	28592642	28592642	C	A	ENST00000241453.7	75	GRCh37					nonsynonymous_variant	NC_000013.10:g.28592642C>A	2017-11-22 19:45:47 UTC
57	https://civic.genome.wustl.edu/links/variants/57	GATA2	2624	EXPRESSION	GATA2 misregulation has been observed in a number of hematologic malignancies, as well as non-small cell lung cancer. Treatment of over-active GATA2 pathways using the proteasome inhibitor bortezomib has shown dramatic tumor regression in lung cancer.		3	128198270	128212028			ENST00000341105.2	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
58	https://civic.genome.wustl.edu/links/variants/58	IDH1	3417	R132	IDH1 R132 mutations have been observed in a number of cancer types, and appear to behave quite differently in different environments. In myelodysplastic syndromes, IDH1 R132 mutations have been shown to be associated with worse outcome and shorter overall survival. They have also been linked to cytogenetically normal AML, an intermediate risk subtype of the disease. However, in glioblastoma and astrocytoma, patients with IDH1 mutations have shown better overall survival than patients with wild-type IDH1. Also in contrast to AML, in glioblastoma, IDH1 mutations have been associated with the specific cytogenetic abnormalities, 1p and 19q deletions.		2	209113111	209113113			ENST00000415913.1	75	GRCh37					protein_altering_variant		2017-11-22 19:45:47 UTC
59	https://civic.genome.wustl.edu/links/variants/59	IDH1	3417	R132C	IDH1 R132 mutations have been observed in a number of cancer types, and appear to behave quite differently in different environments. In myelodysplastic syndromes and acute myeloid leukemia (AML), IDH1 R132 mutations have been shown to be associated with worse outcome and shorter overall survival. They have also been linked to cytogenetically normal AML, an intermediate risk subtype of the disease. However, in glioblastoma and astrocytoma, patients with IDH1 mutations have shown better overall survival than patients with wild-type IDH1. Also in contrast to AML, in glioblastoma, IDH1 mutations have been associated with the specific cytogenetic abnormalities, 1p and 19q deletions.		2	209113113	209113113	G	A	ENST00000415913.1	75	GRCh37					missense_variant	NM_005896.3:c.394C>T,NP_005887.2:p.Arg132Cys,NC_000002.11:g.209113113G>A,ENST00000415913.1:c.394C>T	2017-11-22 19:45:52 UTC
62	https://civic.genome.wustl.edu/links/variants/62	IDH2	3418	R140	IDH2 mutations have been observed in a number of hematologic malignancies. In acute myeloid leukemia, the R140 mutants show mixed results affecting overall survival as compared to their wild-type counterparts. In myelodysplastic syndromes, however, no prognostic link was discovered between IDH2 mutation status and overall survival.		15	90631934	90631934			ENST00000330062.3	75	GRCh37					protein_altering_variant		2017-11-22 19:46:01 UTC
63	https://civic.genome.wustl.edu/links/variants/63	IDH2	3418	R172K	IDH2 mutations have been observed in a number of hematologic malignancies. In acute myeloid leukemia, the R172K mutation has been linked with poorer prognosis and worse overall survival than IDH2 wild-type patients. However, in myelodisplastic syndromes, studies did not find a prognostic association between this variant and patient outcomes.		15	90631838	90631838	C	T	ENST00000330062.3	75	GRCh37					missense_variant	NM_002168.3:c.515G>A,NP_002159.2:p.Arg172Lys,NC_000015.9:g.90631838C>T,ENST00000330062.3:c.515G>A	2017-11-22 19:45:51 UTC
64	https://civic.genome.wustl.edu/links/variants/64	JAK2	3717	V617F	JAK2 V617F is a highly recurrent mutation in myeloproliferative diseases. It is found in around 98% of patients with polycythemia vera, and just over half of the patients with essential thrombocythemia and primary myelofibrosis. While less associated with cancer, when it is seen, it is more likely to be in myeloid leukemias than lymphoid leukemias. The V617F mutation is an activating mutation, resulting in increased kinase activity. The mutation seems to be restricted to hematologic malignancies. Treatment of JAK mutant diseases with ruxolitinib has seen some clinical success.		9	5073770	5073770	G	T	ENST00000381652.3	75	GRCh37					gain_of_function_variant,missense_variant	NC_000009.11:g.5073770G>T,NM_004972.3:c.1849G>T,NP_004963.1:p.Val617Phe,ENST00000381652.3:c.1849G>T	2017-11-22 19:45:50 UTC
65	https://civic.genome.wustl.edu/links/variants/65	KIT	3815	D816V	KIT D816V is a mutation observed in acute myeloid leukemia (AML). This variant has been linked to poorer prognosis and worse outcome in AML patients.	KIT Exon 17	4	55599321	55599321	A	T	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2447A>T,NP_000213.1:p.Asp816Val,ENST00000288135.5:c.2447A>T,NC_000004.11:g.55599321A>T	2017-11-22 19:45:49 UTC
66	https://civic.genome.wustl.edu/links/variants/66	KIT	3815	EXON 11 MUTATION	c-KIT mutations in exon 11 lie within the juxtamembrane domain, and are very recurrent in gastrointestinal stromal tumors, often bearing a poorer prognosis than other KIT mutations. Cells harboring exon 11 mutations have shown sensitivity to the tyrosine kinase inhibitor imatinib, offering a better prognosis to patients treated with the drug in the first year. Small cohorts of melanoma patients harboring exon 11 KIT mutations have shown response to imatinib and sunitinib.	KIT Exon 11	4	55593582	55593708			ENST00000288135.5	75	GRCh37					coding_sequence_variant		2017-11-22 19:45:47 UTC
67	https://civic.genome.wustl.edu/links/variants/67	KIT	3815	INTERNAL DUPLICATION	c-KIT internal duplications have been observed in exon 11, within the juxtamembrane domain. In a case study of an anal melanoma patient harboring this event, imatinib confered marked response. Also, cells harboring exon 11 mutations have shown sensitivity to the tyrosine kinase inhibitor imatinib, offering a better prognosis to patients treated with the drug in the first year.	KIT Exon 11	4	55593582	55593708			ENST00000288135.5	75	GRCh37					inframe_insertion		2017-11-22 19:45:47 UTC
69	https://civic.genome.wustl.edu/links/variants/69	KIT	3815	EXON 14 MUTATION	c-KIT exon 14 mutations lie within the tyrosine kinase domain of the protein. While relatively rare in primary gastrointestinal tumors, they are notably more prevalent in refractory disease, suggesting a role in imatinib resistance. Unlike mutations in other KIT exons, exon 14 mutations seem relatively rare in melanoma.		4	55595501	55595651			ENST00000288135.5	75	GRCh37					exon_variant		2017-11-22 19:45:52 UTC
72	https://civic.genome.wustl.edu/links/variants/72	KIT	3815	L576P	KIT L576P is an exon 11 mutation that lies within the juxtamembrane domain. It is one of the most recurrent KIT mutations in melanoma, and both in vitro and in vivo studies have shown sensitivity to imatinib.	KIT Exon 11	4	55593661	55593661	T	C	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1727T>C,NP_000213.1:p.Leu576Pro,ENST00000288135.5:c.1727T>C,NC_000004.11:g.55593661T>C	2017-11-22 19:45:47 UTC
73	https://civic.genome.wustl.edu/links/variants/73	KIT	3815	V654A	KIT V654A is an exon 13 mutation that lies within the tyrosine kinase 1 domain of the protein. It has been shown to be an activating mutation by in vitro studies. This mutation is associated with imatinib resistance in melanoma patients. However, second generation TKI's such as sunitinib and midostaurin (PKC 412) have seen success in acheiving tumor response.	KIT Exon 11	4	55594258	55594258	T	C	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1961T>C,NP_000213.1:p.Val654Ala,ENST00000288135.5:c.1961T>C,NC_000004.11:g.55594258T>C	2017-11-22 19:45:49 UTC
75	https://civic.genome.wustl.edu/links/variants/75	KRAS	3845	EXON 2 MUTATION	Exon 2 mutations have been associated with reduced response rates or resistance to EGFR inhibitors in non-small cell lung and colorectal cancer. The NCCN guidelines for colorectal cancer contain recommendations that the targeted therapies cetuximab and panitumumab should only be used in the context of wild type KRAS.		12	25398208	25398329			ENST00000256078.4	75	GRCh37					missense_variant,exon_variant		2017-11-22 19:45:47 UTC
76	https://civic.genome.wustl.edu/links/variants/76	KRAS	3845	G12	While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.		12	25398284	25398285			ENST00000256078.4	75	GRCh37					protein_altering_variant		2017-11-22 19:46:01 UTC
77	https://civic.genome.wustl.edu/links/variants/77	KRAS	3845	G12/G13	While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.		12	25398280	25398285			ENST00000256078.4	75	GRCh37					protein_altering_variant		2017-11-22 19:45:52 UTC
78	https://civic.genome.wustl.edu/links/variants/78	KRAS	3845	G12C	While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.	EGFR TKI Resistance	12	25398285	25398285	C	A	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.34G>T,NP_004976.2:p.Gly12Cys,NC_000012.11:g.25398285C>A,ENST00000256078.4:c.34G>T	2017-11-22 19:45:53 UTC
79	https://civic.genome.wustl.edu/links/variants/79	KRAS	3845	G12D	While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still actively debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. The NCCN guidelines for colorectal cancer contain recommendations that the targeted therapies cetuximab and panitumumab should only be used in the context of wild type KRAS. However, cetuximab treatment was shown to extend survival in a single cohort of colorectal patients with G12D mutations. Overall, the interpretation for KRAS mutations in most clinical scenarios is still undecided.	EGFR TKI Resistance	12	25398284	25398284	C	T	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.35G>A,NP_004976.2:p.Gly12Asp,NC_000012.11:g.25398284C>T,ENST00000256078.4:c.35G>A	2017-11-22 19:45:52 UTC
80	https://civic.genome.wustl.edu/links/variants/80	KRAS	3845	G13	While the KRAS G13 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G12 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.		12	25398281	25398282			ENST00000256078.4	75	GRCh37					inframe_insertion,missense_variant		2017-11-22 19:45:53 UTC
81	https://civic.genome.wustl.edu/links/variants/81	KRAS	3845	G13D	While the KRAS G13 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort. This mutation, along with the mutations affecting the neighboring G12 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, results are conflicting with retrospective analyses suggesting a better response to EGFR-Inhibition. A recent prospective phase-II study (12 patients, Schirripa et. al. 2015) could not reproduce this finding and another prospective phase II trial is currently ongoing.		12	25398281	25398281	C	T	ENST00000256078.4	75	GRCh37					missense_variant,coding_sequence_variant	NM_033360.3:c.38G>A,NP_004976.2:p.Gly13Asp,NC_000012.11:g.25398281C>T,ENST00000256078.4:c.38G>A	2017-11-22 19:45:52 UTC
82	https://civic.genome.wustl.edu/links/variants/82	MAP2K1	5604	P124S	MAP2K1 P124S is a recurrent mutation in melanoma, and is seen in bladder and colon cancer to a lesser degree. The P124S mutation has been shown to contribute to AZD6244 resistance in melanoma cell lines, but considerably less so than its Q56P counterpart.		15	66729162	66729162	C	T	ENST00000307102.5	75	GRCh37					missense_variant	ENST00000307102.5:c.370C>T,NC_000015.9:g.66729162C>T,NM_002755.3:c.370C>T,NP_002746.1:p.Pro124Ser	2017-11-22 19:45:49 UTC
83	https://civic.genome.wustl.edu/links/variants/83	MAP2K1	5604	Q56P	MAP2K1 Q56P is a recurrent mutation in melanoma and gastric cancer. This mutation has been shown to confer considerable resistance to AZD6244 treatment of melanoma cell lines.		15	66727451	66727451	A	C	ENST00000307102.5	75	GRCh37					missense_variant	ENST00000307102.5:c.167A>C,NC_000015.9:g.66727451A>C,NM_002755.3:c.167A>C,NP_002746.1:p.Gln56Pro	2017-11-22 19:45:49 UTC
85	https://civic.genome.wustl.edu/links/variants/85	MGMT	4255	PROMOTER METHYLATION	MGMT promoter methylation has been observed to impact tumor progression in glioblastoma multiforme. In patients exhibiting promoter methylation, the akylating agent carmustine has shown efficacy. In patients lacking methylation, combining carmustine with the MGMT inhibitor O(6)-benzylguanine may be effective, but more experiments are required. Clinical trials have also shown selective sensitivity of promoter methylation-positive patients to temozolomide, making a case for wider methylation screening in GBM patients.		10	131264495	131265656			ENST00000306010.7	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
86	https://civic.genome.wustl.edu/links/variants/86	NPM1	4869	EXON 12 MUTATION	NPM1 exon 12 mutations are frequently identified in patients with cytogenetically normal acute myeloid leukemia (AML) and often co-occur with FLT3-ITD. FLT3 status should also be evaluated as co-occurence with FLT3-ITD may impact prognosis. Exon 12 mutations have been identified as a predictor of good prognostic outcomes in the absence of FLT3-ITD. Due to their high frequency, NPM1 mutations have been retrospectively analyzed in the context of a number of therapies including variable results following ATRA treatment as well as improved response to high-dose daunorubicin or valproic acid. Additionally, multiple groups have shown increased surface expression of CD33 associated with NPM1 mutation, suggesting these patients may respond to anti-CD33 therapy. Cytoplasmic sequestration of NPM1 (NPM1c) is associated with a good response to induction therapy.	NPM1 Exon 12	5	170837531	170837569			ENST00000517671.1	75	GRCh37					exon_variant		2017-11-22 19:45:52 UTC
87	https://civic.genome.wustl.edu/links/variants/87	NPM1	4869	W288FS	NPM1 W288fs (aka NPM1-A) is located in exon 12 of NPM1 and is the most common NPM1 mutation identified in acute myeloid leukemia. This mutation results in cytoplasmic localization of NPM1 (NPM1c) which is associated with a good response to induction therapy. Although it is the most extensively studied NPM1 exon 12 mutation, it is generally grouped with other exon 12 mutations for patient analysis (see NPM1 Exon 12 variants for more information).	NPM1 Exon 12	5	170837547	170837548		TCTG	ENST00000517671.1	75	GRCh37					frameshift_elongation	NM_002520.6:c.860_863dupTCTG,NC_000005.9:g.170837544_170837547dupTCTG,NP_002511.1:p.Trp288Cysfs,ENST00000517671.1c.860_863dupTCTG	2017-11-22 19:45:51 UTC
92	https://civic.genome.wustl.edu/links/variants/92	NRAS	4893	G12	While the NRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated.		1	115258747	115258748			ENST00000369535.4	75	GRCh37					missense_variant		2017-11-22 19:45:47 UTC
93	https://civic.genome.wustl.edu/links/variants/93	NRAS	4893	G13D	While the NRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated.		1	115258744	115258744	C	T	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.38G>A,NP_002515.1:p.Gly13Asp,NC_000001.10:g.115258744C>T,ENST00000369535.4:c.38G>A	2017-11-22 19:45:49 UTC
94	https://civic.genome.wustl.edu/links/variants/94	NRAS	4893	Q61	NRAS Q61 mutations have been found in multiple myeloma, gastrointestinal stromal tumors, melanoma, and others. Two melanoma patients, each harboring mutations at this locus (Q61L and Q61R), responded to treatment with the akylating agent temozolomide. However, in colorectal cancer patients, mutations at this locus have been shown to confer resistance to cetuximab. The prognostic impact of mutations at this locus is currently under study.		1	115256528	115256530			ENST00000369535.4	75	GRCh37					missense_variant		2017-11-22 19:45:47 UTC
95	https://civic.genome.wustl.edu/links/variants/95	NRAS	4893	Q61L	NRAS Q61 mutations have been found in multiple myeloma, gastrointestinal stromal tumors, melanoma, and others. A melanoma patient harboring a mutation at this locus responded to treatment with the akylating agent temozolomide. However, in colorectal cancer patients, mutations at this locus have been shown to confer resistance to cetuximab. The prognostic impact of mutations at this locus is currently under study.		1	115256529	115256529	T	A	ENST00000369535.4	75	GRCh37					missense_variant	NP_002515.1:p.Gln61Leu,NC_000001.10:g.115256529T>A,NM_002524.4:c.182A>T,ENST00000369535.4:c.182A>T	2017-11-22 19:45:46 UTC
96	https://civic.genome.wustl.edu/links/variants/96	NRAS	4893	Q61R	NRAS Q61 mutations have been found in multiple myeloma, gastrointestinal stromal tumors, melanoma, and others. A melanoma patient harboring a mutation at this locus responded to treatment with the akylating agent temozolomide. However, in colorectal cancer patients, mutations at this locus have been shown to confer resistance to cetuximab. The prognostic impact of mutations at this locus is currently under study.		1	115256529	115256529	T	C	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.182A>G,NP_002515.1:p.Gln61Arg,NC_000001.10:g.115256529T>C,ENST00000369535.4:c.182A>G	2017-11-22 19:45:49 UTC
98	https://civic.genome.wustl.edu/links/variants/98	PDGFRA	5156	D842I	PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).	Imatinib Resistance	4	55152092	55152093	GA	AT	ENST00000257290.5	75	GRCh37					missense_variant	ENST00000257290.5:c.2524_2525delinsAT,NC_000004.11:g.55152092_55152093delinsAT,NP_006197.1:p.Asp842Ile,NM_006206.5:c.2524_2525delGAinsAT	2017-11-22 19:45:49 UTC
99	https://civic.genome.wustl.edu/links/variants/99	PDGFRA	5156	D842V	PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. Exogenous expression of the A842V mutation resulted in constitutive tyrosine phosphorylation of PDGFRA in the absence of ligand in 293T cells and cytokine-independent proliferation of the IL-3-dependent Ba/F3 cell line, both evidence that this is an activating mutation. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).	Imatinib Resistance	4	55152093	55152093	A	T	ENST00000257290.5	75	GRCh37					missense_variant	NM_006206.4:c.2525A>T,NP_006197.1:p.Asp842Val,ENST00000257290.5:c.2525A>T,NC_000004.11:g.55152093A>T	2017-11-22 19:45:50 UTC
100	https://civic.genome.wustl.edu/links/variants/100	PDGFRA	5156	D842Y	PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).	Imatinib Resistance	4	55152092	55152092	G	T	ENST00000257290.5	75	GRCh37					missense_variant	ENST00000257290.5:c.2524G>T,NC_000004.11:g.55152092G>T,NM_006206.5:c.2524G>T,NP_006197.1:p.Asp842Tyr	2017-11-22 19:45:51 UTC
101	https://civic.genome.wustl.edu/links/variants/101	PDGFRA	5156	I843DEL	PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).	Imatinib Resistance	4	55152095	55152097	ATC		ENST00000257290.5	75	GRCh37					inframe_deletion	ENST00000257290.5:c.2527_2529delATC,NC_000004.11:g.55152095_55152097del	2017-11-22 19:45:47 UTC
102	https://civic.genome.wustl.edu/links/variants/102	PDGFRA	5156	DI842-843VM	PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. The DI842-843VM variant is the result of a double point mutation. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).	Imatinib Resistance	4	55152093	55152097	ACATC	TCATG	ENST00000257290.5	75	GRCh37					missense_variant	NC_000004.11:g.55152093_55152097delinsTCATG	2017-11-22 19:45:47 UTC
103	https://civic.genome.wustl.edu/links/variants/103	PIK3CA	5290	E542K	PIK3CA E545K/E542K are the second most recurrent PIK3CA mutations in breast cancer, and are highly recurrent mutations in many other cancer types. E545K, and possibly the other mutations in the E545 region, may present patients with a poorer prognosis than patients with other PIK3CA variants or wild-type PIK3CA. There is also data to suggest that E545/542 mutations may confer resistance to EGFR inhibitors like cetuximab. While very prevalent, targeted therapies for variants in PIK3CA are still in early clinical trial phases.		3	178936082	178936082	G	A	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1624G>A,NP_006209.2:p.Glu542Lys,ENST00000263967.3:c.1624G>A,NC_000003.11:g.178936082G>A	2017-11-22 19:45:50 UTC
104	https://civic.genome.wustl.edu/links/variants/104	PIK3CA	5290	E545K	PIK3CA E545K/E542K are the second most recurrent PIK3CA mutations in breast cancer, and are highly recurrent mutations in many other cancer types. E545K, and possibly the other mutations in the E545 region, may present patients with a poorer prognosis than patients with either patients with other PIK3CA variant or wild-type PIK3CA. There is also data to suggest that E545/542 mutations may confer resistance to EGFR inhibitors like cetuximab. While very prevalent, targeted therapies for variants in PIK3CA are still in early clinical trial phases.		3	178936091	178936091	G	A	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1633G>A,NP_006209.2:p.Glu545Lys,ENST00000263967.3:c.1633G>A,NC_000003.11:g.178936091G>A	2017-11-22 19:45:51 UTC
105	https://civic.genome.wustl.edu/links/variants/105	PIK3CA	5290	EXON 21 MUTATION	PIK3CA Exon 21 Mutations (e.g., H1047R; often referred to as Exon 20 mutations if counting only coding exons) are among the most recurrent mutations in cancer, especially breast cancer. Of PIK3CA mutant breast cancers, over half harbor this mutation. Meta-analyses have shown that patients harboring this mutation may have worse overall survival, but other studies have shown no difference between Exon 21 and other PIK3CA mutants from a prognostic standpoint. While very prevalent, targeted therapies for this particular mutation are still in early clinical trial phases.		3	178951882	178952495			ENST00000263967.3	75	GRCh37					exon_variant		2017-11-22 19:45:47 UTC
106	https://civic.genome.wustl.edu/links/variants/106	PIK3CA	5290	EXON 10 MUTATION	PIK3CA Exon 10 Mutations (e.g. E545K/E542K; often referred to as Exon 9 mutations if counting only coding exons) are the second most recurrent PIK3CA mutations in breast cancer, and highly recurrent mutations in many other cancer types. E545K, and possibly the other mutations in the E545 region, may present patients with a poorer prognosis than patients with either patients with other PIK3CA variant or wild-type PIK3CA. There is also data to suggest that exon 10 mutations may confer resistance to EGFR inhibitors like cetuximab. While very prevalent, targeted therapies for variants in PIK3CA are still in early clinical trial phases.		3	178935998	178936122			ENST00000263967.3	75	GRCh37					exon_variant		2017-11-22 19:45:47 UTC
107	https://civic.genome.wustl.edu/links/variants/107	PIK3CA	5290	H1047R	PIK3CA H1047R is one of the most recurrent single nucleotide variants in cancer, especially breast cancer. Of PIK3CA-mutant breast cancers, over half harbor this mutation. Meta-analyses have shown that patients harboring this mutation may have worse overall survival, but other studies have shown no difference between H1047R and other PIK3CA mutants from a prognostic standpoint. While very prevalent, targeted therapies for this particular mutation are still in early clinical trial phases.		3	178952085	178952085	A	G	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.3140A>G,NP_006209.2:p.His1047Arg,ENST00000263967.3:c.3140A>G,NC_000003.11:g.178952085A>G	2017-11-22 19:45:49 UTC
108	https://civic.genome.wustl.edu/links/variants/108	PML	5371	PML-RARA	The PML-RARA fusion is seen as a diagnostic event in acute promyelocytic leukemia (APL). Both in vitro and in vivo studies have shown sensitivity to ATRA in APL patients harboring the PML-RARa fusion. Recent interest has been shown in combining ATRA and arsenic trioxide for treating these patients, and early results seem promising.		15	74287058	74325755			ENST00000268058.3	75	GRCh37	17	38504568	38513048	ENST00000254066.5	transcript_fusion		2017-11-22 19:45:50 UTC
110	https://civic.genome.wustl.edu/links/variants/110	PTEN	5728	R233*	PTEN R233* has been shown to be a loss of function mutation, and PTEN loss has been the subject of considerable research in breast cancer. PTEN loss may sensitize cells to PI3K-mTOR inhibition. While still being debated, there is data to support that PTEN loss is both associated with poorer prognosis, and no change in prognosis.	PTEN Loss-of-Function	10	89717672	89717672	C	T	ENST00000371953.3	75	GRCh37					loss_of_function_variant,stop_gained	NM_000314.6:c.697C>T,NP_000305.3:p.Arg233Ter,ENST00000371953.3:c.697C>T,NC_000010.10:g.89717672C>T	2017-11-22 19:45:49 UTC
112	https://civic.genome.wustl.edu/links/variants/112	RET	5979	C634W	RET C634W has been implicated as an alternate mechanism of activating RET in medullary thyroid cancer. While there currently are no RET-specific inhibiting agents, promiscuous kinase inhibitors have seen some success in treating RET overactivity. Data suggests however, that the C634W mutation may lead to drug resistance, especially against the VEGFR-inhibitor motesanib.	Motesanib Resistance	10	43609950	43609950	C	G	ENST00000355710.3	75	GRCh37					missense_variant	NM_020975.4:c.1902C>G,NP_065681.1:p.Cys634Trp,ENST00000355710.3:c.1902C>G,NC_000010.10:g.43609950C>G	2017-11-22 19:45:49 UTC
113	https://civic.genome.wustl.edu/links/variants/113	RET	5979	M918T	RET M819T is the most common somatically acquired mutation in medullary thyroid cancer (MTC). While there currently are no RET-specific inhibiting agents, promiscuous kinase inhibitors have seen some success in treating RET overactivity. Data suggests however, that the M918T mutation may lead to drug resistance, especially against the VEGFR-inhibitor motesanib. It has also been suggested that RET M819T leads to more aggressive MTC with a poorer prognosis.	Motesanib Resistance	10	43617416	43617416	T	C	ENST00000355710.3	75	GRCh37					missense_variant	NM_020975.4:c.2753T>C,NP_065681.1:p.Met918Thr,ENST00000355710.3:c.2753T>C,NC_000010.10:g.43617416T>C	2017-11-22 19:45:49 UTC
114	https://civic.genome.wustl.edu/links/variants/114	SF3B1	23451	K666N	SF3B1 K666N is a variant found in myelodysplastic syndromes, chronic leukemias, and more recently, breast cancer. This somatic mutation has been linked to better overall outcome and event-free survival in MDS patients.	HEAT domain mutation	2	198267359	198267359	C	A	ENST00000335508.6	75	GRCh37					missense_variant	NM_012433.3:c.1998G>T,NP_036565.2:p.Lys666Asn,ENST00000335508.6:c.1998G>T,NC_000002.11:g.198267359C>A	2017-11-22 19:45:49 UTC
116	https://civic.genome.wustl.edu/links/variants/116	TP53	7157	R175H	While loss-of-function events in TP53 are very common in cancer, the R175H variant seems not only to result in loss of tumor-suppression, but also acts as a gain-of-function mutation that promotes tumorigenesis in mouse models. Cell lines harboring this mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been shown that the R175H mutation is correlated with worse overall survival than wild-type TP53, but is not as detrimental as the R248W variant.		17	7578406	7578406	C	T	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.524G>A,NP_000537.3:p.Arg175His,NC_000017.10:g.7578406C>T	2017-11-22 19:45:49 UTC
117	https://civic.genome.wustl.edu/links/variants/117	TP53	7157	R248Q	While loss-of-function events in TP53 are very common in cancer, the R248 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, R248 mutations have been shown to confer worse overall survival. The R248Q mutation has also shown an increased invasive behavior in cell lines. This is specific to the 248Q variant.		17	7577538	7577538	C	T	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.743G>A,NP_000537.3:p.Arg248Gln,NC_000017.10:g.7577538C>T,ENST00000269305.4:c.743G>A	2017-11-22 19:45:49 UTC
118	https://civic.genome.wustl.edu/links/variants/118	TP53	7157	R248W	While loss-of-function events in TP53 are very common in cancer, the R248 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, R248 mutations have been shown to confer worse overall survival.		17	7577539	7577539	G	A	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.742C>T,NP_000537.3:p.Arg248Trp,NC_000017.10:g.7577539G>A	2017-11-22 19:45:49 UTC
119	https://civic.genome.wustl.edu/links/variants/119	TP53	7157	R249	This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been suggested that the R249 mutants have been correlated with worse overall survival in breast cancer patients when compared to wild-type.		17	7577535	7577535	C	G	ENST00000269305.4	75	GRCh37					protein_altering_variant	NC_000017.10:g.7577535C>G	2017-11-22 19:45:49 UTC
121	https://civic.genome.wustl.edu/links/variants/121	TP53	7157	R273C	While loss-of-function events in TP53 are very common in cancer, the R273 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been suggested that the R273 mutants have been correlated with worse overall survival in breast cancer patients when compared to wild-type.		17	7577121	7577121	G	A	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.817C>T,NP_000537.3:p.Arg273Cys,NC_000017.10:g.7577121G>A	2017-11-22 19:45:49 UTC
122	https://civic.genome.wustl.edu/links/variants/122	TP53	7157	R273H	While loss-of-function events in TP53 are very common in cancer, the R273 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been suggested that the R273 mutants have been correlated with worse overall survival in breast cancer patients when compared to wild-type.		17	7577120	7577120	C	T	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.818G>A,NP_000537.3:p.Arg273His,NC_000017.10:g.7577120C>T	2017-11-22 19:45:51 UTC
124	https://civic.genome.wustl.edu/links/variants/124	TSC1	7248	FRAMESHIFT TRUNCATION	In a small cohort study of bladder cancer, patients with TSC1 mutations showed better responses to and increased treatment duration tolerance with the mTOR inhibitor everolimus. Additionally, patient-derived bladder cancer cell lines with TSC1 or TSC2 mutations are much more sensitive to everolimus treatment than TSC1/TSC2 wildtype cells.	TSC Loss	9	135766735	135820008			ENST00000298552.3	75	GRCh37					frameshift_truncation		2017-11-22 19:45:47 UTC
125	https://civic.genome.wustl.edu/links/variants/125	TSC1	7248	LOSS-OF-FUNCTION	In a small cohort study of bladder cancer, patients with TSC1 mutations showed better responses to and increased treatment duration tolerance with the mTOR inhibitor everolimus. Additionally, patient-derived bladder cancer cell lines with TSC1 or TSC2 mutations are much more sensitive to everolimus treatment than TSC1/TSC2 wildtype cells.	TSC Loss	9	135766735	135820008			ENST00000298552.3	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:47 UTC
127	https://civic.genome.wustl.edu/links/variants/127	U2AF1	7307	Q157P/R	U2AF1 Q157P/R has been shown to be a recurrent mutation in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and lung adenocarcinomas. This mutation is less common than the S34F mutation, occurs in the second zinc finger domain of U2AF1 and has been demonstrated to alter splicing. The impact of U2AF1 mutations on overall survival in MDS has been debated, however, patients with U2AF1 mutations were shown to be at an increased risk of transformation to secondary AML. The presence of this mutation was not associated with a specific prognostic outcome in AML when compared to U2AF1 wildtype patients.		21	44514777	44514777	T	G	ENST00000291552.4	75	GRCh37					missense_variant	NC_000021.8:g.44514777T>G	2017-11-22 19:45:50 UTC
128	https://civic.genome.wustl.edu/links/variants/128	U2AF1	7307	S34Y/F	U2AF1 S34Y/F has been shown to be a recurrent mutation in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and lung adenocarcinomas. This mutation is the most commonly identified variant in MDS, occurs in the first zinc finger domain of U2AF1 and has been demonstrated to alter splicing. The impact of U2AF1 mutations on overall survival in MDS has been debated, however, patients with U2AF1 mutations were shown to be at an increased risk of transformation to secondary AML. The presence of this mutation was not associated with a specific prognostic outcome in AML when compared to U2AF1 wildtype patients.		21	44524456	44524456	G	A	ENST00000291552.4	75	GRCh37					missense_variant	NC_000021.8:g.44524456G>A	2017-11-22 19:45:51 UTC
129	https://civic.genome.wustl.edu/links/variants/129	WT1	7490	EXON 7 MUTATION	WT1 exon 7 mutations have been shown to be recurrent in acute myeloid leukemia. Many sources have examined the prognostic impact of these, agreeing that the mutant exon 7 cohort is correlated with worse overall survival and a number of poor prognistic outcomes. This may be the result of an overall poor response to chemotherapy from WT1 mutant tumors.		11	32417803	32417953			ENST00000332351.3	75	GRCh37					exon_variant		2017-11-22 19:45:48 UTC
130	https://civic.genome.wustl.edu/links/variants/130	WT1	7490	EXON 9 MUTATION	WT1 exon 9 mutations have been shown to be recurrent in acute myeloid leukemia, although at a less frequent rate than their exon 7 counterparts. Many sources have examined the prognostic impact of these, agreeing that the mutant exon 9 cohort is correlated with worse overall survival and a number of poor prognistic outcomes. This may be the result of an overall poor response to chemotherapy from WT1 mutant tumors.		11	32413518	32413610			ENST00000332351.3	75	GRCh37					exon_variant		2017-11-22 19:45:50 UTC
131	https://civic.genome.wustl.edu/links/variants/131	BRCA1	672	LOSS-OF-FUNCTION	BRCA1 loss of function mutations have been shown to increase risk of breast and ovarian cancer in those carrying the allele in their germline. Treating BRCA mutant patients with PARP inhibitors such as Olaparib has led to significant response.	BRCA Germline Variants	17	41196312	41277387			ENST00000357654.3	75	GRCh37					loss_of_heterozygosity,loss_of_function_variant		2017-11-22 19:45:48 UTC
132	https://civic.genome.wustl.edu/links/variants/132	BRCA2	675	LOSS-OF-FUNCTION	BRCA2 loss of function mutations have been shown to increase risk of breast and ovarian cancer in those carrying the allele in their germline. Treating BRCA mutant patients with PARP inhibitors such as Olaparib has led to significant response.	BRCA Germline Variants	13	32889611	32973347			ENST00000380152.3	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:51 UTC
133	https://civic.genome.wustl.edu/links/variants/133	EGFR	1956	EXON 19 DELETION	Deletions within exon 19 of EGFR are most common in lung cancer. These deletions, in non-small cell lung cancer, have been shown to be sensitive to the EGFR tyrosine kinase inhibitors gefitinib, afatinib, and erlotinib. There is also data to suggest that this event is a good prognostic marker in lung adenocarcinoma.		7	55242415	55242513			ENST00000275493.2	75	GRCh37					inframe_deletion	ENST00000275493.2:c.2185_2283del	2017-11-22 19:45:53 UTC
134	https://civic.genome.wustl.edu/links/variants/134	EGFR	1956	G719S	While not as recurrent as the L858R mutation, EGFR G719S has also been shown to be an activating mutation. In lung cancer cell lines, it also confers sensitivity to the tyrosine kinase inhibitors gefitinib and erlotinib.		7	55241707	55241707	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2155G>A,NC_000007.13:g.55241707G>A,NM_005228.4:c.2155G>A,NP_005219.2:p.Gly719Ser	2017-11-22 19:45:48 UTC
135	https://civic.genome.wustl.edu/links/variants/135	NOTCH1	4851	D1642H	Activating mutations in NOTCH1, including D1642H, have been shown to be poor prognostic markers in lung cancer.		9	139399219	139399219	C	G	ENST00000277541.6	75	GRCh37					missense_variant	ENST00000277541.6:c.4924G>C,NC_000009.11:g.139399219C>G,NM_017617.4:c.4924G>C,NP_060087.3:p.Asp1642His	2017-11-22 19:45:48 UTC
136	https://civic.genome.wustl.edu/links/variants/136	NOTCH1	4851	R2327W	Activating mutations in NOTCH1, including R2327W, have been shown to be poor prognostic markers in lung cancer.		9	139391212	139391212	G	A	ENST00000277541.6	75	GRCh37					missense_variant	NM_017617.4:c.6979C>T,NP_060087.3:p.Arg2327Trp,NC_000009.11:g.139391212G>A	2017-11-22 19:45:48 UTC
137	https://civic.genome.wustl.edu/links/variants/137	NOTCH1	4851	V2444FS	Activating mutations in NOTCH1, including a frameshift insertion at V2444, have been shown to be poor prognostic markers in lung cancer.		9	139390861	139390861	G	TGT	ENST00000277541.6	75	GRCh37					frameshift_variant	ENST00000277541.6:c.7330delinsACA	2017-11-22 19:45:48 UTC
138	https://civic.genome.wustl.edu/links/variants/138	NOTCH1	4851	S2275FS	Activating mutations in NOTCH1, including a frameshift insertion at S2275, have been shown to be poor prognostic markers in lung cancer.		9	139391369	139391370		A	ENST00000277541.6	75	GRCh37					plus_1_frameshift_variant	ENST00000277541.6:c.6821_6822insT,NC_000009.11:g.139391369_139391370insA	2017-11-22 19:45:47 UTC
139	https://civic.genome.wustl.edu/links/variants/139	DDR2	4921	L63V	Activating mutations in DDR2, including L63V, has been shown to be sensitive to dasatinib in cell lines.		1	162724415	162724415	C	G	ENST00000367922.3	75	GRCh37					missense_variant	NM_006182.2:c.187C>G,NP_006173.2:p.Leu63Val,ENST00000367922.3:c.187C>G,NC_000001.10:g.162724415C>G	2017-11-22 19:45:47 UTC
140	https://civic.genome.wustl.edu/links/variants/140	DDR2	4921	L239R	Activating mutations in DDR2, including L239R, has been shown to be sensitive to dasatinib in cell lines.		1	162729630	162729630	T	G	ENST00000367922.3	75	GRCh37					missense_variant	ENST00000367922.3:c.716T>G,NC_000001.10:g.162729630T>G	2017-11-22 19:45:47 UTC
141	https://civic.genome.wustl.edu/links/variants/141	DDR2	4921	G253C	Activating mutations in DDR2, including G253C, has been shown to be sensitive to dasatinib in cell lines.		1	162729671	162729671	G	T	ENST00000367922.3	75	GRCh37					missense_variant	ENST00000367922.3:c.757G>T,NC_000001.10:g.162729671G>T	2017-11-22 19:45:47 UTC
142	https://civic.genome.wustl.edu/links/variants/142	DDR2	4921	G505S	Activating mutations in DDR2, including G505S, has been shown to be sensitive to dasatinib in cell lines.		1	162741822	162741822	G	A	ENST00000367922.3	75	GRCh37					missense_variant	NM_006182.2:c.1513G>A,NP_006173.2:p.Gly505Ser,ENST00000367922.3:c.1513G>A,NC_000001.10:g.162741822G>A	2017-11-22 19:45:48 UTC
143	https://civic.genome.wustl.edu/links/variants/143	DDR2	4921	I638F	DDR2 I638F has been shown to be a loss of function mutation, but also confers sensitivity to dasatinib in cell lines.		1	162745497	162745497	A	T	ENST00000367922.3	75	GRCh37					missense_variant	ENST00000367922.3:c.1912A>T,NC_000001.10:g.162745497A>T	2017-11-22 19:45:48 UTC
144	https://civic.genome.wustl.edu/links/variants/144	DDR2	4921	G774V	Activating mutations in DDR2, including G774V, has been shown to be sensitive to dasatinib in cell lines.		1	162748407	162748407	G	T	ENST00000367922.3	75	GRCh37					missense_variant	ENST00000367922.3:c.2321G>T,NC_000001.10:g.162748407G>T	2017-11-22 19:45:48 UTC
145	https://civic.genome.wustl.edu/links/variants/145	DDR2	4921	S768R	Activating mutations in DDR2, including S768R, has been shown to be sensitive to dasatinib in cell lines.		1	162748390	162748390	T	A	ENST00000367922.3	75	GRCh37					missense_variant	ENST00000367922.3:c.2304T>A,NC_000001.10:g.162748390T>A	2017-11-22 19:45:51 UTC
148	https://civic.genome.wustl.edu/links/variants/148	KRAS	3845	G12A	KRAS G12A, like EGFR T790M, has been shown to be capable of driving acquired resistance to tyrosine kinase inhibitors in lung adenocarcinoma.	EGFR TKI Resistance	12	25398284	25398284	C	G	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.35G>C,NP_004976.2:p.Gly12Ala,NC_000012.11:g.25398284C>G,ENST00000256078.4:c.35G>C	2017-11-22 19:45:48 UTC
151	https://civic.genome.wustl.edu/links/variants/151	BCL2	596	IGH-BCL2	The typically reciprocal t(14;18)(q32;q21) translocation involves rearrangement between the immunoglobulin heavy chain locus on chromosome 14 and the 3' UTR of BCL2 on chromosome 18, leading to the overexpression of BCL2. This rearrangment is observed in >80% of patients with follicular lymphoma.		14	106032614	107288051				75	GRCh37	18	60794268	60987019	ENST00000333681.4	transcript_regulatory_region_fusion		2017-11-22 19:45:52 UTC
152	https://civic.genome.wustl.edu/links/variants/152	BCL2	596	EXPRESSION			18	60790579	60987361			ENST00000398117.1	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
153	https://civic.genome.wustl.edu/links/variants/153	FOXP1	27086	AMPLIFICATION	Amplication in FOXP1 has been shown to be associated with the ABC subtype of DLBCL.		3	71003844	71633140			ENST00000318789.4	75	GRCh37					transcript_amplification		2017-11-22 19:45:48 UTC
154	https://civic.genome.wustl.edu/links/variants/154	REL	5966	AMPLIFICATION			2	61108709	61149800			ENST00000295025.8	75	GRCh37					transcript_amplification		2017-11-22 19:45:48 UTC
155	https://civic.genome.wustl.edu/links/variants/155	RUNX1	861	MUTATION	RUNX1 mutations are associated with poor prognosis in patients with acute myeloid leukemia or adult T-cell acute lymphocytic leukemia. In younger (<60 years old) AML patients, allogeneic stem cell transplant at complete remission led to much better relapse-free survival than repetitive cycles of high-dose cytarabine.		21	36160098	36421641			ENST00000300305.3	75	GRCh37					loss_of_function_variant,transcript_variant		2017-11-22 19:45:53 UTC
156	https://civic.genome.wustl.edu/links/variants/156	IGF2	3481	OVEREXPRESSION			11	2150348	2170833			ENST00000300632.5	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
157	https://civic.genome.wustl.edu/links/variants/157	TET2	54790	MUTATION	TET2 mutations are commonly found in acute myeloid leukemia occurring in 9-23% of cases with many occurring in the elderly. Generally these mutations are loss-of-function which have been shown in mouse models to impair hematopoietic stem cell differentiation and cause aberrant hematopoiesis. These mutations have been found to be mutually exclusive with MLL and IDH1/2 mutations and have been associated with shortened event-free-survival and disease-free-survival when co-occurring with NPM1+/FLT3- genotypes. Overall Survival has been found to be shorter when occurring with NPM1+/FLT3+ genotypes. Studies involving "CN AML" and "de novo AML" however have been unable to elucidate a clinical impact.		4	106067450	106200973			ENST00000513237.1	75	GRCh37					loss_of_function_variant,gene_variant		2017-11-22 19:46:08 UTC
158	https://civic.genome.wustl.edu/links/variants/158	AURKA	6790	EXPRESSION			20	54944446	54967393			ENST00000395913.3	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
159	https://civic.genome.wustl.edu/links/variants/159	VHL	7428	LOSS-OF-FUNCTION			3	10182692	10193904			ENST00000256474.2	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:48 UTC
160	https://civic.genome.wustl.edu/links/variants/160	VHL	7428	MUTATION			3	10182692	10193904			ENST00000256474.2	75	GRCh37					loss_of_function_variant,gene_variant		2017-11-22 19:45:48 UTC
161	https://civic.genome.wustl.edu/links/variants/161	PBRM1	55193	MUTATION			3	52581857	52719852			ENST00000394830.3	75	GRCh37					transcription_variant,loss_of_function_variant		2017-11-22 19:45:48 UTC
163	https://civic.genome.wustl.edu/links/variants/163	EZH2	2146	MUTATION			7	148504477	148581370			ENST00000320356.2	75	GRCh37					protein_altering_variant		2017-11-22 19:45:48 UTC
164	https://civic.genome.wustl.edu/links/variants/164	FLI1	2313	EWSR1-FLI1 Type 1	Although multiple fusion transcripts have been described, type 1 consists of EWSR1 exon 7 fused to FLI1 exon 6, the most common arrangement in Ewings Sarcoma.		22	29664007	29683123			ENST00000397938.2	75	GRCh37	11	128675261	128683162	ENST00000527786.2	transcript_fusion		2017-11-22 19:45:53 UTC
165	https://civic.genome.wustl.edu/links/variants/165	EZH2	2146	Y646	Mutations of Y646 are associated with a diagnosis of Germinal Center B type DLBCL and Follicular non-Hodgkin Lymphoma. In vitro experimental findings suggest that this may be due to reduced methyltransferase activity of EZH2 on protein H3K27 (Morin et al., 2010).		7	148508726	148508728			ENST00000320356.2	75	GRCh37					protein_altering_variant		2017-11-22 19:45:49 UTC
167	https://civic.genome.wustl.edu/links/variants/167	KMT2D	8085	LOSS-OF-FUNCTION			12	49412758	49449107			ENST00000301067.7	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:49 UTC
168	https://civic.genome.wustl.edu/links/variants/168	BTK	695	C481S			X	100611165	100611165	A	T	ENST00000308731.7	75	GRCh37					missense_variant	ENST00000308731.7:c.1441T>A,NC_000023.10:g.100611165A>T,NM_000061.2:c.1441T>A,NP_000052.1:p.Cys481Ser	2017-11-22 19:45:49 UTC
169	https://civic.genome.wustl.edu/links/variants/169	AKT1	207	Q79K			14	105243048	105243048	G	T	ENST00000407796.2	75	GRCh37					missense_variant	NC_000014.8:g.105243048G>T,NM_001014432.1:c.235C>A,NP_001014432.1:p.Gln79Lys,ENST00000407796.2:c.235C>A	2017-11-22 19:45:50 UTC
170	https://civic.genome.wustl.edu/links/variants/170	ALK	238	EML4-ALK AMPLIFICATION			2	42396490	42528380			ENST00000318522.5	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion,transcript_amplification		2017-11-22 19:45:50 UTC
171	https://civic.genome.wustl.edu/links/variants/171	ALK	238	ALK FUSION G1202R	ALK fusion with G1202R mutation in the ALK kinase domain was first identified in a lung adenocarcinoma patient who had progressed after 10 months of responding to crizotinib. Further characterization of this variant verified crizotinib resistance and additionally demonstrated resistance to multiple next generation ALK inhibitors including ceritinib, alectinib and brigatinib. Experiments using the HSP90 inhibitor  17-AAG have indicated potential sensitivity of EML4-ALK G1202R to this drug, suggesting this variant may be an HSP90 client protein.		2	29443613	29443613	C	T	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	ENST00000389048.3:c.3604G>A,NC_000002.11:g.29443613C>T,NM_004304.4:c.3604G>A,NP_004295.2:p.Gly1202Arg	2017-11-22 19:45:52 UTC
172	https://civic.genome.wustl.edu/links/variants/172	ALK	238	EML4-ALK S1206Y		Crizotinib Resistance	2	29443600	29443600	G	T	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	ENST00000389048.3:c.3617C>A,NC_000002.11:g.29443600G>T,NM_004304.4:c.3617C>A,NP_004295.2:p.Ser1206Tyr	2017-11-22 19:45:50 UTC
173	https://civic.genome.wustl.edu/links/variants/173	ALK	238	EML4-ALK T1151INST	The ALK fusion variant with insertion of T at amino acid 1151 was found in an ALK rearranged lung adenocarcinoma which had progressed after responding to crizotinib treatment. The mutation was absent in tumor sample taken before crizotinib treatment. Characterization of the variant using cell lines expressing EML4-ALK with 1151 T insert found the variant to be highly crizotinib resistant, and other work demonstrated resistance to next generation inhibitor alectinib, while resistance to tool compound TAE684 indicates potential resistance to the next generation ALK inhibitor ceritinib which is derived from TAE684. Other experiments suggest theraputic potential for HSP90 inhibitors, as EML4-ALK T1151 Tins sensitivity to 17-AAG has been observed.		2	29445271	29445272		CGT	ENST00000389048.3	75	GRCh37					transcript_fusion,inframe_insertion	NC_000002.11:g.29445271_29445272insCGT	2017-11-22 19:45:53 UTC
174	https://civic.genome.wustl.edu/links/variants/174	APC	324	MUTATION			5	112043218	112181936			ENST00000457016.1	75	GRCh37							2017-11-22 19:45:50 UTC
175	https://civic.genome.wustl.edu/links/variants/175	AR	367	F877L			X	66943549	66943549	T	C	ENST00000374690.3	75	GRCh37					missense_variant	ENST00000374690.3:c.2629T>C,NC_000023.10:g.66943549T>C,NM_000044.4:c.2629T>C,NP_000035.2:p.Phe877Leu	2017-11-22 19:45:48 UTC
176	https://civic.genome.wustl.edu/links/variants/176	AR	367	W742			X	66937370	66937372			ENST00000374690.3	75	GRCh37					missense_variant		2017-11-22 19:45:50 UTC
177	https://civic.genome.wustl.edu/links/variants/177	ASXL1	171023	MUTATION	ASXL1 mutations are most frequently observed in the absence of FLT3-ITD and NPM1 mutations in acute myeloid leukemia (AML) patients and seem to be enriched in older patients (>60 years). These mutations are associated with poor prognosis with respect to both survival and compete remission rates.		20	30946155	31027122			ENST00000375687.4	75	GRCh37					protein_altering_variant		2017-11-22 19:45:53 UTC
178	https://civic.genome.wustl.edu/links/variants/178	ATM	472	MUTATION			11	108093559	108239826			ENST00000278616.4	75	GRCh37					transcription_variant,loss_of_function_variant		2017-11-22 19:45:50 UTC
179	https://civic.genome.wustl.edu/links/variants/179	ATM	472	UNDEREXPRESSION			11	108093559	108239826			ENST00000278616.4	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
180	https://civic.genome.wustl.edu/links/variants/180	AURKA	6790	AMPLIFICATION			20	54944446	54967393			ENST00000395913.3	75	GRCh37					transcript_amplification		2017-11-22 19:45:47 UTC
181	https://civic.genome.wustl.edu/links/variants/181	AURKA	6790	OVEREXPRESSION			20	54944446	54967393			ENST00000395913.3	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
182	https://civic.genome.wustl.edu/links/variants/182	BAP1	8314	EXPRESSION			3	52435029	52444366			ENST00000460680.1	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
183	https://civic.genome.wustl.edu/links/variants/183	BAP1	8314	MUTATION	BAP1 is a tumor suppressor gene, mutations in this gene have been observed in a number of cancers including melanoma, and renal cancers. These mutations generally lead to loss-of-function and mutations in the UHC domain of BAP1 have been shown to lead to structural instability and -amyloid aggregation in models. Germline mutations are associated with an increased risk of tumorgenesis and can lead to the development of "atypical Spitz tumours (ASTs), cutaneous melanoma (CM), epithelioid malignant mesothelioma (MM) and clear cell RCC".		3	52435029	52444366			ENST00000460680.1	75	GRCh37					loss_of_function_variant,protein_altering_variant		2017-11-22 19:46:06 UTC
184	https://civic.genome.wustl.edu/links/variants/184	BRAF	673	AKAP9-BRAF		BRAF Fusions	7	91570181	91625114			ENST00000356239.3	75	GRCh37	7	140434279	140487384	ENST00000288602.6	transcript_fusion		2017-11-22 19:45:50 UTC
185	https://civic.genome.wustl.edu/links/variants/185	BRCA1	672	MUTATION			17	41196312	41277387			ENST00000357654.3	75	GRCh37					loss_of_function_variant,gene_variant		2017-11-22 19:45:50 UTC
186	https://civic.genome.wustl.edu/links/variants/186	BRCA2	675	MUTATION			13	32889611	32973347			ENST00000380152.3	75	GRCh37					loss_of_function_variant,gene_variant		2017-11-22 19:45:50 UTC
187	https://civic.genome.wustl.edu/links/variants/187	CCNE1	898	AMPLIFICATION			19	30302805	30315215			ENST00000262643.3	75	GRCh37					transcript_amplification		2017-11-22 19:45:50 UTC
189	https://civic.genome.wustl.edu/links/variants/189	DNMT3A	1788	MUTATION	DNMT3A mutations occur in a variety of myeloid malignancies. These mutations are associated with adverse prognosis in acute myeloid leukemia (AML), particularly in the context of NPM1 and FLT3-ITD mutations, which often co-occur. Early results indicate AML patients with DNMT3A mutations may respond better to decitabine than those with wild-type. Shorter survival has been indicated in patients with T-cell acute lymphoblastic leukemia and myelodysplastic syndrome, however, larger cohorts are required to verify this finding. DNMT3A mutations have been suggested as a pre-leukemic lesion and found in older individuals with clonal hematopoiesis but no overt malignancy.		2	25455845	25565459			ENST00000264709.3	75	GRCh37					transcript_variant		2017-11-22 19:45:47 UTC
190	https://civic.genome.wustl.edu/links/variants/190	EGFR	1956	AMPLIFICATION			7	55086794	55279321			ENST00000275493.2	75	GRCh37					transcript_amplification		2017-11-22 19:45:50 UTC
191	https://civic.genome.wustl.edu/links/variants/191	EGFR	1956	COPY NUMBER VARIATION			7	55086794	55279321			ENST00000275493.2	75	GRCh37					copy_number_change		2017-11-22 19:45:50 UTC
193	https://civic.genome.wustl.edu/links/variants/193	EGFR	1956	OVEREXPRESSION			7	55086794	55279321			ENST00000275493.2	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
194	https://civic.genome.wustl.edu/links/variants/194	ERG	2078	EWSR1-ERG	EWSR1-ERG is found in 5% of patients with Ewing Sarcoma and considered to be diagnostic of this disease, a small tumor more often found in bone, but less frequently in soft tissue. To better identify EWSR1-ERG in patients, conventional cytogenetics methods were analyzed: FISH and RT-PCR. Ultimately concluding that more than one method is needed to accurately diagnose patients due to the strengths and weaknesses of each individual method.		22	29664007	29683123			ENST00000397938.2	75	GRCh37	21	39751949	39755845	ENST00000398907.1	transcript_fusion		2017-11-22 19:45:52 UTC
195	https://civic.genome.wustl.edu/links/variants/195	ERG	2078	TMPRSS2-ERG	TMPRSS2 fusions are prevalent in Prostate Cancer. TMPRSS2 fusion with ETS family members such as ERG are among the most common. Fusion of TMPRSS2 with ERG may result in overexpression of ERG driven by the TMPRSS2 androgen-responsive promoter elements. Due to the high prevalence of this fusion, it may have diagnostic utility for prostate cancer, especially ERG expression positive prostate cancer.		21	42879877	42879992			ENST00000398585.3	75	GRCh37	21	39751949	39817544	ENST00000398910.1	transcript_fusion		2017-11-22 19:45:50 UTC
196	https://civic.genome.wustl.edu/links/variants/196	FGFR3	2261	Y375C			4	1806099	1806099	A	G	ENST00000340107.4	75	GRCh37					missense_variant	NC_000004.11:g.1806099A>G	2017-11-22 19:45:50 UTC
197	https://civic.genome.wustl.edu/links/variants/197	FLI1	2313	EWSR1-FLI1			22	29664007	29683123			ENST00000397938.2	75	GRCh37	11	128651853	128683162	ENST00000527786.2	transcript_fusion		2017-11-22 19:45:50 UTC
198	https://civic.genome.wustl.edu/links/variants/198	FOXL2	668	C134W	The variant C134W on the FOXL2 gene was revealed to have a high frequency (95-97%) in the adult form of granulosa cell tumors that comprises 5% of ovarian cancers. Due to the mutation's high frequency, future therapeutics might target for this single apparent mechanism. However, the consequence of this mutation remain unknown.		3	138665163	138665163	G	C	ENST00000330315.3	75	GRCh37					missense_variant	NC_000003.11:g.138665163G>C	2017-11-22 19:45:50 UTC
199	https://civic.genome.wustl.edu/links/variants/199	IDH2	3418	R172	IDH2 R172 is a gain-of-function mutation commonly observed in acute myeloid leukemia and is enriched in those patients which are cytogenetically normal. R172 is analogous to IDH1 R132 mutations and leads to neomorphic enzymatic activity. Specifically this mutation "catalyzes the conversion of alpha ketoglurarate to beta-hydrozyglutarate" leading to increased levels of beta-hydrozyglutarate. This in turn leads to hypermethylation of target genes and an inhibition of cellular differentiation. R172 mutations generally lead to worse overall survival and higher rates of relapse compared to the most common IDH2 mutations in AML (R140).		15	90631837	90631839			ENST00000330062.3	75	GRCh37					protein_altering_variant		2017-11-22 19:46:07 UTC
200	https://civic.genome.wustl.edu/links/variants/200	IKZF1	10320	DELETION	IKZF1 deletions have been reported in a variety of cancer types including pediatric B-cell precursor acute lymphoblastic leukemia (BCP ALL), Chronic Myeloid Leukemia, diffuse large B-cell lymphoma, myelodysplastic syndrome, T-cell ALL as well as solid tumors of the large intestine, lung, and liver. The clinical impact of these deletions is unknown for many cancer types however a poor outcome has been observed in leukemia based disease. This gene has been strongly implicated as a regulator for "normal  hematopoiesis". In regards to BCP ALL, mouse models have shown that mutations in IKZF1 are not sufficient in and of themselves to cause disease.  Haploinsuffeciency in combination with BCR-ABL1 however, will accelerate leukemiagenesis possibly indicating that at least in regards to BCP ALL these are secondary events that may be necessary for the development of leukaemic clones.		7	50344378	50472799			ENST00000331340.3	75	GRCh37					transcript_ablation		2017-11-22 19:46:06 UTC
201	https://civic.genome.wustl.edu/links/variants/201	KIT	3815	M541L			4	55593464	55593464	A	C	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1621A>C,NP_000213.1:p.Met541Leu,ENST00000288135.5:c.1621A>C,NC_000004.11:g.55593464A>C	2017-11-22 19:45:50 UTC
202	https://civic.genome.wustl.edu/links/variants/202	KIT	3815	V560DEL			4	55593612	55593614	GTT		ENST00000288135.5	75	GRCh37					inframe_deletion,amino_acid_deletion	NC_000004.11:g.55593612_55593614del	2017-11-22 19:45:50 UTC
203	https://civic.genome.wustl.edu/links/variants/203	KRAS	3845	Q61			12	25380275	25380277			ENST00000256078.4	75	GRCh37					protein_altering_variant		2017-11-22 19:45:50 UTC
204	https://civic.genome.wustl.edu/links/variants/204	NCOA3	8202	AMPLIFICATION			20	46130646	46285621			ENST00000372004.3	75	GRCh37					transcript_amplification		2017-11-22 19:45:50 UTC
205	https://civic.genome.wustl.edu/links/variants/205	NCOA3	8202	OVEREXPRESSION			20	46130646	46285621			ENST00000372004.3	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
206	https://civic.genome.wustl.edu/links/variants/206	NOTCH1	4851	MUTATION			9	139388896	139440314			ENST00000277541.6	75	GRCh37					protein_altering_variant		2017-11-22 19:45:50 UTC
207	https://civic.genome.wustl.edu/links/variants/207	NOTCH1	4851	P2514FS	This mutation disrupts the C-terminal PEST domain that in normal conditions promotes degradation,  resulting in accumulation of an active NOTCH1 isoform sustaining deregulated signaling.		9	139390649	139390650			ENST00000277541.6	75	GRCh37					frameshift_truncation	NC_000009.11:g.139390649_139390650del	2017-11-22 19:45:50 UTC
208	https://civic.genome.wustl.edu/links/variants/208	NRAS	4893	MUTATION			1	115247090	115259515			ENST00000369535.4	75	GRCh37					gain_of_function_variant,transcript_variant		2017-11-22 19:45:50 UTC
209	https://civic.genome.wustl.edu/links/variants/209	PAX8	7849	PAX8-PPARG	PAX8-PPAR gamma is a oncogene caused by a translocation between 2q13 and 3p25 resulting in an in-frame fusion between the two genes. It has been observed in Follicular Thyroid Cancer (FTC) and is one of two known fusion products involving PPAR gamma in FTC indicating this region may be a breakpoint hotspot. Studies have indicated that the fusion product increases cell viability and proliferation and decreases apoptosis.		2	114036521	113992971			ENST00000429538.3	75	GRCh37	3	12329400	12475810	ENST00000397015.2	transcript_fusion		2017-11-22 19:45:54 UTC
210	https://civic.genome.wustl.edu/links/variants/210	PGR	5241	EXPRESSION			11	100900355	101001255			ENST00000325455.5	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
212	https://civic.genome.wustl.edu/links/variants/212	PIK3CA	5290	AMPLIFICATION			3	178866311	178957881			ENST00000263967.3	75	GRCh37					transcript_amplification		2017-11-22 19:45:50 UTC
213	https://civic.genome.wustl.edu/links/variants/213	PTEN	5728	DELETION			10	89622870	89731687			ENST00000371953.3	75	GRCh37					transcript_ablation		2017-11-22 19:45:50 UTC
214	https://civic.genome.wustl.edu/links/variants/214	PTEN	5728	LOSS			10	89622870	89731687			ENST00000371953.3	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:50 UTC
215	https://civic.genome.wustl.edu/links/variants/215	SF3B1	23451	MUTATION			2	198254508	198299815			ENST00000335508.6	75	GRCh37					protein_altering_variant		2017-11-22 19:45:50 UTC
216	https://civic.genome.wustl.edu/links/variants/216	SMAD4	4089	MUTATION			18	48556583	48611409			ENST00000342988.3	75	GRCh37					loss_of_function_variant,transcript_variant		2017-11-22 19:45:48 UTC
217	https://civic.genome.wustl.edu/links/variants/217	SMARCA4	6597	MUTATION			19	11071598	11172958			ENST00000358026.2	75	GRCh37					loss_of_function_variant,gene_variant		2017-11-22 19:45:48 UTC
218	https://civic.genome.wustl.edu/links/variants/218	SMARCA4	6597	INACTIVATING MUTATION			19	11071598	11172958			ENST00000358026.2	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:47 UTC
219	https://civic.genome.wustl.edu/links/variants/219	TERT	7015	AMPLIFICATION			5	1253282	1295162			ENST00000310581.5	75	GRCh37					transcript_amplification		2017-11-22 19:45:47 UTC
220	https://civic.genome.wustl.edu/links/variants/220	TERT	7015	PROMOTER MUTATION	TERT promoter mutations are activating and commonly found at two hotspots within the TERT promoter region which occur 124 and 146 base pairs (hg19) upstream of the translation start site. These hotspots, termed C228T and C250T are observed in many cancer types and have a particularly high prevalence in glioblastoma (83%), melanoma (71%), bladder cancer (66%) and hepatocelluar carcinoma (HCC) (47%). The two mutations are usually heterozygous and mutually exclusive and result in an increased similarity to an ETS binding domain and may act as a binding site to an ETS transcription factor. These mutations are thought to be early events in tumorgenesis and aid in cellular immortality. Decreased overall survival in patients with these mutations have been observed in medulloblastoma, thyroid cancer, urogenital cancer, melanoma, and laryngeal tumors. The presence of these mutations has also been shown to be predictive of malignant/premalignant nodules in HCC and meningiomas.		5	1295161	1295373			ENST00000310581.5	75	GRCh37					regulatory_region_variant		2017-11-22 19:46:06 UTC
221	https://civic.genome.wustl.edu/links/variants/221	TP53	7157	DELETERIOUS MUTATION	Deleterious mutations are mutations of TP53 with prior characterization demonstrating significant deleterious effect on TP53 protein function. Inactivating TP53 mutations prevent on target activity and efficacy of MDM2-TP53 interaction inhibitors.		17	7571720	7590856			ENST00000269305.4	75	GRCh37							2017-11-22 19:46:06 UTC
222	https://civic.genome.wustl.edu/links/variants/222	TP53	7157	MUTATION			17	7571720	7590856			ENST00000269305.4	75	GRCh37					protein_altering_variant		2017-11-22 19:45:48 UTC
223	https://civic.genome.wustl.edu/links/variants/223	TP53	7157	TRUNCATING MUTATION			17	7573998	7579714			ENST00000269305.4	75	GRCh37					frameshift_truncation		2017-11-22 19:45:47 UTC
224	https://civic.genome.wustl.edu/links/variants/224	TTF1	7270	AMPLIFICATION			9	135251008	135282209			ENST00000334270.2	75	GRCh37					transcript_amplification		2017-11-22 19:45:47 UTC
230	https://civic.genome.wustl.edu/links/variants/230	CHEK2	11200	LOSS-OF-FUNCTION			22	29083732	29137832			ENST00000328354.6	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:50 UTC
236	https://civic.genome.wustl.edu/links/variants/236	CDK12	51755	LOSS-OF-FUNCTION			17	37618292	37691399			ENST00000447079.4	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:50 UTC
238	https://civic.genome.wustl.edu/links/variants/238	NT5C2	22978	R367Q			10	104852955	104852955	C	T	ENST00000343289.5	75	GRCh37					missense_variant	NC_000010.10:g.104852955C>T	2017-11-22 19:45:50 UTC
239	https://civic.genome.wustl.edu/links/variants/239	NT5C2	22978	K359Q			10	104852980	104852980	T	G	ENST00000343289.5	75	GRCh37					missense_variant	NC_000010.10:g.104852980T>G,NM_012229.4:c.1075A>C,NP_036361.1:p.Lys359Gln,ENST00000343289.5:c.1075A>C	2017-11-22 19:45:50 UTC
240	https://civic.genome.wustl.edu/links/variants/240	NT5C2	22978	D407A			10	104850745	104850745	T	G	ENST00000343289.5	75	GRCh37					missense_variant	NC_000010.10:g.104850745T>G,NM_012229.4:c.1220A>C,NP_036361.1:p.Asp407Ala,ENST00000343289.5:c.1220A>C	2017-11-22 19:45:50 UTC
241	https://civic.genome.wustl.edu/links/variants/241	ABL1	25	BCR-ABL F317L	BCR-ABL F317L, like the similar BCR-ABL T315I mutation, is becoming a common clinical marker for resistance to front-line therapies in CML. It has been shown to confer resistance to dasatinib, but responds well to ponatinib and other second generation inhibitors.	Imatinib Resistance	9	133748288	133748288	T	C	ENST00000318560.5	75	GRCh37					transcript_fusion,missense_variant	NC_000009.11:g.133748288T>C,NP_005148.2:p.Phe317Leu,NM_005157.5:c.949T>C,ENST00000318560.5:c.949T>C	2017-11-22 19:45:50 UTC
242	https://civic.genome.wustl.edu/links/variants/242	TP53	7157	DNA BINDING DOMAIN MUTATION			17	7577149	7578443			ENST00000269305.4	75	GRCh37					DNA_binding_site		2017-11-22 19:45:50 UTC
243	https://civic.genome.wustl.edu/links/variants/243	ATM	472	V2288FS*1	A frameshift mutation predicted to cause truncation before the C-terminal phosphoinositide 3-kinase (PI3K) catalytic domain.		11	108196840	108196841	TC		ENST00000278616.4	75	GRCh37					frameshift_truncation	ENST00000278616.4:c.6863_6864delTC	2017-11-22 19:46:01 UTC
244	https://civic.genome.wustl.edu/links/variants/244	ATM	472	N2875H	A missense mutation within the C-terminal phosphoinositide 3-kinase (PI3K) catalytic domain		11	108218044	108218044	A	C	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.8623A>C,NC_000011.9:g.108218044A>C,NM_000051.3:c.8623A>C,NP_000042.3:p.Asn2875His	2017-11-22 19:45:50 UTC
245	https://civic.genome.wustl.edu/links/variants/245	NF2	4771	Y177FS			22	30051593	30051594		T	ENST00000338641.4	75	GRCh37					frameshift_elongation	ENST00000338641.4:c.527_528insT,NC_000022.10:g.30051593_30051594insT	2017-11-22 19:45:50 UTC
247	https://civic.genome.wustl.edu/links/variants/247	PDGFRA	5156	V561A			4	55141036	55141036	T	C	ENST00000257290.5	75	GRCh37					missense_variant	ENST00000257290.5:c.1682T>C,NC_000004.11:g.55141036T>C,NM_006206.5:c.1682T>C,NP_006197.1:p.Val561Ala	2017-11-22 19:45:50 UTC
248	https://civic.genome.wustl.edu/links/variants/248	TERT	7015	C228T			5	1295228	1295228	G	A	ENST00000310581.5	75	GRCh37					regulatory_region_variant	NC_000005.9:g.1295228G>A	2017-11-22 19:45:51 UTC
249	https://civic.genome.wustl.edu/links/variants/249	XRCC1	7515	R194W			19	44057574	44057574	G	A	ENST00000262887.5	75	GRCh37					missense_variant	NC_000019.9:g.44057574G>A	2017-11-22 19:45:51 UTC
250	https://civic.genome.wustl.edu/links/variants/250	GSTP1	2950	DELETION			11	67351066	67354131			ENST00000398606.3	75	GRCh37					transcript_ablation		2017-11-22 19:45:50 UTC
251	https://civic.genome.wustl.edu/links/variants/251	BIRC7	79444	AMPLIFICATION			20	61867235	61871859			ENST00000217169.3	75	GRCh37					transcript_amplification		2017-11-22 19:45:51 UTC
252	https://civic.genome.wustl.edu/links/variants/252	EGFR	1956	EXON 4 DELETION			7	55214299	55214433			ENST00000275493.2	75	GRCh37					exon_loss_variant	ENST00000275493.2:c.425_559del	2017-11-22 19:45:51 UTC
253	https://civic.genome.wustl.edu/links/variants/253	EGFR	1956	3' UTR MUTATION															3_prime_UTR_variant		2017-11-22 19:45:51 UTC
254	https://civic.genome.wustl.edu/links/variants/254	KRAS	3845	RS61764370	Germline variant in the 3' UTR of KRAS that predicts resistance to platinum-based therapy.		12	25360224	25360224	A	C	ENST00000311936.3	75	GRCh37					3_prime_UTR_variant	NC_000012.11:g.25360224A>C	2017-11-22 19:45:47 UTC
255	https://civic.genome.wustl.edu/links/variants/255	ERCC5	2073	RS751402			13	103498198	103498199	A	G	ENST00000355739.4	75	GRCh37					5_prime_UTR_variant,SNP	NC_000013.10:g.103498198A>G	2017-11-22 19:45:51 UTC
256	https://civic.genome.wustl.edu/links/variants/256	KIT	3815	3' UTR MUTATION			4	55604724	55606881			ENST00000288135.5	75	GRCh37					3_prime_UTR_variant		2017-11-22 19:45:51 UTC
257	https://civic.genome.wustl.edu/links/variants/257	EZH2	2146	INTRON 6 MUTATION			7	148524359	148525831			ENST00000320356.2	75	GRCh37					intron_variant		2017-11-22 19:45:51 UTC
258	https://civic.genome.wustl.edu/links/variants/258	MTHFR	4524	A222V			1	11856378	11856378	G	A	ENST00000376592.1	75	GRCh37					missense_variant	NM_005957.4:c.665C>T,NP_005948.3:p.Ala222Val,ENST00000376592.1:c.665G>A,NC_000001.10:g.11856378G>A	2017-11-22 19:45:55 UTC
259	https://civic.genome.wustl.edu/links/variants/259	GSTP1	2950	I105V			11	67352689	67352689	A	G	ENST00000398606.3	75	GRCh37					missense_variant	NM_000852.3:c.313A>G,NP_000843.1:p.Ile105Val,ENST00000398606.3:c.313A>G,NC_000011.9:g.67352689A>G	2017-11-22 19:45:51 UTC
260	https://civic.genome.wustl.edu/links/variants/260	ABCG2	9429	Q141K			4	89052323	89052323	G	T	ENST00000237612.3	75	GRCh37					missense_variant	NC_000004.11:g.89052323G>T	2017-11-22 19:45:52 UTC
261	https://civic.genome.wustl.edu/links/variants/261	XRCC1	7515	Q399R			19	44055726	44055726	T	C	ENST00000262887.5	75	GRCh37					missense_variant	NM_006297.2:c.1196A>G,NP_006288.2:p.Gln399Arg,NC_000019.9:g.44055726T>C	2017-11-22 19:45:53 UTC
262	https://civic.genome.wustl.edu/links/variants/262	ABCB1	5243	S893T			7	87160618	87160618	A	T	ENST00000265724.3	75	GRCh37					missense_variant	NM_000927.4:c.2677T>A,NP_000918.2:p.Ser893Thr,NC_000007.13:g.87160618A>T,ENST00000265724.3:c.2677T>A	2017-11-22 19:45:51 UTC
263	https://civic.genome.wustl.edu/links/variants/263	ABCB1	5243	I1145I			7	87138645	87138645	A	G	ENST00000265724.3	75	GRCh37					synonymous_variant	NM_000927.4:c.3435T>C,NP_000918.2:p.Ile1145=,NC_000007.13:g.87138645A>G,ENST00000265724.3:c.3435T>C	2017-11-22 19:45:49 UTC
264	https://civic.genome.wustl.edu/links/variants/264	ERCC2	2068	K751Q			19	45854919	45854919	T	G	ENST00000391945.4	75	GRCh37					missense_variant	NC_000019.9:g.45854919T>G	2017-11-22 19:45:51 UTC
265	https://civic.genome.wustl.edu/links/variants/265	TYMS	7298	5' TANDEM REPEAT			18	657604	657742			ENST00000323274.10	75	GRCh37					5_prime_UTR_variant,short_tandem_repeat_variation		2017-11-22 19:45:50 UTC
266	https://civic.genome.wustl.edu/links/variants/266	LRP1B	53353	EXON 1222 DELETION			2	141665446	141777671			ENST00000389484.3	75	GRCh37					exon_loss_variant	ENST00000389484.3:c.1790_3520del	2017-11-22 19:45:51 UTC
267	https://civic.genome.wustl.edu/links/variants/267	FGFR1	2260	AMPLIFICATION	FGFR1 amplifications are the most common aberrations of the FGFR family in cancer. One study reports FGFR1 aberrations in 3.5% of 4,853 patients of which most are FGFR1 amplifications (Helsten et. al., 2016). Preclinically, FGFR1 amplifications have also been shown to confer sensitivity to FGFR1 inhibitors (Weiss et. al., 2010). Clinical studies are currently ongoing (e.g. NCT01004224).		8	38268656	38325363			ENST00000425967.3	75	GRCh37					transcript_amplification		2017-11-22 19:45:56 UTC
268	https://civic.genome.wustl.edu/links/variants/268	FGFR1	2260	EXPRESSION	FGFR1 high expression has been reported in 11.8% (178 patients) of oral squamous cell carcinoma patients, and was enriched in early stages (Freier et. al., 2007). Another study reports FGFR1 expression in 35% of primary HNSSC (353 patients) (Gke et. al., 2015). In both studies, FGFR1 gene amplification and expression do not correlate well with about 35% of samples with FGFR1 amplification overexpressing FGFR1 (Gke et. al., 2015). FGFR1 expression also correlated with sensitivity to FGFR1 inhibitors in preclinical models of lung cancer (Wynes et. al., 2014), HNSSC (Gke et. al., 2015) and urothelial carcinoma (Lamont et. al., 2011).		8	38268656	38325363			ENST00000425967.3	75	GRCh37					N/A		2017-11-22 19:46:00 UTC
269	https://civic.genome.wustl.edu/links/variants/269	ROS1	6098	REARRANGEMENT	ROS1 is a receptor tyrosine kinase that frequently forms gene fusions in several cancer types. Approximately 2% of NSCLC patients harbor a ROS1 gene fusion. Several fusion partners have been described with a constant ROS1-breakpoint, maintaining the kinase domain (Solomon B, 2015). Following case-studies and retrospective analyses, an expansion cohort of a phase-1 study showed clinical benefit of crizotinib in ROS1 rearranged NSCLC. The benefit was independent of the type of ROS1-rearrangement (Shaw et. al.,2014).		6	117609463	117747018			ENST00000368508.3	75	GRCh37					transcript_fusion		2017-11-22 19:45:47 UTC
270	https://civic.genome.wustl.edu/links/variants/270	MET	4233	AMPLIFICATION			7	116312459	116436396			ENST00000318493.6	75	GRCh37					transcript_amplification		2017-11-22 19:45:51 UTC
271	https://civic.genome.wustl.edu/links/variants/271	ATR	545	I774FS	Single A insertion or deletion in the 10 A mononucleotide run in exon 10 of ATR results in a frameshift of codon I774. In patients with endometrial cancer, this mutation has only been observed in patients with microsatellite instability.		3	142274740	142274740			ENST00000350721.4	75	GRCh37					frameshift_truncation	NC_000003.11:g.142274740del	2017-11-22 19:45:56 UTC
272	https://civic.genome.wustl.edu/links/variants/272	CDKN2A	1029	p16 EXPRESSION	CDKN2A (p16) expression is a surrogate marker of HPV infection in oropharyngeal squamous cell carcinoma. CDKN2A and p53 are inactivated through HPV proteins E6 and E7 and therefore not altered in expression level in HPV-associated carcinomas. However, there is no perfect overlap between p16 expression and HPV status with some 10-12.5% of HPV-negative tumors expressing p16. (Seiwert, T JCO, 2014). p16 positivity is a well-established positive prognostic factor in squamous cell cancer of the head and neck in the primary and, as increasing evidence suggests, recurrent/metastatic disease settings. Predictive information from HPV status have not been established to date. A lack of benefit from EGFR-inhibitors has been proposed by some studies. Other studies were not able to reproduce this finding.		9	21968055	21974865			ENST00000498124.1	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
273	https://civic.genome.wustl.edu/links/variants/273	RET	5979	KIF5B-RET	In a study by Takeuchi et. al. a fusion screen was performed in 1529 lung cancer samples. 14 adenocarcinomas with KIF5B-RET and CCDC6-RET fusions were identified. (Takeuchi K et. al., 2012)		10	32306071	32345359			ENST00000302418.4	75	GRCh37	10	43609928	43625799	ENST00000355710.3	transcript_fusion		2017-11-22 19:45:52 UTC
274	https://civic.genome.wustl.edu/links/variants/274	HRAS	3265	G13D			11	534285	534285	C	T	ENST00000451590.1	75	GRCh37					missense_variant	NC_000011.9:g.534285C>T,NP_005334.1:p.Gly13Asp,NM_005343.3:c.38G>A,ENST00000451590.1:c.38G>A	2017-11-22 19:45:51 UTC
275	https://civic.genome.wustl.edu/links/variants/275	HRAS	3265	MUTATION			11	533873	534289			ENST00000451590.1	75	GRCh37					coding_transcript_variant		2017-11-22 19:45:51 UTC
276	https://civic.genome.wustl.edu/links/variants/276	CD274	29126	EXPRESSION			9	5450525	5470547			ENST00000381577.3	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
277	https://civic.genome.wustl.edu/links/variants/277	MTOR	2475	MUTATION			1	11166592	11322564			ENST00000361445.4	75	GRCh37					protein_altering_variant		2017-11-22 19:45:51 UTC
278	https://civic.genome.wustl.edu/links/variants/278	AKT2	208	EXPRESSION			19	40736224	40791302			ENST00000392038.2	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
279	https://civic.genome.wustl.edu/links/variants/279	NF2	4771	K159FS*16			22	30050673	30050675			ENST00000338641.4	75	GRCh37					frameshift_truncation		2017-11-22 19:45:50 UTC
281	https://civic.genome.wustl.edu/links/variants/281	FBXW7	55294	MUTATION			4	153245446	153332714			ENST00000281708.4	75	GRCh37					loss_of_function_variant,protein_altering_variant		2017-11-22 19:45:51 UTC
282	https://civic.genome.wustl.edu/links/variants/282	SMAD4	4089	UNDEREXPRESSION			18	48556583	48611409			ENST00000342988.3	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
283	https://civic.genome.wustl.edu/links/variants/283	MTOR	2475	H1968Y			1	11188519	11188519	G	A	ENST00000361445.4	75	GRCh37					gain_of_function_variant,missense_variant	ENST00000361445.4:c.5902C>T,NC_000001.10:g.11188519G>A,NM_004958.3:c.5902C>T,NP_004949.1:p.His1968Tyr	2017-11-22 19:45:51 UTC
284	https://civic.genome.wustl.edu/links/variants/284	MTOR	2475	P2213S			1	11184580	11184580	G	A	ENST00000361445.4	75	GRCh37					gain_of_function_variant,missense_variant	ENST00000361445.4:c.6637C>T,NC_000001.10:g.11184580G>A,NM_004958.3:c.6637C>T,NP_004949.1:p.Pro2213Ser	2017-11-22 19:45:51 UTC
285	https://civic.genome.wustl.edu/links/variants/285	BRAF	673	AGK-BRAF		BRAF Fusions	7	141250989	141255367			ENST00000355413.4	75	GRCh37	7	140434279	140494267	ENST00000288602.6	transcript_fusion		2017-11-22 19:45:51 UTC
286	https://civic.genome.wustl.edu/links/variants/286	BRAF	673	PAPSS1-BRAF		BRAF Fusions	4	108603171	108641608			ENST00000265174.4	75	GRCh37	7	140434279	140487384	ENST00000288602.6	transcript_fusion,gene_fusion		2017-11-22 19:45:51 UTC
287	https://civic.genome.wustl.edu/links/variants/287	BRAF	673	TRIM24-BRAF		BRAF Fusions	7	138145079	138239711			ENST00000343526.4	75	GRCh37	7	140434279	140487384	ENST00000288602.6	transcript_fusion		2017-11-22 19:45:51 UTC
288	https://civic.genome.wustl.edu/links/variants/288	BRAF	673	L597R		Other V600's	7	140453145	140453145	A	C	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1790T>G,NP_004324.2:p.Leu597Arg,NC_000007.13:g.140453145A>C,ENST00000288602.6:c.1790T>G	2017-11-22 19:45:51 UTC
289	https://civic.genome.wustl.edu/links/variants/289	ERBB3	2065	OVEREXPRESSION			12	56473645	56497289			ENST00000267101.3	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
290	https://civic.genome.wustl.edu/links/variants/290	NT5E	4907	OVEREXPRESSION			6	86159809	86205496			ENST00000257770.3	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
291	https://civic.genome.wustl.edu/links/variants/291	EZH2	2146	OVEREXPRESSION			7	148504477	148581370			ENST00000320356.2	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
292	https://civic.genome.wustl.edu/links/variants/292	MYD88	4615	OVEREXPRESSION			3	38179969	38184510			ENST00000417037.2	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
294	https://civic.genome.wustl.edu/links/variants/294	PIK3CA	5290	P471L			3	178928226	178928226	C	T	ENST00000263967.3	75	GRCh37					missense_variant	ENST00000263967.3:c.1412C>T,NC_000003.11:g.178928226C>T,NM_006218.3:c.1412C>T,NP_006209.2:p.Pro471Leu	2017-11-22 19:45:51 UTC
295	https://civic.genome.wustl.edu/links/variants/295	RET	5979	EXPRESSION			10	43572475	43625799			ENST00000355710.3	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
296	https://civic.genome.wustl.edu/links/variants/296	RIT1	6016	OVEREXPRESSION			1	155870065	155880706			ENST00000368322.3	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
297	https://civic.genome.wustl.edu/links/variants/297	RIT1	6016	MUTATION			1	155870065	155880706			ENST00000368322.3	75	GRCh37					transcript_variant		2017-11-22 19:45:50 UTC
298	https://civic.genome.wustl.edu/links/variants/298	MYCN	4613	AMPLIFICATION			2	16080686	16087129			ENST00000281043.3	75	GRCh37					transcript_amplification		2017-11-22 19:45:51 UTC
299	https://civic.genome.wustl.edu/links/variants/299	SMO	6608	D473H			7	128849189	128849189	G	C	ENST00000249373.3	75	GRCh37					missense_variant	NM_005631.4:c.1417G>A,NP_005622.1:p.Asp473His,ENST00000249373.3:c.1417G>A,NC_000007.13:g.128849189G>C	2017-11-22 19:45:49 UTC
300	https://civic.genome.wustl.edu/links/variants/300	SMO	6608	MUTATION			7	128828713	128853386			ENST00000249373.3	75	GRCh37					coding_transcript_variant		2017-11-22 19:45:48 UTC
301	https://civic.genome.wustl.edu/links/variants/301	PTCH1	5727	MUTATION			9	98205262	98270943			ENST00000331920.6	75	GRCh37					loss_of_function_variant,gene_variant		2017-11-22 19:45:51 UTC
302	https://civic.genome.wustl.edu/links/variants/302	PTCH1	5727	LOH			9	98205262	98270943			ENST00000331920.6	75	GRCh37					loss_of_heterozygosity		2017-11-22 19:45:51 UTC
303	https://civic.genome.wustl.edu/links/variants/303	STK11	6794	EXON 1-2 MUTATION			19	1205740	1218499			ENST00000326873.7	75	GRCh37					exon_variant		2017-11-22 19:45:49 UTC
304	https://civic.genome.wustl.edu/links/variants/304	STK11	6794	UNDEREXPRESSION			19	1205740	1228428			ENST00000326873.7	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
305	https://civic.genome.wustl.edu/links/variants/305	SYK	6850	OVEREXPRESSION			9	93564069	93660831			ENST00000375754.4	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
306	https://civic.genome.wustl.edu/links/variants/306	ERBB2	2064	AMPLIFICATION	Her2 (ERBB2) amplifications are seen in up to 20% of breast cancers and were associated with aggressive disease and poor prognosis when discovered. Trastuzumab first found considerable success, and was approved for treatment, in HER2 positive metastatic breast cancer (MBC) which had progressed under chemotherapy.  These metastatic cancers nonetheless progressed under trastuzumab, and other forms of therapy were studied for next line treatments, including tyrosine kinase inhibitors.  Lapatinib, a reversible inhibitor of tyrosine kinase activity in ErbB1 and ErbB2, and afatinib, an irreversible inhibitor of all 4 ErbB forms were shown to have activity in trastuzumab-progressed HER2 MBC.  Interestingly trastuzumab itself also turned out to remain effective in treatment of trastuzumab-progressed HER2 MBC.  The LUX-Breast 1 trial compared a TKI-based treatment (afatinib) to a trastuzumab-based treatment of trastuzumab-progressed HER2 MBC, and the LUX-Breast 3 trial addressed TKI application in the context of HER2 MBC with difficult to treat brain metastases.  In neither of these cases was the TKI more effective, making successful future replacement of trastuzumab-based therapy with a TKI in trastuzumab-progressed HER2 MBC seem unlikely.  Instead, a potential role for TKIs in this disease context is revealed in preclinical work suggesting synergism between TKI and trastuzumab action, and clinical trials with lapatinib or afatinib combined with trastuzumab indicate that dual HER2 blockade may be an effective therapy.  Dual antibody HER2 blockade with pertuzumab instead of TKI in HER2 MBC has also recently shown strong results in the CLEOPATRA trial. HER2 overexpression is targeted in neoadjuvant breast cancer treatment, and has also been successfully targeted in gastric cancer.		17	37856333	37884915			ENST00000269571.5	75	GRCh37					transcript_amplification		2017-11-22 19:45:52 UTC
307	https://civic.genome.wustl.edu/links/variants/307	ALK	238	EML4-ALK L1152R			2	29445270	29445270	A	C	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	ENST00000389048.3:c.3455T>G,NC_000002.11:g.29445270A>C,NM_004304.4:c.3455T>G,NP_004295.2:p.Leu1152Arg	2017-11-22 19:45:51 UTC
308	https://civic.genome.wustl.edu/links/variants/308	ALK	238	EML4-ALK G1269A	The EML4-ALK G1269A mutation has been identified in non-small cell lung cancer patients resistant to crizotinib. Cell line data from multiple groups have shown this mutation enhances resistance to crizotinib treatment in vitro.		2	29432682	29432682	C	G	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	ENST00000389048.3:c.3806G>C,NC_000002.11:g.29432682C>G,NM_004304.4:c.3806G>C,NP_004295.2:p.Gly1269Ala	2017-11-22 19:45:53 UTC
309	https://civic.genome.wustl.edu/links/variants/309	EGFR	1956	AUTOCRINE ACTIVATION			7	55086794	55279321			ENST00000275493.2	75	GRCh37							2017-11-22 19:45:51 UTC
310	https://civic.genome.wustl.edu/links/variants/310	ERBB4	2066	MUTATION	ERBB4 mutations have been identified in melanoma, lung adenocarcinoma and medulloblastoma. In-vitro studies suggest that melanoma cell lines harboring an ERBB4 mutation are sensitive to ERBB4 inhibition with lapatinib.		2	212295697	212578308			ENST00000342788.4	75	GRCh37					gain_of_function_variant,transcript_variant		2017-11-22 19:45:54 UTC
311	https://civic.genome.wustl.edu/links/variants/311	PIK3CA	5290	MUTATION	PIK3CA mutations are observed in many cancers among the most prevalent are breast cancer,  colorectal cancer, and head and neck squamous cell carcinoma. These mutations have been observed in up to 40%, 20%, and 21% respectively for each of these cancer types with mutations commonly occurring within the helical exon 9 and kinase domain of exon 20. In breast cancer PIK3CA mutations have been associated with better prognosis, and a greater survival outcome, however the PI3K pathway is also associated with increased drug resistance ( trastuzumab/lapatinib). PIK3CA mutations in both HNSCC and CRC have been associated with resistance to anti-EGFR therapeutic agents and are associated with a poorer prognosis in CRC. Interestingly PIK3CA mutations in HNSCC have been observed to be absent from a number of ethnic groups including greek, german, and vietnamese populations.		3	178866311	178957881			ENST00000263967.3	75	GRCh37					gain_of_function_variant,transcript_variant		2017-11-22 19:46:06 UTC
312	https://civic.genome.wustl.edu/links/variants/312	EGFR	1956	VIII	The EGFRvIII variant is an oncogenic mutation that has been reported in several cancers including glioblastoma multiforme, breast, lung, head and neck, ovarian and prostate. In high-grade gliomas, EGFRvIII has been reported in about 30% of cases with EGFR amplification. The EGFRvIII mutation leads to deletion of the receptor ectodomain exons 2-7. The presence of this variant has been linked with clinical response to EGFR TKI. (Arteaga and Engelmann, 2014)		7	55087058	55223523			ENST00000275493.2	75	GRCh37					disruptive_inframe_deletion		2017-11-22 19:45:52 UTC
313	https://civic.genome.wustl.edu/links/variants/313	PTEN	5728	EXPRESSION			10	89622870	89731687			ENST00000371953.3	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
314	https://civic.genome.wustl.edu/links/variants/314	NRG1	3084	EXPRESSION			8	31497942	32622294			ENST00000523534.1	75	GRCh37					N/A		2017-11-22 19:45:46 UTC
315	https://civic.genome.wustl.edu/links/variants/315	AREG	374	EXPRESSION			4	75310851	75320726			ENST00000395748.3	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
316	https://civic.genome.wustl.edu/links/variants/316	TGFA	7039	EXPRESSION			2	70674412	70781147			ENST00000295400.6	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
317	https://civic.genome.wustl.edu/links/variants/317	EGFR	1956	G724S			7	55241722	55241722	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2170G>A,NC_000007.13:g.55241722G>A,NM_005228.4:c.2170G>A,NP_005219.2:p.Gly724Ser	2017-11-22 19:45:48 UTC
318	https://civic.genome.wustl.edu/links/variants/318	EREG	2069	EXPRESSION			4	75230860	75254468			ENST00000244869.2	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
319	https://civic.genome.wustl.edu/links/variants/319	EFNA2	1943	EXPRESSION			19	1286153	1301430			ENST00000215368.2	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
320	https://civic.genome.wustl.edu/links/variants/320	MAPK1	5594	E322K			22	22127164	22127164	C	T	ENST00000215832.6	75	GRCh37					gain_of_function_variant,missense_variant	ENST00000215832.6:c.964G>A,NC_000002.11:g.22127164C>T,NP_002736.3:p.Glu322Lys,NM_002745.4:c.964G>A	2017-11-22 19:46:08 UTC
321	https://civic.genome.wustl.edu/links/variants/321	MAPK1	5594	AMPLIFICATION			22	22108789	22221919			ENST00000215832.6	75	GRCh37					transcript_amplification		2017-11-22 19:45:49 UTC
322	https://civic.genome.wustl.edu/links/variants/322	KRAS	3845	A146V			12	25378561	25378561	G	A	ENST00000256078.4	75	GRCh37					missense_variant	ENST00000256078.4:c.437C>T,NC_000012.11:g.25378561G>A,NP_004976.2:p.Ala146Val,NM_004985.4:c.437C>T	2017-11-22 19:45:46 UTC
323	https://civic.genome.wustl.edu/links/variants/323	MET	4233	MUTATION			7	116312459	116436396			ENST00000318493.6	75	GRCh37					transcription_variant,gain_of_function_variant		2017-11-22 19:45:48 UTC
324	https://civic.genome.wustl.edu/links/variants/324	MET	4233	EXON 14 SKIPPING MUTATION	Exon 14 mutations have been observed in ~3% of patients with NSCLC (28/933 reported by Awad et al J Clin Onc 2016), confirmed to cause exon skipping when available, and associated with concurrent MET amplification. Responses to the c-MET inhibitor crizotinib have been reported in preclinical models and in individual case reports as well as a small-scale clinical trial (17 patients treated, Drilon et al., 2016 (suppl; abstr 108; ASCO ID 167889-176)). Larger studies are needed but enrollment of patients with MET exon 14 skipping mutation in trials with MET inhibitors or off-label treatment is encouraged (Paik et al., 2015 (suppl; abstr 8021)).		7	116411903	116412043			ENST00000318493.6	75	GRCh37					exon_loss_variant		2017-11-22 19:45:50 UTC
325	https://civic.genome.wustl.edu/links/variants/325	FGFR3	2261	EXPRESSION			4	1795039	1810599			ENST00000440486.2	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
326	https://civic.genome.wustl.edu/links/variants/326	CBLC	23624	EXPRESSION			19	45281126	45303891			ENST00000270279.3	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
327	https://civic.genome.wustl.edu/links/variants/327	PTPRD	5789	MUTATION			9	8314246	10033790			ENST00000381196.4	75	GRCh37					loss_of_function_variant,transcript_variant		2017-11-22 19:45:49 UTC
328	https://civic.genome.wustl.edu/links/variants/328	DEFA1	1667	EXPRESSION			8	6835172	6837602			ENST00000382692.2	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
329	https://civic.genome.wustl.edu/links/variants/329	ERCC1	2067	EXPRESSION			19	45916692	45926824			ENST00000013807.5	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
330	https://civic.genome.wustl.edu/links/variants/330	NOTCH1	4851	AMPLIFICATION			9	139388896	139440314			ENST00000277541.6	75	GRCh37					transcript_amplification		2017-11-22 19:45:50 UTC
331	https://civic.genome.wustl.edu/links/variants/331	WEE1	7465	POLYMORPHISM															intron_variant,polymorphic_sequence_variant		2017-11-22 19:45:50 UTC
332	https://civic.genome.wustl.edu/links/variants/332	FNTB	2342	RS11623866			14	65453063	65453063	G	C	ENST00000246166.2	75	GRCh37					regulatory_region_variant	NC_000014.8:g.65453063G>C	2017-11-22 19:45:50 UTC
333	https://civic.genome.wustl.edu/links/variants/333	PTPRT	11122	PROMOTER HYPERMETHYLATION															N/A		2017-11-22 19:45:46 UTC
334	https://civic.genome.wustl.edu/links/variants/334	VEGFA	7422	UNDEREXPRESSION			6	43738444	43752346			ENST00000372055.4	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
335	https://civic.genome.wustl.edu/links/variants/335	DNMT1	1786	EXPRESSION			19	10244022	10305811			ENST00000340748.4	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
336	https://civic.genome.wustl.edu/links/variants/336	KRAS	3845	MUTATION			12	25362365	25403737			ENST00000256078.4	75	GRCh37					protein_altering_variant		2017-11-22 19:45:46 UTC
337	https://civic.genome.wustl.edu/links/variants/337	PDCD4	27250	EXPRESSION	A new study, a retrospective analysis of 77 patients, has implicated PDCD4 expression in the sensitivity to paclitaxel. However, this finding came from a large proteome screen and has not yet been replicated in independent patient sets.		10	112631596	112659763			ENST00000393104.2	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
338	https://civic.genome.wustl.edu/links/variants/338	MGMT	4255	RS16906252			10	131265545	131265545	C	T	ENST00000306010.7	75	GRCh37					synonymous_variant	NC_000010.10:g.131265545C>T	2017-11-22 19:45:49 UTC
339	https://civic.genome.wustl.edu/links/variants/339	TFF3	7033	EXPRESSION			21	43731777	43735761			ENST00000518498.1	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
340	https://civic.genome.wustl.edu/links/variants/340	DKK1	22943	NUCLEAR EXPRESSION			10	54074056	54077417			ENST00000373970.3	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
341	https://civic.genome.wustl.edu/links/variants/341	CD44	960	ISOFORM EXPRESSION			11	35160728	35251574			ENST00000428726.2	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
342	https://civic.genome.wustl.edu/links/variants/342	EGF	1950	EXPRESSION			4	110834047	110933422			ENST00000265171.5	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
343	https://civic.genome.wustl.edu/links/variants/343	MDM2	4193	EXPRESSION			12	69201956	69239214			ENST00000462284.1	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
344	https://civic.genome.wustl.edu/links/variants/344	HMOX1	3162	EXPRESSION			22	35776828	35790207			ENST00000216117.8	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
345	https://civic.genome.wustl.edu/links/variants/345	SPHK1	8877	OVEREXPRESSION			17	74380731	74383936			ENST00000323374.4	75	GRCh37					N/A		2017-11-22 19:45:46 UTC
346	https://civic.genome.wustl.edu/links/variants/346	CASP8	841	EXPRESSION			2	202122759	202152434			ENST00000358485.4	75	GRCh37					N/A		2017-11-22 19:45:46 UTC
347	https://civic.genome.wustl.edu/links/variants/347	TYMS	7298	EXPRESSION			18	657604	673578			ENST00000323274.10	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
348	https://civic.genome.wustl.edu/links/variants/348	PBK	55872	OVEREXPRESSION			8	27667137	27695612			ENST00000301905.4	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
349	https://civic.genome.wustl.edu/links/variants/349	SMARCA4	6597	UNDEREXPRESSION			19	11071598	11172958			ENST00000358026.2	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
350	https://civic.genome.wustl.edu/links/variants/350	SETBP1	26040	EXON 4 MUTATION			18	42531877	42531918			ENST00000282030.5	75	GRCh37					exon_variant		2017-11-22 19:45:49 UTC
351	https://civic.genome.wustl.edu/links/variants/351	SETBP1	26040	G870S			18	42531913	42531913	G	A	ENST00000282030.5	75	GRCh37					missense_variant	NM_015559.2:c.2608G>A,NP_056374.2:p.Gly870Ser,ENST00000282030.5:c.2608G>A,NC_000018.9:g.42531913G>A	2017-11-22 19:45:49 UTC
352	https://civic.genome.wustl.edu/links/variants/352	ALK	238	EML4-ALK C1156YL1198F	EML4-ALK C1156Y alone is resistant to crizotinib in non-small cell lung cancer (NSCLC) which has been shown to be modulated (both increased sensitivity and resistance) by additional ALK mutations. A case report showed that an NSCLC harboring EML4-ALK C1156YL1198F was resistant to lorlatinib but this second mutation re-sensitized this tumor to crizotinib.		2	29443625	29445258			ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant		2017-11-22 19:45:50 UTC
354	https://civic.genome.wustl.edu/links/variants/354	EGFR	1956	EXPRESSION			7	55086794	55279321			ENST00000275493.2	75	GRCh37					N/A		2017-11-22 19:45:46 UTC
355	https://civic.genome.wustl.edu/links/variants/355	CDKN1A	1026	EXPRESSION			6	36646487	36655108			ENST00000405375.1	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
356	https://civic.genome.wustl.edu/links/variants/356	ALCAM	214	EXPRESSION			3	105085753	105295744			ENST00000306107.5	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
357	https://civic.genome.wustl.edu/links/variants/357	STMN1	3925	EXPRESSION			1	26211931	26232957			ENST00000426559.2	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
358	https://civic.genome.wustl.edu/links/variants/358	RSF1	51773	AMPLIFICATION			11	77371041	77532063			ENST00000308488.6	75	GRCh37					transcript_amplification		2017-11-22 19:45:49 UTC
359	https://civic.genome.wustl.edu/links/variants/359	AR	367	OVEREXPRESSION			X	66764465	66950461			ENST00000374690.3	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
360	https://civic.genome.wustl.edu/links/variants/360	CDKN1B	1027	CYTOPLASMIC MISLOCALIZATION			12	12870058	12875305			ENST00000228872.4	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
361	https://civic.genome.wustl.edu/links/variants/361	ERBB3	2065	EXPRESSION			12	56473645	56497289			ENST00000267101.3	75	GRCh37					N/A		2017-11-22 19:45:46 UTC
362	https://civic.genome.wustl.edu/links/variants/362	AR	367	SPLICE VARIANT 7			X	66764662	66915917			ENST00000504326.1	75	GRCh37							2017-11-22 19:45:48 UTC
363	https://civic.genome.wustl.edu/links/variants/363	UGT1A	7361	EXPRESSION			2	234526291	234681956			ENST00000373450.4	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
364	https://civic.genome.wustl.edu/links/variants/364	ERBB4	2066	NUCLEAR TRANSLOCATION			2	212240446	213403565			ENST00000342788.4	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
365	https://civic.genome.wustl.edu/links/variants/365	ERBB4	2066	EXPRESSION			2	212240446	213403565			ENST00000342788.4	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
366	https://civic.genome.wustl.edu/links/variants/366	SLFN11	91607	EXPRESSION			17	33677324	33700639			ENST00000394566.1	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
367	https://civic.genome.wustl.edu/links/variants/367	RAC1	5879	P29S			7	6426892	6426892	C	T	ENST00000356142.4	75	GRCh37					missense_variant	ENST00000356142.4:c.85C>T,NC_000007.13:g.6426892C>T	2017-11-22 19:45:46 UTC
368	https://civic.genome.wustl.edu/links/variants/368	BIRC5	332	NUCLEAR EXPRESSION			17	76210267	76221717			ENST00000301633.4	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
369	https://civic.genome.wustl.edu/links/variants/369	TP53	7157	WILD TYPE			17	7571720	7590856			ENST00000269305.4	75	GRCh37					wild_type		2017-11-22 19:45:48 UTC
370	https://civic.genome.wustl.edu/links/variants/370	MRE11	4361	LOSS			11	94152895	94227074			ENST00000323929.3	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:48 UTC
371	https://civic.genome.wustl.edu/links/variants/371	TOP1	7150	AMPLIFICATION			20	39657458	39753127			ENST00000361337.2	75	GRCh37					transcript_amplification		2017-11-22 19:45:46 UTC
372	https://civic.genome.wustl.edu/links/variants/372	CDKN1B	1027	EXPRESSION			12	12870058	12875305			ENST00000228872.4	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
373	https://civic.genome.wustl.edu/links/variants/373	AGR2	10551	EXPRESSION			7	16831435	16844704			ENST00000419304.2	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
374	https://civic.genome.wustl.edu/links/variants/374	NAPRT	93100	PROMOTER HYPERMETHYLATION															N/A		2017-11-22 19:45:49 UTC
375	https://civic.genome.wustl.edu/links/variants/375	EGFR	1956	EXON 18 OVEREXPRESSION			7	55237999	55238735			ENST00000344576.2	75	GRCh37					exon_variant		2017-11-22 19:45:49 UTC
376	https://civic.genome.wustl.edu/links/variants/376	ZEB1	6935	EXPRESSION			10	31608101	31818741			ENST00000361642.5	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
377	https://civic.genome.wustl.edu/links/variants/377	TIMP1	7076	OVEREXPRESSION			X	47441712	47446188			ENST00000218388.4	75	GRCh37					N/A		2017-11-22 19:45:46 UTC
378	https://civic.genome.wustl.edu/links/variants/378	PTP4A3	11156	OVEREXPRESSION			8	142402093	142441394			ENST00000521578.1	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
379	https://civic.genome.wustl.edu/links/variants/379	TYMS	7298	AMPLIFICATION			18	657604	673578			ENST00000323274.10	75	GRCh37					transcript_amplification		2017-11-22 19:45:48 UTC
380	https://civic.genome.wustl.edu/links/variants/380	IGF1R	3480	EXPRESSION			15	99192200	99507759			ENST00000268035.6	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
381	https://civic.genome.wustl.edu/links/variants/381	EPHB4	2050	EXPRESSION			7	100400187	100425121			ENST00000358173.3	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
382	https://civic.genome.wustl.edu/links/variants/382	TYMS	7298	UNDEREXPRESSION			18	657604	673578			ENST00000323274.10	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
383	https://civic.genome.wustl.edu/links/variants/383	TOP2A	7153	EXPRESSION			17	38544768	38574202			ENST00000423485.1	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
384	https://civic.genome.wustl.edu/links/variants/384	TOP1	7150	EXPRESSION			20	39657458	39753127			ENST00000361337.2	75	GRCh37					N/A		2017-11-22 19:45:46 UTC
385	https://civic.genome.wustl.edu/links/variants/385	PRKAA2	5563	T172 PHOSPHORYLATION			1	57159476	57159478			ENST00000371244.4	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
386	https://civic.genome.wustl.edu/links/variants/386	HSPA5	3309	EXPRESSION			9	127997132	128003609			ENST00000324460.6	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
387	https://civic.genome.wustl.edu/links/variants/387	EIF4EBP1	1978	PHOSPHORYLATION			8	37888200	37914663			ENST00000338825.4	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
388	https://civic.genome.wustl.edu/links/variants/388	KIT	3815	MUTATION			4	55524085	55606881			ENST00000288135.5	75	GRCh37					gain_of_function_variant,transcript_variant		2017-11-22 19:45:49 UTC
389	https://civic.genome.wustl.edu/links/variants/389	TUBB3	10381	EXPRESSION			16	89989687	90002505			ENST00000315491.7	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
390	https://civic.genome.wustl.edu/links/variants/390	EGFR	1956	Y1092 PHOSPHORYLATION	Although referred to as Y1068 in the literature, based on the recognition peptide described, this tyrosine occurs at Y1039 (ENST00000454757.2 v75) or Y1092 (ENST00000275493.2 v75).		7	55272951	55272953			ENST00000275493.2	75	GRCh37					N/A		2017-11-22 19:45:46 UTC
391	https://civic.genome.wustl.edu/links/variants/391	IGF1R	3480	NUCLEAR EXPRESSION			15	99192200	99507759			ENST00000268035.6	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
392	https://civic.genome.wustl.edu/links/variants/392	CFLAR	8837	EXPRESSION			2	201980827	202041410			ENST00000309955.3	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
393	https://civic.genome.wustl.edu/links/variants/393	PROM1	8842	EXPRESSION			4	15969857	16085324			ENST00000510224.1	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
394	https://civic.genome.wustl.edu/links/variants/394	FOXP3	50943	EXPRESSION			X	49106897	49121288			ENST00000376207.4	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
395	https://civic.genome.wustl.edu/links/variants/395	RPS6	6194	PHOSPHORYLATION			9	19376309	19376323			ENST00000380394.4	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
396	https://civic.genome.wustl.edu/links/variants/396	JAK1	3716	OVEREXPRESSION			1	65298912	65432187			ENST00000342505.4	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
397	https://civic.genome.wustl.edu/links/variants/397	BRCA1	672	EXPRESSION			17	41196312	41277387			ENST00000357654.3	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
398	https://civic.genome.wustl.edu/links/variants/398	DUSP6	1848	EXPRESSION			12	89741009	89747048			ENST00000279488.7	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
399	https://civic.genome.wustl.edu/links/variants/399	BRAF	673	MUTATION			7	140453136	140481403			ENST00000288602.6	75	GRCh37					gain_of_function_variant,gene_variant		2017-11-22 19:45:49 UTC
400	https://civic.genome.wustl.edu/links/variants/400	HSPB1	3315	EXPRESSION			7	75931861	75933612			ENST00000248553.6	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
401	https://civic.genome.wustl.edu/links/variants/401	NQO1	1728	EXPRESSION			16	69743304	69760854			ENST00000320623.5	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
402	https://civic.genome.wustl.edu/links/variants/402	NQO1	1728	P187S			16	69745145	69745145	G	A	ENST00000320623.5	75	GRCh37					missense_variant	NM_000903.2:c.559C>T,NP_000894.1:p.Pro187Ser,NC_000016.9:g.69745145G>A	2017-11-22 19:45:49 UTC
403	https://civic.genome.wustl.edu/links/variants/403	BRCA1	672	UNDEREXPRESSION			17	41196312	41277387			ENST00000357654.3	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
404	https://civic.genome.wustl.edu/links/variants/404	ABCB1	5243	EXPRESSION			7	87133175	87342564			ENST00000265724.3	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
405	https://civic.genome.wustl.edu/links/variants/405	CXCR4	7852	EXPRESSION			2	136871919	136873813			ENST00000409817.1	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
406	https://civic.genome.wustl.edu/links/variants/406	MAGEH1	28986	EXPRESSION			X	55478538	55479998			ENST00000342972.1	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
407	https://civic.genome.wustl.edu/links/variants/407	ABCC3	8714	AMPLIFICATION			17	48712218	48769613			ENST00000285238.8	75	GRCh37					transcript_amplification		2017-11-22 19:45:51 UTC
408	https://civic.genome.wustl.edu/links/variants/408	ABCC10	89845	EXPRESSION			6	43395292	43418168			ENST00000372530.4	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
409	https://civic.genome.wustl.edu/links/variants/409	ASNS	440	AMPLIFICATION			7	97481430	97501854			ENST00000175506.4	75	GRCh37					transcript_amplification		2017-11-22 19:45:49 UTC
410	https://civic.genome.wustl.edu/links/variants/410	CDX2	1045	EXPRESSION			13	28536274	28545276			ENST00000381020.7	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
411	https://civic.genome.wustl.edu/links/variants/411	STAT3	6774	SH2 DOMAIN MUTATION			17	40465342	40475372			ENST00000264657.5	75	GRCh37					protein_altering_variant		2017-11-22 19:45:52 UTC
412	https://civic.genome.wustl.edu/links/variants/412	POU5F1	5460	EXPRESSION			6	31132120	31138470			ENST00000259915.8	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
413	https://civic.genome.wustl.edu/links/variants/413	ERBB2	2064	KINASE DOMAIN MUTATION			17	37879863	37882870			ENST00000269571.5	75	GRCh37					protein_altering_variant		2017-11-22 19:45:52 UTC
414	https://civic.genome.wustl.edu/links/variants/414	ERBB2	2064	M774INSAYVM	Mutations in the HER2 kinase domain occur at a 2-4% frequency in lung adenocarcinomas, the majority of which are in exon 20 as in-frame duplications or insertions in a small 8 codon region (774-781 or 775-782). These are analogous to the exon 20 alterations found in EGFR TK domain. The M774 insertion, M774insAYVM, represents 62.5% of all HER2 kinase domain mutations identified (when combined with the A775insYVMA mutations as they translate to the identical amino acid sequence changes). As demonstrated in mouse models (Perrera et al., PNAS 2009) and subsequent clinical trials in human lung adenocarcinoma with these insertions, HER2 YVMA mutants predict response to several targeted HER2 agonists such as afatinib, trastuzumab, neratinib and TDM-1 (trastuzumab emtansine) as monotherapy or combined with specific chemotherapies.		17	37880993	37880994		GCTTACGTGATG	ENST00000269571.5	75	GRCh37					inframe_insertion	NC_000017.10:g.37880993_37880994insGCTTACGTGATG	2017-11-22 19:45:52 UTC
415	https://civic.genome.wustl.edu/links/variants/415	EGFR	1956	C797S			7	55249091	55249091	T	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2389T>A,NC_000007.13:g.55249091T>A,NM_005228.4:c.2389T>A,NP_005219.2:p.Cys797Ser	2017-11-22 19:45:51 UTC
416	https://civic.genome.wustl.edu/links/variants/416	ERBB2	2064	SERUM LEVELS			17	37856333	37884915			ENST00000269571.5	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
417	https://civic.genome.wustl.edu/links/variants/417	THBS2	7058	UNDEREXPRESSION			6	169615875	169654139			ENST00000366787.3	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
419	https://civic.genome.wustl.edu/links/variants/419	NTRK1	4914	NTRK1 FUSIONS			1	156844175	156851434			ENST00000524377.1	75	GRCh37					transcript_fusion		2017-11-22 19:45:52 UTC
420	https://civic.genome.wustl.edu/links/variants/420	IDH1	3417	R132H	IDH1 R132 mutations have been observed in a number of cancer types, and appear to behave quite differently in different environments. In myelodysplastic syndromes and acute myeloid leukemia (AML), IDH1 R132 mutations have been shown to be associated with worse outcome and shorter overall survival. They have also been linked to cytogenetically normal AML, an intermediate risk subtype of the disease. However, in glioblastoma and astrocytoma, patients with IDH1 mutations have shown better overall survival than patients with wild-type IDH1. Also in contrast to AML, in glioblastoma, IDH1 mutations have been associated with the specific cytogenetic abnormalities, 1p and 19q deletions.		2	209113112	209113112	C	T	ENST00000415913.1	75	GRCh37					missense_variant	NM_001282386.1:c.395G>A,NP_005887.2:p.Arg132His,NC_000002.11:g.209113112C>T,ENST00000415913.1:c.395G>A	2017-11-22 19:45:52 UTC
421	https://civic.genome.wustl.edu/links/variants/421	TERT	7015	RS2736100			5	1286516	1286516	C	A	ENST00000310581.5	75	GRCh37					coding_transcript_intron_variant,polymorphic_sequence_variant	NC_000005.9:g.1286516C>A	2017-11-22 19:45:52 UTC
422	https://civic.genome.wustl.edu/links/variants/422	STAG2	10735	UNDEREXPRESSION			X	123095568	123236506			ENST00000371157.3	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
423	https://civic.genome.wustl.edu/links/variants/423	HLA-DRA	3122	EXPRESSION			6	32407619	32412823			ENST00000395388.2	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
424	https://civic.genome.wustl.edu/links/variants/424	MYD88	4615	L265P			3	38182641	38182641	T	C	ENST00000396334.3	75	GRCh37					gain_of_function_variant,missense_variant	NC_000003.11:g.38182641T>C	2017-11-22 19:45:48 UTC
425	https://civic.genome.wustl.edu/links/variants/425	KRAS	3845	G12V	KRAS mutations are the most common mutations in pancreatic cancer occurring in > 90% of cases. Of these the G12D activating mutation is the most prevalent and results in a loss of GTPase activity which in turn leads to a constitutively active form of KRAS. This is enough to cause pre-cancerous pancreatic intraepithelial lesions		12	25398284	25398284	C	A	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.35G>T,NP_004976.2:p.Gly12Val,NC_000012.11:g.25398284C>A,ENST00000256078.4:c.35G>T	2017-11-22 19:46:08 UTC
426	https://civic.genome.wustl.edu/links/variants/426	BRAF	673	WILD TYPE			7	140434279	140624564			ENST00000288602.6	75	GRCh37					wild_type		2017-11-22 19:45:51 UTC
427	https://civic.genome.wustl.edu/links/variants/427	NRAS	4893	Q61K			1	115256530	115256530	G	T	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.181C>A,NP_002515.1:p.Gln61Lys,NC_000001.10:g.115256530G>T,ENST00000369535.4:c.181C>A	2017-11-22 19:45:51 UTC
428	https://civic.genome.wustl.edu/links/variants/428	MRE11	4361	FRAMESHIFT MUTATION			11	94152895	94227074			ENST00000323929.3	75	GRCh37					frameshift_variant		2017-11-22 19:45:52 UTC
429	https://civic.genome.wustl.edu/links/variants/429	KIT	3815	EXPRESSION			4	55524085	55606881			ENST00000288135.5	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
431	https://civic.genome.wustl.edu/links/variants/431	CBFB	865	CBFB-MYH11	CBFB-MYH11 is the result of inv(16)(p13q22) or t(16;16)(p13;q22) and is sufficient for the diagnosis of acute myeloid leukemia (in the correct setting) according to WHO criteria, even when blast counts are <20% (Vardiman et al, Blood 2008). This fusion is typically associated with favorable prognosis relative to other AML subtypes (including cytogenetically normal); however, the impact of additional mutations in the context of this fusion is incompletely understood. AMLs with this fusion are often grouped with other rearrangements affecting genes encoding core binding factor subunits, referred to as CBF AMLs.		16	67063148	67116211			ENST00000412916.2	75	GRCh37	16	15797029	15820911	ENST00000396324.3	transcript_fusion		2017-11-22 19:45:53 UTC
432	https://civic.genome.wustl.edu/links/variants/432	KMT2A	4297	MLL-MLLT3															transcript_fusion		2017-11-22 19:45:51 UTC
433	https://civic.genome.wustl.edu/links/variants/433	HIF1A	3091	3' UTR Polymorphism			14	62213848	62213848	T	C	ENST00000394997.1	75	GRCh37					3_prime_UTR_variant,SNP	NC_000014.8:g.62213848T>C	2017-11-22 19:45:49 UTC
434	https://civic.genome.wustl.edu/links/variants/434	HIF1A	3091	OVEREXPRESSION			14	62162258	62214976			ENST00000394997.1	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
435	https://civic.genome.wustl.edu/links/variants/435	EPAS1	2034	OVEREXPRESSION			2	46524541	46613836			ENST00000263734.3	75	GRCh37					N/A		2017-11-22 19:45:50 UTC
436	https://civic.genome.wustl.edu/links/variants/436	VHL	7428	LOSS			3	10182692	10193904			ENST00000256474.2	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:52 UTC
437	https://civic.genome.wustl.edu/links/variants/437	FLT3	2322	D835			13	28592642	28592642	C	A	ENST00000241453.7	75	GRCh37					protein_altering_variant	NC_000013.10:g.28592642C>A	2017-11-22 19:45:51 UTC
438	https://civic.genome.wustl.edu/links/variants/438	PSMB8	5696	NUCLEAR EXPRESSION			6	32808494	32812480			ENST00000374881.2	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
439	https://civic.genome.wustl.edu/links/variants/439	PBK	55872	NUCLEAR EXPRESSION			8	27667137	27695612			ENST00000301905.4	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
440	https://civic.genome.wustl.edu/links/variants/440	PTTG1	9232	OVEREXPRESSION			5	159848829	159855748			ENST00000352433.5	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
441	https://civic.genome.wustl.edu/links/variants/441	LEPR	3953	UNDEREXPRESSION			1	65886335	66107242			ENST00000349533.6	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
442	https://civic.genome.wustl.edu/links/variants/442	EGFR	1956	MUTATION			7	55086794	55279321			ENST00000275493.2	75	GRCh37					inframe_variant		2017-11-22 19:45:52 UTC
443	https://civic.genome.wustl.edu/links/variants/443	EGFR	1956	G465R			7	55227926	55227926	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.1393G>A,NC_000007.13:g.55227926G>A	2017-11-22 19:45:52 UTC
444	https://civic.genome.wustl.edu/links/variants/444	NEDD9	4739	EXPRESSION			6	11185051	11382581			ENST00000504387.1	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
445	https://civic.genome.wustl.edu/links/variants/445	ETS2	2114	RS461155			21	40191638	40191638	A	G	ENST00000360214.3	75	GRCh37					synonymous_variant	NC_000021.8:g.40191638A>G	2017-11-22 19:45:54 UTC
446	https://civic.genome.wustl.edu/links/variants/446	KRT18	3875	UNDEREXPRESSION			12	53342655	53346684			ENST00000388837.2	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
447	https://civic.genome.wustl.edu/links/variants/447	FGF13	2258	CYTOPLASMIC EXPRESSION			X	137715011	138286269			ENST00000370603.3	75	GRCh37					N/A		2017-11-22 19:45:52 UTC
448	https://civic.genome.wustl.edu/links/variants/448	SSX1	6756	SS18-SSX1		SYT-SSX fusions													transcript_fusion		2017-11-22 19:45:47 UTC
449	https://civic.genome.wustl.edu/links/variants/449	SSX2	6757	SS18-SSX2		SYT-SSX fusions													transcript_fusion		2017-11-22 19:45:50 UTC
450	https://civic.genome.wustl.edu/links/variants/450	SSX4	6759	SS18-SSX4		SYT-SSX fusions	18	23612363	23670589			ENST00000415083.2	75	GRCh37	X	48261524	48265521	ENST00000376884.2	transcript_fusion		2017-11-22 19:45:47 UTC
451	https://civic.genome.wustl.edu/links/variants/451	ABCB1	5243	S893A/T	Refer to  https://www.pharmgkb.org/rsid/rs2032582  for more information.		7	87160618	87160618	A	C	ENST00000265724.3	75	GRCh37					missense_variant	NC_000007.13:g.87160618A>C	2017-11-22 19:45:47 UTC
453	https://civic.genome.wustl.edu/links/variants/453	EGFR	1956	S492R			7	55228009	55228009	C	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.1476C>A,NC_000007.13:g.55228009C>A,NP_005219.2:p.Ser492Arg,NM_005228.4:c.1476C>A	2017-11-22 19:45:47 UTC
454	https://civic.genome.wustl.edu/links/variants/454	EGFR	1956	R451C			7	55227884	55227884	C	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.1351C>T,NC_000007.13:g.55227884C>T,NM_001346898.1:c.1351C>T,NP_001333827.1:p.Arg451Cys	2017-11-22 19:45:47 UTC
455	https://civic.genome.wustl.edu/links/variants/455	EGFR	1956	K467T			7	55227933	55227933	A	C	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.1400A>C,NC_000007.13:g.55227933A>C	2017-11-22 19:45:48 UTC
456	https://civic.genome.wustl.edu/links/variants/456	FCGR2A	2212	H167R			1	161479745	161479745	A	G	ENST00000271450.6	75	GRCh37					missense_variant	NM_001136219.1:c.500A>G,NP_001129691.1:p.His167Arg,ENST00000271450.6:c.500A>G,NC_000001.10:g.161479745A>G	2017-11-22 19:45:46 UTC
457	https://civic.genome.wustl.edu/links/variants/457	FCGR3A	2214	F212V			1	161514542	161514542	A	C	ENST00000367969.3	75	GRCh37					missense_variant	NC_000001.10:g.161514542A>C	2017-11-22 19:45:47 UTC
458	https://civic.genome.wustl.edu/links/variants/458	FCGR2B	2213	I232T			1	161643798	161643798	T	C	ENST00000358671.5	75	GRCh37					missense_variant	NM_004001.4:c.695T>C,NP_003992.3:p.Ile232Thr,ENST00000358671.5:c.695T>C,NC_000001.10:g.161643798T>C	2017-11-22 19:45:47 UTC
460	https://civic.genome.wustl.edu/links/variants/460	EGFR	1956	P753S			7	55242487	55242487	C	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2257C>T,NC_000007.13:g.55242487C>T,NM_005228.4:c.2257C>T,NP_005219.2:p.Pro753Ser	2017-11-22 19:45:48 UTC
461	https://civic.genome.wustl.edu/links/variants/461	PML	5371	B2 DOMAIN MUTATION	The B2 domain in PML is the binding site for ATRA. Point mutations in this region have been associated with ATRA resistance in patients with APL.	PML-RARa B2 Domain	15	74315213	74315219			ENST00000268058.3	75	GRCh37					missense_variant		2017-11-22 19:45:48 UTC
462	https://civic.genome.wustl.edu/links/variants/462	PML	5371	PML-RARA A216V	A216V in the B2 domain of PML is one of the variants found in a patient with ATRA-resistant APL.	PML-RARa B2 Domain	15	74315213	74315213	C	T	ENST00000268058.3	75	GRCh37					missense_variant	NC_000015.9:g.74315213C>T	2017-11-22 19:45:53 UTC
463	https://civic.genome.wustl.edu/links/variants/463	PML	5371	PML-RARA L218P	L218P in the B2 domain of PML is one of the variants found in a patient with ATRA-resistant APL.	PML-RARa B2 Domain	15	74315219	74315219	T	C	ENST00000268058.3	75	GRCh37					missense_variant	NC_000015.9:g.74315219T>C	2017-11-22 19:45:48 UTC
464	https://civic.genome.wustl.edu/links/variants/464	MET	4233	EXON 14 MUTATION + AMPLIFICATION			7	116312459	116436396			ENST00000318493.6	75	GRCh37					transcript_amplification,exon_loss_variant		2017-11-22 19:45:47 UTC
465	https://civic.genome.wustl.edu/links/variants/465	ROS1	6098	CD74-ROS1 G2032R	The G2032R missense mutation has been observed in patients with crizotinib-resistant non-small cell lung cancer harboring CD74-ROS1 rearrangement. Independent in vitro studies have confirmed that this mutation confers marked resistance to crizotinib cells over CD74-ROS1 alone. Multiple groups have indicated CD74-ROS1 G2032R expressing cell lines are sensitive to both cabozantinib and foretinib individually administered in vitro. One group additionally showed this mutation conferred relative resistance to alectinib, brigatinib, ceritinib, and AZD3463 in vitro.		6	117638347	117638347	C	T	ENST00000368508.3	75	GRCh37					transcript_fusion,missense_variant	NC_000006.11:g.117638347C>T	2017-11-22 19:45:52 UTC
466	https://civic.genome.wustl.edu/links/variants/466	FGFR1	2260	ZNF198-FGFR1															transcript_fusion		2017-11-22 19:45:50 UTC
467	https://civic.genome.wustl.edu/links/variants/467	KDR	3791	A1065T			4	55955969	55955969	C	T	ENST00000263923.4	75	GRCh37					missense_variant	NM_002253.2:c.3193G>A,NP_002244.1:p.Ala1065Thr,ENST00000263923.4:c.3193G>A,NC_000004.11:g.55955969C>T	2017-11-22 19:45:51 UTC
468	https://civic.genome.wustl.edu/links/variants/468	KDR	3791	D717V			4	55968180	55968180	T	A	ENST00000263923.4	75	GRCh37					missense_variant	ENST00000263923.4:c.2150A>T,NC_000004.11:g.55968180T>A	2017-11-22 19:45:51 UTC
469	https://civic.genome.wustl.edu/links/variants/469	TSC2	7249	Q1178*			16	2130300	2130300	C	T	ENST00000219476.3	75	GRCh37					stop_gained	NM_000548.4:c.3532C>T,NP_000539.2:p.Gln1178Ter,ENST00000219476.3:c.3532C>T,NC_000016.9:g.2130300C>T	2017-11-22 19:45:52 UTC
470	https://civic.genome.wustl.edu/links/variants/470	MTOR	2475	F2108L			1	11187094	11187094	G	T	ENST00000361445.4	75	GRCh37					missense_variant	ENST00000361445.4:c.6324C>A,NC_000001.10:g.11187094G>T	2017-11-22 19:45:52 UTC
471	https://civic.genome.wustl.edu/links/variants/471	RAD51D	5892	R186*			17	33433425	33433425	G	A	ENST00000345365.6	75	GRCh37					stop_gained	NC_000017.10:g.33433425G>A	2017-11-22 19:45:47 UTC
472	https://civic.genome.wustl.edu/links/variants/472	ALDH1A2	8854	EXPRESSION			15	58245622	58358616			ENST00000249750.4	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
473	https://civic.genome.wustl.edu/links/variants/473	ALDH1A2	8854	UNDEREXPRESSION			15	58245622	58358616			ENST00000249750.4	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
474	https://civic.genome.wustl.edu/links/variants/474	KIAA1524	57650	EXPRESSION			3	108268716	108308299			ENST00000295746.8	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
475	https://civic.genome.wustl.edu/links/variants/475	KIAA1524	57650	UNDEREXPRESSION			3	108268716	108308299			ENST00000295746.8	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
476	https://civic.genome.wustl.edu/links/variants/476	MIR218-1	407000	EXPRESSION			4	20529898	20530007			ENST00000384999.1	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
477	https://civic.genome.wustl.edu/links/variants/477	BRCA1	672	P968FS			17	41244645	41244646		GA	ENST00000471181.2	75	GRCh37					frameshift_truncation	NM_007294.3:c.2902_2903insTC,NP_009225.1:p.Pro968Leufs,NC_000017.10:g.41244645_41244646insGA,ENST00000471181.2:c.2902_2903insTC	2017-11-22 19:46:01 UTC
479	https://civic.genome.wustl.edu/links/variants/479	KRAS	3845	Q22*			12	25398255	25398255	G	A	ENST00000256078.4	75	GRCh37					stop_gained	ENST00000256078.4:c.64C>T,NC_000012.11:g.25398255G>A	2017-11-22 19:45:47 UTC
480	https://civic.genome.wustl.edu/links/variants/480	DNMT3A	1788	P904L			2	25457176	25457176	G	A	ENST00000264709.3	75	GRCh37					missense_variant	NC_000002.11:g.25457176G>A	2017-11-22 19:45:49 UTC
481	https://civic.genome.wustl.edu/links/variants/481	DDX43	55510	OVEREXPRESSION			6	74104471	74127292			ENST00000370336.4	75	GRCh37					N/A		2017-11-22 19:45:48 UTC
482	https://civic.genome.wustl.edu/links/variants/482	KIT	3815	RS3733542			4	55602765	55602765	G	C	ENST00000288135.5	75	GRCh37					synonymous_variant	NM_000222.2:c.2586G>C,NP_000213.1:p.Leu862=,ENST00000288135.5:c.2586G>C,NC_000004.11:g.55602765G>C	2017-11-22 19:45:49 UTC
483	https://civic.genome.wustl.edu/links/variants/483	TBK1	29110	OVEREXPRESSION			12	64845660	64895888			ENST00000331710.5	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
485	https://civic.genome.wustl.edu/links/variants/485	STK11	6794	LOSS			19	1205740	1228428			ENST00000326873.7	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:49 UTC
486	https://civic.genome.wustl.edu/links/variants/486	HAVCR2	84868	OVEREXPRESSION			5	156512843	156536725			ENST00000307851.4	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
487	https://civic.genome.wustl.edu/links/variants/487	MMP2	4313	SERUM LEVELS			16	55512883	55540603			ENST00000219070.4	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
488	https://civic.genome.wustl.edu/links/variants/488	MMP9	4318	SERUM LEVELS			20	44637547	44645200			ENST00000372330.3	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
490	https://civic.genome.wustl.edu/links/variants/490	HSPH1	10808	NUCLEAR EXPRESSION			13	31710765	31736064			ENST00000320027.5	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
491	https://civic.genome.wustl.edu/links/variants/491	HSPH1	10808	T17 DELETION			13	31722621	31722637			ENST00000320027.5	75	GRCh37					short_tandem_repeat_variation		2017-11-22 19:45:47 UTC
492	https://civic.genome.wustl.edu/links/variants/492	ECSCR	641700	EXPRESSION															N/A		2017-11-22 19:45:47 UTC
493	https://civic.genome.wustl.edu/links/variants/493	ROBO4	54538	EXPRESSION			11	124753587	124768177			ENST00000306534.3	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
494	https://civic.genome.wustl.edu/links/variants/494	PIM1	5292	NUCLEAR EXPRESSION			6	37137979	37143202			ENST00000373509.5	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
495	https://civic.genome.wustl.edu/links/variants/495	MDM2	4193	SNP309			12	69202580	69202580	T	G	ENST00000462284.1	75	GRCh37					coding_transcript_intron_variant	NC_000012.11:g.69202580T>G	2017-11-22 19:45:47 UTC
496	https://civic.genome.wustl.edu/links/variants/496	ERBB2	2064	L866M	This mutation was shown to be an activating mutation and conferred sensitivity to a combination of trastuzumab with neratinib or lapatinib in colorectal cancer patient-derived xenografts.		17	37881404	37881404	C	A	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2596C>A,NC_000017.10:g.37881404C>A	2017-11-22 19:45:49 UTC
497	https://civic.genome.wustl.edu/links/variants/497	ERBB2	2064	S310F/Y	ERBB2 S310F/Y was one of the first ERBB2 variants to be functionally classified (Greulich et al. 2012). This mutation was shown to be an activating mutation (through hyperphosphorylation) in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in murine Ba/F3 cells have been shown to be sensitive to the ERBB2 inhibitors (afatinib, lapatinib and neratinib). More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.		17	37868208	37868208			ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.929C>T,NC_000017.10:g.37868208C>T	2017-11-22 19:46:07 UTC
498	https://civic.genome.wustl.edu/links/variants/498	MIR218-1	407000	UNDEREXPRESSION			4	20529898	20530007			ENST00000384999.1	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
499	https://civic.genome.wustl.edu/links/variants/499	ALK	238	ALK FUSIONS	Following the initial discovery and characterization of NPM-ALK fusion mutation in anaplastic large cell lymphoma (ALCL), EML4-ALK fusions were found to be driver mutations in a subset of lung adenocarcinomas. ALK fusions bring the C-terminal ALK kinase domain together with the N terminal region of the fusion partner, and have since been found in a range of cancers including inflammatory myofibroblastic tumor, renal cell carcinoma, diffuse large B cell lymphoma and colorectal cancer.   In a Phase I trial for crizotinib, a 92% response rate was seen in the subset of patients with a specific EML4-ALK variant, which was higher than the 57% rate in the overall ALK-rearranged population, but the subpopulation numbers were insufficient to correlate variant type with patient response.   Due to restricted wild-type ALK expression, and also mild phenotypes seen in ALK knockout mice, ALK fusions are desirable targets.  ALK inhibitor TAE684 was used in initial characterizations of ALK fusion cancer drivers, and crizotinib  a small molecule ATP-competitor RTK inhibitor which is highly selective for ALK and MET - has been approved as first line therapy in ALK-rearranged NSCLC.     ALK-rearrangement defines an NSCLC subtype that makes up 3-5% of NSCLC cases, and is characterized by higher proportions of younger patients and never smokers. EML4-ALK variant 1 is the most common ALK fusion in NSCLC and was the first to be discovered and demonstrate cancer driver properties in vitro and in mouse models. A Phase I study of crizotinib in ALK-rearranged NSCLC demonstrated an increase in overall survival when compared to standard chemotherapy. These and other initial results prompted accelerated approval for crizotinib in NSCLC.  Continued clinical work demonstrated benefit with crizotinib over chemotherapy in multi-armed studies, and as first line therapy. Crizotinib was also found to remain beneficial to NSCLC patients who had progressed on crizotinib. Additionally, crizotinib was shown to increase intracranial disease control in brain metastasis occurring from ALK-rearranged NSCLC.	ALK Fusions	2	29415640	29446394			ENST00000389048.3	75	GRCh37					transcript_fusion		2017-11-22 19:45:53 UTC
500	https://civic.genome.wustl.edu/links/variants/500	ALK	238	EML4-ALK E20;A20	EML4-ALK variant 2 consists of a fusion of the ALK kinase domain (exons 20-29) with EML4 exons 1-20. Variant 2 has cytoplasmic distribution and makes up ~10% of EML4-ALK fusions found in NSCLC,. Although the specific variant is not consistently reported, single cases demonstrating response to crizotinib treatment in NSCLC and a differentiated malignant neoplasm of unknown origin have been reported. In vitro, this variant has shown greater sensitivity to ALK inhibition with TAE684 and crizotinib than the EML4-ALK variants 1 (E13;A20), 3a (E6;A20) and 3b (E6ins33;A20). The variant was reported to be less stable in cells than other variants, and may be a client protein of Hsp90. Along these lines the variant has shown preclinical sensitivity to Hsp90 inhibition.	ALK Fusions	2	42396490	42552694			ENST00000318522.5	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2017-11-22 19:45:52 UTC
501	https://civic.genome.wustl.edu/links/variants/501	ALK	238	EML4-ALK E2;A20		ALK Fusions	2	42396490	42472827			ENST00000318522.5	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2017-11-22 19:45:53 UTC
502	https://civic.genome.wustl.edu/links/variants/502	KDR	3791	R961W			4	55961059	55961059	G	A	ENST00000263923.4	75	GRCh37					missense_variant	NM_002253.2:c.2881C>T,NP_002244.1:p.Arg961Trp,ENST00000263923.4:c.2881C>T,NC_000004.11:g.55961059G>A	2017-11-22 19:45:51 UTC
503	https://civic.genome.wustl.edu/links/variants/503	ALK	238	EML4-ALK E6;A20	The EML4-ALK variant 3a consists of the ALK kinase domain fused to EML4 exons 1-6, while the 3b variant has an additional 33bp of intronic EML4 sequence between EML4 and ALK regions. The two variants were found to originate from a single genomic rearrangement, and 3a/3b is found in ~ 30% of EML4-ALK positive NSCLC. Variant 3a has cytoplasmic and nuclear distribution. In vitro, these variants have shown sensitivity to ALK inhibitors TAE684 and crizotinib but less sensitive than other EML4-ALK variants. The H2228 cell line contains 3a and 3b variants and is described as having cyctostatic response to ALK inhibition as opposed to apoptotic. In a study of 31 NSCLC patients with EML4-ALK rearrangements, 4/5 patients with the 3a variant showed a partial response while 1 showed progressive disease (the only PD observed). In cells the 3a variant was reported to be more stable than other variants, less sensitive to crizotinib and not to respond to Hsp90 inhibition.	ALK Fusions	2	42396490	42491871			ENST00000318522.5	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2017-11-22 19:45:53 UTC
504	https://civic.genome.wustl.edu/links/variants/504	TP53	7157	P47S			17	7579548	7579548	G	A	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.139C>T,NP_000537.3:p.Pro47Ser,NC_000017.10:g.7579548G>A	2017-11-22 19:45:52 UTC
505	https://civic.genome.wustl.edu/links/variants/505	GNAQ	2776	MUTATION			9	80331003	80646374			ENST00000286548.4	75	GRCh37							2017-11-22 19:45:52 UTC
506	https://civic.genome.wustl.edu/links/variants/506	GNA11	2767	MUTATION			19	3094408	3124002			ENST00000078429.4	75	GRCh37							2017-11-22 19:45:49 UTC
507	https://civic.genome.wustl.edu/links/variants/507	GNAQ	2776	Q209			9	80409487	80409489			ENST00000286548.4	75	GRCh37					protein_altering_variant		2017-11-22 19:45:47 UTC
508	https://civic.genome.wustl.edu/links/variants/508	PMS2	5395	K706FS*19			7	6022512	6022512			ENST00000265849.7	75	GRCh37					minus_1_frameshift_variant	NM_000535.6:c.2117delA,NP_000526.2:p.Lys706Serfs,NC_000007.13:g.6022512del	2017-11-22 19:45:49 UTC
509	https://civic.genome.wustl.edu/links/variants/509	KIT	3815	EXON 9 MUTATION	In patients with gastrointestinal stromal tumors (GIST), imatinib has improved outcomes for patients with KIT mutations. However, acquired resistance to imatinib is common. Patients harboring exon 9 KIT mutations may benefit from higher imatinib doses (800mg/daily). Similarly, imatinib-refractory tumors showed sensitivity to sunitinib treatment. Improved responses to either treatment were not observed in patients with exon 11 mutations.		4	55592023	55592216			ENST00000288135.5	75	GRCh37					exon_variant		2017-11-22 19:45:52 UTC
510	https://civic.genome.wustl.edu/links/variants/510	PTEN	5728	MUTATION			10	89622870	89731687			ENST00000371953.3	75	GRCh37					protein_altering_variant		2017-11-22 19:45:49 UTC
511	https://civic.genome.wustl.edu/links/variants/511	FGFR2	2263	MUTATION			10	123239371	123357917			ENST00000457416.2	75	GRCh37					gain_of_function_variant,transcript_variant		2017-11-22 19:45:49 UTC
512	https://civic.genome.wustl.edu/links/variants/512	ALK	238	MUTATION			2	29415640	30144432			ENST00000389048.3	75	GRCh37					gain_of_function_variant,gene_variant		2017-11-22 19:45:50 UTC
513	https://civic.genome.wustl.edu/links/variants/513	ALK	238	NPM-ALK		ALK Fusions	5	170814120	170818803			ENST00000517671.1	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2017-11-22 19:45:51 UTC
514	https://civic.genome.wustl.edu/links/variants/514	ALK	238	RANBP2-ALK		ALK Fusions	2	109335937	109375004			ENST00000283195.6	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2017-11-22 19:45:51 UTC
515	https://civic.genome.wustl.edu/links/variants/515	FGFR1	2260	N546K			8	38274849	38274849	G	T	ENST00000341462.5	75	GRCh37					missense_variant	NM_023110.2:c.1638C>A,NP_075598.2:p.Asn546Lys,ENST00000341462.5:c.1638C>A,NC_000008.10:g.38274849G>T	2017-11-22 19:45:52 UTC
516	https://civic.genome.wustl.edu/links/variants/516	ROS1	6098	CD74-ROS1 L2026M	The L2026M mutation is considered a gatekeeper mutation located in the inhibitor binding pocket of ROS1 and corresponding to L1196M in ALK and T790M in EGFR. This mutation has not been reportedly observed in a patient but inferred as a variant likely to emerge in crizotinib-resistant tumors. In vitro kinase activity, structural predictions and growth inhibition assays indicate the L2026M mutation in the CD74-ROS1 fusion provides crizotinib resistance. Additional preclinical assays have indicated that crizotinib resistant cells harboring this mutation are sensitive to PF-06463922 and foretinib.		6	117638365	117638365	G	T	ENST00000368508.3	75	GRCh37					transcript_fusion,missense_variant	NC_000006.11:g.117638365G>T,ENST00000368508.3:c.6076C>A	2017-11-22 19:45:52 UTC
517	https://civic.genome.wustl.edu/links/variants/517	ROS1	6098	CD74-ROS1 L2155S			6	117630062	117630062	A	G	ENST00000368508.3	75	GRCh37					transcript_fusion,missense_variant	NC_000006.11:g.117630062A>G	2017-11-22 19:45:50 UTC
518	https://civic.genome.wustl.edu/links/variants/518	ROS1	6098	CD74-ROS1 G2101A			6	117631376	117631376	C	G	ENST00000368508.3	75	GRCh37					transcript_fusion,missense_variant	NC_000006.11:g.117631376C>G	2017-11-22 19:45:49 UTC
519	https://civic.genome.wustl.edu/links/variants/519	FLT3	2322	MUTATION			13	28577411	28674729			ENST00000241453.7	75	GRCh37					gain_of_function_variant,transcript_variant		2017-11-22 19:46:01 UTC
520	https://civic.genome.wustl.edu/links/variants/520	ALK	238	CLTC-ALK	The t(2;17)(p23;q23) translocation results in the CLTC-ALK fusion protein, the most common ALK fusion observed in diffuse large B cell lymphoma (DLBCL). ALK-rearranged DLBCL is less responsive to CHOP chemotherapy. Preclinical work indicates that CLTC-ALK DLBCL is responsive to ALK inhibition in cell lines and mouse models, and two case studies show short response followed by progression when heavily pretreated and advanced ALK-positive DLBCL is treated with crizotinib (one case CLTC-ALK, one case an unknown ALK fusion).	ALK Fusions	17	57697219	57768072			ENST00000269122.3	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2017-11-22 19:45:53 UTC
521	https://civic.genome.wustl.edu/links/variants/521	U2AF1	7307	MUTATION			21	44513066	44527697			ENST00000291552.4	75	GRCh37					protein_altering_variant		2017-11-22 19:45:50 UTC
522	https://civic.genome.wustl.edu/links/variants/522	BRAF	673	DEL 485-490			7	140477838	140477855	AGGTGCTGTCACATTCAA		ENST00000288602.6	75	GRCh37					inframe_deletion	ENST00000288602.6:c.1453_1470del	2017-11-22 19:45:51 UTC
524	https://civic.genome.wustl.edu/links/variants/524	DUX4	100288687	DUX4 FUSIONS															transcript_fusion		2017-11-22 19:45:52 UTC
525	https://civic.genome.wustl.edu/links/variants/525	B4GALT1	2683	EXPRESSION			9	33110635	33167354			ENST00000379731.4	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
526	https://civic.genome.wustl.edu/links/variants/526	BCL2L11	10018	DELETION POLYMORPHISM			2	111883195	111886097			ENST00000393256.3	75	GRCh37					polymorphic_sequence_variant		2017-11-22 19:45:48 UTC
527	https://civic.genome.wustl.edu/links/variants/527	ALK	238	ALK FUSION I1171	Multiple case reports indicate that the I1171T missense mutation in ALK-rearranged non-small cell lung cancer (NSCLC) confers resistance to crizotinib and alectinib but is sensitive to ceritinib treatment. These results have been validated in vitro. In vitro evidence indicates this mutation interferes with alectinib binding the active site of ALK and may explain the sensitivity to the structurally distinct ALK inhibitor ceritinib.		2	29445213	29445213	A	G	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	ENST00000389048.3:c.3512T>C,NC_000002.11:g.29445213A>G	2017-11-22 19:45:53 UTC
528	https://civic.genome.wustl.edu/links/variants/528	ALK	238	EML4-ALK  V1180L	The V1180L missense mutation was identified in a mutagenesis screen to find mutations that conferred resistance to alectinib in a non-small cell lung cancer cell line. This mutation shows resistance to crizotinib and alectinib but sensitivity to TAE684, ceritinib and more mild sensitivity to brigatinib. Similar to I1171T, it resides in the ATP pocket of ALK and likely interferes with alectinib and crizotinib binding as a mechanism of resistance.		2	29443679	29443679	C	G	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	ENST00000389048.3:c.3538G>C,NC_000002.11:g.29443679C>G,NC_000002.11:G.29443679C>G	2017-11-22 19:45:53 UTC
529	https://civic.genome.wustl.edu/links/variants/529	SIRT1	23411	OVEREXPRESSION			10	69644427	69678147			ENST00000212015.6	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
530	https://civic.genome.wustl.edu/links/variants/530	KRAS	3845	G12R			12	25398285	25398285	C	G	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.34G>C,NP_004976.2:p.Gly12Arg,NC_000012.11:g.25398285C>G,ENST00000256078.4:c.34G>C	2017-11-22 19:45:52 UTC
531	https://civic.genome.wustl.edu/links/variants/531	TP53	7157	P72R	This polymorphism is relatively widely studied across cancer types, but meta-analyses in breast, lung and cervical cancer cohorts have so far been inconclusive as to the significance of a patient's genotype at this locus as it relates to cancer susceptibility and prognosis.		17	7579472	7579472	G	C	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.215C>G,NP_000537.3:p.Pro72Arg,NC_000017.10:g.7579472G>C	2017-11-22 19:45:48 UTC
532	https://civic.genome.wustl.edu/links/variants/532	PALB2	79728	BIALLELIC INACTIVATION			16	23614491	23652631			ENST00000261584.4	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:48 UTC
533	https://civic.genome.wustl.edu/links/variants/533	SMAD4	4089	EXPRESSION			18	48556583	48611409			ENST00000342988.3	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
534	https://civic.genome.wustl.edu/links/variants/534	FANCC	2176	LOSS-OF-FUNCTION			9	97861336	98079984			ENST00000289081.3	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:50 UTC
535	https://civic.genome.wustl.edu/links/variants/535	PDGFRB	5159	EBF1-PDGFRB	EBF1-PDGFRB fusions are associated with Ph-like acute lymphoblastic leukemia lacking the BCR-ABL fusion. Case reports have shown positive responses to imatinib treatment.														transcript_fusion		2017-11-22 19:45:53 UTC
536	https://civic.genome.wustl.edu/links/variants/536	SULT1E1	6783	SNP																	2017-11-22 19:45:51 UTC
537	https://civic.genome.wustl.edu/links/variants/537	RB1	5925	EXPRESSION			13	48877911	49056122			ENST00000267163.4	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
538	https://civic.genome.wustl.edu/links/variants/538	MLH1	4292	METHYLATION															N/A		2017-11-22 19:45:51 UTC
539	https://civic.genome.wustl.edu/links/variants/539	PTPN11	5781	EXPRESSION			12	112856718	112947717			ENST00000351677.2	75	GRCh37					N/A		2017-11-22 19:45:51 UTC
540	https://civic.genome.wustl.edu/links/variants/540	FLT3	2322	T227M	FLT3 T227M (rs1933437) is a common polymorphism with a GMAF around .60 based on the Exome Aggregation Consortium (ExAC) data. Its role in cancer predisposition is still unknown, however it may be associated with the development of leukopenia in patients treated with sunitinib.		13	28624294	28624294	G	A	ENST00000241453.7	75	GRCh37					missense_variant,SNP	NM_004119.2:c.680C>T,NP_004110.2:p.Thr227Met,NC_000013.10:g.28624294G>A	2017-11-22 19:45:53 UTC
541	https://civic.genome.wustl.edu/links/variants/541	PALB2	79728	L531FS*30			16	23646276	23646276			ENST00000261584.4	75	GRCh37					minus_1_frameshift_variant,SNP		2017-11-22 19:46:01 UTC
542	https://civic.genome.wustl.edu/links/variants/542	MTOR	2475	S2215Y			1	11184573	11184573	G	T	ENST00000361445.4	75	GRCh37					missense_variant	ENST00000361445.4:c.6644C>A,NC_000001.10:g.11184573G>T,NM_004958.3:c.6644C>A,NP_004949.1:p.Ser2215Tyr	2017-11-22 19:45:50 UTC
543	https://civic.genome.wustl.edu/links/variants/543	MTOR	2475	C1483Y			1	11217230	11217230	C	T	ENST00000361445.4	75	GRCh37					missense_variant	ENST00000361445.4:c.4448G>A,NC_000001.10:g.11217230C>T,NM_004958.3:c.4448G>A,NP_004949.1:p.Cys1483Tyr	2017-11-22 19:45:51 UTC
544	https://civic.genome.wustl.edu/links/variants/544	MTOR	2475	E1799K			1	11190804	11190804	C	T	ENST00000361445.4	75	GRCh37					missense_variant	NM_004958.3:c.5395G>A,NP_004949.1:p.Glu1799Lys,NC_000001.10:g.11190804C>T,ENST00000361445.4:c.5395G>A	2017-11-22 19:45:49 UTC
545	https://civic.genome.wustl.edu/links/variants/545	FGFR2	2263	N550K			10	123258034	123258034	A	T	ENST00000457416.2	75	GRCh37					gain_of_function_variant,missense_variant	NM_022970.3:c.1650T>A,NP_075259.4:p.Asn550Lys,ENST00000457416.2:c.1650T>A,NC_000010.10:g.123258034A>T	2017-11-22 19:45:51 UTC
546	https://civic.genome.wustl.edu/links/variants/546	ACTA1	58	EXPRESSION			1	229566992	229569841			ENST00000366684.3	75	GRCh37					N/A		2017-11-22 19:46:01 UTC
547	https://civic.genome.wustl.edu/links/variants/547	RB1	5925	OVEREXPRESSION			13	48877911	49056122			ENST00000267163.4	75	GRCh37					N/A		2017-11-22 19:45:49 UTC
548	https://civic.genome.wustl.edu/links/variants/548	PPP1R15A	23645	RS557806			19	49377242	49377242	G	C	ENST00000200453.5	75	GRCh37					missense_variant,polymorphic_sequence_variant	NM_014330.3:c.752G>C,NP_055145.3:p.Arg251Pro,ENST00000200453.5:c.752G>C,NC_000019.9:g.49377242G>C	2017-11-22 19:45:50 UTC
549	https://civic.genome.wustl.edu/links/variants/549	ALK	238	F1245C			2	29436859	29436859	A	C	ENST00000389048.3	75	GRCh37					missense_variant	NM_004304.4:c.3734T>G,NP_004295.2:p.Phe1245Cys,NC_000002.11:g.29436859A>C,ENST00000389048.3:c.3734T>G	2017-11-22 19:45:51 UTC
550	https://civic.genome.wustl.edu/links/variants/550	ALK	238	DEL4-11			2	29497965	29754982			ENST00000389048.3	75	GRCh37					inframe_deletion		2017-11-22 19:45:51 UTC
551	https://civic.genome.wustl.edu/links/variants/551	ALK	238	ALK FUSION F1245C	In neuroblastoma, F1245 is one of three hotspot ALK mutations found at a high frequency. In a case study, a pretreated non-small cell lung cancer (NSCLC) patient with EML4-ALK F1245C mutation responded well to ceritinib after slow disease progression during crizotinib treatment. Crizotinib resistance was attributed to the F1245C mutation, although the ALK-rearrangement was not sequenced prior to crizotinib treatment. The patient's slow onset of disease progression during crizotinib treatment mirrors preclinical findings that indicate ALK-fusion with F1245C has moderate resistance to crizotinib compared to the fusion alone.		2	29436859	29436859	A	C	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	NM_004304.4:c.3734T>G,NP_004295.2:p.Phe1245Cys,NC_000002.11:g.29436859A>C,ENST00000389048.3:c.3734T>G	2017-11-22 19:45:53 UTC
552	https://civic.genome.wustl.edu/links/variants/552	ALK	238	ALK FUSION G1269A			2	29432682	29432682	C	G	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	ENST00000389048.3:c.3806G>C,NC_000002.11:g.29432682C>G,NM_004304.4:c.3806G>C,NP_004295.2:p.Gly1269Ala	2017-11-22 19:45:50 UTC
553	https://civic.genome.wustl.edu/links/variants/553	CDK4	1019	AMPLIFICATION			12	58141510	58146304			ENST00000257904.6	75	GRCh37					transcript_amplification		2017-11-22 19:45:52 UTC
554	https://civic.genome.wustl.edu/links/variants/554	CDKN2A	1029	LOSS			9	21967752	21994623			ENST00000579755.1	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:51 UTC
555	https://civic.genome.wustl.edu/links/variants/555	CDKN2B	1030	LOSS			9	22002902	22009362			ENST00000276925.6	75	GRCh37					transcript_ablation		2017-11-22 19:45:52 UTC
556	https://civic.genome.wustl.edu/links/variants/556	CDK4	1019	R24C			12	58145431	58145431	G	A	ENST00000257904.6	75	GRCh37					missense_variant	NM_000075.3:c.70C>T,NP_000066.1:p.Arg24Cys,ENST00000257904.6:c.70C>T,NC_000012.11:g.58145431G>A	2017-11-22 19:45:51 UTC
557	https://civic.genome.wustl.edu/links/variants/557	ASXL1	171023	EXON 12 MUTATION			20	31021087	31021720			ENST00000375687.4	75	GRCh37					exon_variant		2017-11-22 19:45:52 UTC
558	https://civic.genome.wustl.edu/links/variants/558	GNA11	2767	Q209			19	3118942	3118942			ENST00000078429.4	75	GRCh37					missense_variant		2017-11-22 19:45:52 UTC
559	https://civic.genome.wustl.edu/links/variants/559	CALR	811	EXON 9 FRAMESHIFT	Exon 9 insertions and deletions have become part of the WHO diagnostic criteria for essential thrombocythemia (ET) and primary myelofibrosis (PMF) (Arber et al, 2016). These mutations are typically heterozygous and in the absence of JAK2 and MPL mutations. Approximately 80% of observed mutations are type 1 (p.L367fs*46), the result of a 52bp deletion, or type 2 (p.K385fs*47), the result of a 5-bp TTGTC insertion, and studies have suggested phenotypic and prognostic differences between them. In PMF patients, CALR exon 9 mutations have been associated with improved median survival.		19	13054527	13054727			ENST00000316448.5	75	GRCh37					exon_variant		2017-11-22 19:45:54 UTC
560	https://civic.genome.wustl.edu/links/variants/560	CSF3R	1441	MUTATION			1	36932096	36933444			ENST00000373106.1	75	GRCh37					protein_altering_variant		2017-11-22 19:45:54 UTC
562	https://civic.genome.wustl.edu/links/variants/562	EGFR	1956	S768I			7	55249005	55249005	G	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2303G>T,NC_000007.13:g.55249005G>T,NM_005228.4:c.2303G>T,NP_005219.2:p.Ser768Ile	2017-11-22 19:45:52 UTC
563	https://civic.genome.wustl.edu/links/variants/563	BRAF	673	V600K		Other V600's	7	140453136	140453137	AC	TT	ENST00000288602.6	75	GRCh37					missense_variant	ENST00000288602.6:c.1798_1799delinsAA,NC_000007.13:g.140453136_140453137delinsTT,NM_004333.4:c.1798_1799delGTinsAA,NP_004324.2:p.Val600Lys	2017-11-22 19:45:51 UTC
564	https://civic.genome.wustl.edu/links/variants/564	SMAD4	4089	LOSS			18	48556583	48611409			ENST00000342988.3	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:52 UTC
565	https://civic.genome.wustl.edu/links/variants/565	SF3B1	23451	K700E		HEAT domain mutation	2	198266834	198266834	T	C	ENST00000335508.6	75	GRCh37					missense_variant	NM_012433.3:c.2098A>G,NP_036565.2:p.Lys700Glu,ENST00000335508.6:c.2098A>G,NC_000002.11:g.198266834T>C	2017-11-22 19:45:53 UTC
566	https://civic.genome.wustl.edu/links/variants/566	MAP2K7	5609	E116K			19	7975157	7975157	G	A	ENST00000397979.3	75	GRCh37					missense_variant	NC_000019.9:g.7975157G>A	2017-11-22 19:45:53 UTC
567	https://civic.genome.wustl.edu/links/variants/567	PDGFRA	5156	PDGFRA FUSIONS															transcript_fusion		2017-11-22 19:45:53 UTC
568	https://civic.genome.wustl.edu/links/variants/568	PDGFRB	5159	PDGFRB FUSIONS															transcript_fusion		2017-11-22 19:45:53 UTC
569	https://civic.genome.wustl.edu/links/variants/569	FGFR1	2260	FGFR1 FUSIONS			8	38268656	38325363			ENST00000425967.3	75	GRCh37					transcript_fusion		2017-11-22 19:46:06 UTC
570	https://civic.genome.wustl.edu/links/variants/570	IDH2	3418	MUTATION			15	90626277	90645736			ENST00000330062.3	75	GRCh37					protein_altering_variant		2017-11-22 19:45:53 UTC
571	https://civic.genome.wustl.edu/links/variants/571	JAK2	3717	PCM1-JAK2										GRCh37					transcript_fusion		2017-11-22 19:45:53 UTC
572	https://civic.genome.wustl.edu/links/variants/572	MTOR	2475	E2014K + E2419K			1	11174420	11187857			ENST00000361445.4	75	GRCh37					missense_variant		2017-11-22 19:45:53 UTC
573	https://civic.genome.wustl.edu/links/variants/573	RICTOR	253260	AMPLIFICATION			5	38938021	39074510			ENST00000357387.3	75	GRCh37					transcript_amplification		2017-11-22 19:45:53 UTC
574	https://civic.genome.wustl.edu/links/variants/574	PDGFRA	5156	FIP1L1-PDGFRA	Prospective trials of patients with hypereosinophilic syndrome harboring the FIP1L1-PDGFRA fusion identified marked response to imatinib treatment (Gotlib and Cool, Leukemia 2008). Imatinib is FDA approved for the treatment of &quot;adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the FIP1L1-PDGFR fusion kinase&quot; (NDA021588).		4	54243812	54294350			ENST00000337488.6	75	GRCh37	4	55141008	55164414	ENST00000257290.5	transcript_fusion		2017-11-22 19:45:54 UTC
576	https://civic.genome.wustl.edu/links/variants/576	ROS1	6098	TFG-ROS1			3	100428269	100447702			ENST00000240851.4	75	GRCh37	6	117609463	117642557	ENST00000368508.3	transcript_fusion		2017-11-22 19:45:53 UTC
577	https://civic.genome.wustl.edu/links/variants/577	PDGFRA	5156	FIP1L1-PDGFRA T674I	A case study of relapsed myeloproliferative hypereosinophilic syndrome suggests that a T674I mutation in the PDGFRA split kinase domain of FIP1L1-PDGFRA fusions may confer resistance to imatinib.		4	55144547	55144547	C	T	ENST00000257290.5	75	GRCh37					transcript_fusion,missense_variant	NC_000004.11:g.55144547C>T,ENST00000257290.5:c.2021C>T	2017-11-22 19:45:53 UTC
578	https://civic.genome.wustl.edu/links/variants/578	BIRC5	332	OVEREXPRESSION			17	76210267	76221717			ENST00000301633.4	75	GRCh37					N/A		2017-11-22 19:45:53 UTC
579	https://civic.genome.wustl.edu/links/variants/579	BRAF	673	D594A		Kinase Dead BRAF Mutation	7	140453154	140453154	T	G	ENST00000288602.6	75	GRCh37					missense_variant	ENST00000288602.6:c.1781A>C,NC_000007.13:g.140453154T>G,NM_004333.4:c.1781A>C,NP_004324.2:p.Asp594Ala	2017-11-22 19:45:53 UTC
580	https://civic.genome.wustl.edu/links/variants/580	BRAF	673	D594V		Kinase Dead BRAF Mutation	7	140453154	140453154	T	A	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1781A>T,NP_004324.2:p.Asp594Val,NC_000007.13:g.140453154T>A,ENST00000288602.6:c.1781A>T	2017-11-22 19:45:53 UTC
581	https://civic.genome.wustl.edu/links/variants/581	BRAF	673	K483M	The K483M variant is a kinase dead loss-of-function variant in the catalytic site of BRAF. This engineered variant is often used as a control when evaluating other BRAF variants.	Kinase Dead BRAF Mutation	7	140477859	140477860	TT	CA	ENST00000288602.6	75	GRCh37					loss_of_function_variant,missense_variant	NC_000007.13:g.140477859_140477860delinsCA,ENST00000288602.6:c.1448_1449delinsTG	2017-11-22 19:45:53 UTC
582	https://civic.genome.wustl.edu/links/variants/582	BRAF	673	L597S			7	140453145	140453146	AG	GA	ENST00000288602.6	75	GRCh37					missense_variant	NC_000007.13:g.140453145_140453146delinsGA,NM_004333.4:c.1789_1790delCTinsTC,NP_004324.2:p.Leu597Ser,ENST00000288602.6:c.1789_1790delCTinsTC	2017-11-22 19:45:53 UTC
583	https://civic.genome.wustl.edu/links/variants/583	BRAF	673	L597Q			7	140453145	140453145	A	T	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1790T>A,NP_004324.2:p.Leu597Gln,NC_000007.13:g.140453145A>T,ENST00000288602.6:c.1790T>A	2017-11-22 19:45:53 UTC
584	https://civic.genome.wustl.edu/links/variants/584	BRAF	673	K601E			7	140453134	140453134	T	C	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1801A>G,NP_004324.2:p.Lys601Glu,NC_000007.13:g.140453134T>C,ENST00000288602.6:c.1801A>G	2017-11-22 19:45:53 UTC
585	https://civic.genome.wustl.edu/links/variants/585	BRAF	673	L597V			7	140453146	140453146	G	C	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1789C>G,NP_004324.2:p.Leu597Val,NC_000007.13:g.140453146G>C,ENST00000288602.6:c.1789C>G	2017-11-22 19:45:53 UTC
586	https://civic.genome.wustl.edu/links/variants/586	KIT	3815	AMPLIFICATION			4	55524085	55606881			ENST00000288135.5	75	GRCh37					transcript_amplification		2017-11-22 19:45:53 UTC
587	https://civic.genome.wustl.edu/links/variants/587	NF1	4763	MUTATION			17	29421945	29704695			ENST00000358273.4	75	GRCh37					loss_of_function_variant,protein_altering_variant		2017-11-22 19:45:53 UTC
588	https://civic.genome.wustl.edu/links/variants/588	ALK	238	HIP1-ALK I1171N			2	29445213	29445213	A	T	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	ENST00000389048.3:c.3512T>A,NC_000002.11:g.29445213A>T,NM_004304.4:c.3512T>A,NP_004295.2:p.Ile1171Asn	2017-11-22 19:45:53 UTC
589	https://civic.genome.wustl.edu/links/variants/589	ALK	238	EML4-ALK I1171S			2	29445213	29445213	A	C	ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant	ENST00000389048.3:c.3512T>G,NC_000002.11:g.29445213A>C	2017-11-22 19:45:53 UTC
590	https://civic.genome.wustl.edu/links/variants/590	BIRC3	330	TRUNCATING MUTATION			11	102201730	102207833			ENST00000263464.3	75	GRCh37					frameshift_variant		2017-11-22 19:45:53 UTC
591	https://civic.genome.wustl.edu/links/variants/591	RAF1	5894	AMPLIFICATION			3	12625100	12705725			ENST00000251849.4	75	GRCh37					transcript_amplification		2017-11-22 19:45:53 UTC
592	https://civic.genome.wustl.edu/links/variants/592	KRAS	3845	AMPLIFICATION			12	25362365	25403737			ENST00000256078.4	75	GRCh37					transcript_amplification		2017-11-22 19:45:53 UTC
594	https://civic.genome.wustl.edu/links/variants/594	CEBPA	1050	BIALLELIC INACTIVATION			19	33790840	33793470			ENST00000498907.2	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:53 UTC
595	https://civic.genome.wustl.edu/links/variants/595	SRSF2	6427	MUTATION			17	74732402	74733113			ENST00000392485.2	75	GRCh37					gene_variant		2017-11-22 19:45:53 UTC
596	https://civic.genome.wustl.edu/links/variants/596	NRAS	4893	G12/G13			1	115258744	115258748			ENST00000369535.4	75	GRCh37					protein_altering_variant		2017-11-22 19:45:53 UTC
597	https://civic.genome.wustl.edu/links/variants/597	RET	5979	OVEREXPRESSION			10	43572475	43625799			ENST00000355710.3	75	GRCh37					N/A		2017-11-22 19:45:53 UTC
599	https://civic.genome.wustl.edu/links/variants/599	CTLA4	1493	CTLA4-CD28	A survey of 115 T-cell lymphoma samples of diverse subtypes identified this fusion in 26 of 45 cases of angioimmunoblastic T-cell lymphomas (58%), nine of 39 peripheral T-cell lymphomas, not otherwise specified (23%), and nine of 31 extranodal NK/T cell lymphomas (29%).		2	204732509	204736210			ENST00000302823.3	75	GRCh37	2	204599507	204603635	ENST00000324106.8	transcript_fusion		2017-11-22 19:45:54 UTC
600	https://civic.genome.wustl.edu/links/variants/600	AR	367	MUTATION			X	66764465	66950461			ENST00000374690.3	75	GRCh37					transcript_variant		2017-11-22 19:45:53 UTC
601	https://civic.genome.wustl.edu/links/variants/601	NOTCH1	4851	LOSS-OF-FUNCTION			9	139388896	139440314			ENST00000277541.6	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:53 UTC
602	https://civic.genome.wustl.edu/links/variants/602	CDK6	1021	OVEREXPRESSION			7	92234235	92463231			ENST00000265734.4	75	GRCh37					N/A		2017-11-22 19:45:53 UTC
603	https://civic.genome.wustl.edu/links/variants/603	FLT3	2322	OVEREXPRESSION			13	28577411	28674729			ENST00000241453.7	75	GRCh37					N/A		2017-11-22 19:45:53 UTC
604	https://civic.genome.wustl.edu/links/variants/604	GNAQ	2776	Q209P			9	80409488	80409488	T	G	ENST00000286548.4	75	GRCh37					missense_variant	NC_000009.11:g.80409488T>G,NM_002072.4:c.626A>C,NP_002063.2:p.Gln209Pro,ENST00000286548.4:c.626A>C	2017-11-22 19:45:53 UTC
605	https://civic.genome.wustl.edu/links/variants/605	PTEN	5728	V317FS			10	89720799	89720802	TACT		ENST00000371953.3	75	GRCh37					frameshift_variant	ENST00000371953.3:c.950_953delTACT,NC_000010.10:g.89720799_89720802del	2017-11-22 19:45:53 UTC
606	https://civic.genome.wustl.edu/links/variants/606	RB1	5925	LOSS-OF-FUNCTION			13	48877911	49056122			ENST00000267163.4	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:53 UTC
607	https://civic.genome.wustl.edu/links/variants/607	ESR1	2099	OVEREXPRESSION			6	152128686	152424406			ENST00000206249.3	75	GRCh37					N/A		2017-11-22 19:45:53 UTC
608	https://civic.genome.wustl.edu/links/variants/608	ALK	238	EML4-ALK C1156YL1196M			2	29443631	29445258			ENST00000389048.3	75	GRCh37					transcript_fusion,missense_variant		2017-11-22 19:45:53 UTC
609	https://civic.genome.wustl.edu/links/variants/609	MTOR	2475	M2327I			1	11177096	11177096	C	A	ENST00000361445.4	75	GRCh37					missense_variant	ENST00000361445.4:c.6981G>T,NC_000001.10:g.11177096C>A	2017-11-22 19:45:53 UTC
610	https://civic.genome.wustl.edu/links/variants/610	MTOR	2475	A2034V			1	11187796	11187796	G	A	ENST00000361445.4	75	GRCh37					missense_variant	ENST00000361445.4:c.6101C>T,NC_000001.10:g.11187796G>A	2017-11-22 19:45:53 UTC
611	https://civic.genome.wustl.edu/links/variants/611	BRAF	673	D594G			7	140453154	140453154	T	C	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1781A>G,NP_004324.2:p.Asp594Gly,NC_000007.13:g.140453154T>C,ENST00000288602.6:c.1781A>G	2017-11-22 19:45:53 UTC
612	https://civic.genome.wustl.edu/links/variants/612	FLT3	2322	D835H			13	28592642	28592642	C	G	ENST00000241453.7	75	GRCh37					missense_variant	NM_004119.2:c.2503G>C,NP_004110.2:p.Asp835His,ENST00000241453.7:c.2503G>C,NC_000013.10:g.28592642C>G	2017-11-22 19:45:53 UTC
613	https://civic.genome.wustl.edu/links/variants/613	FLT3	2322	D835H/Y			13	28592642	28592642	C	G/A	ENST00000241453.7	75	GRCh37					missense_variant	NM_004119.2:c.2503G>C,NP_004110.2:p.Asp835His,NM_004119.2:c.2503G>T,NP_004110.2:p.Asp835Tyr,ENST00000241453.7:c.2503G>C,ENST00000241453.7:c.2503G>T	2017-11-22 19:45:53 UTC
614	https://civic.genome.wustl.edu/links/variants/614	JAK1	3716	Q503*			1	65321333	65321333	G	A	ENST00000342505.4	75	GRCh37					stop_gained	NC_000001.10:g.65321333G>A,ENST00000342505.4:c.1507C>T	2017-11-22 19:45:53 UTC
615	https://civic.genome.wustl.edu/links/variants/615	JAK2	3717	Exon 12 splice site insertion			9	5070053	5070054		G	ENST00000381652.3	75	GRCh37						NC_000009.11:g.5070053_5070054insG	2017-11-22 19:46:01 UTC
616	https://civic.genome.wustl.edu/links/variants/616	B2M	567	S14FS			15	45003786	45003789	TCTT		ENST00000558401.1	75	GRCh37					frameshift_truncation	ENST00000558401.1:c.42_45delTCTT,NC_000015.9:g.45003786_45003789del	2017-11-22 19:45:52 UTC
617	https://civic.genome.wustl.edu/links/variants/617	BRAF	673	PPFIBP2-BRAF		BRAF Fusions	11	7535001	7586998			ENST00000299492.4	75	GRCh37	7	140434279	140481493	ENST00000288602.6	transcript_fusion		2017-11-22 19:45:53 UTC
618	https://civic.genome.wustl.edu/links/variants/618	BRAF	673	KIAA1549-BRAF		BRAF Fusions	7	138545885	138666064			ENST00000440172.1	75	GRCh37	7	140434279	140487384	ENST00000288602.6	transcript_fusion		2017-11-22 19:45:54 UTC
619	https://civic.genome.wustl.edu/links/variants/619	PTGS2	5743	OVEREXPRESSION			1	186640923	186649559			ENST00000367468.5	75	GRCh37					N/A		2017-11-22 19:46:01 UTC
621	https://civic.genome.wustl.edu/links/variants/621	MET	4233	OVEREXPRESSION			7	116312459	116436396			ENST00000318493.6	75	GRCh37					N/A		2017-11-22 19:45:53 UTC
623	https://civic.genome.wustl.edu/links/variants/623	POT1	25913	MUTATION			7	124462440	124570035			ENST00000357628.3	75	GRCh37					loss_of_function_variant,protein_altering_variant		2017-11-22 19:45:54 UTC
624	https://civic.genome.wustl.edu/links/variants/624	MKI67	4288	EXPRESSION			10	129894923	129924649			ENST00000368654.3	75	GRCh37					N/A		2017-11-22 19:45:53 UTC
625	https://civic.genome.wustl.edu/links/variants/625	RAD23B	5887	EXPRESSION			9	110045560	110094475			ENST00000358015.3	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
626	https://civic.genome.wustl.edu/links/variants/626	RET	5979	CCDC6-RET															transcript_fusion		2017-11-22 19:45:53 UTC
627	https://civic.genome.wustl.edu/links/variants/627	MAP2K1	5604	C121S			15	66729154	66729154	G	C	ENST00000307102.5	75	GRCh37					missense_variant	ENST00000307102.5:c.362G>C,NC_000015.9:g.66729154G>C,NM_002755.3:c.362G>C,NP_002746.1:p.Cys121Ser	2017-11-22 19:45:53 UTC
628	https://civic.genome.wustl.edu/links/variants/628	FGFR3	2261	S249C			4	1803568	1803568	C	G	ENST00000340107.4	75	GRCh37					missense_variant	NC_000004.11:g.1803568C>G	2017-11-22 19:45:53 UTC
629	https://civic.genome.wustl.edu/links/variants/629	FGFR2	2263	AMPLIFICATION			10	123239371	123357917			ENST00000457416.2	75	GRCh37					transcript_amplification		2017-11-22 19:45:54 UTC
630	https://civic.genome.wustl.edu/links/variants/630	FGF3	2248	AMPLIFICATION			11	69624992	69633792			ENST00000334134.2	75	GRCh37					transcript_amplification		2017-11-22 19:45:54 UTC
631	https://civic.genome.wustl.edu/links/variants/631	VHL	7428	R200W (c.598C>T)			3	10191605	10191605	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.598C>T,NP_000542.1:p.Arg200Trp,ENST00000256474.2:c.598C>T,NC_000003.11:g.10191605C>T	2017-11-22 19:45:54 UTC
632	https://civic.genome.wustl.edu/links/variants/632	RB1	5925	PHOSPHORYLATION			13	48877911	49056122			ENST00000267163.4	75	GRCh37					N/A		2017-11-22 19:45:53 UTC
633	https://civic.genome.wustl.edu/links/variants/633	PIK3R1	5295	MUTATION			5	67511548	67597649			ENST00000521381.1	75	GRCh37					gain_of_function_variant,missense_variant		2017-11-22 19:45:53 UTC
634	https://civic.genome.wustl.edu/links/variants/634	STK11	6794	D194E			19	1220489	1220489	C	A	ENST00000326873.7	75	GRCh37					loss_of_heterozygosity,missense_variant	NM_000455.4:c.582C>A,NP_000446.1:p.Asp194Glu,ENST00000326873.7:c.582C>A,NC_000019.9:g.1220489C>A	2017-11-22 19:45:54 UTC
635	https://civic.genome.wustl.edu/links/variants/635	AKT2	208	AMPLIFICATION			19	40736224	40791302			ENST00000392038.2	75	GRCh37					transcript_amplification		2017-11-22 19:45:54 UTC
636	https://civic.genome.wustl.edu/links/variants/636	PTEN	5728	R130*			10	89692904	89692904	C	T	ENST00000371953.3	75	GRCh37					stop_gained	NM_000314.6:c.388C>T,NP_000305.3:p.Arg130Ter,ENST00000371953.3:c.388C>T,NC_000010.10:g.89692904C>T	2017-11-22 19:45:53 UTC
637	https://civic.genome.wustl.edu/links/variants/637	FBXW7	55294	LOSS-OF-FUNCTION			4	153242410	153457253			ENST00000281708.4	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:54 UTC
638	https://civic.genome.wustl.edu/links/variants/638	RB1	5925	M695FS*26			13	49033946	49033947		A	ENST00000267163.4	75	GRCh37					frameshift_truncation	ENST00000267163.4:c.2083_2084insA,NC_000013.10:g.49033946_49033947insA	2017-11-22 19:45:54 UTC
639	https://civic.genome.wustl.edu/links/variants/639	JUN	3725	OVEREXPRESSION			1	59246465	59249785			ENST00000371222.2	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
640	https://civic.genome.wustl.edu/links/variants/640	FOS	2353	OVEREXPRESSION			14	75745477	75748933			ENST00000303562.4	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
641	https://civic.genome.wustl.edu/links/variants/641	CDKN2A	1029	RS3814960			9	21975017	21975017	C	T	ENST00000498124.1	75	GRCh37					5_prime_UTR_exon_variant	NC_000009.11:g.21975017C>T	2017-11-22 19:45:54 UTC
642	https://civic.genome.wustl.edu/links/variants/642	MDM2	4193	RS34886328			12	69234988	69234988			ENST00000462284.1	75	GRCh37					3_prime_UTR_truncation		2017-11-22 19:45:54 UTC
643	https://civic.genome.wustl.edu/links/variants/643	CBLB	868	RS2305035			3	105439026	105439026	G	A	ENST00000264122.4	75	GRCh37					synonymous_variant,polymorphic_sequence_variant	NC_000003.11:g.105439026G>A,NM_001321788.1:c.1272C>T,ENST00000264122.4:c.1272C>T	2017-11-22 19:45:53 UTC
644	https://civic.genome.wustl.edu/links/variants/644	PRDM1	639	MUTATION			6	106534195	106557813			ENST00000369096.4	75	GRCh37					loss_of_function_variant,transcript_variant		2017-11-22 19:45:54 UTC
645	https://civic.genome.wustl.edu/links/variants/645	IDH1	3417	MUTATION			2	209101803	209116275			ENST00000415913.1	75	GRCh37					transcript_variant		2017-11-22 19:45:53 UTC
646	https://civic.genome.wustl.edu/links/variants/646	SMAD4	4089	DELETION			18	48556583	48611409			ENST00000342988.3	75	GRCh37					transcript_ablation		2017-11-22 19:45:53 UTC
647	https://civic.genome.wustl.edu/links/variants/647	LRP1B	53353	DELETION			2	140988992	142889270			ENST00000389484.3	75	GRCh37					transcript_ablation		2017-11-22 19:45:54 UTC
648	https://civic.genome.wustl.edu/links/variants/648	ATRX	546	UNDEREXPRESSION			X	76760356	77041702			ENST00000373344.5	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
649	https://civic.genome.wustl.edu/links/variants/649	MET	4233	D1228N			7	116423407	116423407	G	A	ENST00000397752.3	75	GRCh37					missense_variant	NM_001127500.2:c.3736G>A,NP_001120972.1:p.Asp1246Asn,NC_000007.13:g.116423407G>A,ENST00000397752.3:c.3682G>A	2017-11-22 19:45:54 UTC
650	https://civic.genome.wustl.edu/links/variants/650	CASP8	841	D302H			2	202149589	202149589	G	C	ENST00000264275.5	75	GRCh37					missense_variant,polymorphic_sequence_variant	NM_001228.4:c.904G>C,NP_001219.2:p.Asp302His,ENST00000264275.5:c.904G>C,NC_000002.11:g.202149589G>C	2017-11-22 19:45:54 UTC
651	https://civic.genome.wustl.edu/links/variants/651	AXL	558	EXPRESSION			19	41725108	41767671			ENST00000301178.4	75	GRCh37					N/A		2017-11-22 19:45:53 UTC
652	https://civic.genome.wustl.edu/links/variants/652	GAS6	2621	EXPRESSION			13	114523524	114567046			ENST00000357389.3	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
653	https://civic.genome.wustl.edu/links/variants/653	ETV4	2118	OVEREXPRESSION			17	41605212	41623800			ENST00000319349.5	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
654	https://civic.genome.wustl.edu/links/variants/654	STAG3	10734	UNDEREXPRESSION			7	99775186	99812003			ENST00000426455.1	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
655	https://civic.genome.wustl.edu/links/variants/655	MAP2K1	5604	Q56_V60del			15	66727449	66727463	CCAGAAGCAGAAGGT		ENST00000307102.5	75	GRCh37					inframe_deletion	ENST00000307102.5:c.165_179del,NC_000015.9:g.66727449_66727463del	2017-11-22 19:45:54 UTC
656	https://civic.genome.wustl.edu/links/variants/656	BRAF	673	BRAF-CUL1		BRAF Fusions	7	140434279	140487384			ENST00000288602.6	75	GRCh37	7	148395737	148457588	ENST00000602748.1	transcript_fusion		2017-11-22 19:45:53 UTC
657	https://civic.genome.wustl.edu/links/variants/657	BRAF	673	ZKSCAN1-BRAF		BRAF Fusions	7	99613222	99627575			ENST00000426572.1	75	GRCh37	7	140434279	140482957	ENST00000288602.6	transcript_fusion		2017-11-22 19:45:54 UTC
658	https://civic.genome.wustl.edu/links/variants/658	BRAF	673	L505H			7	140477794	140477794	A	T	ENST00000288602.6	75	GRCh37					missense_variant	ENST00000288602.6:c.1514T>A,NC_000007.13:g.140477794A>T	2017-11-22 19:45:54 UTC
659	https://civic.genome.wustl.edu/links/variants/659	NF2	4771	MUTATION			22	29999547	30094587			ENST00000338641.4	75	GRCh37					transcript_variant		2017-11-22 19:45:54 UTC
660	https://civic.genome.wustl.edu/links/variants/660	HIF1A	3091	EXPRESSION			14	62164340	62214489			ENST00000539097.1	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
661	https://civic.genome.wustl.edu/links/variants/661	BRCA2	675	D3095E			13	32968854	32968854	C	A	ENST00000544455.1	75	GRCh37					missense_variant	NM_000059.3:c.9285C>A,NP_000050.2:p.Asp3095Glu,ENST00000544455.1:c.9285C>A,NC_000013.10:g.32968854C>A	2017-11-22 19:45:54 UTC
662	https://civic.genome.wustl.edu/links/variants/662	MLH1	4292	EXPRESSION			3	37034823	37092409			ENST00000231790.2	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
663	https://civic.genome.wustl.edu/links/variants/663	BCOR	54880	MUTATION			X	39910501	40036582			ENST00000342274.4	75	GRCh37					transcript_variant		2017-11-22 19:45:54 UTC
664	https://civic.genome.wustl.edu/links/variants/664	CDH1	999	MUTATION			16	68771128	68869451			ENST00000261769.5	75	GRCh37					transcription_variant		2017-11-22 19:45:54 UTC
665	https://civic.genome.wustl.edu/links/variants/665	RHOA	387	MUTATION			3	49412898	49405977			ENST00000418115.1	75	GRCh37					transcription_variant,gain_of_function_variant		2017-11-22 19:45:54 UTC
666	https://civic.genome.wustl.edu/links/variants/666	ERBB2	2064	MUTATION			17	37868196	37881332			ENST00000269571.5	75	GRCh37					missense_variant		2017-11-22 19:45:54 UTC
667	https://civic.genome.wustl.edu/links/variants/667	MEN1	4221	FRAMESHIFT TRUNCATION			11	64572092	64572092	C		ENST00000337652.1	75	GRCh37					frameshift_truncation	NC_000011.9:g.64572092del	2017-11-22 19:45:54 UTC
668	https://civic.genome.wustl.edu/links/variants/668	KMT2C	58508	MUTATION			7	151832010	152133090			ENST00000262189.6	75	GRCh37					transcription_variant,loss_of_function_variant		2017-11-22 19:45:54 UTC
669	https://civic.genome.wustl.edu/links/variants/669	STAG2	10735	MUTATION			X	123176418	123217308			ENST00000218089.9	75	GRCh37					protein_altering_variant		2017-11-22 19:45:54 UTC
670	https://civic.genome.wustl.edu/links/variants/670	MYCL	4610	EXPRESSION			1	40361098	40367685			ENST00000397332.2	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
671	https://civic.genome.wustl.edu/links/variants/671	HGF	3082	EXPRESSION			7	81328322	81399514			ENST00000222390.5	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
672	https://civic.genome.wustl.edu/links/variants/672	SOX10	6663	LOSS			22	38368307	38380544			ENST00000396884.2	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:54 UTC
673	https://civic.genome.wustl.edu/links/variants/673	FGF2	2247	EXPRESSION			4	123747863	123819391			ENST00000264498.3	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
674	https://civic.genome.wustl.edu/links/variants/674	EIF1AX	1964	MUTATION			X	20156713	20159754			ENST00000379607.5	75	GRCh37					transcript_variant		2017-11-22 19:45:54 UTC
683	https://civic.genome.wustl.edu/links/variants/683	PAX8	7849	EXPRESSION			2	113973574	114036527			ENST00000429538.3	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
691	https://civic.genome.wustl.edu/links/variants/691	ERRFI1	54206	E384*			1	8073509	8073509	C	A	ENST00000377482.5	75	GRCh37					loss_of_function_variant,stop_gained	NC_000001.10:g.8073509C>A	2017-11-22 19:45:54 UTC
692	https://civic.genome.wustl.edu/links/variants/692	ESR1	2099	S463P			6	152415537	152415537	T	C	ENST00000440973.1	75	GRCh37					missense_variant	ENST00000440973.1:c.1387T>C,NC_000006.11:g.152415537T>C	2017-11-22 19:45:54 UTC
693	https://civic.genome.wustl.edu/links/variants/693	SGK1	6446	OVEREXPRESSION			6	134490384	134639196			ENST00000367858.5	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
694	https://civic.genome.wustl.edu/links/variants/694	BRAF	673	G596C			7	140453149	140453149	C	A	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1786G>T,NP_004324.2:p.Gly596Cys,NC_000007.13:g.140453149C>A,ENST00000288602.6:c.1786G>T	2017-11-22 19:45:54 UTC
695	https://civic.genome.wustl.edu/links/variants/695	SMARCB1	6598	UNDEREXPRESSION			22	24129150	24176703			ENST00000344921.6	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
696	https://civic.genome.wustl.edu/links/variants/696	SMARCB1	6598	DELETION			22	24129150	24176703			ENST00000344921.6	75	GRCh37					transcript_ablation		2017-11-22 19:45:54 UTC
697	https://civic.genome.wustl.edu/links/variants/697	NF2	4771	LOSS			22	29999547	30094587			ENST00000338641.4	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:54 UTC
698	https://civic.genome.wustl.edu/links/variants/698	NF1	4763	LOSS			17	29421945	29704695			ENST00000358273.4	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:54 UTC
699	https://civic.genome.wustl.edu/links/variants/699	SH2B3	10019	RS3184504			12	111884608	111884608	T	C	ENST00000341259.2	75	GRCh37					missense_variant,polymorphic_sequence_variant	NC_000012.11:g.111884608T>C	2017-11-22 19:45:54 UTC
700	https://civic.genome.wustl.edu/links/variants/700	KIF23	9493	EXPRESSION			15	69706688	69740756			ENST00000260363.4	75	GRCh37					N/A		2017-11-22 19:45:54 UTC
701	https://civic.genome.wustl.edu/links/variants/701	ERBB3	2065	V104M			12	56478854	56478854	G	A	ENST00000267101.3	75	GRCh37					missense_variant	NC_000012.11:g.56478854G>A	2017-11-22 19:45:55 UTC
702	https://civic.genome.wustl.edu/links/variants/702	ERBB3	2065	R103G			12	56478851	56478851	C	G	ENST00000267101.3	75	GRCh37					missense_variant	NC_000012.11:g.56478851C>G	2017-11-22 19:45:54 UTC
703	https://civic.genome.wustl.edu/links/variants/703	ERBB3	2065	G284R			12	56481922	56481922	G	A	ENST00000267101.3	75	GRCh37					missense_variant	NC_000012.11:g.56481922G>A	2017-11-22 19:45:55 UTC
705	https://civic.genome.wustl.edu/links/variants/705	GADD45A	1647	rs681673			1	68152388	68152388	T	C	ENST00000370986.4	75	GRCh37					coding_transcript_intron_variant		2017-11-22 19:45:54 UTC
706	https://civic.genome.wustl.edu/links/variants/706	EWSR1	2130	EWSR1-FLI1	In approximately 90% of Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET) a translocation t(11;22)(q24; q12) is identified, fusing the 5 exons (containing the transactivatin domain, at least exon 1-7) of EWSR1, with the 3 exons (from exon 9, coding the DNA binding domain) of FLI1.		22	29664307	29688158			ENST00000414183.2	75	GRCh37	11	128638013	128683162	ENST00000527786.2	transcript_fusion		2017-11-22 19:45:55 UTC
707	https://civic.genome.wustl.edu/links/variants/707	TMPRSS2	7113	TMPRSS2-ERG			21	42879877	42879992			ENST00000398585.3	75	GRCh37	21	39751949	39817544	ENST00000398910.1	transcript_fusion		2017-11-22 19:45:54 UTC
708	https://civic.genome.wustl.edu/links/variants/708	BRCA2	675	TRUNCATING MUTATION															feature_truncation		2017-11-22 19:45:54 UTC
709	https://civic.genome.wustl.edu/links/variants/709	BRCA1	672	Alu insertion																	2017-11-22 19:45:53 UTC
711	https://civic.genome.wustl.edu/links/variants/711	KLLN	100144748	PROMOTER METHYLATION															gene_silenced_by_DNA_methylation		2017-11-22 19:45:54 UTC
712	https://civic.genome.wustl.edu/links/variants/712	EGFR	1956	D761Y			7	55242511	55242511	G	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2281G>T,NM_005228.4:c.2281G>T,NP_005219.2:p.Asp761Tyr,NC_000007.13:g.55242511G>T	2017-11-22 19:45:54 UTC
713	https://civic.genome.wustl.edu/links/variants/713	CRBN	51185	MUTATION			3	3191695	3221394			ENST00000231948.4	75	GRCh37							2017-11-22 19:45:54 UTC
714	https://civic.genome.wustl.edu/links/variants/714	TSC1	7248	R1062W			9	135771933	135771933	G	A	ENST00000298552.3	75	GRCh37					missense_variant	NM_000368.3:c.3184C>T,NP_000359.1:p.Arg1062Trp,ENST00000298552.3:c.3184C>T,NC_000009.11:g.135771933G>A	2017-11-22 19:45:55 UTC
715	https://civic.genome.wustl.edu/links/variants/715	STK11	6794	MUTATION			19	1205740	1223074			ENST00000326873.7	75	GRCh37					gene_variant		2017-11-22 19:45:55 UTC
716	https://civic.genome.wustl.edu/links/variants/716	PDGFRA	5156	AMPLIFICATION			4	55095264	55164414			ENST00000257290.5	75	GRCh37					transcript_amplification		2017-11-22 19:45:54 UTC
717	https://civic.genome.wustl.edu/links/variants/717	DDIT3	1649	EWSR1-DDIT3			22	29664307	29687588			ENST00000414183.2	75	GRCh37	12	57910376	57911536	ENST00000346473.3	transcript_fusion		2017-11-22 19:45:55 UTC
718	https://civic.genome.wustl.edu/links/variants/718	EGFR	1956	G719			7	55241707	55241708			ENST00000275493.2	75	GRCh37					protein_altering_variant		2017-11-22 19:45:54 UTC
719	https://civic.genome.wustl.edu/links/variants/719	BRD4	23476	BRD4-NUTM1																	2017-11-22 19:45:54 UTC
720	https://civic.genome.wustl.edu/links/variants/720	EGFR	1956	S720			7	55241710	55241711			ENST00000275493.2	75	GRCh37					protein_altering_variant		2017-11-22 19:45:54 UTC
721	https://civic.genome.wustl.edu/links/variants/721	CYP2D6	1565	LOSS-OF-FUNCTION			22	42522501	42526908			ENST00000360608.5	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:55 UTC
722	https://civic.genome.wustl.edu/links/variants/722	DDIT3	1649	FUS-DDIT3															gene_fusion		2017-11-22 19:45:54 UTC
723	https://civic.genome.wustl.edu/links/variants/723	EGFR	1956	K757R			7	55242500	55242500	A	G	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2270A>G,NC_000007.13:g.55242500A>G	2017-11-22 19:45:54 UTC
724	https://civic.genome.wustl.edu/links/variants/724	EGFR	1956	E746G			7	55242467	55242467	A	G	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2237A>G,NC_000007.13:g.55242467A>G	2017-11-22 19:45:55 UTC
725	https://civic.genome.wustl.edu/links/variants/725	MLH1	4292	E13FS*3			3	37035075	37035075	G		ENST00000231790.2	75	GRCh37					frameshift_truncation	NM_000249.3:c.37delG,NP_000240.1:p.Glu13Argfs,ENST00000231790.2:c.37delG,NC_000003.11:g.37035075del	2017-11-22 19:45:55 UTC
726	https://civic.genome.wustl.edu/links/variants/726	EGFR	1956	EXON 20 INSERTION			7	55248991	55249022			ENST00000275493.2	75	GRCh37					inframe_insertion		2017-11-22 19:45:55 UTC
727	https://civic.genome.wustl.edu/links/variants/727	MSH2	4436	R383*			2	47656951	47656951	C	T	ENST00000233146.2	75	GRCh37					stop_gained	NM_000251.2:c.1147C>T,NP_000242.1:p.Arg383Ter,ENST00000233146.2:c.1147C>T,NC_000002.11:g.47656951C>T	2017-11-22 19:45:54 UTC
728	https://civic.genome.wustl.edu/links/variants/728	MLH1	4292	V534R			3	37081718	37081719	GT	AG	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.1600_1601delinsAG,NC_000003.11:g.37081718_37081719delinsAG	2017-11-22 19:45:54 UTC
729	https://civic.genome.wustl.edu/links/variants/729	UGT1A1	54658	UGT1A1*28			2	234668881	234668882		TATATATATATATA	ENST00000305208.5	75	GRCh37					microsatellite	NC_000002.11:g.234668881_234668882TA[7]	2017-11-22 19:45:55 UTC
730	https://civic.genome.wustl.edu/links/variants/730	MLH1	4292	G606FS*2			3	37089094	37089095	GG		ENST00000231790.2	75	GRCh37					frameshift_truncation	ENST00000231790.2:c.1816_1817delGG,NC_000003.11:g.37089094_37089095del	2017-11-22 19:45:54 UTC
731	https://civic.genome.wustl.edu/links/variants/731	MLH1	4292	C.790+1G>A			3	37056036	37056036	G	A	ENST0000023170.2	75	GRCh37					splice_donor_variant	NM_000249.3:c.790+1G>A,NC_000003.11:g.37056036G>A,ENST0000023170.2:c.790+1G>A	2017-11-22 19:45:55 UTC
732	https://civic.genome.wustl.edu/links/variants/732	UGT1A1	54658	UGT1A1*60															microsatellite		2017-11-22 19:45:54 UTC
733	https://civic.genome.wustl.edu/links/variants/733	MLH1	4292	K618DEL			3	37089130	37089132	AAG		ENST00000231790.2	75	GRCh37					inframe_deletion	NC_000003.11:g.37089130_37089132del,ENST00000231790.2:c.1852_1854delAAG,NM_000249.3:c.1852_1854delAAG,NP_000240.1:p.Lys618del	2017-11-22 19:45:55 UTC
734	https://civic.genome.wustl.edu/links/variants/734	MLH1	4292	P138T																	2017-11-22 19:45:54 UTC
735	https://civic.genome.wustl.edu/links/variants/735	MLH1	4292	R687FS			3	37090464	37090464	C		ENST00000231790.2	75	GRCh37					frameshift_variant	NM_000249.3:c.2059delC,NP_000240.1:p.Arg687Glyfs,ENST00000231790.2:c.2059delC,NC_000003.11:g.37090464del	2017-11-22 19:45:55 UTC
736	https://civic.genome.wustl.edu/links/variants/736	EGFR	1956	V769_770insASV			7	55249009	55249010			ENST00000275493.2	75	GRCh37					insertion	NM_005228.4:c.2300_2308dupCCAGCGTGG	2017-11-22 19:45:55 UTC
737	https://civic.genome.wustl.edu/links/variants/737	DPYD	1806	DPYD*2A HOMOZYGOSITY			1	97915614	97915614	C	T	ENST00000370192.3	75	GRCh37					splice_donor_variant	NC_000001.10:g.97915614C>T,NM_000110.3:c.1905+1G>A,ENST00000370192.3:c.1905+1G>A	2017-11-22 19:45:55 UTC
738	https://civic.genome.wustl.edu/links/variants/738	DPYD	1806	DPYD*13 HOMOZYGOSITY			1	97981343	97981343	A	C	ENST00000370192.3	75	GRCh37					missense_variant	NM_000110.3:c.1679T>G,NP_000101.2:p.Ile560Ser,ENST00000370192.3:c.1679T>G,NC_000001.10:g.97981343A>C	2017-11-22 19:45:55 UTC
739	https://civic.genome.wustl.edu/links/variants/739	FOS	2353	TRUNCATING FUSION			14	75745477	75748127			ENST00000303562.4	75	GRCh37					transcript_fusion,stop_gained		2017-11-22 19:45:55 UTC
740	https://civic.genome.wustl.edu/links/variants/740	DPYD	1806	RS67376798 HOMOZYGOSITY															polymorphic_sequence_variant		2017-11-22 19:45:54 UTC
741	https://civic.genome.wustl.edu/links/variants/741	MLH1	4292	R100*			3	37042536	37042536	C	T	ENST00000231790.2	75	GRCh37					stop_gained	NM_000249.3:c.298C>T,NP_000240.1:p.Arg100Ter,ENST00000231790.2:c.298C>T,NC_000003.11:g.37042536C>T	2017-11-22 19:45:55 UTC
742	https://civic.genome.wustl.edu/links/variants/742	WWTR1	25937	WWTR1-CAMTA1			3	149235022	149290787			ENST00000465804.1	75	GRCh37	1	7721786	7829766	ENST00000303635.7	transcript_fusion		2017-11-22 19:45:55 UTC
743	https://civic.genome.wustl.edu/links/variants/743	MLH1	4292	T117M			3	37045935	37045935	C	T	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.350C>T,NP_000240.1:p.Thr117Met,ENST00000231790.2:c.350C>T,NC_000003.11:g.37045935C>T	2017-11-22 19:45:54 UTC
744	https://civic.genome.wustl.edu/links/variants/744	MLH1	4292	Q426FS			3	37067365	37067365	C		ENST00000231790.2	75	GRCh37					frameshift_truncation	ENST00000231790.2:c.1276delC,NC_000003.11:g.37067365del	2017-11-22 19:45:55 UTC
745	https://civic.genome.wustl.edu/links/variants/745	MLH1	4292	V49A			3	37038139	37038139	T	C	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.146T>C,NC_000003.11:g.37038139T>C	2017-11-22 19:45:55 UTC
746	https://civic.genome.wustl.edu/links/variants/746	MLH1	4292	D667FS			3	37090406	37090406	C		ENST00000231790.2	75	GRCh37					frameshift_truncation	NC_000003.11:g.37090406del,ENST00000231790.2:c.2001del	2017-11-22 19:45:55 UTC
747	https://civic.genome.wustl.edu/links/variants/747	MLH1	4292	M1L			3	37035039	37035039	A	T	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.1A>T,NC_000003.11:g.37035039A>T	2017-11-22 19:45:55 UTC
748	https://civic.genome.wustl.edu/links/variants/748	MLH1	4292	*757L			3	37092143	37092143	A	T	ENST00000231790.2	75	GRCh37					stop_lost	ENST00000231790.2:c.2270A>T,NC_000003.11:g.37092143A>T	2017-11-22 19:45:54 UTC
749	https://civic.genome.wustl.edu/links/variants/749	MLH1	4292	R265G			3	37058999	37058999	C	G	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.793C>G,NC_000003.11:g.37058999C>G	2017-11-22 19:45:55 UTC
750	https://civic.genome.wustl.edu/links/variants/750	MLH1	4292	V213FS			3	37053551	37053551	T		ENST00000231790.2	75	GRCh37					frameshift_truncation	ENST00000231790.2:c.638delT,NC_000003.11:g.37053551del	2017-11-22 19:45:54 UTC
751	https://civic.genome.wustl.edu/links/variants/751	MLH1	4292	N551T			3	37081770	37081770	A	C	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.1652A>C,NP_000240.1:p.Asn551Thr,ENST00000231790.2:c.1652A>C,NC_000003.11:g.37081770A>C	2017-11-22 19:45:55 UTC
752	https://civic.genome.wustl.edu/links/variants/752	MLH1	4292	A424T			3	37067359	37067359	G	A	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.1270G>A,NP_000240.1:p.Ala424Thr,ENST00000231790.2:c.1270G>A,NC_000003.11:g.37067359G>A	2017-11-22 19:45:54 UTC
753	https://civic.genome.wustl.edu/links/variants/753	MLH1	4292	Q149*			3	37048546	37048546	C	T	ENST00000231790.2	75	GRCh37					stop_gained	NM_000249.3:c.445C>T,NP_000240.1:p.Gln149Ter,ENST00000231790.2:c.445C>T,NC_000003.11:g.37048546C>T	2017-11-22 19:45:54 UTC
754	https://civic.genome.wustl.edu/links/variants/754	MLH1	4292	R226*			3	37053589	37053589	C	T	ENST00000231790.2	75	GRCh37					stop_gained	NM_000249.3:c.676C>T,NP_000240.1:p.Arg226Ter,ENST00000231790.2:c.676C>T,NC_000003.11:g.37053589C>T	2017-11-22 19:45:54 UTC
755	https://civic.genome.wustl.edu/links/variants/755	MSH6	2956	I972F			2	48028036	48028036	A	T	ENST00000234420.5	75	GRCh37					missense_variant	ENST00000234420.5:c.2914A>T,NC_000002.11:g.48028036A>T	2017-11-22 19:45:55 UTC
756	https://civic.genome.wustl.edu/links/variants/756	MLH1	4292	P536FS			3	37081726	37081726	T		ENST00000231790.2	75	GRCh37					frameshift_truncation	NC_000003.11:g.37081726del,ENST00000231790.2:c.1608del	2017-11-22 19:45:54 UTC
757	https://civic.genome.wustl.edu/links/variants/757	MLH1	4292	G67R			3	37038192	37038192	G	A	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.199G>A,NP_000240.1:p.Gly67Arg,ENST00000231790.2:c.199G>A,NC_000003.11:g.37038192G>A	2017-11-22 19:45:55 UTC
758	https://civic.genome.wustl.edu/links/variants/758	MLH1	4292	I68S			3	37038196	37038196	T	G	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.203T>G,NC_000003.11:g.37038196T>G	2017-11-22 19:45:54 UTC
759	https://civic.genome.wustl.edu/links/variants/759	MLH1	4292	G65D			3	37038187	37038187	G	A	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.194G>A,NP_000240.1:p.Gly65Asp,ENST00000231790.2:c.194G>A,NC_000003.11:g.37038187G>A	2017-11-22 19:45:54 UTC
760	https://civic.genome.wustl.edu/links/variants/760	MLH1	4292	A681V			3	37090447	37090447	C	T	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.2042C>T,NP_000240.1:p.Ala681Val,ENST00000231790.2:c.2042C>T,NC_000003.11:g.37090447C>T	2017-11-22 19:45:54 UTC
761	https://civic.genome.wustl.edu/links/variants/761	MSH6	2956	P138T			2	48018217	48018217	C	A	ENST00000234420.5	75	GRCh37					missense_variant	ENST00000234420.5:c.412C>A,NC_000002.11:g.48018217C>A	2017-11-22 19:45:54 UTC
762	https://civic.genome.wustl.edu/links/variants/762	MSH2	4436	V273FS			2	47641433	47641433	T		ENST00000233146.2	75	GRCh37					frameshift_variant	ENST00000233146.2:c.818delT,NC_000002.11:g.47641433del	2017-11-22 19:45:56 UTC
763	https://civic.genome.wustl.edu/links/variants/763	MSH2	4436	E28FS			2	47630413	47630414		G	ENST00000233146.2	75	GRCh37					frameshift_elongation	NC_000002.11:g.47630414dupG	2017-11-22 19:45:55 UTC
764	https://civic.genome.wustl.edu/links/variants/764	VHL	7428	E55FS (c.163_164delGA)			3	10183694	10183695	GA		ENST00000256474.2	75	GRCh37					frameshift_truncation	NP_000542.1:p.Glu55fs,NC_000003.11:g.10183694_10183695del,ENST00000256474.2:c.163_164delGA	2017-11-22 19:45:56 UTC
765	https://civic.genome.wustl.edu/links/variants/765	MSH6	2956	I891FS			2	48027794	48027795	TC		ENST00000234420.5	75	GRCh37					frameshift_truncation	ENST00000234420.5:c.2672_2673delTC,NC_000002.11:g.48027794_48027795del	2017-11-22 19:45:55 UTC
766	https://civic.genome.wustl.edu/links/variants/766	VHL	7428	E55RfsTer11 (c.163delG)			3	10183694	10183694	G		ENST00000256474.2	75	GRCh37					frameshift_truncation	NP_000542.1:p.Glu55fs,NP_000542.1:p.Glu55ArgfsTer11,NM_000551.2:c.163delG,NC_000003.11:g.10183694del,ENST00000256474.2:c.163delG	2017-11-22 19:45:55 UTC
767	https://civic.genome.wustl.edu/links/variants/767	MSH6	2956	R1242H			2	48033421	48033421	G	A	ENST00000234420.5	75	GRCh37					missense_variant	NM_000179.2:c.3725G>A,NP_000170.1:p.Arg1242His,ENST00000234420.5:c.3725G>A,NC_000002.11:g.48033421G>A	2017-11-22 19:45:55 UTC
768	https://civic.genome.wustl.edu/links/variants/768	PMS2	5395	R315*			7	6031649	6031649	G	A	ENST00000265849.7	75	GRCh37					stop_gained	NM_000535.6:c.943C>T,NP_000526.2:p.Arg315Ter,NC_000007.13:g.6031649G>A	2017-11-22 19:45:54 UTC
769	https://civic.genome.wustl.edu/links/variants/769	MLH1	4292	M490T			3	37070334	37070334	T	C	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.1469T>C,NC_000003.11:g.37070334T>C	2017-11-22 19:45:55 UTC
770	https://civic.genome.wustl.edu/links/variants/770	MSH2	4436	K172*			2	47637380	47637380	A	T	ENST00000233146.2	75	GRCh37					stop_gained	ENST00000233146.2:c.514A>T,NC_000002.11:g.47637380A>T	2017-11-22 19:45:56 UTC
771	https://civic.genome.wustl.edu/links/variants/771	VHL	7428	A56FS (c.164_165insG)			3	10183695	10183696		G	ENST00000256474.2	75	GRCh37					frameshift_truncation	NP_000542.1:p.Ala56fs,NP_000542.1:p.Ala56GlyfsTer74,NM_000551.2:c.164_165insG,NC_000003.11:g.10183695_10183696insG,NC_000003.11:g.10183697dupG	2017-11-22 19:45:54 UTC
772	https://civic.genome.wustl.edu/links/variants/772	HOXB13	10481	G84E			17	46805705	46805705	C	T	ENST00000290295.7	75	GRCh37					missense_variant	NC_000017.10:g.46805705C>T,NM_006361.5:c.251G>A,NP_006352.2:p.Gly84Glu,ENST00000290295.7:c.251G>A	2017-11-22 19:45:54 UTC
773	https://civic.genome.wustl.edu/links/variants/773	MSH2	4436	E483G			2	47690231	47690231	A	G	ENST00000233146.2	75	GRCh37					missense_variant	NC_000002.11:g.47690231A>G,ENST00000233146.2:c.1448A>G	2017-11-22 19:45:55 UTC
774	https://civic.genome.wustl.edu/links/variants/774	PDGFRA	5156	TNKS2-PDGFRA			10	93558069	93619405			ENST00000371627.4	75	GRCh37	4	55141008	55164414	ENST00000257290.5	transcript_fusion		2017-11-22 19:45:55 UTC
775	https://civic.genome.wustl.edu/links/variants/775	MSH6	2956	V352I			2	48026176	48026176	G	A	ENST00000234420.5	75	GRCh37					missense_variant	NM_000179.2:c.1054G>A,NP_000170.1:p.Val352Ile,ENST00000234420.5:c.1054G>A,NC_000002.11:g.48026176G>A	2017-11-22 19:45:55 UTC
776	https://civic.genome.wustl.edu/links/variants/776	MSH6	2956	R1242C			2	48033420	48033420	C	T	ENST00000234420.5	75	GRCh37					missense_variant	NM_000179.2:c.3724C>T,NP_000170.1:p.Arg1242Cys,ENST00000234420.5:c.3724C>T,NC_000002.11:g.48033420C>T	2017-11-22 19:45:55 UTC
777	https://civic.genome.wustl.edu/links/variants/777	SLCO1B1	10599	RS4149056			12	21331549	21331549	T	C	ENST00000256958.2	75	GRCh37					missense_variant,polymorphic_sequence_variant	NC_000012.11:g.21331549T>C	2017-11-22 19:45:55 UTC
778	https://civic.genome.wustl.edu/links/variants/778	SLCO1B1	10599	N130D			12	21329738	21329738	A	G	ENST00000256958.2	75	GRCh37					missense_variant	NC_000012.11:g.21329738A>G	2017-11-22 19:45:53 UTC
779	https://civic.genome.wustl.edu/links/variants/779	TYMS	7298	RS34743033			18	657646	657646	C	T	ENST00000323274.10	75								2017-11-22 19:45:55 UTC
780	https://civic.genome.wustl.edu/links/variants/780	GLI1	2735	ACTB-GLI1	Fusion of the hedgehog pathway component gene GLI1 to the -actin gene (ACTB)  has been described as a mechanism of GLI1,and by extension hedgehog pathway, activation. These fusions have been described in histologically distinctive soft tissue tumours showing a pericytic phenotype.  Gene fusions retain the DNA-binding zinc finger domains of GLI1 and it is likely that the replacement of the promoter region of GLI1with that of the ubiquitously expressed ACTB gene leads to deregulation of GLI expression and its downstream target genes.														gene_fusion		2017-11-22 19:45:55 UTC
781	https://civic.genome.wustl.edu/links/variants/781	ERBB3	2065	V855A			12	56491672	56491672	T	C	ENST000000267101.3	75	GRCh37					missense_variant	NC_000012.11:g.56491672T>C	2017-11-22 19:45:55 UTC
782	https://civic.genome.wustl.edu/links/variants/782	FGFR2	2263	FGFR2-BICC1			10	123239371	123357917			ENST00000457416.2	75	GRCh37	10	60461834	60591195	ENST00000373886.3	transcript_fusion		2017-11-22 19:45:55 UTC
783	https://civic.genome.wustl.edu/links/variants/783	FGFR2	2263	FGFR2-AHCYL1			10	123239371	123357917			ENST00000457416.2	75	GRCh37	1	110554984	110566357	ENST00000369799.5	transcript_fusion		2017-11-22 19:45:55 UTC
784	https://civic.genome.wustl.edu/links/variants/784	CDKN2B	1030	METHYLATION			9	22009121	22009172			ENST00000276925.6	75	GRCh37					N/A		2017-11-22 19:45:55 UTC
785	https://civic.genome.wustl.edu/links/variants/785	CHEK2	11200	1100DELC			22	29091857	29091857	G		ENST00000328354.6	75	GRCh37					frameshift_truncation	NC_000022.10:g.29091857delG,NM_007194.3:c.1100delC,NP_009125.1:p.Thr367Metfs,ENST00000328354.6:c.1100delC,NC_000022.10:g.29091857del	2017-11-22 19:45:57 UTC
787	https://civic.genome.wustl.edu/links/variants/787	CHEK2	11200	I157T			22	29121087	29121087	A	G	ENST00000328354.6	75	GRCh37					missense_variant	NM_007194.3:c.470T>C,NP_009125.1:p.Ile157Thr,ENST00000328354.6:c.470T>C,NC_000022.10:g.29121087A>G	2017-11-22 19:45:56 UTC
788	https://civic.genome.wustl.edu/links/variants/788	CHEK2	11200	IVS2+1G>A																	2017-11-22 19:45:55 UTC
792	https://civic.genome.wustl.edu/links/variants/792	PTPRD	5789	V253I			9	8521481	8521481	C	T	ENST00000381196.4	75	GRCh37					missense_variant	NM_002839.3:c.757G>A,NP_002830.1:p.Val253Ile,NC_000009.11:g.8521481C>T	2017-11-22 19:45:55 UTC
793	https://civic.genome.wustl.edu/links/variants/793	VHL	7428	A56FS (c.164_165insA)			3	10183695	10183696		A	ENST00000256474.2	75	GRCh37					frameshift_truncation	NP_000542.1:p.Ala56fs,NP_000542.1:p.Ala56GlyfsTer74,NM_000551.2:c.164_165insA,NC_000003.11:g.10183695_10183696insA,NC_000003.11:g.10183695dupA	2017-11-22 19:45:56 UTC
794	https://civic.genome.wustl.edu/links/variants/794	VHL	7428	E55E (c.165G>A)			3	10183696	10183696	G	A	ENST00000256474.2	75	GRCh37					silent_mutation	NM_000551.2:c.165G>A,NC_000003.11:g.10183696G>A,ENST00000256474.2:c.165G>A	2017-11-22 19:45:55 UTC
795	https://civic.genome.wustl.edu/links/variants/795	RRM1	6240	OVEREXPRESSION			11	4116039	4160106			ENST00000300738.5	75	GRCh37					N/A		2017-11-22 19:45:55 UTC
796	https://civic.genome.wustl.edu/links/variants/796	RRM2	6241	OVEREXPRESSION			2	10262455	10271545			ENST00000360566.2	75	GRCh37					N/A		2017-11-22 19:45:55 UTC
797	https://civic.genome.wustl.edu/links/variants/797	POLE	5426	MUTATION			12	133202900	133256623			ENST00000320574.5	75	GRCh37					gene_variant		2017-11-22 19:45:55 UTC
798	https://civic.genome.wustl.edu/links/variants/798	MET	4233	D1228V			7	116423408	116423408	A	T	ENST00000397752.3	75	GRCh37					missense_variant	ENST00000397752.3:c.3683A>T,NC_000007.13:g.116423408A>T	2017-11-22 19:45:55 UTC
799	https://civic.genome.wustl.edu/links/variants/799	RB1	5925	MUTATION			13	48877911	49056122			ENST00000267163.4	75	GRCh37					gene_variant		2017-11-22 19:45:57 UTC
800	https://civic.genome.wustl.edu/links/variants/800	NTRK1	4914	SQSTM1-NTRK1																	2017-11-22 19:45:55 UTC
801	https://civic.genome.wustl.edu/links/variants/801	NTRK3	4916	ETV6-NTRK3			12	11802788	12022903			ENST00000396373.4	75	GRCh37	15	88483984	88418230	ENST00000394480.2	transcript_fusion		2017-11-22 19:45:55 UTC
802	https://civic.genome.wustl.edu/links/variants/802	RUNX1	861	K83E			21	36259163	36259163	T	C	ENST00000344691.4	75	GRCh37					missense_variant	NC_000021.8:g.36259163T>C,NP_001001890.1:p.Lys83Glu,NM_001001890.2:c.247A>G,ENST00000344691.4:c.247A>G	2017-11-22 19:45:55 UTC
803	https://civic.genome.wustl.edu/links/variants/803	RUNX1	861	Y260*			21	36171704	36171704	G	T	ENST00000344691.4	75	GRCh37					stop_gained	NM_001001890.2:c.780C>A,NP_001001890.1:p.Tyr260Ter,NC_000021.8:g.36171704G>T,ENST00000344691.4:c.780C>A	2017-11-22 19:45:55 UTC
804	https://civic.genome.wustl.edu/links/variants/804	RUNX1	861	R135FSX177																	2017-11-22 19:45:55 UTC
805	https://civic.genome.wustl.edu/links/variants/805	NTRK3	4916	ETV6-NTRK3 G623R			15	88476265	88476265	C	T	ENST00000394480.2	75	GRCh37					transcript_fusion,missense_variant	NC_000015.9:g.88476265C>T,ENST00000394480.2:c.1867G>A	2017-11-22 19:45:55 UTC
806	https://civic.genome.wustl.edu/links/variants/806	RUNX1	861	D198Y	D198Y was observed in a pedigree with a history of Familial platelet disorder with predisposition to acute myeloid leukemia. It occurs within the Runt domain of RUNX1, known to be associated with the disease.		21	36231792	36231792	C	A	ENST00000300305.3	75	GRCh37					loss_of_function_variant,missense_variant	NC_000021.8:g.36231792C>A	2017-11-22 19:46:06 UTC
807	https://civic.genome.wustl.edu/links/variants/807	RUNX1	861	A107P			21	36252962	36252962	C	G	ENST00000344691.4	75	GRCh37					missense_variant	NM_001754.4:c.400G>C,NP_001745.2:p.Ala134Pro,NC_000021.8:g.36252962C>G,ENST00000344691.4:c.400G>C	2017-11-22 19:45:54 UTC
808	https://civic.genome.wustl.edu/links/variants/808	MSH2	4436	LOSS			2	47630108	47710367			ENST00000233146.2	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:55 UTC
809	https://civic.genome.wustl.edu/links/variants/809	MSH6	2956	LOSS			2	48010221	48037240			ENST00000234420.5	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:55 UTC
810	https://civic.genome.wustl.edu/links/variants/810	RUNX1	861	T148HFSX9			21	36252913	36252920	GCTGCGGT		ENST00000300305.3	75	GRCh37					frameshift_truncation	NM_001754.4:c.442_449delACCGCAGC,NP_001745.2:p.Thr148Hisfs,NC_000021.8:g.36252913_36252920del,ENST00000300305.3:c.442_449delACCGCAGC	2017-11-22 19:45:55 UTC
811	https://civic.genome.wustl.edu/links/variants/811	ETV6	2120	R399C			12	12038902	12038902	C	T	ENST00000396373.4	75	GRCh37					missense_variant	NM_001987.4:c.1195C>T,NP_001978.1:p.Arg399Cys,ENST00000396373.4:c.1195C>T,NC_000012.11:g.12038902C>T	2017-11-22 19:45:55 UTC
812	https://civic.genome.wustl.edu/links/variants/812	ETV6	2120	R369Q			12	12037475	12037475	G	A	ENST00000396373.4	75	GRCh37					missense_variant	NM_001987.4:c.1106G>A,NP_001978.1:p.Arg369Gln,ENST00000396373.4:c.1106G>A,NC_000012.11:g.12037475G>A	2017-11-22 19:45:55 UTC
813	https://civic.genome.wustl.edu/links/variants/813	ETV6	2120	P214L			12	12022535	12022535	C	T	ENST00000396373.4	75	GRCh37					missense_variant		2017-11-22 19:45:56 UTC
814	https://civic.genome.wustl.edu/links/variants/814	DDX41	51428	R164W			5	176942767	176942767	G	A	ENST00000507955.1	75	GRCh37					missense_variant		2017-11-22 19:45:56 UTC
815	https://civic.genome.wustl.edu/links/variants/815	ERBB2	2064	Y772_A775DUP			17	37880996	37880997			ENST00000269571.5	75	GRCh37					inframe_insertion	NM_001005862.2:c.2224_2235dupTACGTGATGGCT,ENST00000269571.5:c.2314_2325dupTACGTGATGGCT,NC_000017.10:g.37880985_37880996dupTACGTGATGGCT	2017-11-22 19:45:55 UTC
816	https://civic.genome.wustl.edu/links/variants/816	ERBB2	2064	G776L			17	37880997	37880998	GG	CT	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2326_2327delinsCT	2017-11-22 19:45:55 UTC
817	https://civic.genome.wustl.edu/links/variants/817	ERBB2	2064	G778_P780DUP			17	37881011	37881012			ENST00000269571.5	75	GRCh37						NM_004448.3:c.2332_2340dupGGCTCCCCA	2017-11-22 19:45:55 UTC
818	https://civic.genome.wustl.edu/links/variants/818	ERBB2	2064	M774DELINSWLV			17	37880991	37880991	A	TGGCTGG	ENST00000269571.5	75	GRCh37					inframe_indel		2017-11-22 19:45:56 UTC
819	https://civic.genome.wustl.edu/links/variants/819	PTPRB	5787	LOSS-OF-FUNCTION			12	70910630	71031220			ENST00000334414.6	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:55 UTC
820	https://civic.genome.wustl.edu/links/variants/820	VHL	7428	A149S (c.445G>T)			3	10188302	10188302	G	T	ENST00000256474.2	75	GRCh37					missense_variant	NP_000542.1:p.Ala149Ser,NM_000551.2:c.445G>T,ENST00000256474.2:c.445G>T,NC_000003.11:g.10188302G>T	2017-11-22 19:45:55 UTC
821	https://civic.genome.wustl.edu/links/variants/821	HLA-C	3107	COPY-NEUTRAL LOSS OF HETEROZYGOSITY																	2017-11-22 19:45:55 UTC
822	https://civic.genome.wustl.edu/links/variants/822	JAK1	3716	S703I			1	65311203	65311203	C	A	ENST00000342505.4	75	GRCh37					missense_variant	ENST00000342505.4:c.2108G>T,NC_000001.10:g.65311203C>A	2017-11-22 19:45:55 UTC
823	https://civic.genome.wustl.edu/links/variants/823	EPCAM	4072	3' EXON DELETION			2	47612305	47614173			ENST00000263735	75	GRCh37					disruptive_inframe_deletion		2017-11-22 19:46:06 UTC
824	https://civic.genome.wustl.edu/links/variants/824	MAP2K1	5604	K57T			15	66727454	66727454	A	C	ENST00000307102.5	75	GRCh37					missense_variant		2017-11-22 19:45:56 UTC
825	https://civic.genome.wustl.edu/links/variants/825	ARAF	369	S490T			X	47429340	47429340	T	A	ENST00000377045.4	75	GRCh37					missense_variant		2017-11-22 19:45:56 UTC
826	https://civic.genome.wustl.edu/links/variants/826	GNAS	2778	R201C			20	57484420	57484420	C	T	ENST00000371085.3	75	GRCh37					missense_variant	NM_000516.5:c.601C>T,NP_000507.1:p.Arg201Cys,NC_000020.10:g.57484420C>T,ENST00000371085.3:c.601C>T	2017-11-22 19:45:55 UTC
827	https://civic.genome.wustl.edu/links/variants/827	FGFR3	2261	MUTATION																	2017-11-22 19:45:52 UTC
828	https://civic.genome.wustl.edu/links/variants/828	FGFR2	2263	FUSION																	2017-11-22 19:45:55 UTC
829	https://civic.genome.wustl.edu/links/variants/829	VHL	7428	M54IFS (c.162_166delGGAGG)			3	10183693	10183697	GGAGG		ENST00000256474.2	75	GRCh37					frameshift_truncation	NM_000551.2:c.162_166delGGAGG,NP_000542.1:p.Met54IlefsTer76,NC_000003.11:g.10183693_10183697del,ENST00000256474.2:c.162_166delGGAGG	2017-11-22 19:45:56 UTC
830	https://civic.genome.wustl.edu/links/variants/830	FGFR3	2261	FGFR3-TACC3																	2017-11-22 19:45:55 UTC
837	https://civic.genome.wustl.edu/links/variants/837	SMO	6608	W535L			7	128850341	128850341	G	T	ENST00000249373.3	75	GRCh37					missense_variant	NM_005631.4:c.1604G>T,NP_005622.1:p.Trp535Leu,ENST00000249373.3:c.1604G>T,NC_000007.13:g.128850341G>T	2017-11-22 19:45:55 UTC
838	https://civic.genome.wustl.edu/links/variants/838	PTEN	5728	R173C			10	89711899	89711899	C	T	ENST00000371953.3	75	GRCh37					missense_variant	NM_000314.6:c.517C>T,NP_000305.3:p.Arg173Cys,ENST00000371953.3:c.517C>T,NC_000010.10:g.89711899C>T	2017-11-22 19:45:55 UTC
839	https://civic.genome.wustl.edu/links/variants/839	ALK	238	ALTERNATIVE TRANSCRIPT (ATI)	This novel ALK transcript (alternative isoform) initiates from a de novo alternative transcription initiation (ATI) site in ALK intron 19.																2017-11-22 19:46:01 UTC
840	https://civic.genome.wustl.edu/links/variants/840	BRAF	673	G469R			7	140481403	140481403	C	G	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1405G>C,NP_004324.2:p.Gly469Arg,NC_000007.13:g.140481403C>G,ENST00000288602.6c.1405G>C	2017-11-22 19:46:00 UTC
841	https://civic.genome.wustl.edu/links/variants/841	BRAF	673	G469V			7	140481402	140481402	C	A	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1406G>T,NP_004324.2:p.Gly469Val,ENST00000288602.6:c.1406G>T,NC_000007.13:g.140481402C>A	2017-11-22 19:45:56 UTC
842	https://civic.genome.wustl.edu/links/variants/842	BRAF	673	APC																	2017-11-22 19:45:56 UTC
843	https://civic.genome.wustl.edu/links/variants/843	VHL	7428	EXON 1-3 DELETION			3	10183532	10191649			ENST00000256474.2	75	GRCh37					exon_loss_variant	ENST00000256474.2:c.1-?_642+?del	2017-11-22 19:45:56 UTC
844	https://civic.genome.wustl.edu/links/variants/844	VHL	7428	EXON 1 DELETION			3	10183532	10183871			ENST00000256474.2	75	GRCh37					exon_loss_variant	ENST00000256474.2:c.1-?_340+?del	2017-11-22 19:45:56 UTC
845	https://civic.genome.wustl.edu/links/variants/845	VHL	7428	EXON 1-2 DELETION			3	10183532	10188320			ENST00000256474.2	75	GRCh37					exon_loss_variant	ENST00000256474.2:c.1-?_463+?del	2017-11-22 19:45:55 UTC
846	https://civic.genome.wustl.edu/links/variants/846	VHL	7428	M1FS (c.1_17del17)			3	10183532	10183548	ATGCCCCGGAGGGCGGA		ENST00000256474.2	75	GRCh37					start_lost	ENST00000256474.2:c.1_17del17,NC_000003.11:g.10183532_10183548del	2017-11-22 19:45:56 UTC
847	https://civic.genome.wustl.edu/links/variants/847	VHL	7428	M1? (c.1-1_20del21)			3	10183531	10183551	AATGCCCCGGAGGGCGGAGAA		ENST00000256474.2	75	GRCh37					start_lost	NP_000542.1:p.0,NP_000542.1:p.Met1?,NM_000551.3:c.1-1_20del21,ENST00000256474.2:c.1-1_20del21,NC_000003.11:g.10183531_10183551del	2017-11-22 19:45:56 UTC
848	https://civic.genome.wustl.edu/links/variants/848	VHL	7428	M1? (c.3G>A)			3	10183534	10183534	G	A	ENST00000256474.2	75	GRCh37					start_lost	NP_000542.1:p.0,NP_000542.1:p.Met1?,NM_000551.3:c.3G>A,ENST00000256474.2:c.3G>A,NC_000003.11:g.10183534G>A	2017-11-22 19:45:56 UTC
849	https://civic.genome.wustl.edu/links/variants/849	VHL	7428	N7D (c.19A>G)			3	10183550	10183550	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NC_000003.11:g.10183550A>G,NM_000551.3:c.19A>G,ENST00000256474.2:c.19A>G,NP_000542.1:c.Asn7Asp	2017-11-22 19:45:56 UTC
850	https://civic.genome.wustl.edu/links/variants/850	VHL	7428	P25L (c.74C>T)			3	10183605	10183605	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.74C>T,NP_000542.1:p.Pro25Leu,ENST00000256474.2:c.74C>T,NC_000003.11:g.10183605C>T	2017-11-22 19:45:55 UTC
851	https://civic.genome.wustl.edu/links/variants/851	VHL	7428	P59fs (c.173_174insC)			3	10183704	10183705		C	ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.173_174insC,NP_000542.1:p.Pro59AlafsTer73,NM_000551.3:c.173_174insC,NC_000003.11:g.10183704_10183705insC	2017-11-22 19:45:56 UTC
852	https://civic.genome.wustl.edu/links/variants/852	VHL	7428	Y98FS (c.291_310DEL20)			3	10183822	10183841	CTACCCAACGCTGCCGCCTG		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.291_310del,NC_000003.11:g.10183822_10183841del	2017-11-22 19:45:55 UTC
853	https://civic.genome.wustl.edu/links/variants/853	NBN	4683	LOSS			8	90945564	90996944			ENST00000265433.3	75	GRCh37					loss_of_function_variant		2017-11-22 19:45:56 UTC
854	https://civic.genome.wustl.edu/links/variants/854	HRAS	3265	Q61L			11	533874	533874	T	A	ENST00000451590.1	75	GRCh37					missense_variant	NM_005343.3:c.182A>T,NP_005334.1:p.Gln61Leu,ENST00000451590.1:c.182A>T,NC_000011.9:g.533874T>A	2017-11-22 19:45:56 UTC
855	https://civic.genome.wustl.edu/links/variants/855	KIT	3815	EXON 8 MUTATION																	2017-11-22 19:45:56 UTC
856	https://civic.genome.wustl.edu/links/variants/856	CREBBP	1387	DELETION																	2017-11-22 19:45:56 UTC
857	https://civic.genome.wustl.edu/links/variants/857	NTRK3	4916	EXPRESSION			15	88418230	88799978			ENST00000394480.2	75	GRCh37					N/A		2017-11-22 19:45:56 UTC
858	https://civic.genome.wustl.edu/links/variants/858	CSF1	1435	OVEREXPRESSION			1	110453255	110473614			ENST00000329608.6	75	GRCh37					N/A		2017-11-22 19:45:56 UTC
859	https://civic.genome.wustl.edu/links/variants/859	ROS1	6098	OVEREXPRESSION			6	117609463	117747018			ENST00000368508.3	75	GRCh37					N/A		2017-11-22 19:45:56 UTC
860	https://civic.genome.wustl.edu/links/variants/860	NTRK1	4914	EXPRESSION			1	156830686	156851434			ENST00000524377.1	75	GRCh37					N/A		2017-11-22 19:45:56 UTC
861	https://civic.genome.wustl.edu/links/variants/861	EGFR	1956	T725M			7	55241726	55241726	C	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2174C>T,NC_000007.13:g.55241726C>T	2017-11-22 19:45:56 UTC
862	https://civic.genome.wustl.edu/links/variants/862	PDGFRA	5156	P577S			4	55141083	55141083	C	T	ENST00000257290.5	75	GRCh37					missense_variant	NM_006206.4:c.1729C>T,NP_006197.1:p.Pro577Ser,NC_000004.11:g.55141083C>T,ENST00000257290.5:c.1729C>T	2017-11-22 19:45:56 UTC
863	https://civic.genome.wustl.edu/links/variants/863	PDGFRA	5156	R841K			4	55152090	55152090	G	A	ENST00000257290.5	75	GRCh37					missense_variant	NM_006206.4:c.2522G>A,NP_006197.1:p.Arg841Lys,NC_000004.11:g.55152090G>A,ENST00000257290.5:c.2522G>A	2017-11-22 19:45:56 UTC
864	https://civic.genome.wustl.edu/links/variants/864	PDGFRA	5156	H845Y			4	55152101	55152101	C	T	ENST00000257290.5	75	GRCh37					missense_variant	NM_006206.4:c.2533C>T,NP_006197.1:p.His845Tyr,NC_000004.11:g.55152101C>T,ENST00000257290.5:c.2533C>T	2017-11-22 19:45:56 UTC
865	https://civic.genome.wustl.edu/links/variants/865	PDGFRA	5156	G853D			4	55152126	55152126	G	A	ENST00000257290.5	75	GRCh37					missense_variant	NM_006206.4:c.2558G>A,NP_006197.1:p.Gly853Asp,NC_000004.11:g.55152126G>A,ENST00000257290.5:c.2558G>A	2017-11-22 19:45:56 UTC
866	https://civic.genome.wustl.edu/links/variants/866	MITF	4286	OVEREXPRESSION			3	69788586	70017487			ENST00000352241.4	75	GRCh37					N/A		2017-11-22 19:45:56 UTC
867	https://civic.genome.wustl.edu/links/variants/867	MTAP	4507	DELETION																	2017-11-22 19:45:56 UTC
868	https://civic.genome.wustl.edu/links/variants/868	VPS37A	137492	UNDEREXPRESSION			8	17104080	17155533			ENST00000324849.4	75	GRCh37					N/A		2017-11-22 19:45:56 UTC
869	https://civic.genome.wustl.edu/links/variants/869	YAP1	10413	OVEREXPRESSION			11	101981192	102104154			ENST00000282441.5	75	GRCh37					N/A		2017-11-22 19:46:01 UTC
870	https://civic.genome.wustl.edu/links/variants/870	BTK	695	T316A			X	100613633	100613633	T	C	ENST00000308731.7	75	GRCh37					missense_variant	ENST00000308731.7:c.946T>C,NM_000061.2:c.946T>C,NC_000023.10:g.100613633T>C	2017-11-22 19:45:56 UTC
871	https://civic.genome.wustl.edu/links/variants/871	ERBB2	2064	T862A			17	37881392	37881392	A	G	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2584A>G,NC_000017.10:g.37881392A>G	2017-11-22 19:45:56 UTC
872	https://civic.genome.wustl.edu/links/variants/872	ERBB2	2064	V773A			17	37880989	37880989	T	C	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2318T>C,NC_000017.10:g.37880989T>C	2017-11-22 19:45:46 UTC
873	https://civic.genome.wustl.edu/links/variants/873	ERBB2	2064	N857S			17	37881378	37881378	A	G	ENST00000269571.5	75	GRCh37					missense_variant	NC_000017.10:g.37881378A>G,NP_004439.2:p.Asn857Ser,NM_004448.3:c.2570A>G,ENST00000269571.5:c.2570A>G	2017-11-22 19:45:56 UTC
874	https://civic.genome.wustl.edu/links/variants/874	ERBB2	2064	H878Y			17	37881440	37881440	C	T	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2632C>T,NC_000017.10:g.37881440C>T	2017-11-22 19:45:47 UTC
875	https://civic.genome.wustl.edu/links/variants/875	ERBB2	2064	OVEREXPRESSION															N/A		2017-11-22 19:45:56 UTC
876	https://civic.genome.wustl.edu/links/variants/876	GNAS	2778	MUTATION																	2017-11-22 19:45:56 UTC
877	https://civic.genome.wustl.edu/links/variants/877	GNAS	2778	T393C			20	57428713	57428713	T	C	ENST00000371100	75	GRCh37					missense_variant		2017-11-22 19:46:06 UTC
878	https://civic.genome.wustl.edu/links/variants/878	NRAS	4893	G12D			1	115258747	115258747	C	T	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.35G>A,NP_002515.1:p.Gly12Asp,NC_000001.10:g.115258747C>T,ENST00000369535.4:c.35G>A	2017-11-22 19:46:00 UTC
879	https://civic.genome.wustl.edu/links/variants/879	TP53	7157	G245S										GRCh37							2017-11-22 19:45:56 UTC
880	https://civic.genome.wustl.edu/links/variants/880	IDH1	3417	R132L			2	209113112	209113112	C	A	ENST00000415913.1	75	GRCh37					missense_variant	NM_001282386.1:c.395G>T,NP_001269315.1:p.Arg132Leu,NC_000002.11:g.209113112C>A,ENST00000415913.1:c.395G>T	2017-11-22 19:45:56 UTC
881	https://civic.genome.wustl.edu/links/variants/881	PIK3CA	5290	E545Q			3	178936091	178936091	G	C	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1633G>C,NP_006209.2:p.Glu545Gln,NC_000003.11:g.178936091G>C,ENST00000263967.3:c.1633G>C	2017-11-22 19:45:56 UTC
882	https://civic.genome.wustl.edu/links/variants/882	PIK3CA	5290	E545A			3	178936092	178936092	A	C	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1634A>C,NP_006209.2:p.Glu545Ala,NC_000003.11:g.178936092A>C,ENST00000263967.3:c.1634A>C	2017-11-22 19:45:56 UTC
883	https://civic.genome.wustl.edu/links/variants/883	PIK3CA	5290	E545G			3	178936092	178936092	A	G	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1634A>G,NP_006209.2:p.Glu545Gly,NC_000003.11:g.178936092A>G,ENST00000263967.3:c.1634A>G	2017-11-22 19:46:00 UTC
884	https://civic.genome.wustl.edu/links/variants/884	PIK3CA	5290	E545V			3	178936092	178936092	A	T	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1634A>T,NP_006209.2:p.Glu545Val,NC_000003.11:g.178936092A>T,ENST00000263967.3:c.1634A>T	2017-11-22 19:45:56 UTC
885	https://civic.genome.wustl.edu/links/variants/885	PIK3CA	5290	Q546K			3	178936094	178936094	C	A	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1636C>A,NP_006209.2:p.Gln546Lys,NC_000003.11:g.178936094C>A,ENST00000263967.3:c.1636C>A	2017-11-22 19:45:56 UTC
886	https://civic.genome.wustl.edu/links/variants/886	PIK3CA	5290	Q546E			3	178936094	178936094	C	G	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1636C>G,NP_006209.2:p.Gln546Glu,NC_000003.11:g.178936094C>G,ENST00000263967.3:c.1636C>G	2017-11-22 19:46:00 UTC
890	https://civic.genome.wustl.edu/links/variants/890	EGFR	1956	L747_S752del			7	55242469	55242486					GRCh37							2017-11-22 19:46:01 UTC
891	https://civic.genome.wustl.edu/links/variants/891	EGFR	1956	S752_I759delSPKANKEI										GRCh37					inframe_deletion		2017-11-22 19:45:56 UTC
892	https://civic.genome.wustl.edu/links/variants/892	ABL1	25	F359V			9	133748414	133748414	T	G	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.1075T>G,NP_005148.2:p.Phe359Val,NC_000009.11:g.133748414T>G,ENST00000318560.5:c.1075T>G	2017-11-22 19:45:56 UTC
893	https://civic.genome.wustl.edu/links/variants/893	NRAS	4893	Q61H			1	115256528	115256528	T	G	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.183A>C,NP_002515.1:p.Gln61His,NC_000001.10:g.115256528T>G,ENST00000369535.4:c.183A>C	2017-11-22 19:45:56 UTC
895	https://civic.genome.wustl.edu/links/variants/895	NRAS	4893	G13C			1	115258745	115258745	C	A	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.37G>T,NP_002515.1:p.Gly13Cys,NC_000001.10:g.115258745C>A,ENST00000369535.4:c.37G>T	2017-11-22 19:45:56 UTC
896	https://civic.genome.wustl.edu/links/variants/896	NRAS	4893	G13R			1	115258745	115258745	C	G	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.37G>C,NP_002515.1:p.Gly13Arg,NC_000001.10:g.115258745C>G,ENST00000369535.4:c.37G>C	2017-11-22 19:45:56 UTC
897	https://civic.genome.wustl.edu/links/variants/897	NRAS	4893	G12C			1	115258748	115258748	C	A	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.34G>T,NP_002515.1:p.Gly12Cys,NC_000001.10:g.115258748C>A,ENST00000369535.4:c.34G>T	2017-11-22 19:45:56 UTC
898	https://civic.genome.wustl.edu/links/variants/898	NRAS	4893	G12S			1	115258748	115258748	C	T	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.34G>A,NP_002515.1:p.Gly12Ser,NC_000001.10:g.115258748C>T,ENST00000369535.4:c.34G>A	2017-11-22 19:45:56 UTC
901	https://civic.genome.wustl.edu/links/variants/901	ATM	472	T2666A			11	108204681	108204681	A	G	ENST00000278616.4	75	GRCh37					missense_variant	NC_000011.9:g.108204681A>G	2017-11-22 19:46:01 UTC
902	https://civic.genome.wustl.edu/links/variants/902	ATM	472	L2890V			11	108218089	108218089	C	G	ENST00000278616.4	75	GRCh37					missense_variant	NM_000051.3:c.8668C>G,NP_000042.3:p.Leu2890Val,NC_000011.9:g.108218089C>G,ENST00000278616.4:c.8668C>G	2017-11-22 19:45:56 UTC
903	https://civic.genome.wustl.edu/links/variants/903	ATM	472	R3008C			11	108236086	108236086	C	T	ENST00000278616.4	75	GRCh37					missense_variant	NC_000011.9:g.108236086C>T	2017-11-22 19:45:57 UTC
904	https://civic.genome.wustl.edu/links/variants/904	ATM	472	R3008H			11	108236087	108236087	G	A	ENST00000278616.4	75	GRCh37					missense_variant	NC_000011.9:g.108236087G>A	2017-11-22 19:45:56 UTC
905	https://civic.genome.wustl.edu/links/variants/905	KRAS	3845	A146P			12	25378562	25378562	C	G	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.436G>C,NP_004976.2:p.Ala146Pro,NC_000012.11:g.25378562C>G,ENST00000256078.4:c.436G>C	2017-11-22 19:45:59 UTC
906	https://civic.genome.wustl.edu/links/variants/906	KRAS	3845	A146T			12	25378562	25378562	C	T	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.436G>A,NP_004976.2:p.Ala146Thr,NC_000012.11:g.25378562C>T,ENST00000256078.4:c.436G>A	2017-11-22 19:45:56 UTC
907	https://civic.genome.wustl.edu/links/variants/907	KRAS	3845	Q61H			12	25380275	25380275	T	G	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.183A>C,NP_004976.2:p.Gln61His,NC_000012.11:g.25380275T>G,ENST00000256078.4:c.183A>C	2017-11-22 19:46:00 UTC
908	https://civic.genome.wustl.edu/links/variants/908	KRAS	3845	Q61L			12	25380276	25380276	T	A	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.182A>T,NP_004976.2:p.Gln61Leu,NC_000012.11:g.25380276T>A,ENST00000256078.4:c.182A>T	2017-11-22 19:45:56 UTC
909	https://civic.genome.wustl.edu/links/variants/909	KRAS	3845	Q61R			12	25380276	25380276	T	C	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.182A>G,NP_004976.2:p.Gln61Arg,NC_000012.11:g.25380276T>C,ENST00000256078.4:c.182A>G	2017-11-22 19:45:52 UTC
910	https://civic.genome.wustl.edu/links/variants/910	KRAS	3845	Q61K			12	25380277	25380277	G	T	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.181C>A,NP_004976.2:p.Gln61Lys,NC_000012.11:g.25380277G>T,ENST00000256078.4:c.181C>A	2017-11-22 19:45:56 UTC
911	https://civic.genome.wustl.edu/links/variants/911	KRAS	3845	G13C			12	25398282	25398282	C	A	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.37G>T,NP_004976.2:p.Gly13Cys,NC_000012.11:g.25398282C>A,ENST00000256078.4:c.37G>T	2017-11-22 19:45:51 UTC
913	https://civic.genome.wustl.edu/links/variants/913	KRAS	3845	G12S			12	25398285	25398285	C	T	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.34G>A,NP_004976.2:p.Gly12Ser,NC_000012.11:g.25398285C>T,ENST00000256078.4:c.34G>A	2017-11-22 19:46:00 UTC
918	https://civic.genome.wustl.edu/links/variants/918	TP53	7157	R273L			17	7577120	7577120	C	A	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.818G>T,NP_000537.3:p.Arg273Leu,NC_000017.10:g.7577120C>A,ENST00000269305.4:c.818G>T	2017-11-22 19:45:56 UTC
922	https://civic.genome.wustl.edu/links/variants/922	TP53	7157	Y220C			17	7578190	7578190	T	C	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.659A>G,NP_000537.3:p.Tyr220Cys,NC_000017.10:g.7578190T>C,ENST00000269305.4:c.659A>G	2017-11-22 19:45:47 UTC
925	https://civic.genome.wustl.edu/links/variants/925	STK11	6794	LKB1										GRCh37							2017-11-22 19:45:56 UTC
927	https://civic.genome.wustl.edu/links/variants/927	IDH1	3417	R132G			2	209113113	209113113	G	C	ENST00000415913.1	75	GRCh37					missense_variant	NM_001282386.1:c.394C>G,NP_001269315.1:p.Arg132Gly,NC_000002.11:g.209113113G>C,ENST00000415913.1:c.394C>G	2017-11-22 19:45:56 UTC
928	https://civic.genome.wustl.edu/links/variants/928	IDH1	3417	R132S			2	209113113	209113113	G	T	ENST00000415913.1	75	GRCh37					missense_variant	NM_001282386.1:c.394C>A,NP_001269315.1:p.Arg132Ser,NC_000002.11:g.209113113G>T,ENST00000415913.1:c.394C>A	2017-11-22 19:45:46 UTC
930	https://civic.genome.wustl.edu/links/variants/930	PIK3CA	5290	N345K										GRCh37					missense_variant		2017-11-22 19:45:56 UTC
931	https://civic.genome.wustl.edu/links/variants/931	PIK3CA	5290	C420R			3	178927980	178927980	T	C	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1258T>C,NP_006209.2:p.Cys420Arg,NC_000003.11:g.178927980T>C,ENST00000263967.3:c.1258T>C	2017-11-22 19:45:59 UTC
933	https://civic.genome.wustl.edu/links/variants/933	PIK3CA	5290	E542Q			3	178936082	178936082	G	C	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1624G>C,NP_006209.2:p.Glu542Gln,NC_000003.11:g.178936082G>C,ENST00000263967.3:c.1624G>C	2017-11-22 19:45:56 UTC
934	https://civic.genome.wustl.edu/links/variants/934	PIK3CA	5290	E545D			3	178936093	178936093	G	C	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1635G>C,NP_006209.2:p.Glu545Asp,NC_000003.11:g.178936093G>C,ENST00000263967.3:c.1635G>C	2017-11-22 19:46:00 UTC
935	https://civic.genome.wustl.edu/links/variants/935	PIK3CA	5290	Y1021C			3	178952007	178952007	A	G	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.3062A>G,NP_006209.2:p.Tyr1021Cys,NC_000003.11:g.178952007A>G,ENST00000263967.3:c.3062A>G	2017-11-22 19:45:52 UTC
937	https://civic.genome.wustl.edu/links/variants/937	PIK3CA	5290	M1043I			3	178952074	178952074	G	T	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.3129G>T,NP_006209.2:p.Met1043Ile,NC_000003.11:g.178952074G>T,ENST00000263967.3:c.3129G>T	2017-11-22 19:46:05 UTC
938	https://civic.genome.wustl.edu/links/variants/938	PIK3CA	5290	H1047Y			3	178952084	178952084	C	T	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.3139C>T,NP_006209.2:p.His1047Tyr,NC_000003.11:g.178952084C>T,ENST00000263967.3:c.3139C>T	2017-11-22 19:45:57 UTC
939	https://civic.genome.wustl.edu/links/variants/939	PIK3CA	5290	G1049S			3	178952090	178952090	G	A	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.3145G>A,NP_006209.2:p.Gly1049Ser,NC_000003.11:g.178952090G>A,ENST00000263967.3:c.3145G>A	2017-11-22 19:45:59 UTC
940	https://civic.genome.wustl.edu/links/variants/940	PIK3CA	5290	G1049R			3	178952090	178952090	G	C	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.3145G>C,NP_006209.2:p.Gly1049Arg,NC_000003.11:g.178952090G>C,ENST00000263967.3:c.3145G>C	2017-11-22 19:45:52 UTC
941	https://civic.genome.wustl.edu/links/variants/941	PDGFRA	5156	V561D										GRCh37							2017-11-22 19:45:57 UTC
946	https://civic.genome.wustl.edu/links/variants/946	KIT	3815	Y503_F504insAY			4	55592185	55592186		GCCTAT	ENST00000288135.5	75	GRCh37						NC_000004.11:g.55592185_55592186insGCCTAT	2017-11-22 19:45:56 UTC
948	https://civic.genome.wustl.edu/links/variants/948	KIT	3815	K550_W557del			4	55593582	55593605	AAACCCATGTATGAAGTACAGTGG				GRCh37							2017-11-22 19:46:07 UTC
949	https://civic.genome.wustl.edu/links/variants/949	KIT	3815	K550_K558DEL			4	55593582	55593608	AAACCCATGTATGAAGTACAGTGGAAG		ENST00000288135.5	75	GRCh37					inframe_deletion	NM_000222.2:c.1648_1674del27,NP_000213.1:p.Lys550_Lys558del,NC_000004.11:g.55593582_55593608del27,ENST00000288135.5:c.1648_1674del27	2017-11-22 19:45:57 UTC
950	https://civic.genome.wustl.edu/links/variants/950	KIT	3815	P551L			4	55593586	55593586	C	T	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.1652C>T	2017-11-22 19:45:57 UTC
951	https://civic.genome.wustl.edu/links/variants/951	KIT	3815	M552_W557DEL			4	55593588	55593605	ATGTATGAAGTACAGTGG		ENST00000288135.5	75	GRCh37					inframe_deletion	ENST00000288135.5:c.1654_1671delATGTATGAAGTACAGTGG	2017-11-22 19:45:57 UTC
952	https://civic.genome.wustl.edu/links/variants/952	KIT	3815	Y553D			4	55593591	55593591	T	G	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.1657T>G,NC_000004.11:g.55593591T>G	2017-11-22 19:45:57 UTC
953	https://civic.genome.wustl.edu/links/variants/953	KIT	3815	Y553_K558DEL			4	55593591	55593608					GRCh37					inframe_deletion		2017-11-22 19:45:57 UTC
954	https://civic.genome.wustl.edu/links/variants/954	KIT	3815	DEL 554-558			4	55593594	55593608	GAAGTACAGTGGAAG		ENST00000288135.5	75	GRCh37					inframe_deletion	ENST00000288135.5:c.1660_1674delGAAGTACAGTGGAAG	2017-11-22 19:45:53 UTC
955	https://civic.genome.wustl.edu/links/variants/955	KIT	3815	E554D			4	55593596	55593596	A	C	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.1662A>C,NC_000004.11:g.55593596A>C	2017-11-22 19:45:56 UTC
956	https://civic.genome.wustl.edu/links/variants/956	KIT	3815	V555_Q556DEL			4	55593597	55593602	GTACAG		ENST00000288135.5	75	GRCh37					inframe_deletion	ENST00000288135.5:c.1663_1668delGTACAG	2017-11-22 19:45:57 UTC
957	https://civic.genome.wustl.edu/links/variants/957	KIT	3815	V555-P573DELVQWKVVEEINGNNYVYIDP			4	55593597	55593653					GRCh37					inframe_deletion		2017-11-22 19:45:57 UTC
958	https://civic.genome.wustl.edu/links/variants/958	KIT	3815	W557R			4	55593603	55593603	T	C	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1669T>C,NP_000213.1:p.Trp557Arg,NC_000004.11:g.55593603T>C,ENST00000288135.5:c.1669T>C	2017-11-22 19:45:52 UTC
959	https://civic.genome.wustl.edu/links/variants/959	KIT	3815	W557G			4	55593603	55593603	T	G	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1669T>G,NP_000213.1:p.Trp557Gly,NC_000004.11:g.55593603T>G,ENST00000288135.5:c.1669T>G	2017-11-22 19:45:57 UTC
960	https://civic.genome.wustl.edu/links/variants/960	KIT	3815	W557T			4	55593603	55593604	TG	AC	ENST00000288135.5	75	GRCh37						ENST00000288135.5:c.1669_1670delinsAC,NC_000004.11:g.55593603_55593604delinsAC	2017-11-22 19:45:57 UTC
961	https://civic.genome.wustl.edu/links/variants/961	KIT	3815	W557_K558DELWK			4	55593603	55593608	TGGAAG				GRCh37							2017-11-22 19:45:57 UTC
962	https://civic.genome.wustl.edu/links/variants/962	KIT	3815	W557_E561DEL			4	55593603	55593617					GRCh37							2017-11-22 19:45:57 UTC
963	https://civic.genome.wustl.edu/links/variants/963	KIT	3815	K558Q			4	55593606	55593606	A	C	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1672A>C,NP_000213.1:p.Lys558Gln,NC_000004.11:g.55593606A>C,ENST00000288135.5:c.1672A>C	2017-11-22 19:45:57 UTC
964	https://civic.genome.wustl.edu/links/variants/964	KIT	3815	K558_V559DEL			4	55593606	55593611	AAGGTT		ENST00000288135.5	75	GRCh37						ENST00000288135.5:c.1672_1677delAAGGTT	2017-11-22 19:45:57 UTC
965	https://civic.genome.wustl.edu/links/variants/965	KIT	3815	K558R			4	55593607	55593607	A	G	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.1673A>G,NC_000004.11:g.55593607A>G	2017-11-22 19:45:57 UTC
966	https://civic.genome.wustl.edu/links/variants/966	KIT	3815	V559DEL			4	55593609	55593611	GTT		ENST00000288135.5	75	GRCh37						ENST00000288135.5:c.1675_1677delGTT,NM_000222.2:c.1675_1677delGTT,NP_000213.1:p.Val559del,NC_000004.11:g.55593609_55593611delGTT	2017-11-22 19:45:57 UTC
967	https://civic.genome.wustl.edu/links/variants/967	KIT	3815	V559_V560DEL			4	55593609	55593614	GTTGTT		ENST00000288135.5	75	GRCh37						ENST00000288135.5:c.1675_1680delGTTGTT	2017-11-22 19:46:01 UTC
968	https://civic.genome.wustl.edu/links/variants/968	KIT	3815	V559D			4	55593610	55593610	T	A			GRCh37					missense_variant		2017-11-22 19:45:57 UTC
969	https://civic.genome.wustl.edu/links/variants/969	KIT	3815	V559A			4	55593610	55593610	T	C	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1676T>C,NP_000213.1:p.Val559Ala,NC_000004.11:g.55593610T>C,ENST00000288135.5:c.1676T>C	2017-11-22 19:45:57 UTC
970	https://civic.genome.wustl.edu/links/variants/970	KIT	3815	V559G			4	55593610	55593610	T	G	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1676T>G,NP_000213.1:p.Val559Gly,NC_000004.11:g.55593610T>G,ENST00000288135.5:c.1676T>G	2017-11-22 19:45:57 UTC
971	https://civic.genome.wustl.edu/links/variants/971	KIT	3815	V560D			4	55593613	55593613	T	A	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.1679T>A,NM_000222.2:c.1679T>A,NP_000213.1:p.Val560Asp,NC_000004.11:g.55593613T>A	2017-11-22 19:45:49 UTC
972	https://civic.genome.wustl.edu/links/variants/972	KIT	3815	V560G			4	55593613	55593613	T	G	ENST00000288135.5	75	GRCh37						NM_000222.2:c.1679T>G,NP_000213.1:p.Val560Gly,NC_000004.11:g.55593613T>G,ENST00000288135.5:c.1679T>G	2017-11-22 19:45:51 UTC
974	https://civic.genome.wustl.edu/links/variants/974	KIT	3815	T574A			4	55593654	55593654	A	G	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.1720A>G,NC_000004.11:g.55593654A>G	2017-11-22 19:45:57 UTC
975	https://civic.genome.wustl.edu/links/variants/975	KIT	3815	Q575L			4	55593658	55593658	A	T	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.1724A>T,NC_000004.11:g.55593658A>T	2017-11-22 19:45:57 UTC
976	https://civic.genome.wustl.edu/links/variants/976	KIT	3815	P577L			4	55593664	55593664	C	T	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.1730C>T,NC_000004.11:g.55593664C>T	2017-11-22 19:46:00 UTC
977	https://civic.genome.wustl.edu/links/variants/977	KIT	3815	D579DEL			4	55593669	55593671	GAT		ENST00000288135.5	75	GRCh37					inframe_deletion	ENST00000288135.5:c.1735_1737delGAT	2017-11-22 19:45:52 UTC
978	https://civic.genome.wustl.edu/links/variants/978	KIT	3815	K642E			4	55594221	55594221	A	G	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1924A>G,NP_000213.1:p.Lys642Glu,NC_000004.11:g.55594221A>G,ENST00000288135.5:c.1924A>G	2017-11-22 19:45:58 UTC
979	https://civic.genome.wustl.edu/links/variants/979	KIT	3815	T661I			4	55594279	55594279	C	T	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.1982C>T,NC_000004.11:g.55594279C>T	2017-11-22 19:45:48 UTC
980	https://civic.genome.wustl.edu/links/variants/980	KIT	3815	S692L			4	55595585	55595585	C	T	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.2075C>T,NP_000213.1:p.Ser692Leu,NC_000004.11:g.55595585C>T,NM_000222.2:c.2075C>T	2017-11-22 19:45:47 UTC
981	https://civic.genome.wustl.edu/links/variants/981	KIT	3815	Q694K			4	55595590	55595590	C	A	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.2080C>A,NC_000004.11:g.55595590C>A	2017-11-22 19:45:57 UTC
983	https://civic.genome.wustl.edu/links/variants/983	KIT	3815	D816H			4	55599320	55599320	G	C	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2446G>C,NP_000213.1:p.Asp816His,NC_000004.11:g.55599320G>C,ENST00000288135.5:c.2446G>C	2017-11-22 19:45:56 UTC
984	https://civic.genome.wustl.edu/links/variants/984	KIT	3815	D816Y										GRCh37							2017-11-22 19:45:57 UTC
986	https://civic.genome.wustl.edu/links/variants/986	KIT	3815	D820Y			4	55599332	55599332	G	T	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2458G>T,NP_000213.1:p.Asp820Tyr,NC_000004.11:g.55599332G>T,ENST00000288135.5:c.2458G>T	2017-11-22 19:45:56 UTC
989	https://civic.genome.wustl.edu/links/variants/989	KIT	3815	Y823D			4	55599341	55599341	T	G	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2467T>G,NP_000213.1:p.Tyr823Asp,NC_000004.11:g.55599341T>G,ENST00000288135.5:c.2467T>G	2017-11-22 19:45:57 UTC
990	https://civic.genome.wustl.edu/links/variants/990	KIT	3815	A829P										GRCh37							2017-11-22 19:45:57 UTC
991	https://civic.genome.wustl.edu/links/variants/991	BRAF	673	V600R										GRCh37							2017-11-22 19:45:57 UTC
992	https://civic.genome.wustl.edu/links/variants/992	BRAF	673	G469A			7	140481402	140481402	C	G	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1406G>C,NP_004324.2:p.Gly469Ala,NC_000007.13:g.140481402C>G,ENST00000288602.6:c.1406G>C	2017-11-22 19:45:56 UTC
994	https://civic.genome.wustl.edu/links/variants/994	EGFR	1956	R108K										GRCh37							2017-11-22 19:45:57 UTC
995	https://civic.genome.wustl.edu/links/variants/995	EGFR	1956	T263P										GRCh37							2017-11-22 19:45:57 UTC
996	https://civic.genome.wustl.edu/links/variants/996	EGFR	1956	A289V			7	55221822	55221822	C	T	ENST00000275493.2	75	GRCh37					missense_variant	NM_005228.4:c.866C>T,NP_005219.2:p.Ala289Val,NC_000007.13:g.55221822C>T,ENST00000275493.2:c.866C>T	2017-11-22 19:45:57 UTC
999	https://civic.genome.wustl.edu/links/variants/999	EGFR	1956	G719A			7	55241708	55241708	G	C	ENST00000275493.2	75	GRCh37					missense_variant	NM_005228.4:c.2156G>C,NP_005219.2:p.Gly719Ala,NC_000007.13:g.55241708G>C,ENST00000275493.2:c.2156G>C	2017-11-22 19:45:57 UTC
1001	https://civic.genome.wustl.edu/links/variants/1001	EGFR	1956	V742A										GRCh37							2017-11-22 19:45:57 UTC
1002	https://civic.genome.wustl.edu/links/variants/1002	EGFR	1956	E746_A750delELREA			7	55242465	55242479					GRCh37					inframe_deletion		2017-11-22 19:46:01 UTC
1003	https://civic.genome.wustl.edu/links/variants/1003	EGFR	1956	E746_T751>I										GRCh37							2017-11-22 19:45:57 UTC
1004	https://civic.genome.wustl.edu/links/variants/1004	EGFR	1956	E746_T751delinsA			7	55242467	55242481	AATTAAGAGAAGCAA		ENST00000275493.2	75	GRCh37							2017-11-22 19:45:57 UTC
1005	https://civic.genome.wustl.edu/links/variants/1005	EGFR	1956	E746V										GRCh37							2017-11-22 19:45:57 UTC
1006	https://civic.genome.wustl.edu/links/variants/1006	EGFR	1956	L747_A750>P			7	55242468	55242478		GC			GRCh37							2017-11-22 19:46:01 UTC
1007	https://civic.genome.wustl.edu/links/variants/1007	EGFR	1956	L747_T751delLREAT			7	55242468	55242482					GRCh37							2017-11-22 19:45:56 UTC
1008	https://civic.genome.wustl.edu/links/variants/1008	EGFR	1956	L747_T751>Q			7	55242468	55242482		GCA			GRCh37							2017-11-22 19:45:57 UTC
1009	https://civic.genome.wustl.edu/links/variants/1009	EGFR	1956	E746_S752>D			7	55242468	55242485					GRCh37					inframe_deletion		2017-11-22 19:45:57 UTC
1010	https://civic.genome.wustl.edu/links/variants/1010	EGFR	1956	L747_T751>P			7	55242469	55242481		C			GRCh37							2017-11-22 19:45:57 UTC
1011	https://civic.genome.wustl.edu/links/variants/1011	EGFR	1956	L747_P753>Q			7	55242469	55242488		CA			GRCh37							2017-11-22 19:45:57 UTC
1012	https://civic.genome.wustl.edu/links/variants/1012	EGFR	1956	L747_P753delinsS			7	55242470	55242487					GRCh37					inframe_deletion		2017-11-22 19:45:56 UTC
1013	https://civic.genome.wustl.edu/links/variants/1013	EGFR	1956	D761N										GRCh37							2017-11-22 19:45:57 UTC
1016	https://civic.genome.wustl.edu/links/variants/1016	EGFR	1956	G810S										GRCh37							2017-11-22 19:45:57 UTC
1017	https://civic.genome.wustl.edu/links/variants/1017	EGFR	1956	R831H			7	55259434	55259434	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2492G>A,NC_000007.13:g.55259434G>A	2017-11-22 19:45:57 UTC
1018	https://civic.genome.wustl.edu/links/variants/1018	EGFR	1956	L838V										GRCh37							2017-11-22 19:45:57 UTC
1020	https://civic.genome.wustl.edu/links/variants/1020	EGFR	1956	L861Q										GRCh37							2017-11-22 19:45:58 UTC
1021	https://civic.genome.wustl.edu/links/variants/1021	ABL1	25	M244V			9	133738330	133738330	A	G	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.730A>G,NP_005148.2:p.Met244Val,NC_000009.11:g.133738330A>G,ENST00000318560.5:c.730A>G	2017-11-22 19:45:57 UTC
1022	https://civic.genome.wustl.edu/links/variants/1022	ABL1	25	L248V			9	133738342	133738342	C	G	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.742C>G,NP_005148.2:p.Leu248Val,NC_000009.11:g.133738342C>G,ENST00000318560.5:c.742C>G	2017-11-22 19:45:57 UTC
1023	https://civic.genome.wustl.edu/links/variants/1023	ABL1	25	G250E			9	133738349	133738349	G	A	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.749G>A,NP_005148.2:p.Gly250Glu,NC_000009.11:g.133738349G>A,ENST00000318560.5:c.749G>A	2017-11-22 19:45:57 UTC
1024	https://civic.genome.wustl.edu/links/variants/1024	ABL1	25	Q252H			9	133738356	133738356	G	C	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.756G>C,NP_005148.2:p.Gln252His,NC_000009.11:g.133738356G>C,ENST00000318560.5:c.756G>C	2017-11-22 19:45:57 UTC
1025	https://civic.genome.wustl.edu/links/variants/1025	ABL1	25	Y253H			9	133738357	133738357	T	C	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.757T>C,NP_005148.2:p.Tyr253His,NC_000009.11:g.133738357T>C,ENST00000318560.5:c.757T>C	2017-11-22 19:45:57 UTC
1026	https://civic.genome.wustl.edu/links/variants/1026	ABL1	25	Y253F			9	133738358	133738358	A	T	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.758A>T,NM_005157.5:c.758A>T,NP_005148.2:p.Tyr253Phe,NC_000009.11:g.133738358A>T	2017-11-22 19:45:57 UTC
1027	https://civic.genome.wustl.edu/links/variants/1027	ABL1	25	D276G			9	133747520	133747520	A	G	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.827A>G,NP_005148.2:p.Asp276Gly,NM_005157.5:c.827A>G,NC_000009.11:g.133747520A>G	2017-11-22 19:45:57 UTC
1028	https://civic.genome.wustl.edu/links/variants/1028	ABL1	25	F317L			9	133748290	133748290	C	G	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.951C>G,NP_005148.2:p.Phe317Leu,NC_000009.11:g.133748290C>G,ENST00000318560.5:c.951C>G	2017-11-22 19:45:57 UTC
1029	https://civic.genome.wustl.edu/links/variants/1029	ABL1	25	M351T			9	133748391	133748391	T	C	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.1052T>C,NP_005148.2:p.Met351Thr,NC_000009.11:g.133748391T>C,ENST00000318560.5:c.1052T>C	2017-11-22 19:45:57 UTC
1030	https://civic.genome.wustl.edu/links/variants/1030	ABL1	25	H396R			9	133750356	133750356	A	G	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.1187A>G,NP_005148.2:p.His396Arg,NC_000009.11:g.133750356A>G,ENST00000318560.5:c.1187A>G	2017-11-22 19:45:57 UTC
1031	https://civic.genome.wustl.edu/links/variants/1031	NOTCH1	4851	L1600P			9	139399344	139399344	A	G	ENST00000277541.6	75	GRCh37					missense_variant	ENST00000277541.6:c.4799T>C,NC_000009.11:g.139399344A>G	2017-11-22 19:45:57 UTC
1032	https://civic.genome.wustl.edu/links/variants/1032	NOTCH1	4851	L1574P			9	139399422	139399422	A	G	ENST00000277541.6	75	GRCh37						ENST00000277541.6:c.4721T>C,NC_000009.11:g.139399422A>G	2017-11-22 19:45:48 UTC
1033	https://civic.genome.wustl.edu/links/variants/1033	NOTCH1	4851	R1598P			9	139399350	139399350	C	G	ENST00000277541.6	75	GRCh37						ENST00000277541.6:c.4793G>C,NC_000009.11:g.139399350C>G	2017-11-22 19:45:57 UTC
1034	https://civic.genome.wustl.edu/links/variants/1034	NOTCH1	4851	L1678P			9	139397768	139397768	A	G	ENST00000277541.6	75	GRCh37						ENST00000277541.6:c.5033T>C,NC_000009.11:g.139397768A>G	2017-11-22 19:45:57 UTC
1049	https://civic.genome.wustl.edu/links/variants/1049	TP53	7157	P278S										GRCh37							2017-11-22 19:45:58 UTC
1066	https://civic.genome.wustl.edu/links/variants/1066	TP53	7157	M237I										GRCh37							2017-11-22 19:45:58 UTC
1068	https://civic.genome.wustl.edu/links/variants/1068	TP53	7157	Y234C			17	7577580	7577580	T	C	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.701A>G,NP_000537.3:p.Tyr234Cys,NC_000017.10:g.7577580T>C,ENST00000269305.4:c.701A>G	2017-11-22 19:45:46 UTC
1092	https://civic.genome.wustl.edu/links/variants/1092	TP53	7157	V157F										GRCh37							2017-11-22 19:45:58 UTC
1103	https://civic.genome.wustl.edu/links/variants/1103	KRAS	3845	Q61P			12	25380276	25380276	T	G	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.182A>C,NP_004976.2:p.Gln61Pro,NC_000012.11:g.25380276T>G,ENST00000256078.4:c.182A>C	2017-11-22 19:45:48 UTC
1104	https://civic.genome.wustl.edu/links/variants/1104	KRAS	3845	Q61E			12	25380277	25380277	G	C	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.181C>G,NP_004976.2:p.Gln61Glu,NC_000012.11:g.25380277G>C,ENST00000256078.4:c.181C>G	2017-11-22 19:45:57 UTC
1105	https://civic.genome.wustl.edu/links/variants/1105	KRAS	3845	Q61FS										GRCh37							2017-11-22 19:45:58 UTC
1106	https://civic.genome.wustl.edu/links/variants/1106	BRAF	673	G464V			7	140481417	140481417	C	A	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1391G>T,NP_004324.2:p.Gly464Val,NC_000007.13:g.140481417C>A,ENST00000288602.6:c.1391G>T	2017-11-22 19:45:58 UTC
1107	https://civic.genome.wustl.edu/links/variants/1107	BRAF	673	D594N			7	140453155	140453155	C	T	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1780G>A,NP_004324.2:p.Asp594Asn,NC_000007.13:g.140453155C>T,ENST00000288602.6:c.1780G>A	2017-11-22 19:46:00 UTC
1108	https://civic.genome.wustl.edu/links/variants/1108	TP53	7157	R282L			17	7577093	7577093	C	A	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.845G>T,NP_000537.3:p.Arg282Leu,NC_000017.10:g.7577093C>A,ENST00000269305.4:c.845G>T	2017-11-22 19:45:58 UTC
1109	https://civic.genome.wustl.edu/links/variants/1109	TP53	7157	R213P			17	7578211	7578211	C	G	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.638G>C,NP_000537.3:p.Arg213Pro,NC_000017.10:g.7578211C>G,ENST00000269305.4:c.638G>C	2017-11-22 19:45:58 UTC
1120	https://civic.genome.wustl.edu/links/variants/1120	KRAS	3845	K117N			12	25378647	25378647	T	A	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.351A>T,NP_004976.2:p.Lys117Asn,NC_000012.11:g.25378647T>A,ENST00000256078.4:c.351A>T	2017-11-22 19:46:08 UTC
1121	https://civic.genome.wustl.edu/links/variants/1121	BRAF	673	F595L			7	140453150	140453150	A	C	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1785T>G,NP_004324.2:p.Phe595Leu,NC_000007.13:g.140453150A>C,ENST00000288602.6:c.1785T>G	2017-11-22 19:45:59 UTC
1127	https://civic.genome.wustl.edu/links/variants/1127	NOTCH1	4851	F1592S			9	139399368	139399368	A	G	ENST00000277541.6	75	GRCh37					missense_variant	ENST00000277541.6:c.4775T>C,NC_000009.11:g.139399368A>G	2017-11-22 19:45:59 UTC
1140	https://civic.genome.wustl.edu/links/variants/1140	NOTCH1	4851	L1600Q			9	139399344	139399344	A	T	ENST00000277541.6	75	GRCh37					missense_variant	ENST00000277541.6:c.4799T>A,NC_000009.11:g.139399344A>T	2017-11-22 19:45:59 UTC
1142	https://civic.genome.wustl.edu/links/variants/1142	NOTCH1	4851	L1585R			9	139399389	139399389	A	C	ENST00000277541.6	75	GRCh37					missense_variant	ENST00000277541.6:c.4754T>G,NC_000009.11:g.139399389A>C	2017-11-22 19:45:59 UTC
1143	https://civic.genome.wustl.edu/links/variants/1143	NOTCH1	4851	V1577A			9	139399413	139399413	A	G	ENST00000277541.6	75	GRCh37					missense_variant	ENST00000277541.6:c.4730T>G,NC_000009.11:g.139399413A>G	2017-11-22 19:45:59 UTC
1144	https://civic.genome.wustl.edu/links/variants/1144	NOTCH1	4851	V1577E			9	139399413	139399413	A	T	ENST00000277541.6	75	GRCh37					missense_variant	ENST00000277541.6:c.4730T>A,NC_000009.11:g.139399413A>T	2017-11-22 19:45:59 UTC
1145	https://civic.genome.wustl.edu/links/variants/1145	NOTCH1	4851	L1574Q			9	139399422	139399422	A	T	ENST00000277541.6	75	GRCh37					missense_variant	ENST00000277541.6:c.4721T>A,NC_000009.11:g.139399422A>T	2017-11-22 19:45:59 UTC
1151	https://civic.genome.wustl.edu/links/variants/1151	PIK3CA	5290	H1047L			3	178952085	178952085	A	T	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.3140A>T,NP_006209.2:p.His1047Leu,NC_000003.11:g.178952085A>T,ENST00000263967.3:c.3140A>T	2017-11-22 19:45:59 UTC
1152	https://civic.genome.wustl.edu/links/variants/1152	ABL1	25	BCR-ABL F486S			9	133755488	133755488	T	C	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.1457T>C,NC_000009.11:g.133755488T>C	2017-11-22 19:45:58 UTC
1153	https://civic.genome.wustl.edu/links/variants/1153	ATM	472	P292R			11	108115727	108115727	C	G	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.875C>G,NC_000011.9:g.108115727C>G	2017-11-22 19:46:01 UTC
1154	https://civic.genome.wustl.edu/links/variants/1154	ATM	472	M1FS										GRCh37					frameshift_variant		2017-11-22 19:45:59 UTC
1155	https://civic.genome.wustl.edu/links/variants/1155	ATM	472	K293*			11	108115729	108115729	A	T	ENST00000278616.4	75	GRCh37					stop_gained	ENST00000278616.4:c.877A>T,NM_000051.3:c.877A>T,NP_000042.3:p.Lys293Ter,NC_000011.9:g.108115729A>T	2017-11-22 19:45:59 UTC
1156	https://civic.genome.wustl.edu/links/variants/1156	ATM	472	R2459C			11	108201008	108201008	C	T			GRCh37					missense_variant	NC_000011.9:g.108201008C>T	2017-11-22 19:46:01 UTC
1157	https://civic.genome.wustl.edu/links/variants/1157	ATM	472	Q984E			11	108142006	108142006	C	G	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.2950C>G,NC_000011.9:g.108142006C>G	2017-11-22 19:46:00 UTC
1158	https://civic.genome.wustl.edu/links/variants/1158	ATM	472	F1025L			11	108142131	108142131	T	G	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.3075T>G,NC_000011.9:g.108142131T>G	2017-11-22 19:46:01 UTC
1159	https://civic.genome.wustl.edu/links/variants/1159	ATM	472	Q1084*			11	108143545	108143545	C	T	ENST00000278616.4	75	GRCh37					stop_gained	ENST00000278616.4:c.3250C>T,NC_000011.9:g.108143545C>T	2017-11-22 19:45:59 UTC
1160	https://civic.genome.wustl.edu/links/variants/1160	ATM	472	D1930V			11	108180913	108180913	A	T	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.5789A>T,NC_000011.9:g.108180913A>T	2017-11-22 19:46:00 UTC
1161	https://civic.genome.wustl.edu/links/variants/1161	ATM	472	R2034P			11	108186743	108186743	G	C	ENST00000278616.4	75	GRCh37						NC_000011.9:g.108186743G>C	2017-11-22 19:45:46 UTC
1162	https://civic.genome.wustl.edu/links/variants/1162	ATM	472	E2187*			11	108192134	108192134	G	T	ENST00000278616.4	75	GRCh37					stop_gained	ENST00000278616.4:c.6559G>T,NC_000011.9:g.108192134G>T	2017-11-22 19:45:47 UTC
1163	https://civic.genome.wustl.edu/links/variants/1163	ATM	472	L2427P			11	108199938	108199938	T	C	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.7280T>C,NC_000011.9:g.108199938T>C	2017-11-22 19:46:00 UTC
1164	https://civic.genome.wustl.edu/links/variants/1164	ATM	472	F2732V			11	108206614	108206614	T	G	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.8194T>G,NC_000011.9:g.108206614T>G,NM_000051.3:c.8194T>G,NP_000042.3:p.Phe2732Val	2017-11-22 19:46:00 UTC
1165	https://civic.genome.wustl.edu/links/variants/1165	ATM	472	R777FS			11	108128286	108128289	AGAA				GRCh37					frameshift_variant		2017-11-22 19:45:59 UTC
1166	https://civic.genome.wustl.edu/links/variants/1166	ATM	472	K468FS			11	108121594	108121595	AA		ENST00000278616.4	75	GRCh37					frameshift_variant	NM_000051.3:c.1402_1403delAA,NP_000042.3:p.Lys468Glufs,NC_000011.9:g.108121594_108121595delAA,ENST00000278616.4:c.1402_1403delAA,NC_000011.9:g.108121594_108121595del	2017-11-22 19:45:59 UTC
1167	https://civic.genome.wustl.edu/links/variants/1167	ATM	472	V1268FS										GRCh37					frameshift_variant		2017-11-22 19:46:00 UTC
1168	https://civic.genome.wustl.edu/links/variants/1168	ATM	472	D1682H			11	108170479	108170479	G	C	ENST00000278616.4	75	GRCh37					missense_variant	NM_000051.3:c.5044G>C,NP_000042.3:p.Asp1682His,NC_000011.9:g.108170479G>C,ENST00000278616.4:c.5044G>C	2017-11-22 19:45:59 UTC
1169	https://civic.genome.wustl.edu/links/variants/1169	ATM	472	A2062V			11	108186827	108186827	C	T	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.6185C>T,NC_000011.9:g.108186827C>T	2017-11-22 19:46:01 UTC
1170	https://civic.genome.wustl.edu/links/variants/1170	ATM	472	R1575H			11	108164152	108164152	G	A	ENST00000278616.4	75	GRCh37					missense_variant	NC_000011.9:g.108164152G>A	2017-11-22 19:45:58 UTC
1171	https://civic.genome.wustl.edu/links/variants/1171	ATM	472	A2274T			11	108196797	108196797	G	A	ENST00000278616.4	75	GRCh37					missense_variant	NM_000051.3:c.6820G>A,NP_000042.3:p.Ala2274Thr,NC_000011.9:g.108196797G>A,ENST00000278616.4:c.6820G>A	2017-11-22 19:45:59 UTC
1172	https://civic.genome.wustl.edu/links/variants/1172	ATM	472	C2488Y			11	108201096	108201096	G	A	ENST00000278616.4	75	GRCh37					missense_variant	NM_000051.3:c.7463G>A,NP_000042.3:p.Cys2488Tyr,NC_000011.9:g.108201096G>A,ENST00000278616.4:c.7463G>A	2017-11-22 19:45:59 UTC
1173	https://civic.genome.wustl.edu/links/variants/1173	ABL1	25	E255V			9	133738364	133738364	A	T	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.764A>T,NP_005148.2:p.Glu255Val,NC_000009.11:g.133738364A>T,ENST00000318560.5:c.764A>T	2017-11-22 19:45:58 UTC
1174	https://civic.genome.wustl.edu/links/variants/1174	NOTCH1	4851	F1592C			9	139399368	139399368	A	C	ENST00000277541.6	75	GRCh37						NM_017617.4:c.4775T>G,NP_060087.3:p.Phe1592Cys,NC_000009.11:g.139399368A>C,ENST00000277541.6:c.4775T>G	2017-11-22 19:45:59 UTC
1175	https://civic.genome.wustl.edu/links/variants/1175	NRAS	4893	G12V										GRCh37							2017-11-22 19:45:59 UTC
1178	https://civic.genome.wustl.edu/links/variants/1178	PIK3CA	5290	R93W			3	178916890	178916890	C	T	ENST00000263967.3	75	GRCh37					missense_variant	ENST00000263967.3:c.277C>T	2017-11-22 19:45:58 UTC
1181	https://civic.genome.wustl.edu/links/variants/1181	EGFR	1956	R776C										GRCh37							2017-11-22 19:45:58 UTC
1182	https://civic.genome.wustl.edu/links/variants/1182	EGFR	1956	S784F										GRCh37							2017-11-22 19:45:58 UTC
1183	https://civic.genome.wustl.edu/links/variants/1183	ABL1	25	E292V			9	133747568	133747568	A	T	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.875A>T,NC_000009.11:g.133747568A>T	2017-11-22 19:45:58 UTC
1184	https://civic.genome.wustl.edu/links/variants/1184	ABL1	25	F359C			9	133748415	133748415	T	G	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.1076T>G,NP_005148.2:p.Phe359Cys,NC_000009.11:g.133748415T>G,ENST00000318560.5:c.1076T>G	2017-11-22 19:45:58 UTC
1187	https://civic.genome.wustl.edu/links/variants/1187	EGFR	1956	A864T			7	55259532	55259532	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2590G>A	2017-11-22 19:46:03 UTC
1188	https://civic.genome.wustl.edu/links/variants/1188	EGFR	1956	N826S										GRCh37							2017-11-22 19:45:58 UTC
1196	https://civic.genome.wustl.edu/links/variants/1196	BRAF	673	G466A			7	140481411	140481411	C	G	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1397G>C,NP_004324.2:p.Gly466Ala,NC_000007.13:g.140481411C>G,ENST00000288602.6:c.1397G>C	2017-11-22 19:46:07 UTC
1206	https://civic.genome.wustl.edu/links/variants/1206	KIT	3815	S501_A502INSAY			4	55592179	55592180		GCCTAT			GRCh37					inframe_insertion	NC_000004.11:g.55592179_55592180insGCCTAT	2017-11-22 19:46:00 UTC
1214	https://civic.genome.wustl.edu/links/variants/1214	EGFR	1956	E746_T751delinsVA			7	55242467	55242483	AATTAAGAGAAGCAACA	TTGCT	ENST00000275493.2	75	GRCh37					inframe_deletion		2017-11-22 19:45:47 UTC
1227	https://civic.genome.wustl.edu/links/variants/1227	AKT3	10000	E17K			1	243859016	243859016	C	T	ENST00000366539.1	75	GRCh37					missense_variant	NM_001206729.1:c.49G>A,NP_001193658.1:p.Glu17Lys,NC_000001.10:g.243859016C>T,ENST00000366539.1:c.49G>A	2017-11-22 19:46:08 UTC
1230	https://civic.genome.wustl.edu/links/variants/1230	ABL1	25	L384M			9	133750319	133750319	C	A	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.1150C>A,NC_000009.11:g.133750319C>A	2017-11-22 19:46:00 UTC
1231	https://civic.genome.wustl.edu/links/variants/1231	ABL1	25	V299L			9	133747588	133747588	G	C	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.895G>C,NP_005148.2:p.Val299Leu,NC_000009.11:g.133747588G>C,ENST00000318560.5:c.895G>C	2017-11-22 19:46:00 UTC
1232	https://civic.genome.wustl.edu/links/variants/1232	ABL1	25	L387F			9	133750330	133750330	G	C	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.1161G>C,NC_000009.11:g.133750330G>C	2017-11-22 19:46:00 UTC
1233	https://civic.genome.wustl.edu/links/variants/1233	ABL1	25	BCR-ABL G398R			9	133750361	133750361	G	C	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.1192G>C,NC_000009.11:g.133750361G>C	2017-11-22 19:45:59 UTC
1234	https://civic.genome.wustl.edu/links/variants/1234	PIK3CA	5290	K111N			3	178916946	178916946	G	C	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.333G>C,NP_006209.2:p.Lys111Asn,NC_000003.11:g.178916946G>C,ENST00000263967.3:c.333G>C	2017-11-22 19:46:00 UTC
1235	https://civic.genome.wustl.edu/links/variants/1235	PIK3CA	5290	I391M			3	178927410	178927410	A	G	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1173A>G,NP_006209.2:p.Ile391Met,NC_000003.11:g.178927410A>G,ENST00000263967.3:c.1173A>G	2017-11-22 19:46:00 UTC
1236	https://civic.genome.wustl.edu/links/variants/1236	BRCA1	672	M1V			17	41276113	41276113	T	C	ENST00000471181.2	75	GRCh37					start_lost	NM_007294.3:c.1A>G,NP_009225.1:p.Met1Val,NC_000017.10:g.41276113T>C,ENST00000471181.2:c.1A>G	2017-11-22 19:46:00 UTC
1237	https://civic.genome.wustl.edu/links/variants/1237	BRCA1	672	M1I			17	41276111	41276111	C	A	ENST00000471181.2	75	GRCh37					start_lost	NM_007294.3:c.3G>T,NP_009225.1:p.Met1Ile,NC_000017.10:g.41276111C>A,ENST00000471181.2:c.3G>T	2017-11-22 19:46:00 UTC
1238	https://civic.genome.wustl.edu/links/variants/1238	BRCA1	672	C61G			17	41258504	41258504	A	C	ENST00000471181.2	75	GRCh37					missense_variant	NM_007294.3:c.181T>G,NP_009225.1:p.Cys61Gly,NC_000017.10:g.41258504A>C,ENST00000471181.2:c.181T>G	2017-11-22 19:46:00 UTC
1239	https://civic.genome.wustl.edu/links/variants/1239	BRCA1	672	C64Y			17	41258494	41258494	C	T	ENST00000471181.2	75	GRCh37					missense_variant	NM_007294.3:c.191G>A,NP_009225.1:p.Cys64Tyr,NC_000017.10:g.41258494C>T,ENST00000471181.2:c.191G>A	2017-11-22 19:46:00 UTC
1240	https://civic.genome.wustl.edu/links/variants/1240	BRCA1	672	R71G			17	41258474	41258474	T	C	ENST00000471181.2	75	GRCh37					missense_variant	NM_007294.3:c.211A>G,NP_009225.1:p.Arg71Gly,NC_000017.10:g.41258474T>C,ENST00000471181.2:c.211A>G	2017-11-22 19:45:47 UTC
1241	https://civic.genome.wustl.edu/links/variants/1241	BRCA1	672	R71K			17	41258473	41258473	C	T	ENST00000471181.2	75	GRCh37					missense_variant	NM_007294.3:c.212G>A,NP_009225.1:p.Arg71Lys,NC_000017.10:g.41258473C>T,ENST00000471181.2:c.212G>A	2017-11-22 19:45:59 UTC
1242	https://civic.genome.wustl.edu/links/variants/1242	BRCA1	672	R1495M			17	41228505	41228505	C	A	ENST00000357654.3	75	GRCh37					missense_variant	ENST00000357654.3:c.4484G>T,NM_007294.3:c.4484G>T,NP_009225.1:p.Arg1495Met,NC_000017.10:g.41228505C>A	2017-11-22 19:45:59 UTC
1243	https://civic.genome.wustl.edu/links/variants/1243	BRCA1	672	E1559K			17	41226348	41226348	C	T	ENST00000357654.3	75	GRCh37					missense_variant	NM_007294.3:c.4675G>A,NP_009225.1:p.Glu1559Lys,NC_000017.10:g.41226348C>T,ENST00000357654.3:c.4675G>A	2017-11-22 19:46:00 UTC
1244	https://civic.genome.wustl.edu/links/variants/1244	BRCA1	672	D1692N			17	41219625	41219625	C	T	ENST00000357654.3	75	GRCh37					missense_variant	NM_007294.3:c.5074G>A,NP_009225.1:p.Asp1692Asn,NC_000017.10:g.41219625C>T,ENST00000357654.3:c.5074G>A	2017-11-22 19:46:00 UTC
1245	https://civic.genome.wustl.edu/links/variants/1245	BRCA1	672	R1443*			17	41234451	41234451	G	A	ENST00000471181.2	75	GRCh37					stop_gained	NM_007294.3:c.4327C>T,NP_009225.1:p.Arg1443Ter,NC_000017.10:g.41234451G>A,ENST00000471181.2:c.4327C>T	2017-11-22 19:45:47 UTC
1246	https://civic.genome.wustl.edu/links/variants/1246	BRCA1	672	Q1467*			17	41228590	41228590	G	A	ENST00000357654.3	75	GRCh37					stop_gained	NM_007294.3:c.4399C>T,NP_009225.1:p.Gln1467Ter,NC_000017.10:g.41228590G>A,ENST00000357654.3:c.4399C>T	2017-11-22 19:45:59 UTC
1247	https://civic.genome.wustl.edu/links/variants/1247	BRCA2	675	M1R			13	32890599	32890599	T	G	ENST00000544455.1		GRCh37					missense_variant	NM_000059.3:c.2T>G,NC_000013.10:g.32890599T>G,NP_000050.2:p.Met1Arg,ENST00000544455.1:c.2T>G	2017-11-22 19:45:59 UTC
1248	https://civic.genome.wustl.edu/links/variants/1248	BRCA2	675	M1I			13	32890600	32890600	G	T	ENST00000544455.1	75	GRCh37					missense_variant	NC_000013.10:g.32890600G>T,NM_000059.3:c.3G>T,NP_000050.2:p.Met1Ile,ENST00000544455.1:c.3G>T	2017-11-22 19:45:59 UTC
1249	https://civic.genome.wustl.edu/links/variants/1249	BRCA2	675	V159M			13	32900287	32900287	G	A	ENST00000544455.1	75	GRCh37					missense_variant	ENST00000544455.1:c.475G>A,NM_000059.3:c.475G>A,NP_000050.2:p.Val159Met,NC_000013.10:g.32900287G>A	2017-11-22 19:45:59 UTC
1250	https://civic.genome.wustl.edu/links/variants/1250	BRCA2	675	V211L			13	32900751	32900751	G	C			GRCh37					missense_variant	NC_000013.10:g.32900751G>C	2017-11-22 19:46:00 UTC
1251	https://civic.genome.wustl.edu/links/variants/1251	BRCA2	675	V211I			13	32900751	32900751	G	A			GRCh37					missense_variant	NC_000013.10:g.32900751G>A	2017-11-22 19:46:00 UTC
1252	https://civic.genome.wustl.edu/links/variants/1252	BRCA2	675	R2336P			13	32921033	32921033	G	C	ENST00000544455.1	75	GRCh37					missense_variant	NM_000059.3:c.7007G>C,NP_000050.2:p.Arg2336Pro,NC_000013.10:g.32921033G>C,ENST00000544455.1:c.7007G>C	2017-11-22 19:46:00 UTC
1253	https://civic.genome.wustl.edu/links/variants/1253	BRCA2	675	R2336H			13	32921033	32921033	G	A	ENST00000544455.1	75	GRCh37					missense_variant	NM_000059.3:c.7007G>A,NP_000050.2:p.Arg2336His,ENST00000544455.1:c.7007G>A,NC_000013.10:g.32921033G>A	2017-11-22 19:46:00 UTC
1254	https://civic.genome.wustl.edu/links/variants/1254	TP53	7157	V143A			17	7578502	7578502	A	G	ENST00000269305.4	75	GRCh37					missense_variant	ENST00000269305.4:c.428T>C,NC_000017.10:g.7578502A>G	2017-11-22 19:45:48 UTC
1255	https://civic.genome.wustl.edu/links/variants/1255	MGMT	4255	UNDEREXPRESSION			10	131265448	131566271			ENST00000306010.7	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
1256	https://civic.genome.wustl.edu/links/variants/1256	TERT	7015	OVEREXPRESSION			5	1253282	1295162			ENST00000310581.5	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
1257	https://civic.genome.wustl.edu/links/variants/1257	RRM1	6240	UNDEREXPRESSION			11	4116039	4160106			ENST00000300738.5	75	GRCh37					N/A		2017-11-22 19:46:01 UTC
1258	https://civic.genome.wustl.edu/links/variants/1258	PTPRF	5792	EXPRESSION			1	43996547	44089337			ENST00000359947.4	75	GRCh37					N/A		2017-11-22 19:45:47 UTC
1259	https://civic.genome.wustl.edu/links/variants/1259	AEBP1	165	OVEREXPRESSION																	2017-11-22 19:45:47 UTC
1260	https://civic.genome.wustl.edu/links/variants/1260	RET	5979	C609Y	There is some functional evidence that this variant leads to reduced RET activity (PMID: 9230192) and increased cell proliferation and resistance to apoptosis (PMID: 16715139). It has been widely reported in both familial and sporadic cases of multiple endocrine neoplasia type 2 with medullary thyroid cancers. Despite extensive WGS and Exome coverage for a combined total of ~150k alleles in the GNOMAD browser, this variant has never been observed.		10	43609070	43609070	G	A	ENST00000355710.3	75	GRCh37					missense_variant	NM_020630.4:c.1826G>A,NC_000010.10:g.43609070G>A,NP_065681.1:p.Cys609Tyr,ENST00000355710.3:c.1826G>A	2017-11-22 19:45:52 UTC
1261	https://civic.genome.wustl.edu/links/variants/1261	MDM2	4193	AMPLIFICATION																	2017-11-22 19:45:46 UTC
1262	https://civic.genome.wustl.edu/links/variants/1262	MDM4	4194	EXPRESSION																	2017-11-22 19:45:47 UTC
1263	https://civic.genome.wustl.edu/links/variants/1263	KIT	3815	N822K			4	55599340	55599340	T	A	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2466T>A,NP_000213.1:p.Asn822Lys,NC_000004.11:g.55599340T>A,ENST00000288135.5:c.2466T>A	2017-11-22 19:45:49 UTC
1264	https://civic.genome.wustl.edu/links/variants/1264	KIT	3815	C809G			4	55599299	55599299	T	G	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.2425T>G,NC_000004.11:g.55599299T>G	2017-11-22 19:45:56 UTC
1265	https://civic.genome.wustl.edu/links/variants/1265	KIT	3815	D820A			4	55599333	55599333	A	C	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.2459A>C,NC_000004.11:g.55599333A>C	2017-11-22 19:45:48 UTC
1266	https://civic.genome.wustl.edu/links/variants/1266	KIT	3815	D820G			4	55599333	55599333	A	G	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2459A>G,NP_000213.1:p.Asp820Gly,NC_000004.11:g.55599333A>G,ENST00000288135.5:c.2459A>G	2017-11-22 19:45:49 UTC
1267	https://civic.genome.wustl.edu/links/variants/1267	KIT	3815	T670I			4	55595519	55595519	C	T	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2009C>T,NP_000213.1:p.Thr670Ile,NC_000004.11:g.55595519C>T,ENST00000288135.5:c.2009C>T	2017-11-22 19:45:48 UTC
1268	https://civic.genome.wustl.edu/links/variants/1268	MDM4	4194	AMPLIFICATION																	2017-11-22 19:45:48 UTC
1269	https://civic.genome.wustl.edu/links/variants/1269	BRAF	673	AMPLIFICATION			7	140434279	140624564			ENST00000288602.6	75	GRCh37					transcript_amplification		2017-11-22 19:45:51 UTC
1270	https://civic.genome.wustl.edu/links/variants/1270	MAP2K1	5604	F53L			15	66727441	66727441	T	C	ENST00000307102.5	75	GRCh37					missense_variant	NM_002755.3:c.157T>C,NP_002746.1:p.Phe53Leu,NC_000015.9:g.66727441T>C,ENST00000307102.5:c.157T>C	2017-11-22 19:45:48 UTC
1271	https://civic.genome.wustl.edu/links/variants/1271	ROS1	6098	G2032R			6	117638347	117638347	C	T	ENST00000368508.3	75	GRCh37					missense_variant	NC_000006.11:g.117638347C>T,NM_002944.2:c.6094G>A,NP_002935.2:p.Gly2032Arg,ENST00000368508.3:c.6094G>A	2017-11-22 19:45:52 UTC
1272	https://civic.genome.wustl.edu/links/variants/1272	MAP2K1	5604	K57N			15	66727455	66727455	G	T	ENST00000307102.5	75	GRCh37					missense_variant	NM_002755.3:c.171G>T,NP_002746.1:p.Lys57Asn,NC_000015.9:g.66727455G>T,ENST00000307102.5:c.171G>T,NG_008305.1:g.53245G>T	2017-11-22 19:45:52 UTC
1273	https://civic.genome.wustl.edu/links/variants/1273	CTAG1B	1485	OVEREXPRESSION																	2017-11-22 19:45:52 UTC
1274	https://civic.genome.wustl.edu/links/variants/1274	CTAG2	30848	OVEREXPRESSION																	2017-11-22 19:45:53 UTC
1275	https://civic.genome.wustl.edu/links/variants/1275	ALK	238	L1198F			2	29443625	29443625	G	A	ENST00000389048.3	75	GRCh37					missense_variant	ENST00000389048.3:c.3592C>T,NC_000002.11:g.29443625G>A	2017-11-22 19:46:01 UTC
1276	https://civic.genome.wustl.edu/links/variants/1276	SMO	6608	AMPLIFICATION																	2017-11-22 19:45:56 UTC
1277	https://civic.genome.wustl.edu/links/variants/1277	NTRK3	4916	FUSIONS																	2017-11-22 19:45:56 UTC
1278	https://civic.genome.wustl.edu/links/variants/1278	NTRK1	4914	LMNA-NTRK1			1	156084498	156108548			ENST00000368300.4	75	GRCh37	1	156844363	156851434	ENST00000524377.1	transcript_fusion		2017-11-22 19:46:08 UTC
1279	https://civic.genome.wustl.edu/links/variants/1279	BRD4	23476	OVEREXPRESSION			19	15347647	15391262			ENST00000263377.2	75	GRCh37					N/A		2017-11-22 19:45:57 UTC
1280	https://civic.genome.wustl.edu/links/variants/1280	NTRK1	4914	AMPLIFICATION			1	156830686	156851434			ENST00000524377.1	75	GRCh37					transcript_amplification		2017-11-22 19:45:57 UTC
1281	https://civic.genome.wustl.edu/links/variants/1281	NTRK3	4916	AMPLIFICATION			15	88418230	88799978			ENST00000394480.2	75	GRCh37					transcript_amplification		2017-11-22 19:45:57 UTC
1282	https://civic.genome.wustl.edu/links/variants/1282	NTRK1	4914	LMNA-NTRK1 G595R AND G667C			1	156846342	156849107			ENST00000524377.1	75	GRCh37					missense_variant		2017-11-22 19:46:08 UTC
1283	https://civic.genome.wustl.edu/links/variants/1283	CDK2	1017	CYTOPLASMIC EXPRESSION			12	56360553	56366568			ENST00000266970.4	75	GRCh37					N/A		2017-11-22 19:45:57 UTC
1284	https://civic.genome.wustl.edu/links/variants/1284	DCC	1630	EXPRESSION																	2017-11-22 19:45:56 UTC
1285	https://civic.genome.wustl.edu/links/variants/1285	CTNNB1	1499	T41A			3	41266124	41266124	A	G	ENST00000349496.5	75	GRCh37					missense_variant	NM_001904.3:c.121A>G,NP_001895.1:p.Thr41Ala,NC_000003.11:g.41266124A>G,ENST00000349496.5:c.121A>G	2017-11-22 19:45:56 UTC
1286	https://civic.genome.wustl.edu/links/variants/1286	CTNNB1	1499	S45F			3	41266137	41266137	C	T	ENST00000349496.5	75	GRCh37					missense_variant	NM_001904.3:c.134C>T,NP_001895.1:p.Ser45Phe,NC_000003.11:g.41266137C>T,ENST00000349496.5:c.134C>T	2017-11-22 19:45:57 UTC
1287	https://civic.genome.wustl.edu/links/variants/1287	CTNNB1	1499	S45P			3	41266136	41266136	T	C	ENST00000349496.5	75	GRCh37					missense_variant	NM_001904.3:c.133T>C,NP_001895.1:p.Ser45Pro,NC_000003.11:g.41266136T>C,ENST00000349496.5:c.133T>C	2017-11-22 19:45:57 UTC
1288	https://civic.genome.wustl.edu/links/variants/1288	JAK3	3718	M511I			19	17949108	17949108	C	T	ENST00000458235.1	75	GRCh37					missense_variant	ENST00000458235.1:c.1533G>A,NM_000215.3:c.1533G>A,NP_000206.2:p.Met511Ile,NC_000019.9:g.17949108C>T	2017-11-22 19:45:59 UTC
1289	https://civic.genome.wustl.edu/links/variants/1289	JAK3	3718	V722I			19	17945696	17945696	C	T	ENST00000458235.1	75	GRCh37					missense_variant	NM_000215.3:c.2164G>A,NP_000206.2:p.Val722Ile,NC_000019.9:g.17945696C>T,ENST00000458235.1:c.2164G>A	2017-11-22 19:45:59 UTC
1290	https://civic.genome.wustl.edu/links/variants/1290	JAK3	3718	S61C			19	17955046	17955046	T	A	ENST00000458235.1	75	GRCh37					missense_variant	ENST00000458235.1:c.181A>T,NC_000019.9:g.17955046T>A	2017-11-22 19:45:47 UTC
1291	https://civic.genome.wustl.edu/links/variants/1291	JAK1	3716	P429S			1	65325837	65325837	G	A	ENST00000342505.4	75	GRCh37					missense_variant	ENST00000342505.4:c.1285C>T,NC_000001.10:g.65325837G>A	2017-11-22 19:45:52 UTC
1292	https://civic.genome.wustl.edu/links/variants/1292	JAK1	3716	W690*			1	65311241	65311242			ENST00000342505.4	75	GRCh37					stop_gained		2017-11-22 19:45:47 UTC
1293	https://civic.genome.wustl.edu/links/variants/1293	ARID1A	8289	LOSS-OF-FUNCTION																	2017-11-22 19:45:58 UTC
1294	https://civic.genome.wustl.edu/links/variants/1294	VHL	7428	W8* (c.24G>A)			3	10183555	10183555	G	A	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.24G>A,ENST00000256474.2:c.24G>A,NC_000003.11:g.10183555G>A	2017-11-22 19:45:59 UTC
1295	https://civic.genome.wustl.edu/links/variants/1295	ALK	238	F1245V			2	29436860	29436860	A	C	ENST00000389048.3	75	GRCh37					missense_variant	NM_004304.4:c.3733T>G,NP_004295.2:p.Phe1245Val,NC_000002.11:g.29436860A>C,ENST00000389048.3:c.3733T>G	2017-11-22 19:45:58 UTC
1296	https://civic.genome.wustl.edu/links/variants/1296	CTNNB1	1499	ACTIVATING MUTATION			3	41240930	41281936			ENST00000349496.5	75	GRCh37					gain_of_function_variant,transcript_variant		2017-11-22 19:45:59 UTC
1298	https://civic.genome.wustl.edu/links/variants/1298	BRAF	673	599INST																	2017-11-22 19:45:58 UTC
1299	https://civic.genome.wustl.edu/links/variants/1299	MERTK	10461	OVEREXPRESSION			2	112656056	112787138			ENST00000295408.4	75	GRCh37					N/A		2017-11-22 19:45:59 UTC
1300	https://civic.genome.wustl.edu/links/variants/1300	TP53	7157	CONSERVED DOMAIN MUT																	2017-11-22 19:45:58 UTC
1301	https://civic.genome.wustl.edu/links/variants/1301	AKT3	10000	OVEREXPRESSION																	2017-11-22 19:45:57 UTC
1302	https://civic.genome.wustl.edu/links/variants/1302	FLT3	2322	D835V			13	28592641	28592641	T	A	ENST00000241453.7	75	GRCh37					missense_variant	ENST00000241453.7:c.2504A>T,NM_004119.2:c.2504A>T,NP_004110.2:p.Asp835Val,NC_000013.10:g.28592641T>A	2017-11-22 19:45:59 UTC
1303	https://civic.genome.wustl.edu/links/variants/1303	MYC	4609	OVEREXPRESSION																	2017-11-22 19:45:52 UTC
1304	https://civic.genome.wustl.edu/links/variants/1304	ERBB2	2064	L755P			17	37880219	37880220	TT	CC	ENST00000269571.5	75	GRCh37					missense_variant	NP_004439.2:p.Leu755Pro,NM_004448.3:c.2263_2264delinsCC,NC_000017.13:g.37880219_37880220delinsCC	2017-11-22 19:45:56 UTC
1305	https://civic.genome.wustl.edu/links/variants/1305	ERBB2	2064	T798M			17	37881064	37881065	CA	TG	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2393_2394delCAinsTG,NC_000017.10:g.37881064_37881065delinsTG	2017-11-22 19:45:56 UTC
1306	https://civic.genome.wustl.edu/links/variants/1306	TP53	7157	OVEREXPRESSION			17	7571720	7590856			ENST00000269305.4	75	GRCh37							2017-11-22 19:46:01 UTC
1307	https://civic.genome.wustl.edu/links/variants/1307	TP53	7157	ALTERATION	P53 ALTERATION is a bucket type variant used in studies which is constructed by combining all cases of p53 mutation together with p53 overexpression. This includes cases which have p53 mutation or overexpression alone or as well as cases where both occur in combination.																2017-11-22 19:46:01 UTC
1308	https://civic.genome.wustl.edu/links/variants/1308	ERBB2	2064	L768S			17	37880259	37880259	T	C	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2303T>C	2017-11-22 19:46:01 UTC
1309	https://civic.genome.wustl.edu/links/variants/1309	ERBB2	2064	L638S																	2017-11-22 19:46:01 UTC
1310	https://civic.genome.wustl.edu/links/variants/1310	ERBB2	2064	V773																	2017-11-22 19:46:01 UTC
1311	https://civic.genome.wustl.edu/links/variants/1311	ERBB2	2064	V773L																	2017-11-22 19:46:01 UTC
1312	https://civic.genome.wustl.edu/links/variants/1312	ERBB2	2064	K753E			17	37880213	37880213	A	G	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2257A>G	2017-11-22 19:46:01 UTC
1313	https://civic.genome.wustl.edu/links/variants/1313	ERBB2	2064	L753E																	2017-11-22 19:46:01 UTC
1314	https://civic.genome.wustl.edu/links/variants/1314	ERBB2	2064	K755S																	2017-11-22 19:46:01 UTC
1316	https://civic.genome.wustl.edu/links/variants/1316	KIT	3815	V559																	2017-11-22 19:45:47 UTC
1317	https://civic.genome.wustl.edu/links/variants/1317	NRAS	4893	G13V																	2017-11-22 19:45:46 UTC
1318	https://civic.genome.wustl.edu/links/variants/1318	TP53	7157	L3 Domain Mutation																	2017-11-22 19:45:46 UTC
1319	https://civic.genome.wustl.edu/links/variants/1319	GNAS	2778	R201H																	2017-11-22 19:45:53 UTC
1320	https://civic.genome.wustl.edu/links/variants/1320	ERBB2	2064	NON-AMPLIFICATION																	2017-11-22 19:45:53 UTC
1387	https://civic.genome.wustl.edu/links/variants/1387	HRAS	3265	G12D										GRCh37							2017-11-22 19:46:03 UTC
1390	https://civic.genome.wustl.edu/links/variants/1390	EGFR	1956	E884K										GRCh37							2017-11-22 19:46:00 UTC
1391	https://civic.genome.wustl.edu/links/variants/1391	HRAS	3265	Q61R										GRCh37							2017-11-22 19:46:00 UTC
1392	https://civic.genome.wustl.edu/links/variants/1392	HRAS	3265	Q61K										GRCh37							2017-11-22 19:46:00 UTC
1393	https://civic.genome.wustl.edu/links/variants/1393	HRAS	3265	G13R										GRCh37							2017-11-22 19:46:00 UTC
1394	https://civic.genome.wustl.edu/links/variants/1394	HRAS	3265	G12V										GRCh37							2017-11-22 19:46:00 UTC
1395	https://civic.genome.wustl.edu/links/variants/1395	KRAS	3845	G13R			12	25398282	25398282	C	G	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.37G>C,NP_004976.2:p.Gly13Arg,NC_000012.11:g.25398282C>G,ENST00000256078.4:c.37G>C	2017-11-22 19:46:00 UTC
1396	https://civic.genome.wustl.edu/links/variants/1396	KRAS	3845	G13S			12	25398282	25398282	C	T	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.37G>A,NP_004976.2:p.Gly13Ser,NC_000012.11:g.25398282C>T,ENST00000256078.4:c.37G>A	2017-11-22 19:46:00 UTC
1397	https://civic.genome.wustl.edu/links/variants/1397	FLT3	2322	D835E			13	28592640	28592640	A	T			GRCh37					missense_variant		2017-11-22 19:46:00 UTC
1398	https://civic.genome.wustl.edu/links/variants/1398	MAP2K2	5605	F57C			19	4117550	4117550	A	C			GRCh37					missense_variant		2017-11-22 19:46:00 UTC
1399	https://civic.genome.wustl.edu/links/variants/1399	PIK3CA	5290	D549N			3	178936103	178936103	G	A	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1645G>A,NP_006209.2:p.Asp549Asn,NC_000003.11:g.178936103G>A,ENST00000263967.3:c.1645G>A	2017-11-22 19:46:05 UTC
1400	https://civic.genome.wustl.edu/links/variants/1400	FGFR3	2261	K650E										GRCh37							2017-11-22 19:46:00 UTC
1402	https://civic.genome.wustl.edu/links/variants/1402	KIT	3815	D816G										GRCh37							2017-11-22 19:46:00 UTC
1420	https://civic.genome.wustl.edu/links/variants/1420	EGFR	1956	G719D										GRCh37							2017-11-22 19:46:01 UTC
1432	https://civic.genome.wustl.edu/links/variants/1432	EGFR	1956	E746_T751delELREAT			7	55242466	55242483					GRCh37					inframe_deletion		2017-11-22 19:46:00 UTC
1433	https://civic.genome.wustl.edu/links/variants/1433	EGFR	1956	E746_S752>A										GRCh37							2017-11-22 19:46:01 UTC
1435	https://civic.genome.wustl.edu/links/variants/1435	EGFR	1956	L747_T751>S										GRCh37							2017-11-22 19:46:01 UTC
1443	https://civic.genome.wustl.edu/links/variants/1443	EGFR	1956	S768N										GRCh37							2017-11-22 19:46:01 UTC
1445	https://civic.genome.wustl.edu/links/variants/1445	EGFR	1956	D770_N771insSVD			7	55249013	55249014		GCGTGGACA			GRCh37							2017-11-22 19:46:00 UTC
1446	https://civic.genome.wustl.edu/links/variants/1446	EGFR	1956	H773_V774insH										GRCh37							2017-11-22 19:46:00 UTC
1457	https://civic.genome.wustl.edu/links/variants/1457	EGFR	1956	L838P										GRCh37							2017-11-22 19:46:02 UTC
1463	https://civic.genome.wustl.edu/links/variants/1463	EGFR	1956	T847I										GRCh37							2017-11-22 19:46:02 UTC
1465	https://civic.genome.wustl.edu/links/variants/1465	EGFR	1956	P848L										GRCh37							2017-11-22 19:46:03 UTC
1466	https://civic.genome.wustl.edu/links/variants/1466	EGFR	1956	V851I										GRCh37							2017-11-22 19:46:03 UTC
1467	https://civic.genome.wustl.edu/links/variants/1467	EGFR	1956	T854A										GRCh37							2017-11-22 19:46:03 UTC
1474	https://civic.genome.wustl.edu/links/variants/1474	EGFR	1956	A859T			7	55259517	55259517	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2575G>A	2017-11-22 19:46:01 UTC
1477	https://civic.genome.wustl.edu/links/variants/1477	EGFR	1956	L861R										GRCh37							2017-11-22 19:46:02 UTC
1482	https://civic.genome.wustl.edu/links/variants/1482	EGFR	1956	E868G										GRCh37							2017-11-22 19:46:02 UTC
1487	https://civic.genome.wustl.edu/links/variants/1487	ABL1	25	E355G										GRCh37							2017-11-22 19:46:02 UTC
1488	https://civic.genome.wustl.edu/links/variants/1488	ABL1	25	L387M										GRCh37							2017-11-22 19:46:02 UTC
1489	https://civic.genome.wustl.edu/links/variants/1489	HRAS	3265	G13V										GRCh37							2017-11-22 19:46:02 UTC
1491	https://civic.genome.wustl.edu/links/variants/1491	KRAS	3845	A59T			12	25380283	25380283	C	T	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.175G>A,NP_004976.2:p.Ala59Thr,NC_000012.11:g.25380283C>T,ENST00000256078.4:c.175G>A	2017-11-22 19:46:02 UTC
1492	https://civic.genome.wustl.edu/links/variants/1492	ALK	238	F1174C			2	29443696	29443696	A	C	ENST00000	75	GRCh37					missense_variant	ENST00000389048.3:c.3521T>G	2017-11-22 19:46:01 UTC
1493	https://civic.genome.wustl.edu/links/variants/1493	ALK	238	T1151M								ENST00000389048.3	75	GRCh37					missense_variant	NM_004304.4:c.3452C>T,NP_004295.2:p.Thr1151Met,NC_000002.11:g.29445273G>A,ENST00000389048.3:c.3452C>T	2017-11-22 19:46:02 UTC
1494	https://civic.genome.wustl.edu/links/variants/1494	ABL1	25	T277A										GRCh37							2017-11-22 19:46:02 UTC
1495	https://civic.genome.wustl.edu/links/variants/1495	ABL1	25	S438C								ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.1313C>G	2017-11-22 19:46:01 UTC
1496	https://civic.genome.wustl.edu/links/variants/1496	ABL1	25	E450G										GRCh37							2017-11-22 19:46:02 UTC
1497	https://civic.genome.wustl.edu/links/variants/1497	KIT	3815	P551_E554DELPMYE										GRCh37							2017-11-22 19:46:02 UTC
1498	https://civic.genome.wustl.edu/links/variants/1498	KIT	3815	W557_V559INSC										GRCh37							2017-11-22 19:46:02 UTC
1499	https://civic.genome.wustl.edu/links/variants/1499	PIK3CA	5290	S158L			3	178917598	178917598	C	T	ENST00000263967.3	75	GRCh37					missense_variant	ENST00000263967.3:c.473C>T	2017-11-22 19:46:01 UTC
1500	https://civic.genome.wustl.edu/links/variants/1500	PIK3CA	5290	E81K			3	178916854	178916854	G	A	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.241G>A,NP_006209.2:p.Glu81Lys,NC_000003.11:g.178916854G>A,ENST00000263967.3:c.241G>A	2017-11-22 19:46:05 UTC
1501	https://civic.genome.wustl.edu/links/variants/1501	PIK3CA	5290	G1049A			3	178952091	178952091	G	C	ENST00000263967.3	75	GRCh37					missense_variant	ENST00000263967.3:c.3146G>C	2017-11-22 19:46:05 UTC
1503	https://civic.genome.wustl.edu/links/variants/1503	FBXW7	55294	R505C								ENST00000281708.4	75	GRCh37					missense_variant	NM_033632.3:c.1513C>T,NP_361014.1:p.Arg505Cys,NC_000004.11:g.153247289G>A,ENST00000281708.4:c.1513C>T	2017-11-22 19:46:02 UTC
1504	https://civic.genome.wustl.edu/links/variants/1504	FBXW7	55294	R505H										GRCh37							2017-11-22 19:46:02 UTC
1505	https://civic.genome.wustl.edu/links/variants/1505	ALK	238	F1174V			2	29443697	29443697	A	C	ENST00000389048.3	75	GRCh37					missense_variant	ENST00000389048.3:c.3520T>G	2017-11-22 19:46:01 UTC
1506	https://civic.genome.wustl.edu/links/variants/1506	ABL1	25	L298V										GRCh37							2017-11-22 19:46:02 UTC
1507	https://civic.genome.wustl.edu/links/variants/1507	ABL1	25	F311I										GRCh37							2017-11-22 19:46:02 UTC
1508	https://civic.genome.wustl.edu/links/variants/1508	ABL1	25	L364I										GRCh37							2017-11-22 19:46:02 UTC
1509	https://civic.genome.wustl.edu/links/variants/1509	ABL1	25	E453Q										GRCh37							2017-11-22 19:46:02 UTC
1510	https://civic.genome.wustl.edu/links/variants/1510	ARID1A	8289	Q456X										GRCh37							2017-11-22 19:46:02 UTC
1511	https://civic.genome.wustl.edu/links/variants/1511	EGFR	1956	S768_D770dup										GRCh37							2017-11-22 19:46:02 UTC
1513	https://civic.genome.wustl.edu/links/variants/1513	EGFR	1956	H773_V774insNPH			7	55249012	55249013		AACCCCCAC			GRCh37					inframe_insertion		2017-11-22 19:46:08 UTC
1514	https://civic.genome.wustl.edu/links/variants/1514	EGFR	1956	D770_N771insGL			7	55249012	55249013		GGGTTA	ENST00000275493.2		GRCh37					inframe_insertion		2017-11-22 19:46:02 UTC
1515	https://civic.genome.wustl.edu/links/variants/1515	EGFR	1956	A763_Y764insFQEA			7	55248992	55248993		TCCAGGAAGCCT	ENST00000275493.2		GRCh37					inframe_insertion		2017-11-22 19:46:02 UTC
1517	https://civic.genome.wustl.edu/links/variants/1517	KRAS	3845	G13V			12	25398280	25398281	GC	AA			GRCh37							2017-11-22 19:46:02 UTC
1518	https://civic.genome.wustl.edu/links/variants/1518	PDGFRA	5156	DIM842_844DEL										GRCh37							2017-11-22 19:46:02 UTC
1519	https://civic.genome.wustl.edu/links/variants/1519	EGFR	1956	L747FS*10										GRCh37							2017-11-22 19:46:02 UTC
1520	https://civic.genome.wustl.edu/links/variants/1520	MTOR	2475	Q2223K										GRCh37							2017-11-22 19:46:02 UTC
1521	https://civic.genome.wustl.edu/links/variants/1521	CDKN2A	1029	W110*			9	21971028	21971028	C	T	ENST00000498124.1	75	GRCh37					stop_gained	NP_000068.1:p.Trp110Ter,NC_000009.11:g.21971028C>T,NM_000077.4:c.330G>A,ENST00000498124.1:c.330G>A	2017-11-22 19:46:02 UTC
1522	https://civic.genome.wustl.edu/links/variants/1522	CDKN2A	1029	A20P			9	21974769	21974769	C	G	ENST00000498124.1	75	GRCh37					missense_variant	ENST00000498124.1:c.58G>C	2017-11-22 19:46:07 UTC
1523	https://civic.genome.wustl.edu/links/variants/1523	ABL1	25	F359I										GRCh37							2017-11-22 19:46:02 UTC
1524	https://civic.genome.wustl.edu/links/variants/1524	ABL1	25	M343T										GRCh37							2017-11-22 19:46:02 UTC
1525	https://civic.genome.wustl.edu/links/variants/1525	ABL1	25	F317V										GRCh37							2017-11-22 19:46:02 UTC
1526	https://civic.genome.wustl.edu/links/variants/1526	ABL1	25	E279K										GRCh37							2017-11-22 19:46:02 UTC
1527	https://civic.genome.wustl.edu/links/variants/1527	ABL1	25	Q300R								ENST00000318560.5	75	GRCh37						ENST00000318560.5:c.899A>G	2017-11-22 19:46:01 UTC
1528	https://civic.genome.wustl.edu/links/variants/1528	ABL1	25	F311L										GRCh37							2017-11-22 19:46:02 UTC
1529	https://civic.genome.wustl.edu/links/variants/1529	ABL1	25	N331S										GRCh37							2017-11-22 19:46:02 UTC
1530	https://civic.genome.wustl.edu/links/variants/1530	ABL1	25	L364P										GRCh37							2017-11-22 19:46:02 UTC
1531	https://civic.genome.wustl.edu/links/variants/1531	ABL1	25	H396P										GRCh37							2017-11-22 19:46:02 UTC
1532	https://civic.genome.wustl.edu/links/variants/1532	ABL1	25	D421G										GRCh37							2017-11-22 19:46:03 UTC
1533	https://civic.genome.wustl.edu/links/variants/1533	ABL1	25	I432T										GRCh37							2017-11-22 19:46:03 UTC
1534	https://civic.genome.wustl.edu/links/variants/1534	ABL1	25	E450V										GRCh37							2017-11-22 19:46:03 UTC
1535	https://civic.genome.wustl.edu/links/variants/1535	ABL1	25	E453K										GRCh37							2017-11-22 19:46:01 UTC
1536	https://civic.genome.wustl.edu/links/variants/1536	ABL1	25	E453A										GRCh37							2017-11-22 19:46:01 UTC
1537	https://civic.genome.wustl.edu/links/variants/1537	ABL1	25	P480A										GRCh37							2017-11-22 19:46:01 UTC
1538	https://civic.genome.wustl.edu/links/variants/1538	ABL1	25	F486Y										GRCh37							2017-11-22 19:46:03 UTC
1539	https://civic.genome.wustl.edu/links/variants/1539	PDGFRA	5156	W559_R560DELWR										GRCh37							2017-11-22 19:46:02 UTC
1540	https://civic.genome.wustl.edu/links/variants/1540	PDGFRA	5156	L579M										GRCh37							2017-11-22 19:46:03 UTC
1541	https://civic.genome.wustl.edu/links/variants/1541	KIT	3815	Q556_I571DEL										GRCh37							2017-11-22 19:46:03 UTC
1542	https://civic.genome.wustl.edu/links/variants/1542	KIT	3815	Y553_W557DELYEVQW										GRCh37							2017-11-22 19:46:03 UTC
1543	https://civic.genome.wustl.edu/links/variants/1543	KIT	3815	V555_I571DEL										GRCh37							2017-11-22 19:46:03 UTC
1544	https://civic.genome.wustl.edu/links/variants/1544	FLT3	2322	E611_F612INS25										GRCh37							2017-11-22 19:46:03 UTC
1545	https://civic.genome.wustl.edu/links/variants/1545	KIT	3815	K550_W557DELKPMYEVQW										GRCh37							2017-11-22 19:46:03 UTC
1546	https://civic.genome.wustl.edu/links/variants/1546	KIT	3815	T417_D419DELTYDINSI										GRCh37							2017-11-22 19:46:03 UTC
1547	https://civic.genome.wustl.edu/links/variants/1547	KIT	3815	D579_H580INSIDPTQLPYD										GRCh37							2017-11-22 19:46:03 UTC
1548	https://civic.genome.wustl.edu/links/variants/1548	KIT	3815	Y570_L576DEL										GRCh37							2017-11-22 19:46:03 UTC
1549	https://civic.genome.wustl.edu/links/variants/1549	KIT	3815	K558NP										GRCh37							2017-11-22 19:46:03 UTC
1550	https://civic.genome.wustl.edu/links/variants/1550	KIT	3815	V560_L576DEL										GRCh37							2017-11-22 19:46:03 UTC
1551	https://civic.genome.wustl.edu/links/variants/1551	KIT	3815	V569_L576DEL										GRCh37							2017-11-22 19:46:03 UTC
1552	https://civic.genome.wustl.edu/links/variants/1552	MAPK1	5594	E278E			22	22127162	22127162	C	T	ENST00000544786.1	75	GRCh37					synonymous_variant	ENST00000544786.1:c.834G>A	2017-11-22 19:46:02 UTC
1553	https://civic.genome.wustl.edu/links/variants/1553	ALK	238	L1196Q			2	29443630	29443630	A	T	ENST00000389048.3	75	GRCh37					missense_variant	ENST00000389048.3:c.3587T>A	2017-11-22 19:46:02 UTC
1554	https://civic.genome.wustl.edu/links/variants/1554	ALK	238	L1152P			2	29445270	29445270	A	G	ENST00000389048.3	75	GRCh37					missense_variant	ENST00000389048.3:c.3455T>C	2017-11-22 19:46:02 UTC
1555	https://civic.genome.wustl.edu/links/variants/1555	BRCA1	672	W1815X										GRCh37							2017-11-22 19:46:03 UTC
1556	https://civic.genome.wustl.edu/links/variants/1556	ALK	238	L1198P			2	29443624	29443624	A	G	ENST00000389048.3	75	GRCh37					missense_variant	ENST00000389048.3:c.3593T>C	2017-11-22 19:46:02 UTC
1557	https://civic.genome.wustl.edu/links/variants/1557	ERBB2	2064	ERBB2 G776INSV_G/C			17	37880999	37881000		TGT			GRCh37					inframe_insertion		2017-11-22 19:46:02 UTC
1558	https://civic.genome.wustl.edu/links/variants/1558	KIT	3815	A502_Y503INSAY										GRCh37							2017-11-22 19:46:03 UTC
1559	https://civic.genome.wustl.edu/links/variants/1559	KIT	3815	D816E										GRCh37							2017-11-22 19:46:03 UTC
1560	https://civic.genome.wustl.edu/links/variants/1560	SMO	6608	D473G										GRCh37							2017-11-22 19:46:03 UTC
1561	https://civic.genome.wustl.edu/links/variants/1561	SMO	6608	D473Y										GRCh37							2017-11-22 19:46:03 UTC
1562	https://civic.genome.wustl.edu/links/variants/1562	SMO	6608	S278I										GRCh37							2017-11-22 19:46:03 UTC
1563	https://civic.genome.wustl.edu/links/variants/1563	SMO	6608	W281C										GRCh37							2017-11-22 19:46:03 UTC
1564	https://civic.genome.wustl.edu/links/variants/1564	SMO	6608	Q477E										GRCh37							2017-11-22 19:46:03 UTC
1566	https://civic.genome.wustl.edu/links/variants/1566	EGFR	1956	D770_N771insGT			7	55249012	55249013		GGCACA	ENST00000275493.2		GRCh37					inframe_insertion		2017-11-22 19:46:02 UTC
1567	https://civic.genome.wustl.edu/links/variants/1567	EGFR	1956	V774_C775insHV										GRCh37					inframe_insertion		2017-11-22 19:46:02 UTC
1569	https://civic.genome.wustl.edu/links/variants/1569	EGFR	1956	D770_N771insNPG										GRCh37					inframe_insertion		2017-11-22 19:46:02 UTC
1570	https://civic.genome.wustl.edu/links/variants/1570	SMO	6608	L412F			7	128846398	128846398	C	T	ENST00000249373.3	75	GRCh37					missense_variant	NM_005631.4:c.1234C>T,NP_005622.1:p.Leu412Phe,NC_000007.13:g.128846398C>T,ENST00000249373.3:c.1234C>T	2017-11-22 19:46:06 UTC
1571	https://civic.genome.wustl.edu/links/variants/1571	EGFR	1956	W731L										GRCh37							2017-11-22 19:46:03 UTC
1572	https://civic.genome.wustl.edu/links/variants/1572	EGFR	1956	E734Q										GRCh37					missense_variant		2017-11-22 19:46:03 UTC
1573	https://civic.genome.wustl.edu/links/variants/1573	EGFR	1956	T785A										GRCh37							2017-11-22 19:46:03 UTC
1574	https://civic.genome.wustl.edu/links/variants/1574	EGFR	1956	C797Y			7	55249092	55249092	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2390G>A	2017-11-22 19:46:08 UTC
1575	https://civic.genome.wustl.edu/links/variants/1575	EGFR	1956	Y801H										GRCh37							2017-11-22 19:46:03 UTC
1576	https://civic.genome.wustl.edu/links/variants/1576	SMO	6608	V321M										GRCh37							2017-11-22 19:46:03 UTC
1577	https://civic.genome.wustl.edu/links/variants/1577	EGFR	1956	E709_T710>D										GRCh37							2017-11-22 19:46:03 UTC
1578	https://civic.genome.wustl.edu/links/variants/1578	EGFR	1956	V769A										GRCh37							2017-11-22 19:46:03 UTC
1579	https://civic.genome.wustl.edu/links/variants/1579	EGFR	1956	A767_V769dupASV			7	55249000	55249001		GCCAGCGTG	ENST00000275493.2		GRCh37					inframe_insertion		2017-11-22 19:46:08 UTC
1580	https://civic.genome.wustl.edu/links/variants/1580	EGFR	1956	L747_S752INSQ										GRCh37							2017-11-22 19:46:03 UTC
1581	https://civic.genome.wustl.edu/links/variants/1581	EGFR	1956	N771>GY										GRCh37							2017-11-22 19:46:03 UTC
1582	https://civic.genome.wustl.edu/links/variants/1582	EGFR	1956	P546S										GRCh37							2017-11-22 19:46:03 UTC
1583	https://civic.genome.wustl.edu/links/variants/1583	SMO	6608	W281L										GRCh37							2017-11-22 19:46:03 UTC
1584	https://civic.genome.wustl.edu/links/variants/1584	SMO	6608	G497W										GRCh37							2017-11-22 19:46:03 UTC
1585	https://civic.genome.wustl.edu/links/variants/1585	SMO	6608	I408V										GRCh37							2017-11-22 19:46:03 UTC
1586	https://civic.genome.wustl.edu/links/variants/1586	SMO	6608	C469Y										GRCh37							2017-11-22 19:46:03 UTC
1587	https://civic.genome.wustl.edu/links/variants/1587	SMO	6608	T241M										GRCh37							2017-11-22 19:46:03 UTC
1588	https://civic.genome.wustl.edu/links/variants/1588	SMO	6608	A459V										GRCh37							2017-11-22 19:46:03 UTC
1589	https://civic.genome.wustl.edu/links/variants/1589	SMO	6608	S533N										GRCh37							2017-11-22 19:46:03 UTC
1590	https://civic.genome.wustl.edu/links/variants/1590	PTCH1	5727	W170X										GRCh37							2017-11-22 19:46:03 UTC
1591	https://civic.genome.wustl.edu/links/variants/1591	PTCH1	5727	W712X										GRCh37							2017-11-22 19:46:03 UTC
1592	https://civic.genome.wustl.edu/links/variants/1592	PTCH1	5727	Q787X										GRCh37							2017-11-22 19:46:03 UTC
1593	https://civic.genome.wustl.edu/links/variants/1593	PTCH1	5727	Q17X										GRCh37							2017-11-22 19:46:03 UTC
1594	https://civic.genome.wustl.edu/links/variants/1594	PIK3CA	5290	R1023Q			3	178952013	178952013	G	A	ENST00000263967.3	75	GRCh37					missense_variant	ENST00000263967.3:c.3068G>A	2017-11-22 19:46:05 UTC
1595	https://civic.genome.wustl.edu/links/variants/1595	ABL1	25	H201L										GRCh37							2017-11-22 19:46:03 UTC
1596	https://civic.genome.wustl.edu/links/variants/1596	ABL1	25	Y232S			9	133738295	133738295	A	C	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.695A>C	2017-11-22 19:46:02 UTC
1597	https://civic.genome.wustl.edu/links/variants/1597	ABL1	25	M237V										GRCh37							2017-11-22 19:46:03 UTC
1598	https://civic.genome.wustl.edu/links/variants/1598	ABL1	25	I242T										GRCh37							2017-11-22 19:46:03 UTC
1599	https://civic.genome.wustl.edu/links/variants/1599	ABL1	25	G250V										GRCh37							2017-11-22 19:46:03 UTC
1600	https://civic.genome.wustl.edu/links/variants/1600	ABL1	25	Q252R										GRCh37							2017-11-22 19:46:03 UTC
1601	https://civic.genome.wustl.edu/links/variants/1601	ABL1	25	E258D										GRCh37							2017-11-22 19:46:03 UTC
1602	https://civic.genome.wustl.edu/links/variants/1602	ABL1	25	L273M										GRCh37							2017-11-22 19:46:03 UTC
1603	https://civic.genome.wustl.edu/links/variants/1603	ABL1	25	E281K										GRCh37							2017-11-22 19:46:03 UTC
1604	https://civic.genome.wustl.edu/links/variants/1604	ABL1	25	V289I			9	133747558	133747558	G	A	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.865G>A	2017-11-22 19:46:02 UTC
1605	https://civic.genome.wustl.edu/links/variants/1605	ABL1	25	Y342H			9	133748363	133748363	T	C	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.1024T>C	2017-11-22 19:46:02 UTC
1606	https://civic.genome.wustl.edu/links/variants/1606	ABL1	25	D363Y										GRCh37							2017-11-22 19:46:03 UTC
1607	https://civic.genome.wustl.edu/links/variants/1607	ABL1	25	A365V								ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.1094C>T	2017-11-22 19:46:02 UTC
1608	https://civic.genome.wustl.edu/links/variants/1608	ABL1	25	A366G										GRCh37							2017-11-22 19:46:03 UTC
1609	https://civic.genome.wustl.edu/links/variants/1609	ABL1	25	V379I			9	133750304	133750304	G	A	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.1135G>A	2017-11-22 19:46:02 UTC
1610	https://civic.genome.wustl.edu/links/variants/1610	ABL1	25	M388L										GRCh37							2017-11-22 19:46:03 UTC
1611	https://civic.genome.wustl.edu/links/variants/1611	ABL1	25	Y393C			9	133750347	133750347	A	G	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.1178A>G	2017-11-22 19:46:02 UTC
1612	https://civic.genome.wustl.edu/links/variants/1612	ABL1	25	A397P										GRCh37							2017-11-22 19:46:03 UTC
1613	https://civic.genome.wustl.edu/links/variants/1613	ABL1	25	S417Y										GRCh37							2017-11-22 19:46:03 UTC
1614	https://civic.genome.wustl.edu/links/variants/1614	ABL1	25	I418V										GRCh37							2017-11-22 19:46:03 UTC
1615	https://civic.genome.wustl.edu/links/variants/1615	ABL1	25	I418S										GRCh37							2017-11-22 19:46:03 UTC
1616	https://civic.genome.wustl.edu/links/variants/1616	ABL1	25	P441L										GRCh37							2017-11-22 19:46:03 UTC
1617	https://civic.genome.wustl.edu/links/variants/1617	ABL1	25	E450K										GRCh37							2017-11-22 19:46:03 UTC
1618	https://civic.genome.wustl.edu/links/variants/1618	ABL1	25	E450Q										GRCh37							2017-11-22 19:46:03 UTC
1619	https://civic.genome.wustl.edu/links/variants/1619	ABL1	25	E450A										GRCh37							2017-11-22 19:46:03 UTC
1620	https://civic.genome.wustl.edu/links/variants/1620	ABL1	25	E453V										GRCh37							2017-11-22 19:46:03 UTC
1621	https://civic.genome.wustl.edu/links/variants/1621	ABL1	25	E459G										GRCh37							2017-11-22 19:46:03 UTC
1622	https://civic.genome.wustl.edu/links/variants/1622	ABL1	25	M472I										GRCh37							2017-11-22 19:46:03 UTC
1623	https://civic.genome.wustl.edu/links/variants/1623	ABL1	25	P480L										GRCh37							2017-11-22 19:46:03 UTC
1624	https://civic.genome.wustl.edu/links/variants/1624	ABL1	25	G514S										GRCh37							2017-11-22 19:46:04 UTC
1625	https://civic.genome.wustl.edu/links/variants/1625	ABL1	25	F317I										GRCh37							2017-11-22 19:46:04 UTC
1626	https://civic.genome.wustl.edu/links/variants/1626	MAP2K1	5604	E203K			15	66774131	66774131	G	A	ENST00000307102.5	75	GRCh37					missense_variant	NM_002755.3:c.607G>A,NP_002746.1:p.Glu203Lys,NC_000015.9:g.66774131G>A,ENST00000307102.5:c.607G>A	2017-11-22 19:46:03 UTC
1627	https://civic.genome.wustl.edu/links/variants/1627	BRAF	673	G596R			7	140453149	140453149	C	G	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1786G>C,NP_004324.2:p.Gly596Arg,NC_000007.13:g.140453149C>G,ENST00000288602.6:c.1786G>C	2017-11-22 19:46:07 UTC
1628	https://civic.genome.wustl.edu/links/variants/1628	NF1	4763	R163X										GRCh37					stop_gained		2017-11-22 19:46:04 UTC
1630	https://civic.genome.wustl.edu/links/variants/1630	FLT3	2322	Y591_V592INSVDFREYE										GRCh37							2017-11-22 19:46:04 UTC
1631	https://civic.genome.wustl.edu/links/variants/1631	FLT3	2322	E588_Y589INSKYFYVDFRE										GRCh37							2017-11-22 19:46:04 UTC
1632	https://civic.genome.wustl.edu/links/variants/1632	FLT3	2322	V592_D593INSDFREY										GRCh37							2017-11-22 19:46:04 UTC
1633	https://civic.genome.wustl.edu/links/variants/1633	EGFR	1956	E746_S752>I										GRCh37							2017-11-22 19:46:04 UTC
1634	https://civic.genome.wustl.edu/links/variants/1634	EGFR	1956	E746_T751>V										GRCh37							2017-11-22 19:46:04 UTC
1635	https://civic.genome.wustl.edu/links/variants/1635	EGFR	1956	E746_A750>IP										GRCh37							2017-11-22 19:46:04 UTC
1636	https://civic.genome.wustl.edu/links/variants/1636	EGFR	1956	E746_T751>IP										GRCh37							2017-11-22 19:46:04 UTC
1637	https://civic.genome.wustl.edu/links/variants/1637	EGFR	1956	E746_P753>VS										GRCh37							2017-11-22 19:46:04 UTC
1638	https://civic.genome.wustl.edu/links/variants/1638	EGFR	1956	K745_E749delKELRE										GRCh37							2017-11-22 19:46:03 UTC
1639	https://civic.genome.wustl.edu/links/variants/1639	ABL1	25	C475V										GRCh37							2017-11-22 19:46:04 UTC
1640	https://civic.genome.wustl.edu/links/variants/1640	ABL1	25	N336S										GRCh37							2017-11-22 19:46:04 UTC
1641	https://civic.genome.wustl.edu/links/variants/1641	ROS1	6098	D2033N										GRCh37							2017-11-22 19:46:04 UTC
1642	https://civic.genome.wustl.edu/links/variants/1642	POLD1	5424	Y956N										GRCh37							2017-11-22 19:46:04 UTC
1643	https://civic.genome.wustl.edu/links/variants/1643	SCN8A	6334	Q225X										GRCh37							2017-11-22 19:46:04 UTC
1644	https://civic.genome.wustl.edu/links/variants/1644	PXDNL	137902	P1460T										GRCh37							2017-11-22 19:46:04 UTC
1645	https://civic.genome.wustl.edu/links/variants/1645	PAPPA2	60676	Y1520X										GRCh37							2017-11-22 19:46:04 UTC
1646	https://civic.genome.wustl.edu/links/variants/1646	POLE4	56655	A59E										GRCh37							2017-11-22 19:46:04 UTC
1647	https://civic.genome.wustl.edu/links/variants/1647	POLD1	5424	C284Y										GRCh37							2017-11-22 19:46:04 UTC
1648	https://civic.genome.wustl.edu/links/variants/1648	POLD1	5424	E374K										GRCh37							2017-11-22 19:46:04 UTC
1649	https://civic.genome.wustl.edu/links/variants/1649	MET	4233	D1010Y										GRCh37							2017-11-22 19:46:04 UTC
1650	https://civic.genome.wustl.edu/links/variants/1650	BRAF	673	G596V										GRCh37					missense_variant		2017-11-22 19:46:04 UTC
1651	https://civic.genome.wustl.edu/links/variants/1651	MET	4233	D1010N										GRCh37							2017-11-22 19:46:04 UTC
1652	https://civic.genome.wustl.edu/links/variants/1652	PIK3R2	5296	N561D										GRCh37							2017-11-22 19:46:04 UTC
1653	https://civic.genome.wustl.edu/links/variants/1653	PIK3CA	5290	D350G			3	178921567	178921567	A	G	ENST00000263967.3	75	GRCh37					missense_variant	ENST00000263967.3:c.1049A>G	2017-11-22 19:46:05 UTC
1654	https://civic.genome.wustl.edu/links/variants/1654	NRAS	4893	Q179X										GRCh37							2017-11-22 19:46:04 UTC
1656	https://civic.genome.wustl.edu/links/variants/1656	ABL1	25	R351W								ENST00000372348.2	75	GRCh37						ENST00000372348.2:c.1051C>T	2017-11-22 19:46:03 UTC
1657	https://civic.genome.wustl.edu/links/variants/1657	ABL1	25	G340L; G321L										GRCh37							2017-11-22 19:46:04 UTC
1658	https://civic.genome.wustl.edu/links/variants/1658	BRAF	673	V600_K601DELINSD										GRCh37					inframe_deletion		2017-11-22 19:46:04 UTC
1659	https://civic.genome.wustl.edu/links/variants/1659	KIT	3815	S628N										GRCh37							2017-11-22 19:46:04 UTC
1660	https://civic.genome.wustl.edu/links/variants/1660	MET	4233	D1010H										GRCh37							2017-11-22 19:46:04 UTC
1661	https://civic.genome.wustl.edu/links/variants/1661	ALK	238	R1192P			2	29443642	29443642	C	G	ENST00000389048.3	75	GRCh37					missense_variant	NM_004304.4:c.3575G>C,NP_004295.2:p.Arg1192Pro,NC_000002.11:g.29443642C>G,ENST00000389048.3:c.3575G>C	2017-11-22 19:46:03 UTC
1662	https://civic.genome.wustl.edu/links/variants/1662	EGFR	1956	N771DELinsVH										GRCh37							2017-11-22 19:46:03 UTC
1663	https://civic.genome.wustl.edu/links/variants/1663	BRAF	673	DELNVTAP										GRCh37					inframe_deletion		2017-11-22 19:46:04 UTC
1664	https://civic.genome.wustl.edu/links/variants/1664	EGFR	1956	M766_A767insAI										GRCh37							2017-11-22 19:46:03 UTC
1665	https://civic.genome.wustl.edu/links/variants/1665	EGFR	1956	Y764_V765insHH										GRCh37							2017-11-22 19:46:03 UTC
1666	https://civic.genome.wustl.edu/links/variants/1666	EGFR	1956	D770_N771insGY										GRCh37					inframe_insertion		2017-11-22 19:46:03 UTC
1667	https://civic.genome.wustl.edu/links/variants/1667	EGFR	1956	P772_H773insYNP										GRCh37					inframe_insertion		2017-11-22 19:46:03 UTC
1668	https://civic.genome.wustl.edu/links/variants/1668	EGFR	1956	P772_V774insPHV										GRCh37					inframe_insertion		2017-11-22 19:46:03 UTC
1669	https://civic.genome.wustl.edu/links/variants/1669	LYN	4067	Y508F										GRCh37							2017-11-22 19:46:04 UTC
1670	https://civic.genome.wustl.edu/links/variants/1670	ROS1	6098	S1986Y										GRCh37							2017-11-22 19:46:04 UTC
1671	https://civic.genome.wustl.edu/links/variants/1671	ROS1	6098	S1986F										GRCh37							2017-11-22 19:46:04 UTC
1672	https://civic.genome.wustl.edu/links/variants/1672	EGFR	1956	Y69FS*11										GRCh37							2017-11-22 19:46:04 UTC
1673	https://civic.genome.wustl.edu/links/variants/1673	ERBB4	2066	G1109C			2	212251734	212251734	C	A	ENST00000342788.4	75	GRCh37					missense_variant	ENST00000342788.4:c.3325G>T	2017-11-22 19:46:03 UTC
1674	https://civic.genome.wustl.edu/links/variants/1674	ESR1	2099	E380Q										GRCh37							2017-11-22 19:46:04 UTC
1675	https://civic.genome.wustl.edu/links/variants/1675	ESR1	2099	L536R										GRCh37							2017-11-22 19:46:04 UTC
1676	https://civic.genome.wustl.edu/links/variants/1676	FBXW7	55294	S668FS*39										GRCh37							2017-11-22 19:46:04 UTC
1677	https://civic.genome.wustl.edu/links/variants/1677	FBXW7	55294	L403FS*34										GRCh37							2017-11-22 19:46:04 UTC
1678	https://civic.genome.wustl.edu/links/variants/1678	FBXW7	55294	G579W										GRCh37							2017-11-22 19:46:04 UTC
1679	https://civic.genome.wustl.edu/links/variants/1679	FBXW7	55294	R658Q										GRCh37							2017-11-22 19:46:04 UTC
1680	https://civic.genome.wustl.edu/links/variants/1680	RAF1	5894	R391W										GRCh37							2017-11-22 19:46:04 UTC
1681	https://civic.genome.wustl.edu/links/variants/1681	JAK2	3717	F547 SPLICE SITE MUTATION			9	5070054	5070054	T	G			GRCh37					splice_donor_variant		2017-11-22 19:46:03 UTC
1682	https://civic.genome.wustl.edu/links/variants/1682	ARID1A	8289	P1175FS*5										GRCh37							2017-11-22 19:46:04 UTC
1683	https://civic.genome.wustl.edu/links/variants/1683	ALK	238	R214H			2	30142885	30142885	C	T			GRCh37					missense_variant		2017-11-22 19:46:03 UTC
1684	https://civic.genome.wustl.edu/links/variants/1684	PSMD4	5710	AMPLIFICATION																	2017-11-22 19:45:47 UTC
1685	https://civic.genome.wustl.edu/links/variants/1685	CDK6	1021	AMPLIFICATION																	2017-11-22 19:45:47 UTC
1686	https://civic.genome.wustl.edu/links/variants/1686	ACVR1	90	G328V																	2017-11-22 19:45:47 UTC
1687	https://civic.genome.wustl.edu/links/variants/1687	RET	5979	FUSION																	2017-11-22 19:45:48 UTC
1688	https://civic.genome.wustl.edu/links/variants/1688	RET	5979	KIF5B-RET V804L																	2017-11-22 19:45:48 UTC
1689	https://civic.genome.wustl.edu/links/variants/1689	RET	5979	KIF5B-RET G810A																	2017-11-22 19:45:49 UTC
1690	https://civic.genome.wustl.edu/links/variants/1690	RET	5979	MUTATION																	2017-11-22 19:45:49 UTC
1691	https://civic.genome.wustl.edu/links/variants/1691	FGFR3	2261	FGFR3 Fusion																	2017-11-22 19:45:49 UTC
1692	https://civic.genome.wustl.edu/links/variants/1692	FGFR3	2261	G691R																	2017-11-22 19:45:50 UTC
1693	https://civic.genome.wustl.edu/links/variants/1693	CHEK1	1111	OVEREXPRESSION																	2017-11-22 19:45:50 UTC
1694	https://civic.genome.wustl.edu/links/variants/1694	VHL	7428	E12D (c.36G>C)																	2017-11-22 19:45:52 UTC
1695	https://civic.genome.wustl.edu/links/variants/1695	TP53	7157	R158H																	2017-11-22 19:45:52 UTC
1696	https://civic.genome.wustl.edu/links/variants/1696	TP53	7157	R249S																	2017-11-22 19:45:52 UTC
1697	https://civic.genome.wustl.edu/links/variants/1697	TP53	7157	R280K																	2017-11-22 19:45:53 UTC
1698	https://civic.genome.wustl.edu/links/variants/1698	TP53	7157	R280T																	2017-11-22 19:45:53 UTC
1699	https://civic.genome.wustl.edu/links/variants/1699	TP53	7157	R158L																	2017-11-22 19:45:52 UTC
1700	https://civic.genome.wustl.edu/links/variants/1700	RET	5979	C634R																	2017-11-22 19:45:52 UTC
1733	https://civic.genome.wustl.edu/links/variants/1733	VHL	7428	E46fs (c.136G>T)																	2017-11-22 19:46:01 UTC
1734	https://civic.genome.wustl.edu/links/variants/1734	VHL	7428	E52K (c.154G>A)																	2017-11-22 19:46:02 UTC
1735	https://civic.genome.wustl.edu/links/variants/1735	VHL	7428	E52fs* (c.156G>T)																	2017-11-22 19:46:02 UTC
1736	https://civic.genome.wustl.edu/links/variants/1736	VHL	7428	E55fs* (c.163G>T)																	2017-11-22 19:46:03 UTC
1737	https://civic.genome.wustl.edu/links/variants/1737	VHL	7428	G39AfsTer26 (c.327delC)																	2017-11-22 19:45:47 UTC
1738	https://civic.genome.wustl.edu/links/variants/1738	VHL	7428	L158P (c.473T>C)																	2017-11-22 19:45:49 UTC
1739	https://civic.genome.wustl.edu/links/variants/1739	VHL	7428	R167Q (c.500G>A)	R167Q is the most common point mutation in hereditary Von Hippel-Lindau (VHL) disease and disrupts the VHL genes binding to elongin C reducing the levels of the VHL-elongin B-elongin C (VBC) E3 ligase complex and inhibiting the ability of VHL to regulate HIF2. This partial function in turn leads to an increased risk of tumorgenesis. VHL derived clear cell renal cell carcinoma models however have shown the proteasome inhibitors bortezomib and carfilzomib can act to stabilize mutant VHL-R167Q leading to downregulation of HIF2 and suprressed tumorgenesis.		3	10191507	10191507	G	A	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.500G>A,NP_000542.1:p.Arg167Gln,NC_000003.11:g.10191507G>A,ENST00000256474.2:c.500G>A	2017-11-22 19:46:08 UTC
1740	https://civic.genome.wustl.edu/links/variants/1740	VHL	7428	S183C (c.548delC)																	2017-11-22 19:45:51 UTC
1741	https://civic.genome.wustl.edu/links/variants/1741	VHL	7428	Y98H (c.292T>C)																	2017-11-22 19:45:52 UTC
1742	https://civic.genome.wustl.edu/links/variants/1742	VHL	7428	H115Q (c.345C>A)																	2017-11-22 19:45:53 UTC
1743	https://civic.genome.wustl.edu/links/variants/1743	VHL	7428	F119L (c.357C>G)																	2017-11-22 19:45:50 UTC
1744	https://civic.genome.wustl.edu/links/variants/1744	VHL	7428	A149T (c.445G>A)			3	10188302	10188302	G	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.445G>A,NM_000551.3:c.445G>A	2017-11-22 19:46:08 UTC
1745	https://civic.genome.wustl.edu/links/variants/1745	VHL	7428	T157I (c.470C>T)			3	10191477	10191477	C	T	ENST00000	75	GRCh37					missense_variant	NM_000551.3:c.470C>T,NP_000542.1:p.Thr157Ile,NC_000003.11:g.10191477C>T,ENST00000256474.2:c.470C>T	2017-11-22 19:45:52 UTC
1746	https://civic.genome.wustl.edu/links/variants/1746	VHL	7428	R161Q (c.482G>A)																	2017-11-22 19:45:50 UTC
1747	https://civic.genome.wustl.edu/links/variants/1747	VHL	7428	R167W (c.499C>T)			3	10191506	10191506	C	T	ENST00000	75	GRCh37					missense_variant	NM_000551.3:c.499C>T,NP_000542.1:p.Arg167Trp,NC_000003.11:g.10191506C>T,ENST00000256474.2:c.499C>T	2017-11-22 19:45:51 UTC
1748	https://civic.genome.wustl.edu/links/variants/1748	VHL	7428	L178P (c.533T>C)			3	10191540	10191540	T	C	ENST0	75	GRCh37					missense_variant	ENST00000256474.2:c.533T>C	2017-11-22 19:45:52 UTC
1749	https://civic.genome.wustl.edu/links/variants/1749	VHL	7428	F76I (c.226T>A)			3	10183757	10183757	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.226T>A	2017-11-22 19:45:50 UTC
1750	https://civic.genome.wustl.edu/links/variants/1750	VHL	7428	V62C (c.180delG)			3	10183711	10183711	G		ENST	75	GRCh37					inframe_deletion	NM_000551.3:c.180delG,NP_000542.1:p.Val62Cysfs,NC_000003.11:g.10183711delG,ENST00000256474.2:c.180delG	2017-11-22 19:46:08 UTC
1751	https://civic.genome.wustl.edu/links/variants/1751	VHL	7428	S65W (c.194C>G)			3	10183725	10183725	C	G	ENST00000	75	GRCh37					missense_variant	ENST00000256474.2:c.194C>G	2017-11-22 19:46:08 UTC
1752	https://civic.genome.wustl.edu/links/variants/1752	VHL	7428	Q73* (c.217C>T)			3	10183748	10183748	C	T	ENST00000	75	GRCh37					stop_gained	NM_000551.3:c.217C>T,NP_000542.1:p.Gln73Ter,NC_000003.11:g.10183748C>T,ENST00000256474.2:c.217C>T	2017-11-22 19:46:08 UTC
1753	https://civic.genome.wustl.edu/links/variants/1753	VHL	7428	F76fs (c.226_228delTTC)																	2017-11-22 19:45:54 UTC
1754	https://civic.genome.wustl.edu/links/variants/1754	VHL	7428	N78H (c.232A>C)			3	10183763	10183763	A	C	ENST0000	75	GRCh37					missense_variant	ENST00000256474.2:c.232A>C	2017-11-22 19:45:55 UTC
1755	https://civic.genome.wustl.edu/links/variants/1755	VHL	7428	N78S (c.233A>G)			3	10183764	10183764	A	G	ENST	75	GRCh37					missense_variant	NM_000551.3:c.233A>G,NP_000542.1:p.Asn78Ser,NC_000003.11:g.10183764A>G,ENST00000256474.2:c.233A>G	2017-11-22 19:46:00 UTC
1756	https://civic.genome.wustl.edu/links/variants/1756	VHL	7428	N78T (c.233A>C)			3	10183764	10183764	A	C	ENST000	75	GRCh37					missense_variant	NM_000551.3:c.233A>C,NP_000542.1:p.Asn78Thr,NC_000003.11:g.10183764A>C,ENST00000256474.2:c.233A>C	2017-11-22 19:46:08 UTC
1757	https://civic.genome.wustl.edu/links/variants/1757	VHL	7428	S80I (c.239G>T)			3	10183770	10183770	G	T	ENST00000	75	GRCh37					missense_variant	ENST00000256474.2:c.239G>T	2017-11-22 19:46:00 UTC
1758	https://civic.genome.wustl.edu/links/variants/1758	VHL	7428	N131* (c.255insC)																	2017-11-22 19:45:55 UTC
1759	https://civic.genome.wustl.edu/links/variants/1759	VHL	7428	P86A (c.256C>G)			3	10183787	10183787	C	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.256C>G,NP_000542.1:p.Pro86Ala,NC_000003.11:g.10183787C>G,ENST00000256474.2:c.256C>G	2017-11-22 19:46:02 UTC
1760	https://civic.genome.wustl.edu/links/variants/1760	VHL	7428	P86L (c.257C>T)			3	10183788	10183788	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.257C>T,NP_000542.1:p.Pro86Leu,NC_000003.11:g.10183788C>T,ENST00000256474.2:c.257C>T	2017-11-22 19:46:08 UTC
1761	https://civic.genome.wustl.edu/links/variants/1761	VHL	7428	W88R (c.262T>A)			3	10183793	10183793	T	A	ENST00000	75	GRCh37					missense_variant	ENST00000256474.2:c.262T>A	2017-11-22 19:45:47 UTC
1762	https://civic.genome.wustl.edu/links/variants/1762	VHL	7428	L158* (c.331delA)																	2017-11-22 19:45:49 UTC
1763	https://civic.genome.wustl.edu/links/variants/1763	VHL	7428	S111N (c.332G>A)																	2017-11-22 19:45:50 UTC
1764	https://civic.genome.wustl.edu/links/variants/1764	VHL	7428	S111R (c.333C>G)																	2017-11-22 19:45:51 UTC
1765	https://civic.genome.wustl.edu/links/variants/1765	EGFR	1956	Gain-of-function																	2017-11-22 19:45:52 UTC
1766	https://civic.genome.wustl.edu/links/variants/1766	VHL	7428	Y112* (c.336C>A)																	2017-11-22 19:45:53 UTC
1767	https://civic.genome.wustl.edu/links/variants/1767	VHL	7428	W117C (c.351G>T)																	2017-11-22 19:45:55 UTC
1768	https://civic.genome.wustl.edu/links/variants/1768	VHL	7428	L129Q (c.386insAGA)																	2017-11-22 19:46:00 UTC
1769	https://civic.genome.wustl.edu/links/variants/1769	VHL	7428	L135* (c.404T>A)			3	10188261	10188261	T	A	ENST	75	GRCh37					stop_gained	ENST00000256474.2:c.404T>A	2017-11-22 19:46:02 UTC
1770	https://civic.genome.wustl.edu/links/variants/1770	VHL	7428	N150I (c.448delA)																	2017-11-22 19:46:02 UTC
1771	https://civic.genome.wustl.edu/links/variants/1771	VHL	7428	V155C (c.462delA)																	2017-11-22 19:46:03 UTC
1772	https://civic.genome.wustl.edu/links/variants/1772	VHL	7428	C162R (c.484T>C)			3	10191491	10191491	T	C	ENST00000	75	GRCh37					missense_variant	ENST00000256474.2:c.484T>C	2017-11-22 19:45:47 UTC
1773	https://civic.genome.wustl.edu/links/variants/1773	VHL	7428	C162F (c.485G>T)			3	10191492	10191492	G	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.485G>T,NP_000542.1:p.Cys162Phe,NC_000003.11:g.10191492G>T,ENST00000256474.2:c.485G>T	2017-11-22 19:46:06 UTC
1774	https://civic.genome.wustl.edu/links/variants/1774	VHL	7428	C162W (c.486C>G)			3	10191493	10191493	C	G	ENST0	75	GRCh37					missense_variant	NM_000551.3:c.486C>G,NP_000542.1:p.Cys162Trp,NC_000003.11:g.10191493C>G,ENST00000256474.2:c.486C>G	2017-11-22 19:46:08 UTC
1775	https://civic.genome.wustl.edu/links/variants/1775	VHL	7428	V166D (c.497T>A)																	2017-11-22 19:45:50 UTC
1776	https://civic.genome.wustl.edu/links/variants/1776	VHL	7428	L184P (c.551T>C)																	2017-11-22 19:45:51 UTC
1777	https://civic.genome.wustl.edu/links/variants/1777	VHL	7428	E186* (c.556G>T)																	2017-11-22 19:45:52 UTC
1778	https://civic.genome.wustl.edu/links/variants/1778	VHL	7428	E186K (c.556G>A)																	2017-11-22 19:45:53 UTC
1779	https://civic.genome.wustl.edu/links/variants/1779	VHL	7428	R167fs (c.502insTTGTTCGT)																	2017-11-22 19:46:01 UTC
1780	https://civic.genome.wustl.edu/links/variants/1780	VHL	7428	Y175fs (c.526delA)			3	10191533	10191533	A		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.526delA	2017-11-22 19:46:02 UTC
1781	https://civic.genome.wustl.edu/links/variants/1781	VHL	7428	Q145H (c.435_436delGC)																	2017-11-22 19:46:02 UTC
1782	https://civic.genome.wustl.edu/links/variants/1782	VHL	7428	P154L (c.461C>T)			3	10188318	10188318	C	T	ENST00000	75	GRCh37					missense_variant	ENST00000256474.2:c.461C>T	2017-11-22 19:46:02 UTC
1783	https://civic.genome.wustl.edu/links/variants/1783	VHL	7428	T157fs (c.472insT)																	2017-11-22 19:46:02 UTC
1784	https://civic.genome.wustl.edu/links/variants/1784	VHL	7428	S183* (c.548C>A)																	2017-11-22 19:45:47 UTC
1785	https://civic.genome.wustl.edu/links/variants/1785	VHL	7428	A56D (c.167insA)																	2017-11-22 19:46:02 UTC
1786	https://civic.genome.wustl.edu/links/variants/1786	VHL	7428	P59R (c.175delC)			3	10183706	10183706	C		ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.175delC	2017-11-22 19:46:03 UTC
1787	https://civic.genome.wustl.edu/links/variants/1787	VHL	7428	S65W (c.194C>G)			3	10183725	10183725	C	G	ENST00000	75	GRCh37					missense_variant	ENST00000256474.2:c.194C>G,NM_000551.3:c.194C>G,NP_000542.1:p.Ser65Trp,NC_000003.11:g.10183725C>G	2017-11-22 19:46:03 UTC
1788	https://civic.genome.wustl.edu/links/variants/1788	VHL	7428	S65L (c.194C>T)			3	10183725	10183725	C	T	ENST00000	75	GRCh37					missense_variant	NM_000551.3:c.194C>T,NP_000542.1:p.Ser65Leu,NC_000003.11:g.10183725C>T,ENST00000256474.2:c.194C>T	2017-11-22 19:46:03 UTC
1789	https://civic.genome.wustl.edu/links/variants/1789	VHL	7428	V66* (c.196delG)																	2017-11-22 19:45:47 UTC
1790	https://civic.genome.wustl.edu/links/variants/1790	VHL	7428	C77L (c.228insC)																	2017-11-22 19:45:52 UTC
1791	https://civic.genome.wustl.edu/links/variants/1791	VHL	7428	R79P (c.236G>C)																	2017-11-22 19:45:53 UTC
1792	https://civic.genome.wustl.edu/links/variants/1792	VHL	7428	S80R (c.240T>G)																	2017-11-22 19:46:01 UTC
1793	https://civic.genome.wustl.edu/links/variants/1793	VHL	7428	L89P (c.266T>C)			3	10183797	10183797	T	C	ENST0000	75	GRCh37					missense_variant	NM_000551.3:c.266T>C,NP_000542.1:p.Leu89Pro,NC_000003.11:g.10183797T>C,ENST00000256474.2:c.266T>C	2017-11-22 19:46:02 UTC
1794	https://civic.genome.wustl.edu/links/variants/1794	VHL	7428	E94* (c.280G>T)			3	10183811	10183811	G	T	ENST	75	GRCh37					stop_gained	ENST00000256474.2:c.280G>T	2017-11-22 19:45:53 UTC
1795	https://civic.genome.wustl.edu/links/variants/1795	VHL	7428	G104H (c.309_310delTG)			3	10183840	10183841	TG		ENST00000256474.2	75	GRCh37					inframe_deletion	ENST00000256474.2:c.309_310delTG	2017-11-22 19:46:02 UTC
1796	https://civic.genome.wustl.edu/links/variants/1796	VHL	7428	R113* (c.337C>T)																	2017-11-22 19:46:01 UTC
1797	https://civic.genome.wustl.edu/links/variants/1797	VHL	7428	G114C (c.340G>T)			3	10183871	10183871	G	T	ENST	75	GRCh37					missense_variant	ENST00000256474.2:c.340G>T	2017-11-22 19:46:02 UTC
1798	https://civic.genome.wustl.edu/links/variants/1798	VHL	7428	L118P (c.353T>C)			3	10188210	10188210	T	C	ENST00	75	GRCh37					missense_variant	ENST00000256474.2:c.353T>C	2017-11-22 19:46:02 UTC
1799	https://civic.genome.wustl.edu/links/variants/1799	VHL	7428	D126R (c.375insC)																	2017-11-22 19:46:01 UTC
1800	https://civic.genome.wustl.edu/links/variants/1800	VHL	7428	N131P (c.390_391delTA)			3	10188247	10188248	TA		ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.390_391delTA	2017-11-22 19:46:08 UTC
1801	https://civic.genome.wustl.edu/links/variants/1801	VHL	7428	F136S (c.407T>C)																	2017-11-22 19:46:04 UTC
1802	https://civic.genome.wustl.edu/links/variants/1802	VHL	7428	L153C (c.457delC)																	2017-11-22 19:46:04 UTC
1803	https://civic.genome.wustl.edu/links/variants/1803	VHL	7428	L158V (c.472C>G)			3	10191479	10191479	C	G	ENST0	75	GRCh37					missense_variant	ENST00000256474.2:c.472C>G	2017-11-22 19:46:05 UTC
1804	https://civic.genome.wustl.edu/links/variants/1804	VHL	7428	R161* (c.481C>T)																	2017-11-22 19:46:04 UTC
1805	https://civic.genome.wustl.edu/links/variants/1805	VHL	7428	R167G (c.499C>G)																	2017-11-22 19:46:04 UTC
1806	https://civic.genome.wustl.edu/links/variants/1806	VHL	7428	V170F (c.508G>T)																	2017-11-22 19:46:04 UTC
1807	https://civic.genome.wustl.edu/links/variants/1807	VHL	7428	I180V (c.538A>G)																	2017-11-22 19:46:04 UTC
1808	https://civic.genome.wustl.edu/links/variants/1808	VHL	7428	L184R (c.551T>G)																	2017-11-22 19:46:04 UTC
1809	https://civic.genome.wustl.edu/links/variants/1809	VHL	7428	Y185* (c.555C>G)																	2017-11-22 19:46:04 UTC
1810	https://civic.genome.wustl.edu/links/variants/1810	VHL	7428	Q195* (c.583C>T)			3	10191590	10191590	C	T	ENST	75	GRCh37					stop_gained	NM_000551.3:c.583C>T,NP_000542.1:p.Gln195Ter,NC_000003.11:g.10191590C>T,ENST00000256474.2:c.583C>T	2017-11-22 19:46:05 UTC
1811	https://civic.genome.wustl.edu/links/variants/1811	VHL	7428	S65* (c.194C>A)																	2017-11-22 19:46:04 UTC
1812	https://civic.genome.wustl.edu/links/variants/1812	VHL	7428	G93A (c.277delG)																	2017-11-22 19:46:04 UTC
1813	https://civic.genome.wustl.edu/links/variants/1813	VHL	7428	D121G (c.362A>G)																	2017-11-22 19:46:04 UTC
1814	https://civic.genome.wustl.edu/links/variants/1814	VHL	7428	F136C (c.407T>G)																	2017-11-22 19:46:04 UTC
1815	https://civic.genome.wustl.edu/links/variants/1815	VHL	7428	V84L (c.250G>T)																	2017-11-22 19:46:04 UTC
1816	https://civic.genome.wustl.edu/links/variants/1816	VHL	7428	S72P (c.214delT)			3	10183745	10183745	T		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.214delT	2017-11-22 19:46:08 UTC
1817	https://civic.genome.wustl.edu/links/variants/1817	VHL	7428	Q73* (c.214insGCCC)																	2017-11-22 19:46:04 UTC
1818	https://civic.genome.wustl.edu/links/variants/1818	VHL	7428	Q96P (c.287A>C)																	2017-11-22 19:46:04 UTC
1820	https://civic.genome.wustl.edu/links/variants/1820	VHL	7428	L116V (c.346C>G)			3	10188203	10188203	C	G	ENST0	75	GRCh37					missense_variant	ENST00000256474.2:c.346C>G	2017-11-22 19:46:05 UTC
1821	https://civic.genome.wustl.edu/links/variants/1821	VHL	7428	W117* (c.351G>A)																	2017-11-22 19:46:04 UTC
1822	https://civic.genome.wustl.edu/links/variants/1822	VHL	7428	L118R (c.353T>G)																	2017-11-22 19:46:04 UTC
1823	https://civic.genome.wustl.edu/links/variants/1823	VHL	7428	N141fs (c.421delA)			3	10188278	10188278	A		ENST00000256474.2	75	GRCh37					minus_1_frameshift	ENST00000256474.2:c.421delA	2017-11-22 19:46:09 UTC
1824	https://civic.genome.wustl.edu/links/variants/1824	VHL	7428	C162Y (c.485G>A)																	2017-11-22 19:46:04 UTC
1825	https://civic.genome.wustl.edu/links/variants/1825	VHL	7428	V166F (c.496G>T)																	2017-11-22 19:46:04 UTC
1826	https://civic.genome.wustl.edu/links/variants/1826	VHL	7428	V170D (c.509T>A)																	2017-11-22 19:46:04 UTC
1827	https://civic.genome.wustl.edu/links/variants/1827	VHL	7428	R177* (c.529A>T)																	2017-11-22 19:46:04 UTC
1828	https://civic.genome.wustl.edu/links/variants/1828	VHL	7428	L188R (c.563delT)																	2017-11-22 19:46:04 UTC
1829	https://civic.genome.wustl.edu/links/variants/1829	VHL	7428	E186del (c.558_560delAGA)																	2017-11-22 19:46:04 UTC
1830	https://civic.genome.wustl.edu/links/variants/1830	POLE	5426	P286R																	2017-11-22 19:46:04 UTC
1831	https://civic.genome.wustl.edu/links/variants/1831	POLE	5426	V411L																	2017-11-22 19:46:04 UTC
1832	https://civic.genome.wustl.edu/links/variants/1832	POLE	5426	S459F																	2017-11-22 19:46:04 UTC
1833	https://civic.genome.wustl.edu/links/variants/1833	VHL	7428	V166F (c.498C>G)																	2017-11-22 19:46:04 UTC
1834	https://civic.genome.wustl.edu/links/variants/1834	VHL	7428	E70* (c.208G>T)			3	10183739	10183739	G	T	ENST	75	GRCh37					stop_gained	NM_000551.3:c.208G>T,NP_000542.1:p.Glu70Ter,NC_000003.11:g.10183739G>T,ENST00000256474.2:c.208G>T	2017-11-22 19:46:08 UTC
1835	https://civic.genome.wustl.edu/links/variants/1835	VHL	7428	F76S (c.227T>C)																	2017-11-22 19:46:04 UTC
1836	https://civic.genome.wustl.edu/links/variants/1836	VHL	7428	L188V (c.562C>G)																	2017-11-22 19:46:04 UTC
1837	https://civic.genome.wustl.edu/links/variants/1837	VHL	7428	P81S (c.241C>T)																	2017-11-22 19:46:04 UTC
1838	https://civic.genome.wustl.edu/links/variants/1838	VHL	7428	L101G (c.301C>G)																	2017-11-22 19:46:04 UTC
1839	https://civic.genome.wustl.edu/links/variants/1839	VHL	7428	T105P (c.313A>C)																	2017-11-22 19:46:04 UTC
1840	https://civic.genome.wustl.edu/links/variants/1840	VHL	7428	R107P (c.320G>C)																	2017-11-22 19:46:04 UTC
1841	https://civic.genome.wustl.edu/links/variants/1841	VHL	7428	L118T (c.352insA)																	2017-11-22 19:46:04 UTC
1842	https://civic.genome.wustl.edu/links/variants/1842	VHL	7428	N167T (c.392A>C)																	2017-11-22 19:46:04 UTC
1843	https://civic.genome.wustl.edu/links/variants/1843	VHL	7428	L132fs (c.395delA)																	2017-11-22 19:46:04 UTC
1844	https://civic.genome.wustl.edu/links/variants/1844	VHL	7428	D143T (c.430delG)																	2017-11-22 19:46:04 UTC
1845	https://civic.genome.wustl.edu/links/variants/1845	VHL	7428	Q164* (c.490C>T)			3	10191497	10191497	C	T	ENST	75	GRCh37					stop_gained	NM_000551.3:c.490C>T,NP_000542.1:p.Gln164Ter,NC_000003.11:g.10191497C>T,ENST00000256474.2:c.490C>T	2017-11-22 19:46:05 UTC
1846	https://civic.genome.wustl.edu/links/variants/1846	VHL	7428	Y175D (c.523T>G)			3	10191530	10191530	T	G	ENST	75	GRCh37					missense_variant	ENST00000256474.2:c.523T>G	2017-11-22 19:46:05 UTC
1847	https://civic.genome.wustl.edu/links/variants/1847	VHL	7428	V181G (c.540_543delCGTC)																	2017-11-22 19:46:04 UTC
1848	https://civic.genome.wustl.edu/links/variants/1848	VHL	7428	Q96* (c.286C>T)																	2017-11-22 19:46:04 UTC
1849	https://civic.genome.wustl.edu/links/variants/1849	VHL	7428	P86R (c.257C>G)			3	10183788	10183788	C	G	ENST	75	GRCh37					missense_variant	NM_000551.3:c.257C>G,NP_000542.1:p.Pro86Arg,NC_000003.11:g.10183788C>G,ENST00000256474.2:c.257C>G	2017-11-22 19:46:05 UTC
1850	https://civic.genome.wustl.edu/links/variants/1850	VHL	7428	G144* (c.430G>T)																	2017-11-22 19:46:04 UTC
1851	https://civic.genome.wustl.edu/links/variants/1851	VHL	7428	L128F (c.381-382GC>TT)																	2017-11-22 19:46:04 UTC
1852	https://civic.genome.wustl.edu/links/variants/1852	VHL	7428	L188P (c.563T>C)																	2017-11-22 19:46:04 UTC
1853	https://civic.genome.wustl.edu/links/variants/1853	VHL	7428	S111C (c.330CA>TT)																	2017-11-22 19:46:04 UTC
1854	https://civic.genome.wustl.edu/links/variants/1854	EGFR	1956	Ex19 del L858R															missense_variant,inframe_deletion		2017-11-22 19:46:04 UTC
1855	https://civic.genome.wustl.edu/links/variants/1855	VHL	7428	R161P (c.482G>C)																	2017-11-22 19:46:04 UTC
1856	https://civic.genome.wustl.edu/links/variants/1856	VHL	7428	Q164R (c.491A>G)																	2017-11-22 19:46:04 UTC
1857	https://civic.genome.wustl.edu/links/variants/1857	VHL	7428	G114R (c.340G>C)																	2017-11-22 19:46:04 UTC
1858	https://civic.genome.wustl.edu/links/variants/1858	VHL	7428	G93D (c.278G>A)																	2017-11-22 19:46:04 UTC
1859	https://civic.genome.wustl.edu/links/variants/1859	VHL	7428	G93S (c.277G>A)																	2017-11-22 19:46:04 UTC
1860	https://civic.genome.wustl.edu/links/variants/1860	VHL	7428	L101R (c.302T>G)																	2017-11-22 19:46:04 UTC
1861	https://civic.genome.wustl.edu/links/variants/1861	VHL	7428	L188Q (c.563T>A)																	2017-11-22 19:46:04 UTC
1862	https://civic.genome.wustl.edu/links/variants/1862	VHL	7428	K159E (c.475A>G)																	2017-11-22 19:46:04 UTC
1863	https://civic.genome.wustl.edu/links/variants/1863	EGFR	1956	RARE EX 18-21 MUT															exon_variant		2017-11-22 19:46:04 UTC
1864	https://civic.genome.wustl.edu/links/variants/1864	VHL	7428	P192Q (c.573delC)																	2017-11-22 19:46:04 UTC
1865	https://civic.genome.wustl.edu/links/variants/1865	VHL	7428	Y112H (c.334T>C)																	2017-11-22 19:46:04 UTC
1866	https://civic.genome.wustl.edu/links/variants/1866	EGFR	1956	L861																	2017-11-22 19:46:04 UTC
1867	https://civic.genome.wustl.edu/links/variants/1867	VHL	7428	R64P (c.191G>C)																	2017-11-22 19:46:05 UTC
1868	https://civic.genome.wustl.edu/links/variants/1868	VHL	7428	N131fs (c.393CC>A)																	2017-11-22 19:46:05 UTC
1869	https://civic.genome.wustl.edu/links/variants/1869	VHL	7428	E189L (c.565delG)																	2017-11-22 19:46:05 UTC
1870	https://civic.genome.wustl.edu/links/variants/1870	VHL	7428	G114C (c.340+1G>A)																	2017-11-22 19:46:05 UTC
1871	https://civic.genome.wustl.edu/links/variants/1871	VHL	7428	I151T (c.452T>C)			3	10188309	10188309	T	C	ENST	75	GRCh37					missense_variant	NM_000551.3:c.452T>C,NP_000542.1:p.Ile151Thr,NC_000003.11:g.10188309T>C,ENST00000256474.2:c.452T>C	2017-11-22 19:46:05 UTC
1872	https://civic.genome.wustl.edu/links/variants/1872	VHL	7428	L158fs (c.473insT)																	2017-11-22 19:46:05 UTC
1873	https://civic.genome.wustl.edu/links/variants/1873	VHL	7428	S68P (c.202T>C)																	2017-11-22 19:46:05 UTC
1874	https://civic.genome.wustl.edu/links/variants/1874	VHL	7428	S80N (c.239G>A)																	2017-11-22 19:46:05 UTC
1875	https://civic.genome.wustl.edu/links/variants/1875	VHL	7428	V130F (c.388G>T)																	2017-11-22 19:46:05 UTC
1876	https://civic.genome.wustl.edu/links/variants/1876	CIC	23152	LOSS																	2017-11-22 19:46:05 UTC
1877	https://civic.genome.wustl.edu/links/variants/1877	ETV1	2115	OVEREXPRESSION																	2017-11-22 19:46:05 UTC
1878	https://civic.genome.wustl.edu/links/variants/1878	ETV5	2119	OVEREXPRESSION																	2017-11-22 19:46:05 UTC
1879	https://civic.genome.wustl.edu/links/variants/1879	ATXN1L	342371	LOSS																	2017-11-22 19:46:05 UTC
1880	https://civic.genome.wustl.edu/links/variants/1880	ATM	472	LOSS																	2017-11-22 19:46:05 UTC
1881	https://civic.genome.wustl.edu/links/variants/1881	ATM	472	F858L																	2017-11-22 19:46:05 UTC
1882	https://civic.genome.wustl.edu/links/variants/1882	VHL	7428	Q132P (c.395A>C)			3	10188252	10188252	A	C	ENST00000256474.2	75	GRCh37							2017-11-22 19:46:09 UTC
1883	https://civic.genome.wustl.edu/links/variants/1883	VHL	7428	Q145* (c.433C>T)			3	10188290	10188290	C	T	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.433C>T	2017-11-22 19:46:05 UTC
1884	https://civic.genome.wustl.edu/links/variants/1884	VHL	7428	E134* (c.400G>T)			3	10188257	10188257	G	T	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.400G>T	2017-11-22 19:46:05 UTC
1885	https://civic.genome.wustl.edu/links/variants/1885	VHL	7428	H115P (c.344A>C)			3	10188201	10188201	A	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.344A>C	2017-11-22 19:46:05 UTC
1886	https://civic.genome.wustl.edu/links/variants/1886	VHL	7428	L128R (c.383T>G)			3	10188240	10188240	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.383T>G	2017-11-22 19:46:05 UTC
1887	https://civic.genome.wustl.edu/links/variants/1887	VHL	7428	L169P (c.506T>C)																	2017-11-22 19:46:05 UTC
1888	https://civic.genome.wustl.edu/links/variants/1888	VHL	7428	L178R (c.533T>G)																	2017-11-22 19:46:05 UTC
1889	https://civic.genome.wustl.edu/links/variants/1889	VHL	7428	M54* (c.162insT)																	2017-11-22 19:46:05 UTC
1891	https://civic.genome.wustl.edu/links/variants/1891	EGFR	1956	L747P																	2017-11-22 19:46:05 UTC
1892	https://civic.genome.wustl.edu/links/variants/1892	EGFR	1956	V774A																	2017-11-22 19:46:05 UTC
1893	https://civic.genome.wustl.edu/links/variants/1893	VHL	7428	F91* (c.272T>A)																	2017-11-22 19:46:05 UTC
1894	https://civic.genome.wustl.edu/links/variants/1894	EGFR	1956	V774M																	2017-11-22 19:46:05 UTC
1895	https://civic.genome.wustl.edu/links/variants/1895	EGFR	1956	K806E			7	55249118	55249118	A	G	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2416A>G	2017-11-22 19:46:08 UTC
1896	https://civic.genome.wustl.edu/links/variants/1896	EGFR	1956	N826Y																	2017-11-22 19:46:05 UTC
1897	https://civic.genome.wustl.edu/links/variants/1897	EGFR	1956	V834I																	2017-11-22 19:46:05 UTC
1899	https://civic.genome.wustl.edu/links/variants/1899	EGFR	1956	N842S																	2017-11-22 19:46:05 UTC
1902	https://civic.genome.wustl.edu/links/variants/1902	VHL	7428	P86S (c.256C>T)			3	10183787	10183787	C	T	ENST	75	GRCh37					missense_variant	NM_000551.3:c.256C>T,NP_000542.1:p.Pro86Ser,NC_000003.11:g.10183787C>T,ENST00000256474.2:c.256C>T	2017-11-22 19:46:06 UTC
1903	https://civic.genome.wustl.edu/links/variants/1903	VHL	7428	S65P (c.193T>C)			3	10183724	10183724	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.193T>C	2017-11-22 19:46:06 UTC
1904	https://civic.genome.wustl.edu/links/variants/1904	VHL	7428	S72P (c.214T>C)			3	10183745	10183745	T	C	ENST	75	GRCh37					missense_variant	NM_000551.3:c.214T>C,NP_000542.1:p.Ser72Pro,NC_000003.11:g.10183745T>C,ENST00000256474.2:c.214T>C	2017-11-22 19:46:06 UTC
1905	https://civic.genome.wustl.edu/links/variants/1905	VHL	7428	G123fs (c.367delG)			3	10188224	10188224	G		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.367delG	2017-11-22 19:46:06 UTC
1906	https://civic.genome.wustl.edu/links/variants/1906	VHL	7428	L135fs (c.404delT)			3	10188261	10188261	T		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.404delT	2017-11-22 19:46:06 UTC
1907	https://civic.genome.wustl.edu/links/variants/1907	VHL	7428	R176fs (c.528delG)																	2017-11-22 19:46:05 UTC
1908	https://civic.genome.wustl.edu/links/variants/1908	VHL	7428	W88* (c.264G>A)			3	10183795	10183795	G	A	ENST	75	GRCh37					stop_gained	ENST00000256474.2:c.264G>A	2017-11-22 19:46:08 UTC
1909	https://civic.genome.wustl.edu/links/variants/1909	VHL	7428	V155E (c.464T>A)			3	10191471	10191471	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.464T>A	2017-11-22 19:46:09 UTC
1910	https://civic.genome.wustl.edu/links/variants/1910	VHL	7428	V170G (c.509T>C)																	2017-11-22 19:46:05 UTC
1911	https://civic.genome.wustl.edu/links/variants/1911	VHL	7428	R58fs (c.173_174_insC)																	2017-11-22 19:46:05 UTC
1912	https://civic.genome.wustl.edu/links/variants/1912	VHL	7428	V74fs (c.223_224insT)																	2017-11-22 19:46:05 UTC
1913	https://civic.genome.wustl.edu/links/variants/1913	VHL	7428	K196* (c.586A>T)			3	10191593	10191593	A	T	ENST	75	GRCh37					stop_gained	NM_000551.3:c.586A>T,NP_000542.1:p.Lys196Ter,NC_000003.11:g.10191593A>T,ENST00000256474.2:c.586A>T	2017-11-22 19:46:06 UTC
1914	https://civic.genome.wustl.edu/links/variants/1914	VHL	7428	R120G (c.358A>G)																	2017-11-22 19:46:05 UTC
1915	https://civic.genome.wustl.edu/links/variants/1915	VHL	7428	R161G (c.481C>G)																	2017-11-22 19:46:05 UTC
1916	https://civic.genome.wustl.edu/links/variants/1916	VHL	7428	R167L (c.500G>T)																	2017-11-22 19:46:05 UTC
1917	https://civic.genome.wustl.edu/links/variants/1917	VHL	7428	N141fs (c.422_440del19)																	2017-11-22 19:46:05 UTC
1918	https://civic.genome.wustl.edu/links/variants/1918	VHL	7428	D126fs (c.375_376insC)																	2017-11-22 19:46:05 UTC
1919	https://civic.genome.wustl.edu/links/variants/1919	VHL	7428	E160fs (c.479_480delAG)			3	10191486	10191487	AG		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.479_480delAG	2017-11-22 19:46:06 UTC
1920	https://civic.genome.wustl.edu/links/variants/1920	VHL	7428	G93R (c.277G>C)																	2017-11-22 19:46:05 UTC
1921	https://civic.genome.wustl.edu/links/variants/1921	VHL	7428	H115Y (c.343C>T)																	2017-11-22 19:46:05 UTC
1922	https://civic.genome.wustl.edu/links/variants/1922	VHL	7428	I109fs (c.326delT)																	2017-11-22 19:46:05 UTC
1923	https://civic.genome.wustl.edu/links/variants/1923	VHL	7428	L153P (c.458T>C)																	2017-11-22 19:46:05 UTC
1924	https://civic.genome.wustl.edu/links/variants/1924	VHL	7428	L188R (c.563T>G)																	2017-11-22 19:46:05 UTC
1925	https://civic.genome.wustl.edu/links/variants/1925	VHL	7428	L85fs (c.253_254ins38)																	2017-11-22 19:46:05 UTC
1926	https://civic.genome.wustl.edu/links/variants/1926	VHL	7428	F76del (c.227_229delTCT)			3	10183758	10183760	TCT		ENST00000256474.2	75	GRCh37					inframe_deletion	NM_000551.3:c.227_229delTCT,NP_000542.1:p.Phe76del,NC_000003.11:g.10183758_10183760delTCT,ENST00000256474.2:c.227_229delTCT	2017-11-22 19:46:06 UTC
1927	https://civic.genome.wustl.edu/links/variants/1927	VHL	7428	P103A (c.307C>G)																	2017-11-22 19:46:05 UTC
1928	https://civic.genome.wustl.edu/links/variants/1928	VHL	7428	P138T (c.412C>A)																	2017-11-22 19:46:05 UTC
1929	https://civic.genome.wustl.edu/links/variants/1929	VHL	7428	P59fs (c.176delC)																	2017-11-22 19:46:05 UTC
1930	https://civic.genome.wustl.edu/links/variants/1930	VHL	7428	P59S (c.175C>T)																	2017-11-22 19:46:05 UTC
1931	https://civic.genome.wustl.edu/links/variants/1931	VHL	7428	P61P (c.183C>G)																	2017-11-22 19:46:05 UTC
1932	https://civic.genome.wustl.edu/links/variants/1932	VHL	7428	Y175* (c.525C>A)																	2017-11-22 19:46:05 UTC
1933	https://civic.genome.wustl.edu/links/variants/1933	VHL	7428	Y98C  (c.293A>G)																	2017-11-22 19:46:05 UTC
1934	https://civic.genome.wustl.edu/links/variants/1934	VHL	7428	V155G (c.464T>G)																	2017-11-22 19:46:05 UTC
1935	https://civic.genome.wustl.edu/links/variants/1935	VHL	7428	V170G (c.509T>G)																	2017-11-22 19:46:05 UTC
1936	https://civic.genome.wustl.edu/links/variants/1936	VHL	7428	V66G (c.197T>G)																	2017-11-22 19:46:05 UTC
1937	https://civic.genome.wustl.edu/links/variants/1937	VHL	7428	V84L (c.250G>C)																	2017-11-22 19:46:05 UTC
1938	https://civic.genome.wustl.edu/links/variants/1938	VHL	7428	EXON 2 DELETION																	2017-11-22 19:46:05 UTC
1939	https://civic.genome.wustl.edu/links/variants/1939	VHL	7428	EXON 3 DELETION																	2017-11-22 19:46:05 UTC
1940	https://civic.genome.wustl.edu/links/variants/1940	VHL	7428	EXON 2-3 DELETION																	2017-11-22 19:46:05 UTC
1941	https://civic.genome.wustl.edu/links/variants/1941	VHL	7428	S168T (c.503G>C)																	2017-11-22 19:46:05 UTC
1943	https://civic.genome.wustl.edu/links/variants/1943	VHL	7428	Q164H (c.492G>C)																	2017-11-22 19:46:05 UTC
1944	https://civic.genome.wustl.edu/links/variants/1944	VHL	7428	L63P (188T>C)																	2017-11-22 19:46:05 UTC
1945	https://civic.genome.wustl.edu/links/variants/1945	VHL	7428	p.Phe119Glnfs*12 (c.354_355delCT)																	2017-11-22 19:46:05 UTC
1946	https://civic.genome.wustl.edu/links/variants/1946	VHL	7428	Y156C (c.467A>G)																	2017-11-22 19:46:05 UTC
1947	https://civic.genome.wustl.edu/links/variants/1947	VHL	7428	Partial deletion of 4.6 Kb																	2017-11-22 19:46:05 UTC
1948	https://civic.genome.wustl.edu/links/variants/1948	VHL	7428	S68fs (c.204InsG)																	2017-11-22 19:46:05 UTC
1949	https://civic.genome.wustl.edu/links/variants/1949	VHL	7428	G144fs (c.432insG)																	2017-11-22 19:46:05 UTC
1951	https://civic.genome.wustl.edu/links/variants/1951	VHL	7428	Null (Partial deletion of Exon 2)																	2017-11-22 19:46:05 UTC
1952	https://civic.genome.wustl.edu/links/variants/1952	VHL	7428	Null (Partial deletion of Exon 3)																	2017-11-22 19:46:05 UTC
1953	https://civic.genome.wustl.edu/links/variants/1953	VHL	7428	N131K (c.393C>A)																	2017-11-22 19:46:05 UTC
1954	https://civic.genome.wustl.edu/links/variants/1954	VHL	7428	T105fs (c.315insAC)																	2017-11-22 19:46:05 UTC
1955	https://civic.genome.wustl.edu/links/variants/1955	VHL	7428	P71fs (c.211insT)																	2017-11-22 19:46:06 UTC
1956	https://civic.genome.wustl.edu/links/variants/1956	VHL	7428	E70L (c.208G>A)																	2017-11-22 19:46:06 UTC
1957	https://civic.genome.wustl.edu/links/variants/1957	VHL	7428	H115Q (c.345C>G)																	2017-11-22 19:46:06 UTC
1958	https://civic.genome.wustl.edu/links/variants/1958	VHL	7428	H191fs (c.571delC)			3	10191578	10191578	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.571delC	2017-11-22 19:46:06 UTC
1959	https://civic.genome.wustl.edu/links/variants/1959	VHL	7428	Null (c.1-?_463+?del)																	2017-11-22 19:46:06 UTC
1960	https://civic.genome.wustl.edu/links/variants/1960	VHL	7428	L140fs (c.417_to_418delTC)																	2017-11-22 19:46:06 UTC
1961	https://civic.genome.wustl.edu/links/variants/1961	VHL	7428	M54fs (c.161insT)																	2017-11-22 19:46:06 UTC
1962	https://civic.genome.wustl.edu/links/variants/1962	VHL	7428	P154P (c.462A>C)																	2017-11-22 19:46:06 UTC
1963	https://civic.genome.wustl.edu/links/variants/1963	VHL	7428	S80R (c.238A>C)																	2017-11-22 19:46:06 UTC
1964	https://civic.genome.wustl.edu/links/variants/1964	VHL	7428	R60fs (c.179delG)																	2017-11-22 19:46:06 UTC
1965	https://civic.genome.wustl.edu/links/variants/1965	VHL	7428	p.Ile109ThrfsX50 (c.326delT)																	2017-11-22 19:46:06 UTC
1966	https://civic.genome.wustl.edu/links/variants/1966	VHL	7428	W88S (c.263G>C)																	2017-11-22 19:46:06 UTC
1967	https://civic.genome.wustl.edu/links/variants/1967	VHL	7428	Y156D (c.466T>G)																	2017-11-22 19:46:06 UTC
1968	https://civic.genome.wustl.edu/links/variants/1968	VHL	7428	Y156* (c.468T>G)																	2017-11-22 19:46:06 UTC
1969	https://civic.genome.wustl.edu/links/variants/1969	VHL	7428	Y175* (c.525C>G)																	2017-11-22 19:46:06 UTC
1970	https://civic.genome.wustl.edu/links/variants/1970	VHL	7428	V130L (c.388G>C)																	2017-11-22 19:46:06 UTC
1971	https://civic.genome.wustl.edu/links/variants/1971	VHL	7428	Null (c.341-?_642+?del)																	2017-11-22 19:46:06 UTC
1972	https://civic.genome.wustl.edu/links/variants/1972	VHL	7428	Splicing alteration (c.463+1G>A)																	2017-11-22 19:46:06 UTC
1973	https://civic.genome.wustl.edu/links/variants/1973	VHL	7428	Null (c.464-?_642+?del)																	2017-11-22 19:46:06 UTC
1974	https://civic.genome.wustl.edu/links/variants/1974	VHL	7428	Splicing alteration (c.464-1G>A)			3	10191470	10191470	G	A	ENST00000256474.2	75	GRCh37					splice_acceptor_variant	NM_000551.3:c.464-1G>A,NC_000003.11:g.10191470G>A,ENST00000256474.2:c.464-1G>A	2017-11-22 19:46:08 UTC
1975	https://civic.genome.wustl.edu/links/variants/1975	VHL	7428	R167fsX4 (c.499_504delinsT)																	2017-11-22 19:46:06 UTC
1976	https://civic.genome.wustl.edu/links/variants/1976	VHL	7428	Q173* (c.517G>T)																	2017-11-22 19:46:06 UTC
1977	https://civic.genome.wustl.edu/links/variants/1977	VHL	7428	V194fsX39 (c.579_580delTG)																	2017-11-22 19:46:06 UTC
1978	https://civic.genome.wustl.edu/links/variants/1978	VHL	7428	Null (c.-678-?_340+?del)																	2017-11-22 19:46:06 UTC
1979	https://civic.genome.wustl.edu/links/variants/1979	VHL	7428	Null (c.-678-?_642+?del)																	2017-11-22 19:46:06 UTC
1980	https://civic.genome.wustl.edu/links/variants/1980	VHL	7428	R82P (c.245G>C)																	2017-11-22 19:46:06 UTC
1981	https://civic.genome.wustl.edu/links/variants/1981	VHL	7428	N100fsX131 (c.298_299InsA)																	2017-11-22 19:46:06 UTC
1982	https://civic.genome.wustl.edu/links/variants/1982	SUFU	51684	DELETION																	2017-11-22 19:46:06 UTC
1983	https://civic.genome.wustl.edu/links/variants/1983	PTCH1	5727	DELETION																	2017-11-22 19:46:06 UTC
1984	https://civic.genome.wustl.edu/links/variants/1984	VHL	7428	Splicing alteration (c.553+1G>A)																	2017-11-22 19:46:06 UTC
1985	https://civic.genome.wustl.edu/links/variants/1985	VHL	7428	Splicing alteration (c.553+5G>C)																	2017-11-22 19:46:06 UTC
1986	https://civic.genome.wustl.edu/links/variants/1986	VHL	7428	X214L (c.641G>T)																	2017-11-22 19:46:06 UTC
1987	https://civic.genome.wustl.edu/links/variants/1987	VHL	7428	*214W (c.642A>G)			3	10191649	10191649	A	G	ENST00000256474.2	75	GRCh37					stop_lost	NM_000551.3:c.642A>G,NP_000542.1:p.Ter214Trp,ENST00000256474.2:c.642A>G,NC_000003.11:g.10191649A>G	2017-11-22 19:46:06 UTC
1988	https://civic.genome.wustl.edu/links/variants/1988	VHL	7428	X214C (c.642A>T)																	2017-11-22 19:46:06 UTC
1989	https://civic.genome.wustl.edu/links/variants/1989	VHL	7428	G144fs (c.431delG)																	2017-11-22 19:46:06 UTC
1990	https://civic.genome.wustl.edu/links/variants/1990	VHL	7428	Splicing alteration (c.464-1G>T)																	2017-11-22 19:46:06 UTC
1991	https://civic.genome.wustl.edu/links/variants/1991	PIK3CA	5290	EXON 9 + EXON 20 MUTATIONS																	2017-11-22 19:46:06 UTC
1992	https://civic.genome.wustl.edu/links/variants/1992	VHL	7428	Splicing alteration (c.464-2A>T)			3	10191469	10191469	A	T	ENST00000256474.2	75	GRCh37					splice_acceptor_variant	NM_000551.3:c.464-2A>T,NC_000003.11:g.10191469A>T,ENST00000256474.2:c.464-2A>T	2017-11-22 19:46:06 UTC
1993	https://civic.genome.wustl.edu/links/variants/1993	VHL	7428	Splicing alteration (c.463+2C>T)																	2017-11-22 19:46:06 UTC
1994	https://civic.genome.wustl.edu/links/variants/1994	VHL	7428	Q132* (c.394C>T)			3	10188251	10188251	C	T	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.394C>T,NP_000542.1:p.Gln132Ter,NC_000003.11:g.10188251C>T,ENST00000256474.2:c.394C>T	2017-11-22 19:46:06 UTC
1995	https://civic.genome.wustl.edu/links/variants/1995	VHL	7428	C77fs (c.230_insTCT)																	2017-11-22 19:46:06 UTC
1996	https://civic.genome.wustl.edu/links/variants/1996	VHL	7428	L129fs (c.384delT)			3	10188241	10188241	T		ENST00000256474.2	75	GRCh37					frameshift_variant	ENST00000256474.2:c.384delT	2017-11-22 19:46:08 UTC
1997	https://civic.genome.wustl.edu/links/variants/1997	VHL	7428	L178Q (c.533T>A)																	2017-11-22 19:46:06 UTC
1998	https://civic.genome.wustl.edu/links/variants/1998	VHL	7428	Splicing alteration (c.463+1G>C)																	2017-11-22 19:46:06 UTC
1999	https://civic.genome.wustl.edu/links/variants/1999	VHL	7428	V74G (c.221T>G)			3	10183752	10183752	T	G	ENST	75	GRCh37					missense_variant	ENST00000256474.2:c.221T>G	2017-11-22 19:46:08 UTC
2000	https://civic.genome.wustl.edu/links/variants/2000	VHL	7428	H115R (c.344A>G)																	2017-11-22 19:46:06 UTC
2001	https://civic.genome.wustl.edu/links/variants/2001	VHL	7428	R131S (c.392A>G)																	2017-11-22 19:46:06 UTC
2002	https://civic.genome.wustl.edu/links/variants/2002	VHL	7428	Q73fs (c.215delC)																	2017-11-22 19:46:06 UTC
2003	https://civic.genome.wustl.edu/links/variants/2003	VHL	7428	S111R (c.333C>A)																	2017-11-22 19:46:06 UTC
2004	https://civic.genome.wustl.edu/links/variants/2004	VHL	7428	S168fs (c.503delG)																	2017-11-22 19:46:06 UTC
2005	https://civic.genome.wustl.edu/links/variants/2005	VHL	7428	P172fs  (c.516delT)																	2017-11-22 19:46:06 UTC
2006	https://civic.genome.wustl.edu/links/variants/2006	VHL	7428	Y112N (c.334T>A)																	2017-11-22 19:46:06 UTC
2007	https://civic.genome.wustl.edu/links/variants/2007	VHL	7428	R107G  (c.319C>G)																	2017-11-22 19:46:06 UTC
2009	https://civic.genome.wustl.edu/links/variants/2009	VHL	7428	G93V (c.278G>T)																	2017-11-22 19:46:06 UTC
2010	https://civic.genome.wustl.edu/links/variants/2010	VHL	7428	L198Q  (c.593T>A)																	2017-11-22 19:46:06 UTC
2011	https://civic.genome.wustl.edu/links/variants/2011	VHL	7428	S65A (c.193T>G)																	2017-11-22 19:46:06 UTC
2012	https://civic.genome.wustl.edu/links/variants/2012	VHL	7428	S65W (c.203C>G)																	2017-11-22 19:46:06 UTC
2013	https://civic.genome.wustl.edu/links/variants/2013	VHL	7428	Y156N (c.466T>A)																	2017-11-22 19:46:06 UTC
2014	https://civic.genome.wustl.edu/links/variants/2014	VHL	7428	P61fs (c.183insC)																	2017-11-22 19:46:07 UTC
2015	https://civic.genome.wustl.edu/links/variants/2015	VHL	7428	F76del (c.226_228delTTC)			3	10183757	10183759	TTC		ENST00000256474.2	75	GRCh37					inframe_deletion	NM_000551.3:c.226_228delTTC,NC_000003.11:g.10183757_10183759delTTC,ENST00000256474.2:c.226_228delTTC	2017-11-22 19:46:08 UTC
2016	https://civic.genome.wustl.edu/links/variants/2016	VHL	7428	Null (Complete deletion)																	2017-11-22 19:46:07 UTC
2017	https://civic.genome.wustl.edu/links/variants/2017	VHL	7428	Splicing alteration (IVS1-1G>A)																	2017-11-22 19:46:07 UTC
2018	https://civic.genome.wustl.edu/links/variants/2018	VHL	7428	I75fs (c.227_229delTCT)																	2017-11-22 19:46:07 UTC
2019	https://civic.genome.wustl.edu/links/variants/2019	VHL	7428	Splicing alteration (IVS2-1G>C)																	2017-11-22 19:46:07 UTC
2020	https://civic.genome.wustl.edu/links/variants/2020	VHL	7428	L85P (c.254T>C)			3	10183785	10183785	T	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.254T>C,NP_000542.1:p.Leu85Pro,NC_000003.11:g.10183785T>C,ENST00000256474.2:c.254T>C	2017-11-22 19:46:07 UTC
2021	https://civic.genome.wustl.edu/links/variants/2021	VHL	7428	R108ins (c.324InsCGC)																	2017-11-22 19:46:07 UTC
2022	https://civic.genome.wustl.edu/links/variants/2022	VHL	7428	V194fs (c.581_582delTG)																	2017-11-22 19:46:07 UTC
2023	https://civic.genome.wustl.edu/links/variants/2023	VHL	7428	A149fs (c.449del14-nt)																	2017-11-22 19:46:07 UTC
2024	https://civic.genome.wustl.edu/links/variants/2024	VHL	7428	3'UTR alteration (c.639+10C>G)																	2017-11-22 19:46:07 UTC
2026	https://civic.genome.wustl.edu/links/variants/2026	VHL	7428	G114S (c.340G>A)																	2017-11-22 19:46:07 UTC
2027	https://civic.genome.wustl.edu/links/variants/2027	VHL	7428	W117fs (c.349dupT)																	2017-11-22 19:46:07 UTC
2028	https://civic.genome.wustl.edu/links/variants/2028	VHL	7428	A121I (c.364_365GC>AT)																	2017-11-22 19:46:07 UTC
2029	https://civic.genome.wustl.edu/links/variants/2029	VHL	7428	N150fs (c.445_458del)																	2017-11-22 19:46:07 UTC
2030	https://civic.genome.wustl.edu/links/variants/2030	VHL	7428	I151M (c.453>G)																	2017-11-22 19:46:07 UTC
2031	https://civic.genome.wustl.edu/links/variants/2031	VHL	7428	Splicing alteration (c.462-2A>G)																	2017-11-22 19:46:07 UTC
2032	https://civic.genome.wustl.edu/links/variants/2032	VHL	7428	E160fs (c.478_479delGA)																	2017-11-22 19:46:07 UTC
2033	https://civic.genome.wustl.edu/links/variants/2033	VHL	7428	L163H (c.488T>A)																	2017-11-22 19:46:07 UTC
2034	https://civic.genome.wustl.edu/links/variants/2034	VHL	7428	L129P (c.386T>C)																	2017-11-22 19:46:07 UTC
2035	https://civic.genome.wustl.edu/links/variants/2035	VHL	7428	C162fs (c.483delA)																	2017-11-22 19:46:07 UTC
2036	https://civic.genome.wustl.edu/links/variants/2036	VHL	7428	Null (Partial deletion of Exons 2 & 3)																	2017-11-22 19:46:07 UTC
2037	https://civic.genome.wustl.edu/links/variants/2037	VHL	7428	N78I (c.233A>T)																	2017-11-22 19:46:07 UTC
2038	https://civic.genome.wustl.edu/links/variants/2038	VHL	7428	I147V (c.439A>G)																	2017-11-22 19:46:07 UTC
2039	https://civic.genome.wustl.edu/links/variants/2039	VHL	7428	W88fs (c.263_265delGGCinsTT)																	2017-11-22 19:46:07 UTC
2040	https://civic.genome.wustl.edu/links/variants/2040	VHL	7428	K159fs (c.477_478insCA)																	2017-11-22 19:46:07 UTC
2041	https://civic.genome.wustl.edu/links/variants/2041	VHL	7428	Q73fs (c.217delC)																	2017-11-22 19:46:07 UTC
2042	https://civic.genome.wustl.edu/links/variants/2042	VHL	7428	A149fs (c.445delG)																	2017-11-22 19:46:07 UTC
2043	https://civic.genome.wustl.edu/links/variants/2043	VHL	7428	G104A (c.311G>C)																	2017-11-22 19:46:07 UTC
2044	https://civic.genome.wustl.edu/links/variants/2044	VHL	7428	R107H (c.320G>A)																	2017-11-22 19:46:07 UTC
2045	https://civic.genome.wustl.edu/links/variants/2045	VHL	7428	S111C (c.331A>T)																	2017-11-22 19:46:07 UTC
2046	https://civic.genome.wustl.edu/links/variants/2046	VHL	7428	V155L (c.463G>C)																	2017-11-22 19:46:07 UTC
2047	https://civic.genome.wustl.edu/links/variants/2047	CTNNB1	1499	EXON 3 DELETION																	2017-11-22 19:46:07 UTC
2048	https://civic.genome.wustl.edu/links/variants/2048	VHL	7428	Splicing alteration (c.463+1G>T)																	2017-11-22 19:46:07 UTC
2049	https://civic.genome.wustl.edu/links/variants/2049	VHL	7428	Null (Deletion of Exon 2)																	2017-11-22 19:46:07 UTC
2050	https://civic.genome.wustl.edu/links/variants/2050	DICER1	23405	E1705K																	2017-11-22 19:46:07 UTC
2051	https://civic.genome.wustl.edu/links/variants/2051	DICER1	23405	D1709N																	2017-11-22 19:46:07 UTC
2052	https://civic.genome.wustl.edu/links/variants/2052	DICER1	23405	E1813Q																	2017-11-22 19:46:07 UTC
2053	https://civic.genome.wustl.edu/links/variants/2053	VHL	7428	D126Y (c.376G>T)																	2017-11-22 19:46:07 UTC
2054	https://civic.genome.wustl.edu/links/variants/2054	VHL	7428	T124I (c.371C>T)			3	10188228	10188228	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.371C>T,NP_000542.1:p.Thr124Ile,NC_000003.11:g.10188228C>T,ENST00000256474.2:c.371C>T	2017-11-22 19:46:08 UTC
2055	https://civic.genome.wustl.edu/links/variants/2055	VHL	7428	P146fs (c.436delC)																	2017-11-22 19:46:07 UTC
2056	https://civic.genome.wustl.edu/links/variants/2056	VHL	7428	W88R (c.262T>C)																	2017-11-22 19:46:06 UTC
2057	https://civic.genome.wustl.edu/links/variants/2057	VHL	7428	H115fs (c.344delA)																	2017-11-22 19:46:06 UTC
2058	https://civic.genome.wustl.edu/links/variants/2058	VHL	7428	P102fs (c.305delC)																	2017-11-22 19:46:06 UTC
2059	https://civic.genome.wustl.edu/links/variants/2059	VHL	7428	G144R (c.430G>A)																	2017-11-22 19:46:06 UTC
2060	https://civic.genome.wustl.edu/links/variants/2060	VHL	7428	H125P (c.374A>C)																	2017-11-22 19:46:06 UTC
2061	https://civic.genome.wustl.edu/links/variants/2061	ACVR1	90	Gain-of-Function																	2017-11-22 19:46:06 UTC
2062	https://civic.genome.wustl.edu/links/variants/2062	VHL	7428	Q164H (c.491G>C)																	2017-11-22 19:46:06 UTC
2063	https://civic.genome.wustl.edu/links/variants/2063	STK11	6794	F354L																	2017-11-22 19:46:06 UTC
2064	https://civic.genome.wustl.edu/links/variants/2064	VHL	7428	P192S (c.574C>T)																	2017-11-22 19:46:06 UTC
2065	https://civic.genome.wustl.edu/links/variants/2065	VHL	7428	Splicing alteration (IVS2+3A>G)																	2017-11-22 19:46:06 UTC
2066	https://civic.genome.wustl.edu/links/variants/2066	VHL	7428	Y175N (c.523T>A)			3	10191530	10191530	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.523T>A	2017-11-22 19:46:06 UTC
2067	https://civic.genome.wustl.edu/links/variants/2067	VHL	7428	Y175C (c.524A>G)			3	10191531	10191531	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.524A>G,NP_000542.1:p.Tyr175Cys,NC_000003.11:g.10191531A>G,ENST00000256474.2:c.524A>G	2017-11-22 19:46:08 UTC
2068	https://civic.genome.wustl.edu/links/variants/2068	VHL	7428	V87A (c.260T>C)																	2017-11-22 19:46:07 UTC
2069	https://civic.genome.wustl.edu/links/variants/2069	VHL	7428	P97L (c.290C>T)																	2017-11-22 19:46:07 UTC
2070	https://civic.genome.wustl.edu/links/variants/2070	VHL	7428	L184H (c.551T>A)																	2017-11-22 19:46:07 UTC
2071	https://civic.genome.wustl.edu/links/variants/2071	VHL	7428	R69fs (c.204insG)																	2017-11-22 19:46:07 UTC
2073	https://civic.genome.wustl.edu/links/variants/2073	VHL	7428	G106fs (c.316insA)																	2017-11-22 19:46:07 UTC
2074	https://civic.genome.wustl.edu/links/variants/2074	VHL	7428	Splicing alteration (c.340+1G>T)																	2017-11-22 19:46:07 UTC
2075	https://civic.genome.wustl.edu/links/variants/2075	VHL	7428	Splicing alteration (c.463+2T>C)																	2017-11-22 19:46:07 UTC
2076	https://civic.genome.wustl.edu/links/variants/2076	VHL	7428	V155M (c.463G>A)																	2017-11-22 19:46:07 UTC
2077	https://civic.genome.wustl.edu/links/variants/2077	VHL	7428	Splicing alteration (c.464-1G>C)			3	10191470	10191470	G	C	ENST00000256474.2	75	GRCh37					splice_acceptor_variant	NM_000551.3:c.464-1G>C,NC_000003.11:g.10191470G>C,ENST00000256474.2:c.464-1G>C	2017-11-22 19:46:08 UTC
2078	https://civic.genome.wustl.edu/links/variants/2078	VHL	7428	Splicing alteration (c.464-2A>G)			3	10191469	10191469	A	G	ENST00000256474.2	75	GRCh37					splice_acceptor_variant	NM_000551.3:c.464-2A>G,NC_000003.11:g.10191469A>G,ENST00000256474.2:c.464-2A>G	2017-11-22 19:46:08 UTC
2079	https://civic.genome.wustl.edu/links/variants/2079	VHL	7428	Q164L (c.491A>T)																	2017-11-22 19:46:07 UTC
2080	https://civic.genome.wustl.edu/links/variants/2080	VHL	7428	R176fs (c.527delG)																	2017-11-22 19:46:07 UTC
2081	https://civic.genome.wustl.edu/links/variants/2081	VHL	7428	V194fs (c.581_582delGT)																	2017-11-22 19:46:07 UTC
2082	https://civic.genome.wustl.edu/links/variants/2082	VHL	7428	Null (Partial deletion of Exon 1)																	2017-11-22 19:46:07 UTC
2083	https://civic.genome.wustl.edu/links/variants/2083	VHL	7428	Null (Partial deletion of Exons 1 & 2)																	2017-11-22 19:46:07 UTC
2084	https://civic.genome.wustl.edu/links/variants/2084	VHL	7428	P81L (c.242C>T)																	2017-11-22 19:46:07 UTC
2085	https://civic.genome.wustl.edu/links/variants/2085	VHL	7428	T152I (c.455C>T)																	2017-11-22 19:46:07 UTC
2086	https://civic.genome.wustl.edu/links/variants/2086	VHL	7428	V130I (c.388G>A)/ R200W (c.598C>T)																	2017-11-22 19:46:07 UTC
2087	https://civic.genome.wustl.edu/links/variants/2087	VHL	7428	L63fs (c.189_192delGCGC)																	2017-11-22 19:46:07 UTC
2088	https://civic.genome.wustl.edu/links/variants/2088	VHL	7428	F76del (c.224_226delTCT)																	2017-11-22 19:46:07 UTC
2089	https://civic.genome.wustl.edu/links/variants/2089	VHL	7428	P81delRVV (c.243_251delGCGCGTCGT)																	2017-11-22 19:46:07 UTC
2090	https://civic.genome.wustl.edu/links/variants/2090	VHL	7428	P40fs (c.118ins)																	2017-11-22 19:46:07 UTC
2091	https://civic.genome.wustl.edu/links/variants/2091	VHL	7428	T152fs (c.455insA)																	2017-11-22 19:46:07 UTC
2092	https://civic.genome.wustl.edu/links/variants/2092	VHL	7428	T157fs (c.472ins)																	2017-11-22 19:46:07 UTC
2093	https://civic.genome.wustl.edu/links/variants/2093	VHL	7428	Splicing alteration (c.464-2A>C)																	2017-11-22 19:46:07 UTC
2094	https://civic.genome.wustl.edu/links/variants/2094	VHL	7428	T157fs (c.472ins1-nt)																	2017-11-22 19:46:06 UTC
2095	https://civic.genome.wustl.edu/links/variants/2095	VHL	7428	I151fs (c.452insA)																	2017-11-22 19:46:06 UTC
2096	https://civic.genome.wustl.edu/links/variants/2096	VHL	7428	F158ins (c.472insTTT)																	2017-11-22 19:46:07 UTC
2097	https://civic.genome.wustl.edu/links/variants/2097	VHL	7428	D92fs (c.275del18-nt)																	2017-11-22 19:46:07 UTC
2098	https://civic.genome.wustl.edu/links/variants/2098	VHL	7428	K159fs (c.475delA)																	2017-11-22 19:46:07 UTC
2099	https://civic.genome.wustl.edu/links/variants/2099	VHL	7428	V66fs (c.197_220delTGA)																	2017-11-22 19:46:07 UTC
2100	https://civic.genome.wustl.edu/links/variants/2100	VHL	7428	S183fs (c.548delC)																	2017-11-22 19:46:07 UTC
2101	https://civic.genome.wustl.edu/links/variants/2101	VHL	7428	V84M (c.250G>A)																	2017-11-22 19:46:07 UTC
2102	https://civic.genome.wustl.edu/links/variants/2102	VHL	7428	Splicing alteration (IVS1+5G>C)																	2017-11-22 19:46:07 UTC
2103	https://civic.genome.wustl.edu/links/variants/2103	VHL	7428	Null (Partial deletion)																	2017-11-22 19:46:07 UTC
2104	https://civic.genome.wustl.edu/links/variants/2104	VHL	7428	Splicing alteration (c.340+5G>C)																	2017-11-22 19:46:07 UTC
2105	https://civic.genome.wustl.edu/links/variants/2105	VHL	7428	D197N (c.591G>A)																	2017-11-22 19:46:07 UTC
2106	https://civic.genome.wustl.edu/links/variants/2106	VHL	7428	S80G (c.238A>G)																	2017-11-22 19:46:07 UTC
2107	https://civic.genome.wustl.edu/links/variants/2107	VHL	7428	F76L (c.228C>G)																	2017-11-22 19:46:07 UTC
2108	https://civic.genome.wustl.edu/links/variants/2108	ARID1A	8289	UNDEREXPRESSION			1	27022524	27108595			ENST00000324856.7	75	GRCh37					N/A		2017-11-22 19:46:08 UTC
2109	https://civic.genome.wustl.edu/links/variants/2109	EZH2	2146	Y646 or Y641																	2017-11-22 19:46:07 UTC
2110	https://civic.genome.wustl.edu/links/variants/2110	VHL	7428	R82L (c.245G>T)																	2017-11-22 19:46:07 UTC
2111	https://civic.genome.wustl.edu/links/variants/2111	VHL	7428	F76fs (c.227_229delTCT)																	2017-11-22 19:46:07 UTC
2112	https://civic.genome.wustl.edu/links/variants/2112	VHL	7428	N78D (c.232A>G)																	2017-11-22 19:46:07 UTC
2113	https://civic.genome.wustl.edu/links/variants/2113	VHL	7428	N78Y (c.232A>T)																	2017-11-22 19:46:07 UTC
2114	https://civic.genome.wustl.edu/links/variants/2114	VHL	7428	Splicing alteration (c.340+1G>A)																	2017-11-22 19:46:07 UTC
2115	https://civic.genome.wustl.edu/links/variants/2115	VHL	7428	Y185* (c.555C>A)																	2017-11-22 19:46:07 UTC
2116	https://civic.genome.wustl.edu/links/variants/2116	VHL	7428	R167Q (c.499C>T)																	2017-11-22 19:46:07 UTC
2117	https://civic.genome.wustl.edu/links/variants/2117	VHL	7428	P95R (c.284C>G)																	2017-11-22 19:46:07 UTC
2118	https://civic.genome.wustl.edu/links/variants/2118	VHL	7428	P103L (c.308C>T)																	2017-11-22 19:46:07 UTC
2119	https://civic.genome.wustl.edu/links/variants/2119	VHL	7428	F119S (c.356T>C)																	2017-11-22 19:46:07 UTC
2120	https://civic.genome.wustl.edu/links/variants/2120	VHL	7428	P138L (c.413C>T)																	2017-11-22 19:46:07 UTC
2121	https://civic.genome.wustl.edu/links/variants/2121	VHL	7428	P61fs (c.181delCCGT)																	2017-11-22 19:46:08 UTC
2122	https://civic.genome.wustl.edu/links/variants/2122	VHL	7428	S65* (c.203C>A)																	2017-11-22 19:46:08 UTC
2123	https://civic.genome.wustl.edu/links/variants/2123	VHL	7428	C77del (c.229_231delTGC)																	2017-11-22 19:46:08 UTC
2124	https://civic.genome.wustl.edu/links/variants/2124	VHL	7428	W88C (c.264G>C)																	2017-11-22 19:46:08 UTC
2125	https://civic.genome.wustl.edu/links/variants/2125	VHL	7428	Q132P (c.395A>C)																	2017-11-22 19:46:08 UTC
2126	https://civic.genome.wustl.edu/links/variants/2126	VHL	7428	D198fs (c.592delCT)																	2017-11-22 19:46:08 UTC
2127	https://civic.genome.wustl.edu/links/variants/2127	VHL	7428	G93fs (c.279delC)																	2017-11-22 19:46:08 UTC
2128	https://civic.genome.wustl.edu/links/variants/2128	VHL	7428	P97P (c.291C>G)																	2017-11-22 19:46:08 UTC
2129	https://civic.genome.wustl.edu/links/variants/2129	VHL	7428	G114dup (c.342dupGGT)																	2017-11-22 19:46:08 UTC
2130	https://civic.genome.wustl.edu/links/variants/2130	VHL	7428	S65fs (c.194delC)			3	10183725	10183725	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.194delC	2017-11-22 19:46:08 UTC
2131	https://civic.genome.wustl.edu/links/variants/2131	VHL	7428	Q73fs (c.214insGCCC)																	2017-11-22 19:46:08 UTC
2132	https://civic.genome.wustl.edu/links/variants/2132	VHL	7428	F76fs (c.227insC)																	2017-11-22 19:46:08 UTC
2133	https://civic.genome.wustl.edu/links/variants/2133	VHL	7428	Splicing alteration (c.341-2A>C)			3	10188196	10188196	A	C	ENST00000256474.2	75	GRCh37					splice_acceptor_variant	NC_000003.11:g.10188196A>C,NM_000551.3:c.341-2A>C,ENST00000256474.2:c.341-2A>C	2017-11-22 19:46:09 UTC
2134	https://civic.genome.wustl.edu/links/variants/2134	VHL	7428	G114fs (c.341delCGTTTCCAACAATTTCTCGGTGT)																	2017-11-22 19:46:08 UTC
2135	https://civic.genome.wustl.edu/links/variants/2135	VHL	7428	G123fs (c.369_375delGACACAC)			3	10188226	10188232	GACACAC		ENST00000256474.2	75	GRCh37					frameshift_variant	ENST00000256474.2:c.369_375delGACACAC	2017-11-22 19:46:08 UTC
2136	https://civic.genome.wustl.edu/links/variants/2136	VHL	7428	H125fs (c.374insA)																	2017-11-22 19:46:08 UTC
2137	https://civic.genome.wustl.edu/links/variants/2137	VHL	7428	L158fs (c.474_476delGAAinsC)																	2017-11-22 19:46:08 UTC
2138	https://civic.genome.wustl.edu/links/variants/2138	VHL	7428	Y175fs (c.525delC)																	2017-11-22 19:46:08 UTC
2139	https://civic.genome.wustl.edu/links/variants/2139	VHL	7428	L188fs (c.562delC)																	2017-11-22 19:46:08 UTC
2140	https://civic.genome.wustl.edu/links/variants/2140	VHL	7428	Q195fs (c.584_585delAG)																	2017-11-22 19:46:08 UTC
2141	https://civic.genome.wustl.edu/links/variants/2141	VHL	7428	D197fs (c.589delG)																	2017-11-22 19:46:08 UTC
2142	https://civic.genome.wustl.edu/links/variants/2142	VHL	7428	T202fs (c.606insA)																	2017-11-22 19:46:08 UTC
2143	https://civic.genome.wustl.edu/links/variants/2143	VHL	7428	R113fs (c.337delC)			3	10183868	10183868	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.337delC	2017-11-22 19:46:08 UTC
2144	https://civic.genome.wustl.edu/links/variants/2144	VHL	7428	E55fs (c.165_166dupG)																	2017-11-22 19:46:08 UTC
2145	https://civic.genome.wustl.edu/links/variants/2145	VHL	7428	P61fs (c.182_185delCCGT)			3	10183713	10183716	CCGT		ENST00000256474.2	75	GRCh37					frameshift_variant	ENST00000256474.2:c.182_185delCCGT	2017-11-22 19:46:08 UTC
2146	https://civic.genome.wustl.edu/links/variants/2146	VHL	7428	Splicing alteration (c.463+3A>T)			3	10188323	10188323	A	T	ENST00000256474.2	75	GRCh37					intron_variant	NM_000551.3:c.463+3A>T,NC_000003.11:g.10188323A>T,ENST00000256474.2:c.463+3A>T	2017-11-22 19:46:08 UTC
2147	https://civic.genome.wustl.edu/links/variants/2147	VHL	7428	K196E (c.586A>G)																	2017-11-22 19:46:08 UTC
2148	https://civic.genome.wustl.edu/links/variants/2148	VHL	7428	R161R (c.481C>A)																	2017-11-22 19:46:08 UTC
2149	https://civic.genome.wustl.edu/links/variants/2149	VHL	7428	N90I (c.269A>T)																	2017-11-22 19:46:08 UTC
2150	https://civic.genome.wustl.edu/links/variants/2150	VHL	7428	I151F (c.451A>T)																	2017-11-22 19:46:08 UTC
2151	https://civic.genome.wustl.edu/links/variants/2151	VHL	7428	W88* (c.263G>A)																	2017-11-22 19:46:08 UTC
2152	https://civic.genome.wustl.edu/links/variants/2152	VHL	7428	3'UTR alteration (c.642+70C>A)																	2017-11-22 19:46:08 UTC
2153	https://civic.genome.wustl.edu/links/variants/2153	VHL	7428	G114fs (c.326_339dupTCCACAGCTACCGA)																	2017-11-22 19:46:08 UTC
2154	https://civic.genome.wustl.edu/links/variants/2154	VHL	7428	D121H (c.361G>C)																	2017-11-22 19:46:08 UTC
2155	https://civic.genome.wustl.edu/links/variants/2155	VHL	7428	R145fs (c.432_433insA)																	2017-11-22 19:46:08 UTC
2156	https://civic.genome.wustl.edu/links/variants/2156	VHL	7428	S111R (c.331A>C)																	2017-11-22 19:46:08 UTC
2157	https://civic.genome.wustl.edu/links/variants/2157	VHL	7428	L128P (c.383T>C)																	2017-11-22 19:46:08 UTC
2158	https://civic.genome.wustl.edu/links/variants/2158	VHL	7428	F76fs (c.222_225dupCATC)																	2017-11-22 19:46:08 UTC
2159	https://civic.genome.wustl.edu/links/variants/2159	AR	367	V9, truncated variant, contiguous splicing of exons 1, 2, 3, and CE5																	2017-11-22 19:46:08 UTC
2160	https://civic.genome.wustl.edu/links/variants/2160	VHL	7428	Y98fs (c.291delC)																	2017-11-22 19:46:08 UTC
2161	https://civic.genome.wustl.edu/links/variants/2161	VHL	7428	S183L (c.548C>T)																	2017-11-22 19:46:08 UTC
2162	https://civic.genome.wustl.edu/links/variants/2162	VHL	7428	N150S (c.449A>G)																	2017-11-22 19:46:08 UTC
2163	https://civic.genome.wustl.edu/links/variants/2163	CTLA4	1493	EXPRESSION			2	204732509	204738683			ENST00000302823.3	75	GRCh37					N/A		2017-11-22 19:46:08 UTC
2164	https://civic.genome.wustl.edu/links/variants/2164	CX3CL1	6376	UNDEREXPRESSION																	2017-11-22 19:46:08 UTC
2165	https://civic.genome.wustl.edu/links/variants/2165	FANCA	2175	S1088F			16	89815152	89815152	G	A	ENST00000568369.1	75	GRCh37					missense_variant	NM_000135.2:c.3263C>T,NP_000126.2:p.Ser1088Phe,NC_000016.9:g.89815152G>A,ENST00000568369.1:c.3263C>T	2017-11-22 19:46:08 UTC
2166	https://civic.genome.wustl.edu/links/variants/2166	NRG1	3084	SLC3A2-NRG1																	2017-11-22 19:46:08 UTC
2167	https://civic.genome.wustl.edu/links/variants/2167	FGFR4	2264	OVEREXPRESSION																	2017-11-22 19:46:08 UTC
2168	https://civic.genome.wustl.edu/links/variants/2168	RAD50	10111	L1237F																	2017-11-22 19:46:08 UTC
2169	https://civic.genome.wustl.edu/links/variants/2169	BTK	695	MUTATION																	2017-11-22 19:46:08 UTC
2170	https://civic.genome.wustl.edu/links/variants/2170	PLCG2	5336	MUTATION																	2017-11-22 19:46:08 UTC
2171	https://civic.genome.wustl.edu/links/variants/2171	TSC2	7249	LOSS-OF-FUNCTION																	2017-11-22 19:46:08 UTC
2172	https://civic.genome.wustl.edu/links/variants/2172	MTOR	2475	Gain-of-Function																	2017-11-22 19:46:08 UTC
2173	https://civic.genome.wustl.edu/links/variants/2173	VHL	7428	E94K (c.280G>A)																	2017-11-22 19:46:08 UTC
2174	https://civic.genome.wustl.edu/links/variants/2174	EGFR	1956	WILDTYPE																	2017-11-22 19:46:08 UTC
2175	https://civic.genome.wustl.edu/links/variants/2175	VHL	7428	R79C (c.235C>T)																	2017-11-22 19:46:08 UTC
2176	https://civic.genome.wustl.edu/links/variants/2176	VHL	7428	Y175C (c.523A>G)																	2017-11-22 19:46:08 UTC
2177	https://civic.genome.wustl.edu/links/variants/2177	VHL	7428	M54I (c.162G>C)																	2017-11-22 19:46:08 UTC
2178	https://civic.genome.wustl.edu/links/variants/2178	NRG1	3084	ATP1B1-NRG1 fusion		NRG1 gene fusions															2017-11-22 19:46:08 UTC
2179	https://civic.genome.wustl.edu/links/variants/2179	NRG1	3084	SDC4-NRG1		NRG1 gene fusions															2017-11-22 19:46:08 UTC
2180	https://civic.genome.wustl.edu/links/variants/2180	TSPYL1	7259	rs3828743																	2017-11-22 19:46:09 UTC
2181	https://civic.genome.wustl.edu/links/variants/2181	VHL	7428	R177ins (c.531insCTGAGAGTAAAGCCTGAA)																	2017-11-22 19:46:09 UTC
2182	https://civic.genome.wustl.edu/links/variants/2182	VHL	7428	Null (Large deletion)																	2017-11-22 19:46:09 UTC
